data_2jqg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.151 0.501 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 22.7 pt-20 -93.86 120.37 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.382 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' R' ' 41' ' ' PHE . 0.7 OUTLIER -94.04 127.96 40.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 111.3 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 32' ' ' THR . . . . . 0.55 ' O ' ' N ' ' R' ' 156' ' ' SER . 92.6 m -102.19 146.76 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -139.64 167.83 21.2 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.007 -178.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . 0.55 ' HB2' ' CG1' ' R' ' 154' ' ' VAL . 63.6 t80 -41.19 -44.27 2.54 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -75.93 15.47 0.53 Allowed 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 122.594 2.452 . . . . 0.0 113.927 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 -5.92 42.41 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 119.87 -1.769 . . . . 0.0 112.963 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . 0.631 ' HB3' HD23 ' R' ' 33' ' ' LEU . 82.9 tt0 -79.97 137.7 36.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.504 -1.586 . . . . 0.0 110.354 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -120.13 113.96 21.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 109.392 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.476 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 22.2 tptt -122.93 131.74 53.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 40' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' R' ' 30' ' ' GLU . 0.9 OUTLIER -85.9 122.72 30.36 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.924 0.868 . . . . 0.0 112.203 -177.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.921 ' CD1' HD12 ' R' ' 31' ' ' LEU . 0.5 OUTLIER -107.54 159.91 16.07 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' R' ' 42' ' ' TYR . 68.2 m-85 -98.94 134.1 42.28 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.414 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 43' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' R' ' 164' ' ' ASP . 7.0 m -112.7 94.75 5.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.362 -0.836 . . . . 0.0 110.498 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.67 136.09 9.79 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.58 126.83 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.374 1.197 . . . . 0.0 110.008 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . 0.426 ' CB ' ' HB3' ' R' ' 50' ' ' ASN . 0.3 OUTLIER -97.35 -120.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 109.396 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . 0.41 ' H ' ' HB3' ' R' ' 46' ' ' ASN . 1.2 p-10 -128.61 77.23 1.76 Allowed 'General case' 0 N--CA 1.512 2.634 0 O-C-N 120.242 -1.536 . . . . 0.0 111.262 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 74.6 m80 48.44 16.98 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.801 -0.562 . . . . 0.0 112.345 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . 0.538 ' HB3' ' HA ' ' R' ' 96' ' ' GLU . 37.3 m-20 -146.66 47.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.024 . . . . 0.0 108.725 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . 0.712 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 24.1 p30 -114.72 -21.68 10.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' R' ' 149' ' ' ALA 0.282 . . -66.32 -41.93 88.97 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.282 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.672 ' CG ' ' HA2' ' R' ' 97' ' ' GLY . 39.6 m95 -59.71 -34.78 73.35 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.912 -1.515 . . . . 0.0 107.256 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.688 HD13 HG13 ' R' ' 83' ' ' ILE . 20.2 mt -68.18 -35.2 77.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . 0.568 ' OD1' ' NE2' ' R' ' 58' ' ' GLN . 56.6 t-20 -48.92 -28.11 3.59 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . 0.866 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.13 -64.72 0.8 Allowed 'General case' 0 C--O 1.203 -1.371 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -57.13 -36.32 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.751 178.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . 0.845 ' N ' HD22 ' R' ' 57' ' ' LEU . 3.9 mm? -68.61 -72.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.623 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . 0.568 ' NE2' ' OD1' ' R' ' 54' ' ' ASN . 0.7 OUTLIER -57.85 -29.68 65.19 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.637 -1.289 . . . . 0.0 108.536 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.866 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 0.2 OUTLIER -70.43 -37.26 74.35 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.852 ' HA ' ' HD3' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -50.68 -53.02 34.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . 0.614 ' N ' ' CG ' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -55.87 -48.46 75.52 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.104 -1.039 . . . . 0.0 113.343 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' R' ' 153' ' ' CYS . 0.1 OUTLIER -90.69 -47.7 7.5 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 119.962 -1.711 . . . . 0.0 113.921 -176.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . 0.776 ' O ' ' CB ' ' R' ' 64' ' ' GLU . 47.7 t -77.76 -24.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.169 -0.957 . . . . 0.0 111.811 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . 0.776 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 88.2 tt0 124.33 117.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.131 0.967 . . . . 0.0 109.346 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' R' ' 60' ' ' PHE . 0.1 OUTLIER -44.28 100.32 0.23 Allowed Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.852 ' HD3' ' HA ' ' R' ' 60' ' ' PHE . 51.8 Cg_endo -85.45 -162.12 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.589 2.192 . . . . 0.0 107.399 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' R' ' 69' ' ' ASP . 34.4 t80 -45.0 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 O-C-N 121.769 -0.582 . . . . 0.0 112.022 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' R' ' 66' ' ' PRO . 0.7 OUTLIER -37.52 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.008 -1.057 . . . . 0.0 113.031 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' R' ' 67' ' ' PHE . 51.0 m-20 -49.12 -34.34 13.87 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.62 -0.675 . . . . 0.0 112.234 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' R' ' 82' ' ' ALA . 70.2 m95 -64.43 -31.24 72.37 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.572 -1.33 . . . . 0.0 109.858 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.584 HG22 ' CB ' ' R' ' 82' ' ' ALA . 46.9 t -70.81 -67.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . 0.528 ' CD1' HG13 ' R' ' 71' ' ' VAL . 13.3 m-30 -77.42 -30.36 53.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.739 . . . . 0.0 111.878 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 73' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 22.4 t -60.83 -19.34 59.66 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.318 -1.353 . . . . 0.0 109.049 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 74' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 38.5 m -77.2 139.87 65.18 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.771 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 -27.55 39.77 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.92 164.76 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.79 . . . . 0.0 109.679 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -52.59 110.26 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.197 -0.94 . . . . 0.0 110.088 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mp -126.81 47.36 2.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.677 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 79' ' ' THR . . . . . 0.712 ' OG1' ' HA ' ' R' ' 50' ' ' ASN . 0.5 OUTLIER -65.99 -52.19 51.63 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.009 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' R' ' 79' ' ' THR . 0.0 OUTLIER -51.04 -59.39 4.21 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.678 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.38 -28.0 69.69 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.498 -1.376 . . . . 0.0 109.736 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . 0.584 ' CB ' HG22 ' R' ' 71' ' ' VAL . . . -56.29 -51.1 69.43 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.48 -0.762 . . . . 0.0 111.624 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . 0.688 HG13 HD13 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -85.41 -36.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.045 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' R' ' 87' ' ' GLU . 32.9 tttt -49.82 -33.52 16.97 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . 0.419 ' HG2' ' CE2' ' R' ' 70' ' ' TRP . 50.9 tp60 -77.15 -36.4 55.28 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . 0.585 ' CD2' HG23 ' R' ' 90' ' ' THR . 2.7 tm? -66.75 -40.62 88.38 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.807 -0.558 . . . . 0.0 110.176 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' R' ' 91' ' ' GLY . 10.7 pt-20 -66.08 -31.73 72.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.944 -1.098 . . . . 0.0 108.27 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.06 -31.36 69.91 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.389 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . 0.472 HD21 HG23 ' R' ' 90' ' ' THR . 1.1 tt -93.59 -48.89 6.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.581 -0.699 . . . . 0.0 111.042 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 90' ' ' THR . . . . . 0.585 HG23 ' CD2' ' R' ' 86' ' ' LEU . 68.1 p -74.89 -24.06 58.47 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' R' ' 87' ' ' GLU . . . 68.95 26.35 74.73 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.033 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . 0.559 HD21 ' O ' ' R' ' 101' ' ' ALA . 0.3 OUTLIER -105.94 -17.53 14.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.823 -1.398 . . . . 0.0 111.354 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' R' ' 92' ' ' LEU . 81.6 tt0 65.44 122.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' R' ' 83' ' ' ILE . 0.3 OUTLIER -166.39 12.5 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . 0.535 ' HA ' HD11 ' R' ' 83' ' ' ILE . 0.7 OUTLIER -42.39 -29.12 0.25 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.607 -0.683 . . . . 0.0 109.234 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . 0.538 ' HA ' ' HB3' ' R' ' 49' ' ' ASP . 98.5 mt-10 -116.15 23.33 12.25 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.647 -0.658 . . . . 0.0 110.854 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . 0.672 ' HA2' ' CG ' ' R' ' 52' ' ' TRP . . . 156.08 128.56 1.11 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.651 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' R' ' 101' ' ' ALA . . . 152.02 75.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.686 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . 0.843 ' HG2' ' HD2' ' R' ' 100' ' ' PRO . 33.5 Cg_endo -86.13 -90.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.564 1.999 0 C-N-CA 121.32 1.347 . . . . 0.0 110.406 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . 0.843 ' HD2' ' HG2' ' R' ' 99' ' ' PRO . 37.1 Cg_endo -62.55 -16.97 55.78 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 106.108 -2.305 . . . . 0.0 106.108 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . 0.789 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.263 . . -30.87 61.82 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 113.61 -1.632 . . . . 0.0 112.587 175.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . 0.837 ' N ' ' O ' ' R' ' 100' ' ' PRO . 48.2 mt 39.38 0.74 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.671 -175.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . 0.789 ' N ' ' O ' ' R' ' 101' ' ' ALA . 21.8 t -52.68 -40.58 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . 0.576 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 32.3 pt -75.56 -36.54 34.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.373 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.62 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 61.5 t90 -64.63 -43.0 95.1 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.579 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' R' ' 90' ' ' THR . 27.3 m120 -78.35 -27.08 46.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.723 -1.236 . . . . 0.0 112.066 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . 0.637 ' CG2' ' HB2' ' R' ' 110' ' ' LEU . 63.3 mt -78.18 16.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 111.762 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' R' ' 105' ' ' TRP . 80.4 mttt -30.49 -52.22 0.16 Allowed 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.525 ' CD2' ' CD2' ' R' ' 110' ' ' LEU . 36.9 p-80 -57.51 -26.98 62.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.143 -2.223 . . . . 0.0 112.458 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.637 ' HB2' ' CG2' ' R' ' 107' ' ' ILE . 0.2 OUTLIER -100.43 -39.49 7.93 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 176.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.1 OUTLIER -78.49 -96.91 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 111.523 -2.581 . . . . 0.0 114.608 -176.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' R' ' 111' ' ' LEU . 85.4 t60 -13.62 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 123.897 1.808 . . . . 0.0 109.986 -173.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.823 ' N ' ' O ' ' R' ' 111' ' ' LEU . 7.2 t -97.85 -173.43 2.61 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.446 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' R' ' 123' ' ' GLU . . . -68.66 105.8 1.57 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.617 HD12 HG21 ' R' ' 124' ' ' VAL . 3.5 mm -109.88 143.55 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.539 -1.565 . . . . 0.0 110.581 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.11 -154.65 6.19 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.183 -1.484 . . . . 0.0 112.114 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 117' ' ' THR . . . . . 0.517 ' HA ' ' CG2' ' R' ' 126' ' ' VAL . 5.1 m -133.03 165.08 25.56 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' R' ' 130' ' ' THR . . . -53.21 -36.35 60.91 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.38 -1.45 . . . . 0.0 110.369 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.2 m -64.59 -36.28 83.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -124.19 94.18 45.67 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.502 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.44 134.32 30.56 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.753 1.396 . . . . 0.0 112.061 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 122' ' ' SER . . . . . . . . . . . . . 3.5 m -134.11 -162.88 1.29 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' R' ' 114' ' ' GLY . 77.1 mm-40 -55.01 -41.24 71.04 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.567 -1.333 . . . . 0.0 108.377 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . 0.617 HG21 HD12 ' R' ' 115' ' ' ILE . 0.9 OUTLIER -129.07 147.35 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.484 ' SG ' ' CZ ' ' R' ' 180' ' ' PHE . 5.9 t -127.74 159.35 35.04 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.218 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . 0.739 ' C ' ' HA ' ' R' ' 179' ' ' VAL . 15.7 m -85.2 -163.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.898 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 1.1 p -60.68 -160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.726 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' R' ' 130' ' ' THR . 28.9 p-10 -96.55 -74.91 0.55 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.746 -1.221 . . . . 0.0 113.21 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' R' ' 128' ' ' ASP . . . 58.7 5.38 2.72 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 130' ' ' THR . . . . . 0.609 ' CG2' ' CB ' ' R' ' 118' ' ' ALA . 11.3 t -127.93 167.33 16.78 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.279 0.632 . . . . 0.0 109.355 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.4 74.44 2.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.466 ' HG3' HG21 ' R' ' 130' ' ' THR . 56.2 mtt -127.88 167.0 17.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.85 -170.87 3.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.281 -0.887 . . . . 0.0 111.381 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . 0.609 ' CD1' ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -38.87 -56.36 1.38 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 121.591 0.71 . . . . 0.0 112.538 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.57 -19.96 62.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' R' ' 183' ' ' TYR . 0.8 OUTLIER -55.71 -38.37 69.63 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.455 -1.403 . . . . 0.0 112.369 -178.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . 0.55 ' CB ' ' CD1' ' R' ' 180' ' ' PHE . 0.3 OUTLIER -142.38 168.69 19.15 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.947 -1.095 . . . . 0.0 108.173 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' R' ' 153' ' ' CYS . 14.8 m-70 -134.8 63.58 1.62 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.272 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . 166.52 165.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.786 -0.571 . . . . 0.0 110.119 175.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.02 -178.97 32.28 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.216 -1.468 . . . . 0.0 111.954 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . 0.638 ' HB ' ' CG1' ' R' ' 179' ' ' VAL . 10.7 mt -112.05 119.23 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 122.015 -0.697 . . . . 0.0 110.392 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.766 ' CD2' HG13 ' R' ' 177' ' ' VAL . 8.0 m-85 -109.28 134.94 51.15 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.097 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' R' ' 143' ' ' LEU . 4.6 mm? -85.72 101.23 12.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -93.55 124.53 37.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 110.934 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.69 -145.32 8.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -111.52 138.98 47.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.996 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' R' ' 147' ' ' GLU . 79.7 tt0 54.67 44.34 28.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 122.03 14.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . 0.595 ' O ' ' HB1' ' R' ' 51' ' ' ALA . . . -109.56 139.26 44.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 110.641 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.662 ' C ' ' CD1' ' R' ' 151' ' ' PHE . 35.7 m -139.52 153.27 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.055 -1.028 . . . . 0.0 109.174 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.804 ' CE2' ' HA ' ' R' ' 55' ' ' ALA . 82.0 m-85 -147.19 124.68 11.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.769 -1.207 . . . . 0.0 110.438 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.999 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.03 171.93 7.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.365 -1.459 . . . . 0.0 112.743 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.569 ' HB2' ' CZ ' ' R' ' 62' ' ' TYR . 9.1 t -167.3 136.05 2.65 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.587 ' O ' ' CB ' ' R' ' 33' ' ' LEU . 53.2 t -56.5 109.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.354 -1.466 . . . . 0.0 111.654 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 155' ' ' THR . . . . . 0.677 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 77.2 p -89.63 -169.59 2.52 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 156' ' ' SER . . . . . 0.55 ' N ' ' O ' ' R' ' 32' ' ' THR . 44.7 t -60.34 -21.25 61.84 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.777 -1.202 . . . . 0.0 108.428 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CE1' ' R' ' 160' ' ' TYR . 79.4 m-20 -95.96 3.71 53.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' R' ' 154' ' ' VAL . . . 106.23 -160.78 14.46 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.537 ' HB3' ' HD3' ' R' ' 172' ' ' PRO . 5.5 m-90 -57.36 101.58 0.07 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.625 -0.927 . . . . 0.0 108.687 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . 0.677 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 4.2 m-85 -127.52 131.47 50.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . 0.999 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -106.27 146.73 29.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 119.979 -1.701 . . . . 0.0 110.937 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' R' ' 41' ' ' PHE . 96.9 mt -102.66 90.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' R' ' 164' ' ' ASP . 3.6 t0 -88.58 122.46 32.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' R' ' 163' ' ' ASP . 26.0 t0 -3.45 -64.69 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' R' ' 163' ' ' ASP . 97.1 mt-10 -59.34 -42.21 90.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.696 -1.253 . . . . 0.0 114.37 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -167.26 172.92 9.4 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 119.811 -1.806 . . . . 0.0 113.215 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.57 ' CD1' HG12 ' R' ' 162' ' ' ILE . 3.5 m-30 -98.43 129.13 45.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . 0.637 ' CE1' ' HB1' ' R' ' 161' ' ' ALA . 2.1 p90 -141.15 163.86 39.39 Favored Pre-proline 0 C--N 1.29 -2.01 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.94 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . 0.452 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.3 Cg_endo -69.84 108.52 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . 0.5 OUTLIER -138.9 153.81 48.31 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 171' ' ' THR . . . . . 0.609 ' CG2' ' CD1' ' R' ' 134' ' ' LEU . 1.0 OUTLIER -101.93 151.23 37.95 Favored Pre-proline 0 C--N 1.278 -2.541 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.29 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.582 ' HD2' HD11 ' R' ' 134' ' ' LEU . 45.3 Cg_endo -94.37 32.97 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.865 1.71 . . . . 0.0 109.411 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . 0.582 ' O ' ' CG1' ' R' ' 177' ' ' VAL . 0.6 OUTLIER -76.77 153.27 83.17 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.357 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' R' ' 177' ' ' VAL . 49.5 Cg_endo -75.67 26.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.968 1.51 . . . . 0.0 111.206 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 175' ' ' SER . . . . . 0.401 ' H ' ' C ' ' R' ' 173' ' ' ASP . 23.3 t -69.89 -48.3 59.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.985 -1.072 . . . . 0.0 110.897 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -125.6 13.45 8.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.766 HG13 ' CD2' ' R' ' 142' ' ' PHE . 0.1 OUTLIER -121.48 153.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.832 . . . . 0.0 109.736 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . 0.898 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 2.1 mm? -127.63 46.6 2.52 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.062 -1.455 . . . . 0.0 108.932 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.739 ' HA ' ' C ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.61 124.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.55 ' CD1' ' CB ' ' R' ' 137' ' ' PHE . 4.2 p90 -125.12 168.17 13.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.544 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' R' ' 139' ' ' ALA . 1.0 OUTLIER -122.87 111.99 30.73 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.122 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' R' ' 125' ' ' CYS . 47.7 Cg_endo -76.04 156.14 38.34 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.615 1.324 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' R' ' 138' ' ' HIS . 1.1 p90 -91.43 -2.21 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.517 -0.739 . . . . 0.0 110.873 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 111.2 179.313 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.05 0.452 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -117.5 119.43 35.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.16 -0.962 . . . . 0.0 111.282 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . 0.715 HD12 ' CE1' ' R' ' 160' ' ' TYR . 3.8 mm? -94.8 166.81 11.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.392 -0.817 . . . . 0.0 109.546 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 32' ' ' THR . . . . . 0.561 ' CB ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -126.47 140.23 52.63 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -173.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.897 ' HA ' ' HA ' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -17.64 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.84 0 CA-C-N 111.837 -2.438 . . . . 0.0 116.463 176.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . 0.776 ' C ' ' O ' ' R' ' 33' ' ' LEU . 92.5 m-85 -19.58 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.977 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' R' ' 33' ' ' LEU . 7.0 m120 -131.84 62.41 1.63 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . 1.216 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 141.75 36.8 0.09 OUTLIER Glycine 0 N--CA 1.479 1.521 0 C-N-CA 117.055 -2.498 . . . . 0.0 110.465 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . 1.216 ' O ' ' O ' ' R' ' 36' ' ' GLY . 80.7 mm-40 -11.68 -167.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 122.455 0.302 . . . . 0.0 110.848 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.33 92.73 0.29 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 116.23 -2.188 . . . . 0.0 106.809 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' R' ' 37' ' ' GLU . 36.2 mmtt -123.76 119.87 31.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 40' ' ' THR . . . . . 0.44 ' O ' ' NH2' ' R' ' 61' ' ' ARG . 0.9 OUTLIER -91.29 115.08 27.74 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.452 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.713 ' CD1' ' CD2' ' R' ' 31' ' ' LEU . 3.0 m-85 -98.42 162.83 12.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . 0.772 ' O ' ' HB3' ' R' ' 165' ' ' GLU . 97.4 m-85 -95.4 158.58 15.4 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 46.7 m -115.57 94.9 4.9 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . 0.504 ' H ' ' CB ' ' R' ' 165' ' ' GLU . 0.0 OUTLIER -167.64 124.16 0.89 Allowed Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.306 -0.871 . . . . 0.0 109.096 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.18 126.35 13.59 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 N-CA-C 108.625 -1.336 . . . . 0.0 108.625 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 74.4 m-20 -88.12 152.97 21.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.149 -0.97 . . . . 0.0 109.033 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.39 80.24 1.82 Allowed 'General case' 0 N--CA 1.507 2.387 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.257 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . 0.6 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 5.3 p-80 178.62 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 1.5 p30 157.16 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . 0.491 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 8.4 p30 -142.88 -25.75 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.911 -1.118 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . 0.615 ' HA ' ' HB3' ' R' ' 54' ' ' ASN 0.271 . . -64.98 -44.24 89.96 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.056 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.477 ' CE2' ' HA2' ' R' ' 97' ' ' GLY . 75.3 m95 -58.01 -36.17 72.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.898 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.737 HD11 HD12 ' R' ' 83' ' ' ILE . 11.6 mt -69.38 -44.73 70.92 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' R' ' 58' ' ' GLN . 0.0 OUTLIER -43.28 -32.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 108.921 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -64.93 -67.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.591 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . 0.569 ' H ' HD11 ' R' ' 56' ' ' ILE . 0.2 OUTLIER -84.19 -41.74 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 117.884 -1.527 . . . . 0.0 109.885 178.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . 0.67 ' CB ' ' O ' ' R' ' 53' ' ' LEU 0.265 1.5 tm? -48.25 -61.87 1.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.604 0.716 . . . . 0.0 111.207 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . 0.618 ' HB2' ' O ' ' R' ' 54' ' ' ASN . 73.4 mt-30 -70.06 -27.77 64.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.865 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 3.4 tp -55.93 -38.51 70.38 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.64 ' CE2' ' HB3' ' R' ' 67' ' ' PHE . 22.9 m-30 -58.41 -41.18 84.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.144 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . 0.51 ' CB ' ' CZ ' ' R' ' 41' ' ' PHE . 0.0 OUTLIER -64.88 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.344 -1.472 . . . . 0.0 114.473 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.637 ' CD1' ' O ' ' R' ' 59' ' ' LEU . 1.4 p90 -82.78 -42.39 17.99 Favored 'General case' 0 N--CA 1.516 2.826 0 O-C-N 119.575 -1.953 . . . . 0.0 114.731 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . 0.698 ' O ' ' CB ' ' R' ' 64' ' ' GLU . 24.5 t -73.77 -14.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 119.825 -1.797 . . . . 0.0 111.179 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . 0.698 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 65.0 tt0 98.91 29.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 1.8 tp10 -132.33 90.15 34.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.663 -1.273 . . . . 0.0 107.788 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' R' ' 60' ' ' PHE . 48.3 Cg_endo -78.09 83.55 2.18 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.706 1.372 . . . . 0.0 113.966 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . 0.64 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 48.0 t80 -83.35 -19.11 36.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . 0.633 ' HB2' ' CD1' ' R' ' 57' ' ' LEU . 0.0 OUTLIER -62.38 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.012 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.656 ' O ' ' HB3' ' R' ' 73' ' ' SER . 94.8 m-20 -46.8 -39.37 11.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.457 -0.777 . . . . 0.0 111.775 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.443 ' O ' ' HB2' ' R' ' 77' ' ' ASN . 35.3 m95 -69.82 -37.28 76.19 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.766 -1.208 . . . . 0.0 109.635 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.56 ' CG2' HD22 ' R' ' 57' ' ' LEU 0.252 43.5 t -70.34 -75.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . 0.51 ' HB2' ' CE2' ' R' ' 68' ' ' PHE . 18.8 m-30 -86.65 -35.96 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 111.737 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 73' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' R' ' 69' ' ' ASP . 9.6 t -71.03 -17.33 62.63 Favored 'General case' 0 N--CA 1.509 2.511 0 C-N-CA 117.702 -1.599 . . . . 0.0 108.909 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 74' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' R' ' 70' ' ' TRP . 0.4 OUTLIER -117.47 114.41 38.22 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.366 -0.834 . . . . 0.0 109.334 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.34 -11.65 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.539 1.283 . . . . 0.0 110.528 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -104.84 -64.47 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 111.169 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . 0.459 ' CA ' ' HB2' ' R' ' 81' ' ' GLU . 11.6 m120 -44.54 -44.18 8.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 112.047 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . 0.474 ' C ' ' HA ' ' R' ' 71' ' ' VAL . 6.1 mp 49.57 -154.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.893 -1.129 . . . . 0.0 111.008 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 79' ' ' THR . . . . . 0.669 ' HA ' ' CD1' ' R' ' 53' ' ' LEU . 2.0 t -68.67 -59.23 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.899 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . 0.432 ' H ' ' CG2' ' R' ' 79' ' ' THR . 0.4 OUTLIER -50.13 -52.26 36.59 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . 0.459 ' HB2' ' CA ' ' R' ' 77' ' ' ASN . 72.2 mt-10 -69.75 -27.92 65.35 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.077 -1.639 . . . . 0.0 109.302 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' R' ' 79' ' ' THR . . . -58.9 -53.7 55.49 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.683 -0.636 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . 0.737 HD12 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -86.4 -33.62 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.44 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' R' ' 83' ' ' ILE . 16.4 tttt -49.81 -36.36 26.11 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.89 -41.01 92.07 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . 0.664 ' HB3' ' HG1' ' R' ' 90' ' ' THR . 13.2 mt -67.03 -34.29 77.4 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.804 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . 0.592 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -51.63 -42.06 61.74 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.8 -36.03 82.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.551 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . 0.518 ' CD2' HG23 ' R' ' 90' ' ' THR . 5.1 tt -99.07 -52.45 3.54 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.695 -1.253 . . . . 0.0 111.824 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 90' ' ' THR . . . . . 0.753 ' HA ' ' CB ' ' R' ' 106' ' ' ASN . 64.8 p -70.72 -24.74 62.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 61.83 21.89 61.52 Favored Glycine 0 N--CA 1.502 3.052 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.673 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . 0.664 HD12 HD21 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -93.59 -16.09 24.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.225 -1.162 . . . . 0.0 111.193 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . 0.48 ' H ' HD11 ' R' ' 92' ' ' LEU . 95.9 mt-10 52.13 93.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.387 -0.821 . . . . 0.0 108.835 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.664 HD21 HD12 ' R' ' 92' ' ' LEU . 2.5 pp -145.09 4.94 1.1 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.977 -1.077 . . . . 0.0 109.91 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . 0.58 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.9 OUTLIER -39.31 -33.87 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.422 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.49 21.82 11.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.568 -0.707 . . . . 0.0 110.658 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . 0.644 ' O ' ' HB2' ' R' ' 94' ' ' LEU . . . 160.16 -115.26 0.65 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.087 -1.53 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' R' ' 97' ' ' GLY . . . 55.81 166.48 0.05 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' R' ' 102' ' ' LEU . 47.9 Cg_endo -79.43 125.23 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.73 1.384 . . . . 0.0 110.575 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . 0.539 ' O ' HG23 ' R' ' 56' ' ' ILE . 39.3 Cg_endo -64.71 -34.35 51.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.487 1.257 . . . . 0.0 109.859 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . 0.566 ' O ' HG12 ' R' ' 104' ' ' ILE 0.251 . . -57.6 -39.73 77.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.956 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . 0.474 ' CG ' ' HG2' ' R' ' 99' ' ' PRO . 3.5 mm? -56.08 -31.75 63.5 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.027 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' R' ' 107' ' ' ILE . 14.8 t -59.18 -52.85 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . 0.566 HG12 ' O ' ' R' ' 101' ' ' ALA . 43.5 pt -66.04 -34.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 111.108 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.484 ' N ' HG13 ' R' ' 104' ' ' ILE . 8.4 m95 -60.7 -38.97 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 111.816 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . 0.753 ' CB ' ' HA ' ' R' ' 90' ' ' THR . 71.3 m-80 -82.26 -34.56 28.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.702 -1.249 . . . . 0.0 113.265 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' R' ' 110' ' ' LEU . 0.2 OUTLIER -92.76 22.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.601 -1.312 . . . . 0.0 110.368 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' R' ' 112' ' ' HIS . 32.3 tttt -29.58 -58.99 0.16 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.616 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.3 m-70 -63.12 -13.59 38.5 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.129 2.24 . . . . 0.0 111.232 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.616 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -111.11 -7.46 14.49 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -142.99 -111.34 0.12 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.197 -1.365 . . . . 0.0 114.449 -173.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . 0.626 ' C ' ' O ' ' R' ' 111' ' ' LEU . 82.8 t60 -19.47 81.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 123.768 1.747 . . . . 0.0 109.871 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.749 ' N ' ' O ' ' R' ' 111' ' ' LEU 0.25 4.5 t -70.12 -162.55 0.06 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.14 177.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -68.1 97.84 0.46 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.631 ' CD1' HG22 ' R' ' 113' ' ' THR . 3.3 mm -113.01 145.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.784 -1.421 . . . . 0.0 110.601 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' R' ' 122' ' ' SER . . . -124.92 -143.99 6.23 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.925 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 117' ' ' THR . . . . . 0.54 ' HA ' ' CG2' ' R' ' 126' ' ' VAL . 24.9 m -138.05 174.5 10.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . 0.59 ' HB1' ' HB ' ' R' ' 130' ' ' THR . . . -55.66 -29.45 59.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.389 -1.325 . . . . 0.0 109.62 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 39.6 m -87.11 -33.19 19.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -101.16 119.8 56.89 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.247 -0.908 . . . . 0.0 110.384 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.79 124.91 4.68 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.627 1.33 . . . . 0.0 112.228 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.433 ' HB2' ' N ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER -140.74 -170.08 2.94 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' R' ' 114' ' ' GLY . 52.7 mt-10 -55.59 -44.74 77.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.52 -1.362 . . . . 0.0 107.862 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . 0.618 HG22 HD13 ' R' ' 115' ' ' ILE . 1.9 m -120.25 138.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.542 ' O ' ' O ' ' R' ' 180' ' ' PHE . 43.1 t -123.05 135.22 54.34 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.237 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . 0.922 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 10.4 m -80.64 -173.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.417 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.862 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 3.6 m -117.16 -42.01 2.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.802 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . 0.418 ' N ' ' CG2' ' R' ' 127' ' ' VAL . 89.2 m-20 42.55 37.12 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.566 -1.334 . . . . 0.0 111.021 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.33 39.92 91.83 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 130' ' ' THR . . . . . 0.59 ' HB ' ' HB1' ' R' ' 118' ' ' ALA . 90.7 m -113.34 152.62 29.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.694 -0.886 . . . . 0.0 111.627 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' R' ' 130' ' ' THR . 65.6 m-20 70.73 -166.88 0.15 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.864 0.84 . . . . 0.0 111.987 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.522 ' O ' ' OD2' ' R' ' 173' ' ' ASP . 87.2 mtp -83.83 177.5 8.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.889 -0.507 . . . . 0.0 111.111 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' R' ' 134' ' ' LEU . 0.5 OUTLIER -89.22 -171.22 3.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.69 -0.631 . . . . 0.0 111.253 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . 1.038 ' CA ' ' HB2' ' R' ' 173' ' ' ASP . 0.3 OUTLIER -3.76 -70.35 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' R' ' 133' ' ' CYS . . . -54.19 3.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . 0.607 ' O ' ' CZ ' ' R' ' 183' ' ' TYR . 14.5 t70 -84.98 -90.47 0.1 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 119.396 -2.065 . . . . 0.0 111.598 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . 0.797 ' CE1' ' HB2' ' R' ' 180' ' ' PHE . 14.3 p90 -102.47 -176.19 3.03 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . 0.694 ' HB2' ' CG2' ' R' ' 154' ' ' VAL . 0.0 OUTLIER -149.53 79.96 1.39 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.183 -1.807 . . . . 0.0 111.196 176.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.78 ' HB2' ' CG1' ' R' ' 181' ' ' VAL . . . 176.96 161.29 0.41 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.656 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 131.45 -165.62 23.17 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.826 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' R' ' 177' ' ' VAL . 62.0 mt -106.8 119.18 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.8 -0.823 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.736 ' CD2' HG11 ' R' ' 177' ' ' VAL . 0.4 OUTLIER -109.72 140.01 44.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.718 0.771 . . . . 0.0 109.688 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.42 119.36 38.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.33 -0.857 . . . . 0.0 108.978 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -100.73 121.26 41.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.751 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.75 -124.08 32.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -133.92 154.64 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.8 31.0 2.88 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.99 125.23 20.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.508 -0.745 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' R' ' 51' ' ' ALA . . . -112.43 142.91 44.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 110.233 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.3 m -142.15 167.63 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.0 109.7 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.525 ' O ' ' N ' ' R' ' 162' ' ' ILE . 52.2 t80 -150.35 121.68 7.86 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.257 -0.902 . . . . 0.0 112.214 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 1.089 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.44 168.0 10.23 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 119.985 -1.697 . . . . 0.0 110.264 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.753 ' HB2' ' CE2' ' R' ' 160' ' ' TYR . 0.5 OUTLIER -168.56 144.82 3.7 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.361 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.694 ' CG2' ' HB2' ' R' ' 138' ' ' HIS . 41.4 t -55.55 123.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.081 -1.637 . . . . 0.0 114.028 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 155' ' ' THR . . . . . 0.585 ' CG2' ' HB3' ' R' ' 160' ' ' TYR . 21.9 p -126.88 -179.56 4.89 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.127 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 42.1 m -56.36 -20.29 18.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.169 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . 0.492 ' HB3' ' HG3' ' R' ' 169' ' ' PRO . 79.1 m-20 -92.66 -5.2 51.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.576 -0.702 . . . . 0.0 111.855 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 116.96 -135.44 11.96 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.996 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.793 ' O ' ' HA ' ' R' ' 169' ' ' PRO . 0.0 OUTLIER -82.34 82.17 7.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . 0.753 ' CE2' ' HB2' ' R' ' 153' ' ' CYS . 0.0 OUTLIER -64.22 160.04 19.42 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . 1.089 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -147.12 113.23 5.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.687 ' CG2' ' O ' ' R' ' 162' ' ' ILE . 0.7 OUTLIER -72.43 83.69 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 123.103 1.43 . . . . 0.0 111.101 -175.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -80.01 131.0 35.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' R' ' 163' ' ' ASP . 92.6 m-20 32.82 65.16 0.24 Allowed 'General case' 0 N--CA 1.518 2.94 0 O-C-N 120.884 -1.135 . . . . 0.0 112.465 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' R' ' 42' ' ' TYR . 5.3 mt-10 58.75 8.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.232 -1.542 . . . . 0.0 112.129 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 74.5 m-20 -109.44 152.54 25.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 119.977 -1.702 . . . . 0.0 108.754 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.584 ' HB2' ' CD1' ' R' ' 160' ' ' TYR . 19.5 p90 -124.7 130.39 52.33 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.868 1.318 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' R' ' 161' ' ' ALA . 2.0 p90 -159.42 144.03 11.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.685 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . 0.793 ' HA ' ' O ' ' R' ' 159' ' ' TRP . 50.3 Cg_endo -72.89 107.7 2.41 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 O-C-N 123.088 1.046 . . . . 0.0 112.802 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.576 ' O ' ' CG2' ' R' ' 171' ' ' THR . 0.6 OUTLIER -135.3 18.28 3.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 117.123 -1.831 . . . . 0.0 112.66 175.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 171' ' ' THR . . . . . 0.576 ' CG2' ' O ' ' R' ' 170' ' ' TRP . 0.1 OUTLIER 167.43 121.01 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.965 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 175.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.677 ' HB3' ' CD1' ' R' ' 159' ' ' TRP . 42.2 Cg_endo -101.65 16.76 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.235 1.29 . . . . 0.0 113.421 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . 1.038 ' HB2' ' CA ' ' R' ' 134' ' ' LEU . 0.1 OUTLIER -144.48 -173.1 0.34 Allowed Pre-proline 0 N--CA 1.511 2.583 0 O-C-N 118.216 -2.802 . . . . 0.0 114.923 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . 0.864 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.4 Cg_endo -86.39 34.07 0.45 Allowed 'Trans proline' 0 C--O 1.217 -0.57 0 O-C-N 124.29 1.679 . . . . 0.0 112.143 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 175' ' ' SER . . . . . 0.418 ' OG ' HD22 ' R' ' 134' ' ' LEU . 15.0 m -62.18 -43.45 98.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.816 -1.178 . . . . 0.0 108.436 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -123.09 0.82 9.13 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.63 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.864 HG13 ' HA ' ' R' ' 174' ' ' PRO . 0.2 OUTLIER -109.34 157.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.304 -0.873 . . . . 0.0 109.838 -178.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . 0.862 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.5 OUTLIER -132.1 38.34 3.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 117.529 -1.668 . . . . 0.0 110.606 177.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.922 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 7.7 p -165.63 129.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.797 ' HB2' ' CE1' ' R' ' 137' ' ' PHE . 7.1 p90 -136.72 179.44 6.37 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.174 -1.41 . . . . 0.0 111.227 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . 0.78 ' CG1' ' HB2' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -112.21 137.98 21.67 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.395 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.49 141.34 60.88 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.5 1.263 . . . . 0.0 111.866 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 15.7 p90 -138.35 172.74 12.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 50.4 p30 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.18 -0.95 . . . . 0.0 110.947 -179.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' R' R ' 29' ' ' MET . . . . . 0.521 ' HB2' ' CE2' ' R' ' 167' ' ' PHE . 89.2 mtp . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.291 0.567 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 93.2 mt-10 -97.77 114.71 26.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 111.372 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . 0.757 ' HB3' ' CD2' ' R' ' 167' ' ' PHE . 1.2 pt? -122.9 135.52 54.53 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.49 -1.284 . . . . 0.0 111.025 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 32' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' R' ' 38' ' ' LYS . 8.8 t -91.58 156.24 17.79 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.574 ' H ' HD21 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -106.26 -173.97 2.42 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.655 -0.653 . . . . 0.0 110.595 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . 0.713 ' N ' ' O ' ' R' ' 154' ' ' VAL . 19.2 p90 -48.14 -49.8 31.01 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' R' ' 34' ' ' TYR . 12.4 p-10 -76.57 17.99 0.36 Allowed 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 122.417 2.371 . . . . 0.0 114.303 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -13.74 40.47 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 120.07 -1.644 . . . . 0.0 112.795 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . 0.542 ' HB3' HD22 ' R' ' 33' ' ' LEU . 81.2 tt0 -61.18 131.88 51.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.637 1.718 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' R' ' 32' ' ' THR . 52.6 pttt -100.93 113.03 25.63 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.925 0.869 . . . . 0.0 111.062 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' R' ' 61' ' ' ARG . 67.1 mttm -113.21 117.77 32.81 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 40' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' R' ' 40' ' ' THR . 1.3 t -94.69 133.0 38.82 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.358 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.944 ' CZ ' HD13 ' R' ' 162' ' ' ILE . 0.1 OUTLIER -145.67 166.73 24.95 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.739 176.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . 0.512 ' O ' ' OG ' ' R' ' 43' ' ' SER . 87.0 m-85 -79.35 175.86 10.21 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.964 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 43' ' ' SER . . . . . 0.689 ' O ' ' O ' ' R' ' 44' ' ' ARG . 0.8 OUTLIER 169.62 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . 0.689 ' O ' ' O ' ' R' ' 43' ' ' SER . 5.7 ptt180 -32.87 163.97 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.019 -1.05 . . . . 0.0 111.483 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 29.3 Cg_endo -52.28 104.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.347 1.183 . . . . 0.0 110.874 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' R' ' 76' ' ' GLU . 7.3 t-20 -92.63 -127.67 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.555 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' R' ' 48' ' ' HIS . 0.4 OUTLIER -134.55 138.12 44.36 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.613 -1.304 . . . . 0.0 111.661 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . 0.553 ' HB2' ' O ' ' R' ' 47' ' ' ASN . 92.9 m-70 72.52 42.98 0.5 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.423 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' R' ' 48' ' ' HIS . 80.1 m-20 55.26 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.439 -0.788 . . . . 0.0 109.357 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -111.63 1.98 17.06 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.623 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . 0.438 ' O ' ' HB1' ' R' ' 149' ' ' ALA 0.253 . . -68.51 -41.86 79.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.696 -0.628 . . . . 0.0 111.716 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.503 ' CD2' ' O ' ' R' ' 97' ' ' GLY . 33.2 m95 -60.13 -33.64 72.42 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.08 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.948 ' CD1' HG12 ' R' ' 83' ' ' ILE . 2.3 mt -79.53 -40.37 29.75 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' R' ' 58' ' ' GLN . 8.3 t30 -55.15 -28.79 55.31 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . 0.792 ' HA ' ' CD1' ' R' ' 151' ' ' PHE . . . -64.43 -64.37 0.9 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . 0.65 ' HB ' ' CE2' ' R' ' 68' ' ' PHE . 0.6 OUTLIER -67.27 -29.2 45.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 O-C-N 120.231 -1.543 . . . . 0.0 108.174 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' R' ' 71' ' ' VAL . 1.8 mm? -52.62 -54.57 31.31 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 109.139 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' R' ' 54' ' ' ASN . 1.8 mt-30 -55.03 -31.73 61.31 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.616 HD11 ' CE1' ' R' ' 62' ' ' TYR . 1.4 tp -67.84 -40.71 83.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.728 ' HB2' ' HD2' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -54.14 -47.28 72.09 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.955 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . 0.575 ' HG2' ' CZ ' ' R' ' 60' ' ' PHE . 16.2 mmt180 -57.8 -54.32 48.22 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.884 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.616 ' CE1' HD11 ' R' ' 59' ' ' LEU . 21.6 p90 -92.6 -31.76 15.04 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 119.598 -1.939 . . . . 0.0 114.016 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . 0.73 ' O ' ' CB ' ' R' ' 64' ' ' GLU . 56.1 t -77.18 -24.85 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 120.137 -1.602 . . . . 0.0 110.233 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . 0.73 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 87.3 tt0 123.22 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.546 ' HB3' ' HD1' ' R' ' 60' ' ' PHE . 3.5 pt-20 -50.44 100.92 0.24 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.728 ' HD2' ' HB2' ' R' ' 60' ' ' PHE . 46.7 Cg_endo -86.69 -165.23 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 N-CA-C 106.023 -2.337 . . . . 0.0 106.023 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' R' ' 69' ' ' ASP . 76.6 m-85 -41.95 -19.35 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . 0.65 ' CE2' ' HB ' ' R' ' 56' ' ' ILE . 3.2 m-30 -58.24 -3.01 0.22 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.286 -1.509 . . . . 0.0 110.452 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.523 ' HA ' ' CE2' ' R' ' 72' ' ' TYR . 19.8 t70 -58.35 -30.39 66.71 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.717 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.429 ' CB ' ' HA ' ' R' ' 82' ' ' ALA . 85.2 m95 -61.58 -33.51 74.01 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.848 -1.158 . . . . 0.0 108.886 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.756 ' HB ' HD12 ' R' ' 57' ' ' LEU . 55.5 t -68.39 -62.2 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.535 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' R' ' 69' ' ' ASP . 0.8 OUTLIER -71.98 -30.75 65.58 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.207 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 73' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 34.0 t -63.99 -23.24 67.26 Favored 'General case' 0 N--CA 1.51 2.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.434 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 148.93 80.45 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' R' ' 42' ' ' TYR . 38.8 Cg_endo -65.03 -17.46 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.712 1.375 . . . . 0.0 110.025 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' R' ' 78' ' ' LEU . 96.1 mt-10 -141.28 58.84 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.5 -0.75 . . . . 0.0 109.499 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' R' ' 78' ' ' LEU . 28.7 t-20 57.38 -84.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.818 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' R' ' 77' ' ' ASN . 0.1 OUTLIER 78.33 67.28 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 79' ' ' THR . . . . . 0.578 ' O ' ' CG1' ' R' ' 83' ' ' ILE . 5.3 t -65.25 -52.64 53.14 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.834 -0.541 . . . . 0.0 110.573 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . 0.471 ' O ' ' HG3' ' R' ' 84' ' ' LYS . 0.4 OUTLIER -49.85 -53.12 27.65 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.56 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.12 -28.22 67.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.059 -1.651 . . . . 0.0 110.277 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' CB ' ' CG2' ' R' ' 71' ' ' VAL . . . -66.61 -46.74 74.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.768 0.794 . . . . 0.0 112.436 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . 0.948 HG12 ' CD1' ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.36 -39.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.565 -176.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' R' ' 80' ' ' LEU . 35.4 mttm -49.74 -35.86 23.63 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . 0.738 ' O ' HD11 ' R' ' 89' ' ' LEU . 68.3 tp60 -70.93 -44.57 65.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . 0.591 HD13 HG22 ' R' ' 103' ' ' VAL . 1.4 tm? -55.11 -38.4 68.12 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . 0.552 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.8 tt0 -59.37 -33.22 70.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.915 -1.115 . . . . 0.0 108.15 177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 82.0 m-20 -55.14 -32.49 62.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.956 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . 0.738 HD11 ' O ' ' R' ' 85' ' ' GLN . 0.3 OUTLIER -102.61 -49.1 3.93 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.938 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 90' ' ' THR . . . . . 0.885 ' OG1' HD23 ' R' ' 92' ' ' LEU . 35.0 p -78.6 -27.79 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 73.12 23.61 77.32 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.154 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . 0.885 HD23 ' OG1' ' R' ' 90' ' ' THR . 0.3 OUTLIER -108.12 -160.88 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.063 -1.257 . . . . 0.0 112.042 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . 0.591 ' C ' HD13 ' R' ' 94' ' ' LEU . 95.5 mt-10 -144.56 104.79 4.09 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.725 HD23 HG22 ' R' ' 103' ' ' VAL . 0.3 OUTLIER -105.28 9.97 33.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.853 -1.155 . . . . 0.0 110.762 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' R' ' 94' ' ' LEU . 17.0 m170 -45.29 -29.75 1.09 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' R' ' 94' ' ' LEU . 80.4 tt0 -150.49 33.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' R' ' 52' ' ' TRP . . . -95.64 -111.58 2.59 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.02 -1.05 . . . . 0.0 110.731 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . 178.14 -161.44 28.32 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . 0.661 ' CD ' ' HD2' ' R' ' 100' ' ' PRO . 31.3 Cg_endo -72.69 -64.84 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 O-C-N 123.849 1.447 . . . . 0.0 114.108 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . 0.932 ' O ' ' N ' ' R' ' 102' ' ' LEU . 33.6 Cg_endo -57.22 -28.32 78.9 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 N-CA-C 107.181 -1.892 . . . . 0.0 107.181 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.251 . . -29.35 60.44 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.197 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . 0.932 ' N ' ' O ' ' R' ' 100' ' ' PRO . 7.3 mp 35.45 -4.74 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . 0.949 ' O ' ' HB ' ' R' ' 107' ' ' ILE . 34.3 t -61.74 -44.99 99.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 C-N-CA 114.855 -2.738 . . . . 0.0 105.641 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' R' ' 100' ' ' PRO . 19.0 pt -84.14 -36.09 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.339 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.711 ' HB3' ' HA ' ' R' ' 102' ' ' LEU . 48.0 t-105 -60.27 -45.26 93.91 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.152 -1.419 . . . . 0.0 111.419 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -84.88 -22.53 29.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.891 -1.131 . . . . 0.0 111.794 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . 0.949 ' HB ' ' O ' ' R' ' 103' ' ' VAL . 0.2 OUTLIER -67.48 -14.43 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 111.33 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 107' ' ' ILE . 75.2 tttt -33.96 -59.73 0.41 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.0 -7.67 59.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.274 -2.141 . . . . 0.0 111.451 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.692 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.1 OUTLIER -84.26 -30.85 25.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.516 -1.365 . . . . 0.0 109.199 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' R' ' 107' ' ' ILE 0.281 57.6 mt -68.11 161.03 27.79 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.692 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -117.14 60.13 0.75 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.516 ' CG2' HD13 ' R' ' 115' ' ' ILE . 97.4 m -145.12 138.36 26.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.395 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -74.67 98.4 1.05 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 105.615 -2.994 . . . . 0.0 105.615 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.551 HD12 ' CG2' ' R' ' 124' ' ' VAL . 31.1 mm -93.24 142.5 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.814 -1.404 . . . . 0.0 109.828 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' R' ' 122' ' ' SER . . . -133.46 -165.78 11.18 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.869 -1.634 . . . . 0.0 111.952 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 117' ' ' THR . . . . . 0.573 ' HA ' HG21 ' R' ' 126' ' ' VAL . 7.2 m -134.63 -175.43 3.88 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . 0.562 ' HB1' ' OG1' ' R' ' 130' ' ' THR . . . -64.58 -37.86 89.0 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.795 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -66.71 -36.35 82.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.67 101.79 36.26 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.022 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.07 135.73 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.621 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.471 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 0.2 OUTLIER -145.22 -158.99 0.94 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.637 -0.665 . . . . 0.0 109.426 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.409 ' HB2' HG23 ' R' ' 113' ' ' THR . 77.0 mm-40 -56.13 -43.9 78.67 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.796 -1.19 . . . . 0.0 108.433 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . 0.551 ' CG2' HD12 ' R' ' 115' ' ' ILE . 10.7 m -115.95 135.14 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.446 ' O ' ' CD1' ' R' ' 180' ' ' PHE . 7.0 t -134.3 136.9 43.83 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.966 0.888 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . 0.929 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 6.1 m -82.53 -179.92 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.31 1.053 . . . . 0.0 111.18 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.907 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 5.0 m -121.55 -1.01 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . 0.428 ' CA ' ' CD1' ' R' ' 178' ' ' LEU . 55.9 t0 -60.49 92.96 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.764 -1.21 . . . . 0.0 110.374 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.49 67.45 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 130' ' ' THR . . . . . 0.562 ' OG1' ' HB1' ' R' ' 118' ' ' ALA . 1.4 m -97.38 146.71 24.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.685 -0.891 . . . . 0.0 111.267 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -66.32 -32.39 73.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.461 ' HB3' ' CZ ' ' R' ' 180' ' ' PHE . 64.0 mtt -90.34 141.62 28.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.0 110.962 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.31 -165.32 1.78 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.71 -0.619 . . . . 0.0 110.228 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . 0.609 ' CD1' ' CG2' ' R' ' 171' ' ' THR . 0.9 OUTLIER -45.67 -30.0 1.42 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.77 -41.45 32.36 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . 0.644 ' O ' ' CD2' ' R' ' 137' ' ' PHE . 94.0 m-20 -71.15 -140.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . 0.681 ' HB2' ' CE2' ' R' ' 183' ' ' TYR . 0.4 OUTLIER -173.37 101.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 116.593 -2.043 . . . . 0.0 112.266 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . 0.952 ' HB3' ' O ' ' R' ' 181' ' ' VAL . 0.2 OUTLIER -163.32 -138.63 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.214 1.007 . . . . 0.0 109.857 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.777 ' H ' HG11 ' R' ' 181' ' ' VAL 0.261 . . -104.81 179.69 4.2 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.744 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 161.52 -178.68 37.33 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . 0.629 HG12 ' CZ ' ' R' ' 151' ' ' PHE . 3.6 mt -108.35 115.69 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.627 -0.925 . . . . 0.0 110.616 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 1.047 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 3.0 m-85 -114.82 154.64 28.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.8 129.37 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' R' ' 148' ' ' HIS . 36.1 tttp -109.12 122.37 47.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.24 -130.6 49.73 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.49 -129.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.353 -1.087 . . . . 0.0 109.554 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.63 92.65 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 109.802 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' R' ' 144' ' ' LYS . 1.9 t60 -146.47 122.15 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.462 -0.773 . . . . 0.0 108.92 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . 0.453 ' CB ' ' CE3' ' R' ' 52' ' ' TRP . . . -94.47 118.87 32.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.797 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' R' ' 142' ' ' PHE . 34.7 m -133.62 147.63 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.005 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.792 ' CD1' ' HA ' ' R' ' 55' ' ' ALA . 3.3 m-85 -136.11 131.78 35.23 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.867 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.63 169.91 8.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.597 -1.314 . . . . 0.0 111.29 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 3.9 t -163.37 133.09 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' R' ' 34' ' ' TYR . 48.3 t -50.91 117.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.101 -1.44 . . . . 0.0 111.919 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 155' ' ' THR . . . . . 0.742 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 66.4 p -104.4 -158.34 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 83.5 p -65.73 -15.47 62.86 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.672 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 86.0 m-20 -113.01 9.47 18.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.358 -0.839 . . . . 0.0 111.969 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' R' ' 160' ' ' TYR . . . 100.92 -153.96 19.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.757 ' CG ' ' O ' ' R' ' 171' ' ' THR . 0.0 OUTLIER -57.91 94.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.322 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . 0.742 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 0.2 OUTLIER -115.79 119.04 34.72 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . 0.867 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -109.94 147.99 32.42 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.44 -1.413 . . . . 0.0 110.114 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.944 HD13 ' CZ ' ' R' ' 41' ' ' PHE . 6.0 pt -117.51 91.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-O 124.191 1.948 . . . . 0.0 112.029 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.666 ' O ' ' C ' ' R' ' 164' ' ' ASP . 63.6 m-20 -83.0 120.26 25.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 111.784 -2.462 . . . . 0.0 106.169 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . 0.666 ' C ' ' O ' ' R' ' 163' ' ' ASP . 96.8 m-20 11.93 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.113 0.959 . . . . 0.0 111.553 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' R' ' 163' ' ' ASP . 98.6 mt-10 -31.41 -52.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 19.8 t0 -172.5 177.9 2.88 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 119.339 -2.101 . . . . 0.0 113.496 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.849 ' HA ' HG22 ' R' ' 162' ' ' ILE . 2.1 m-30 -93.52 129.35 39.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' R' ' 161' ' ' ALA . 36.9 p90 -155.42 170.18 9.13 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.556 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 41.3 Cg_endo -68.61 113.38 3.15 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.748 -1.674 . . . . 0.0 107.748 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.685 ' HA ' ' HE3' ' R' ' 170' ' ' TRP . 0.0 OUTLIER -117.66 -129.24 0.29 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 123.361 1.553 . . . . 0.0 111.956 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 171' ' ' THR . . . . . 0.757 ' O ' ' CG ' ' R' ' 159' ' ' TRP 0.319 1.4 m -32.22 97.74 0.11 Allowed Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 112.904 -1.953 . . . . 0.0 115.389 -174.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.482 ' HD2' ' H ' ' R' ' 173' ' ' ASP . 53.2 Cg_endo -92.93 -30.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.53 1.805 . . . . 0.0 108.037 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . 0.532 ' CA ' ' HG ' ' R' ' 134' ' ' LEU . 18.0 p30 -148.15 170.43 7.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.448 -0.783 . . . . 0.0 108.915 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' R' ' 134' ' ' LEU . 49.5 Cg_endo -85.64 51.36 2.87 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 83.4 p -82.15 -34.13 29.28 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -125.41 6.11 7.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.557 -1.339 . . . . 0.0 111.054 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 1.047 ' HB ' ' CG ' ' R' ' 142' ' ' PHE 0.259 2.3 p -112.31 148.49 15.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.231 -0.918 . . . . 0.0 110.687 -177.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . 0.907 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.4 OUTLIER -133.05 46.26 2.63 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.893 175.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.929 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.43 131.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' R' ' 182' ' ' PRO . 2.3 p90 -132.46 178.53 6.76 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.686 1.231 . . . . 0.0 108.987 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . 0.952 ' O ' ' HB3' ' R' ' 138' ' ' HIS . 0.8 OUTLIER -121.64 93.3 48.73 Favored Pre-proline 0 C--N 1.265 -3.088 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . 0.506 ' HB3' ' CE2' ' R' ' 180' ' ' PHE . 36.5 Cg_endo -60.05 109.29 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 120.862 1.041 . . . . 0.0 113.629 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.681 ' CE2' ' HB2' ' R' ' 137' ' ' PHE . 0.0 OUTLIER -67.12 -151.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.036 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.2 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.109 -0.994 . . . . 0.0 110.483 -179.565 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' R' R ' 29' ' ' MET . . . . . 0.429 ' HB2' ' CZ ' ' R' ' 167' ' ' PHE . 88.0 mtp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.162 0.506 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 84.1 tt0 -110.44 126.95 54.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.822 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . 0.647 ' CD1' ' CG2' ' R' ' 162' ' ' ILE . 1.7 pt? -139.02 163.4 32.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.459 -0.776 . . . . 0.0 109.632 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 32' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' R' ' 38' ' ' LYS . 31.8 p -104.78 129.26 53.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.145 . . . . 0.0 111.973 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.682 ' CD1' ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -130.68 136.03 48.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.41 -0.806 . . . . 0.0 109.773 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . 0.465 ' CB ' HG13 ' R' ' 154' ' ' VAL . 58.2 t80 -33.48 -36.18 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' R' ' 62' ' ' TYR . 97.4 m-20 -105.34 65.13 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.837 -1.789 . . . . 0.0 111.287 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . 0.972 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 128.33 35.27 0.51 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . 0.972 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.0 mt-10 -13.82 -150.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' R' ' 38' ' ' LYS . 9.5 pttm -52.29 109.1 0.35 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.356 -1.465 . . . . 0.0 112.518 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.51 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 30.0 mmtm -150.09 147.19 27.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.315 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 40' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' R' ' 72' ' ' TYR . 0.8 OUTLIER -85.4 125.42 32.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.126 -0.984 . . . . 0.0 110.019 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.714 ' CD2' ' CE2' ' R' ' 151' ' ' PHE . 84.2 m-85 -110.09 154.02 23.85 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.934 1.349 . . . . 0.0 114.42 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . 0.634 ' O ' ' CB ' ' R' ' 43' ' ' SER . 76.2 m-85 -116.45 164.22 14.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.256 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 43' ' ' SER . . . . . 0.728 ' HA ' ' HA ' ' R' ' 51' ' ' ALA . 0.6 OUTLIER 155.71 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 119.446 1.021 . . . . 0.0 113.304 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . 0.576 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 4.5 mtt180 -72.28 175.74 2.92 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 109.24 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' R' ' 44' ' ' ARG . 37.5 Cg_endo -61.65 100.59 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.286 1.15 . . . . 0.0 113.204 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . 0.424 ' H ' ' H ' ' R' ' 47' ' ' ASN . 2.1 m-20 -150.73 -11.85 0.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . 0.424 ' H ' ' H ' ' R' ' 46' ' ' ASN . 0.2 OUTLIER -135.78 -178.67 5.24 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . 0.455 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 77.4 m80 -92.7 -6.93 48.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.639 -1.288 . . . . 0.0 109.824 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 12.5 p30 172.17 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 109.605 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . 0.451 ' CG ' ' HB ' ' R' ' 79' ' ' THR . 0.2 OUTLIER -138.58 -3.13 1.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' R' ' 43' ' ' SER 0.255 . . -66.3 -44.54 83.18 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.712 -0.617 . . . . 0.0 110.718 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.633 ' CD2' ' HA2' ' R' ' 97' ' ' GLY . 55.2 m95 -61.1 -36.63 80.21 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.555 -1.658 . . . . 0.0 107.795 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.914 ' CD1' HG12 ' R' ' 83' ' ' ILE . 2.4 mt -68.49 -34.86 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . 0.608 ' HB2' ' O ' ' R' ' 42' ' ' TYR . 0.0 OUTLIER -47.6 -26.98 1.64 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . 0.826 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.52 -56.98 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . 0.626 ' O ' ' CG ' ' R' ' 60' ' ' PHE 0.291 1.2 mp -62.58 -42.39 95.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 122.379 1.085 . . . . 0.0 108.311 177.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . 0.861 HD13 ' CD1' ' R' ' 72' ' ' TYR . 4.2 mm? -65.03 -60.7 2.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.953 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . 0.678 ' HB2' ' CD1' ' R' ' 151' ' ' PHE . 4.6 pt20 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.826 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 1.6 mp -70.97 -48.54 52.77 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.566 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.626 ' CG ' ' O ' ' R' ' 56' ' ' ILE . 12.7 m-30 -61.51 -45.93 92.12 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.474 -1.29 . . . . 0.0 110.59 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . 0.51 ' HD3' ' HB3' ' R' ' 39' ' ' LYS . 1.5 tpm_? -58.3 -31.23 67.29 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 119.67 -1.894 . . . . 0.0 110.139 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.725 ' HB3' HG21 ' R' ' 181' ' ' VAL . 22.0 m-30 -61.7 -54.01 48.32 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.541 -1.35 . . . . 0.0 111.986 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . 0.492 ' CG1' HG22 ' R' ' 113' ' ' THR . 3.9 t -85.79 3.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.363 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 74.4 tt0 67.04 44.91 1.85 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.515 ' CG ' ' CE1' ' R' ' 112' ' ' HIS . 4.4 mp0 -133.88 89.18 30.46 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' CE2' ' R' ' 68' ' ' PHE . 53.1 Cg_endo -79.27 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.543 1.286 . . . . 0.0 113.757 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . 0.53 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 55.1 t80 -82.98 -25.71 32.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . 0.709 ' HB2' HD11 ' R' ' 57' ' ' LEU . 2.0 p90 -72.6 19.15 0.08 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.991 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' R' ' 73' ' ' SER . 95.5 m-20 -38.2 -37.29 0.27 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.451 -0.781 . . . . 0.0 112.868 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.498 ' HB2' ' HA ' ' R' ' 82' ' ' ALA . 84.8 m95 -62.03 -30.44 70.97 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.24 -1.538 . . . . 0.0 110.113 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.647 HG13 ' HG ' ' R' ' 57' ' ' LEU . 65.5 t -78.7 -67.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . 0.861 ' CD1' HD13 ' R' ' 57' ' ' LEU . 9.9 m-30 -67.89 -38.8 83.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.239 -0.913 . . . . 0.0 110.94 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 73' ' ' SER . . . . . 0.56 ' HB2' ' O ' ' R' ' 69' ' ' ASP . 6.1 m -63.35 -21.62 66.38 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.739 -1.185 . . . . 0.0 109.561 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 74' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 16.4 t -99.6 119.71 59.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.957 . . . . 0.0 110.513 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.97 -19.25 46.2 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.569 1.299 . . . . 0.0 110.279 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.61 165.19 11.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.449 -0.782 . . . . 0.0 109.849 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -58.52 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.825 . . . . 0.0 110.728 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . 0.415 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.4 mm? -107.82 21.81 16.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 79' ' ' THR . . . . . 0.541 ' O ' ' CG1' ' R' ' 83' ' ' ILE . 3.1 t -55.48 -52.64 62.97 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.506 -0.746 . . . . 0.0 109.956 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . 0.45 ' H ' ' CG2' ' R' ' 79' ' ' THR . 1.2 pp -49.86 -50.84 44.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.692 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . 0.409 ' OE2' ' CZ3' ' R' ' 70' ' ' TRP . 84.8 tt0 -67.08 -28.63 68.34 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.28 -1.513 . . . . 0.0 110.104 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . 0.526 ' CB ' HG23 ' R' ' 71' ' ' VAL . . . -67.01 -48.45 68.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.93 0.871 . . . . 0.0 111.572 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . 0.914 HG12 ' CD1' ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.76 -38.52 11.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.443 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 83' ' ' ILE . 36.7 tttm -50.49 -35.34 28.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -73.55 -36.56 65.65 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . 0.636 HD13 ' CG2' ' R' ' 90' ' ' THR . 2.6 tm? -63.13 -38.18 90.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . 0.57 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 83.0 tt0 -60.9 -39.71 90.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 108.824 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.08 -32.3 72.82 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.273 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . 0.47 ' CD2' HG23 ' R' ' 90' ' ' THR . 2.6 tt -94.91 -51.25 4.76 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.08 -1.013 . . . . 0.0 111.805 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 90' ' ' THR . . . . . 0.636 ' CG2' HD13 ' R' ' 86' ' ' LEU . 69.7 p -76.58 -25.64 54.21 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . 0.57 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 67.29 26.15 73.52 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.692 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . 0.608 HD11 HD22 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -104.54 -17.98 14.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.02 -1.283 . . . . 0.0 111.756 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . 0.518 ' O ' ' O ' ' R' ' 92' ' ' LEU . 84.1 tt0 58.42 115.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.608 HD22 HD11 ' R' ' 92' ' ' LEU . 3.7 pp -156.75 21.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.688 -1.257 . . . . 0.0 111.181 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' R' ' 94' ' ' LEU . 5.7 p80 -42.42 -28.35 0.2 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.2 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . 0.451 ' C ' ' CD1' ' R' ' 52' ' ' TRP . 23.1 pt-20 -120.39 36.11 4.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . 0.633 ' HA2' ' CD2' ' R' ' 52' ' ' TRP . . . 145.87 110.78 0.67 Allowed Glycine 0 N--CA 1.504 3.182 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.329 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' R' ' 94' ' ' LEU . . . -170.68 65.29 0.16 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.023 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . 0.834 ' HB2' ' CD ' ' R' ' 100' ' ' PRO . 42.8 Cg_endo -84.56 -108.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.965 0 O-C-N 123.322 1.169 . . . . 0.0 109.211 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . 0.881 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.3 Cg_endo -60.18 -17.88 48.49 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 N-CA-C 106.845 -2.021 . . . . 0.0 106.845 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.254 . . -31.22 61.27 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.195 175.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . 0.881 ' N ' ' O ' ' R' ' 100' ' ' PRO . 80.8 mt 41.0 -3.42 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.369 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.008 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . 0.892 ' O ' HG12 ' R' ' 107' ' ' ILE . 13.4 t -56.98 -47.75 82.85 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 C-N-CA 114.335 -2.946 . . . . 0.0 104.079 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.46 -39.36 85.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.932 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.615 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 51.9 t90 -63.02 -36.31 83.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.12 -1.432 . . . . 0.0 111.25 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . 0.494 ' CB ' HG23 ' R' ' 90' ' ' THR . 22.3 m120 -84.87 -23.19 29.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.086 -1.009 . . . . 0.0 113.26 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . 0.892 HG12 ' O ' ' R' ' 103' ' ' VAL . 3.4 mm -70.6 -10.95 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.242 -1.536 . . . . 0.0 110.02 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' R' ' 107' ' ' ILE . 62.1 mttt -33.47 -57.93 0.41 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.587 ' C ' HD11 ' R' ' 110' ' ' LEU . 4.1 m-70 -72.91 -9.68 58.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 119.181 -2.199 . . . . 0.0 111.506 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.587 HD11 ' C ' ' R' ' 109' ' ' HIS . 0.2 OUTLIER -106.54 -16.82 14.43 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' R' ' 107' ' ' ILE 0.323 0.1 OUTLIER -109.71 127.62 54.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.835 -176.52 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' CG ' ' R' ' 65' ' ' GLU . 55.4 p-80 -115.37 76.91 1.03 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.633 HG23 HD12 ' R' ' 115' ' ' ILE . 18.0 m -132.14 136.42 47.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.278 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' R' ' 123' ' ' GLU . . . -75.73 104.36 1.78 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.727 HD13 HG21 ' R' ' 124' ' ' VAL . 3.3 mm -90.9 144.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.634 -1.509 . . . . 0.0 109.358 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . 0.746 ' O ' ' HB3' ' R' ' 125' ' ' CYS . . . -145.42 -118.79 1.2 Allowed Glycine 0 N--CA 1.509 3.562 0 C-N-CA 118.408 -1.853 . . . . 0.0 112.462 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 117' ' ' THR . . . . . 0.406 ' C ' HG23 ' R' ' 126' ' ' VAL . 0.0 OUTLIER -178.95 -175.2 0.38 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.204 -1.174 . . . . 0.0 108.814 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . 0.687 ' HB3' ' CB ' ' R' ' 130' ' ' THR 0.278 . . -66.84 -43.62 83.22 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.31 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -37.77 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 108.889 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.22 104.11 35.28 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.33 131.17 27.38 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.524 1.276 . . . . 0.0 111.224 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.442 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 46.7 m -146.05 -168.91 3.12 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.541 ' O ' HG23 ' R' ' 181' ' ' VAL . 76.8 mm-40 -63.18 -43.16 99.02 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.8 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . 0.727 HG21 HD13 ' R' ' 115' ' ' ILE . 0.6 OUTLIER -149.17 122.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.337 -1.477 . . . . 0.0 112.566 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.746 ' HB3' ' O ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER 152.74 138.03 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.061 176.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . 0.734 HG23 ' O ' ' R' ' 125' ' ' CYS . 1.1 t -176.55 -172.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 1.06 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 33.4 m 36.91 -3.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 127.779 2.432 . . . . 0.0 116.863 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' R' ' 126' ' ' VAL . 44.9 t0 -57.22 55.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.659 -1.276 . . . . 0.0 111.752 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 105.28 15.56 19.12 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 130' ' ' THR . . . . . 0.687 ' CB ' ' HB3' ' R' ' 118' ' ' ALA . 87.1 m -116.53 154.32 30.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -1.175 . . . . 0.0 112.164 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -58.78 159.59 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.773 -0.579 . . . . 0.0 109.52 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' R' ' 174' ' ' PRO . 28.2 mtt -123.81 136.36 54.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.283 -0.885 . . . . 0.0 111.326 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.3 134.64 36.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.027 -1.045 . . . . 0.0 111.086 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' R' ' 173' ' ' ASP . 0.2 OUTLIER -59.89 -42.22 93.34 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.244 1.021 . . . . 0.0 110.587 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.4 0.52 9.95 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -73.31 -65.74 0.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.106 . . . . 0.0 111.827 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . 0.714 ' CG ' ' CD2' ' R' ' 180' ' ' PHE . 19.5 p90 -146.85 178.23 8.5 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.091 -1.006 . . . . 0.0 110.2 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' R' ' 172' ' ' PRO . 29.3 m80 -143.14 72.66 1.37 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.245 -1.382 . . . . 0.0 112.212 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' R' ' 181' ' ' VAL . . . 171.81 153.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.626 ' O ' ' OE1' ' R' ' 58' ' ' GLN . . . 144.16 -176.23 23.53 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.283 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . 0.703 ' CG1' ' HA ' ' R' ' 55' ' ' ALA . 0.5 OUTLIER -98.8 128.91 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.841 ' HA ' ' HA ' ' R' ' 177' ' ' VAL . 0.2 OUTLIER -111.48 141.56 44.89 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.501 -1.279 . . . . 0.0 109.021 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' R' ' 143' ' ' LEU . 4.6 mm? -88.95 109.38 20.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.934 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -108.79 120.3 42.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.17 -137.72 44.16 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . 0.435 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 93.9 mt-30 -126.52 150.73 48.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -1.034 . . . . 0.0 110.16 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 51.27 37.56 18.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . 0.435 ' CD2' ' O ' ' R' ' 146' ' ' GLN . 56.1 m-70 -142.86 123.61 14.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.31 -0.869 . . . . 0.0 109.672 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' ND2' ' R' ' 54' ' ' ASN . . . -105.33 136.27 45.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' R' ' 142' ' ' PHE . 31.2 m -127.9 165.72 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.025 -1.047 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.714 ' CE2' ' CD2' ' R' ' 41' ' ' PHE 0.26 0.0 OUTLIER -148.11 125.22 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.736 -1.186 . . . . 0.0 113.494 -177.613 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.895 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -132.81 164.29 27.16 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.606 -1.309 . . . . 0.0 109.238 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.541 ' HB3' ' CE1' ' R' ' 62' ' ' TYR . 22.6 p -176.29 176.39 1.68 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' R' ' 158' ' ' GLY . 64.9 t -63.59 103.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 CA-C-O 121.684 0.754 . . . . 0.0 110.992 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 155' ' ' THR . . . . . 0.693 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 41.7 p -88.75 -160.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 84.5 p -61.82 -18.65 60.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 90.4 m-20 -111.39 2.69 17.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.7 . . . . 0.0 111.502 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 92.91 -118.15 5.55 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 120.704 -1.248 . . . . 0.0 112.124 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.642 ' HB3' ' HD2' ' R' ' 172' ' ' PRO . 0.0 OUTLIER -60.79 92.5 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.645 1.212 . . . . 0.0 108.89 -177.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . 0.727 ' HA ' ' H ' ' R' ' 170' ' ' TRP . 3.3 m-85 -145.0 163.47 34.1 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . 0.895 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -134.72 131.24 37.4 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.774 -1.204 . . . . 0.0 107.767 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' R' ' 167' ' ' PHE . 1.2 pt -122.53 92.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-O 123.981 1.848 . . . . 0.0 112.811 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.628 ' O ' ' C ' ' R' ' 164' ' ' ASP . 74.8 m-20 -96.06 129.0 43.46 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.105 -2.316 . . . . 0.0 108.637 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . 0.699 ' O ' ' CB ' ' R' ' 165' ' ' GLU . 11.2 t0 -34.37 117.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.699 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 42.9 tp10 135.06 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -169.19 161.14 10.12 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.32 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' R' ' 162' ' ' ILE . 10.1 m-30 -107.38 122.07 45.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' R' ' 168' ' ' TYR . 9.7 p90 -141.63 160.54 56.11 Favored Pre-proline 0 C--N 1.294 -1.817 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.835 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . 0.495 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.1 Cg_endo -69.52 113.45 3.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.36 1.716 . . . . 0.0 108.591 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.727 ' H ' ' HA ' ' R' ' 160' ' ' TYR . 0.0 OUTLIER -142.47 169.73 17.02 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 171' ' ' THR . . . . . 0.598 ' CG2' HD12 ' R' ' 134' ' ' LEU . 0.2 OUTLIER -100.27 99.83 10.49 Favored Pre-proline 0 C--N 1.274 -2.684 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.433 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' R' ' 159' ' ' TRP . 52.0 Cg_endo -75.61 55.67 4.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.884 1.465 . . . . 0.0 108.639 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' R' ' 134' ' ' LEU . 3.7 m-20 -115.39 -176.76 0.39 Allowed Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.89 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' R' ' 173' ' ' ASP . 52.8 Cg_endo -79.81 31.36 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.568 1.299 . . . . 0.0 112.352 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 20.2 t -63.3 -51.19 67.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.733 -1.229 . . . . 0.0 109.387 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -131.86 13.99 4.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.708 . . . . 0.0 110.284 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.841 ' HA ' ' HA ' ' R' ' 142' ' ' PHE . 0.5 OUTLIER -102.69 168.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.894 -1.129 . . . . 0.0 113.221 -177.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . 1.06 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 1.1 mm? -100.59 -95.12 0.27 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.939 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.666 ' HA ' ' N ' ' R' ' 126' ' ' VAL . 28.6 m -80.69 135.42 25.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.714 ' CD2' ' CG ' ' R' ' 137' ' ' PHE 0.261 2.9 p90 -128.85 -178.81 4.77 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.549 1.166 . . . . 0.0 112.315 -173.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' R' ' 62' ' ' TYR . 0.5 OUTLIER -134.19 122.42 16.12 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.554 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' R' ' 180' ' ' PHE . 50.1 Cg_endo -76.34 161.35 34.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.49 1.258 . . . . 0.0 112.142 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' R' ' 137' ' ' PHE . 25.4 p90 -127.14 -173.97 3.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 56.5 t0 . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 0.0 111.434 -179.295 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.054 0.454 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.89 137.39 53.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . 0.684 HD22 HD12 ' R' ' 162' ' ' ILE . 1.3 pt? -145.63 153.0 40.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 32' ' ' THR . . . . . 0.472 ' O ' ' N ' ' R' ' 156' ' ' SER . 1.9 p -112.26 142.88 44.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.202 -0.936 . . . . 0.0 109.562 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.666 ' CD1' ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -134.37 141.91 47.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.268 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' R' ' 154' ' ' VAL . 45.3 t80 -37.56 -38.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' R' ' 62' ' ' TYR . 24.0 m120 -104.21 66.1 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.736 -1.852 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . 0.94 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 129.63 35.25 0.46 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . 0.94 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.3 mt-10 -11.37 -159.14 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' R' ' 38' ' ' LYS . 5.1 pttt -44.98 110.96 0.27 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.053 1.406 . . . . 0.0 113.845 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.508 ' HG2' ' CA ' ' R' ' 61' ' ' ARG . 32.2 tptt -141.49 135.54 30.33 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.26 125.57 32.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 113.609 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.651 ' CD1' ' CD2' ' R' ' 31' ' ' LEU . 31.3 m-85 -100.95 169.82 8.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' R' ' 72' ' ' TYR . 85.6 m-85 -101.04 161.2 13.76 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.641 0.734 . . . . 0.0 111.759 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 43' ' ' SER . . . . . 0.616 ' CA ' ' HB2' ' R' ' 165' ' ' GLU . 36.9 m -55.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.648 0.737 . . . . 0.0 111.696 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' R' ' 164' ' ' ASP . 0.4 OUTLIER -74.49 168.71 24.32 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.48 -0.762 . . . . 0.0 109.373 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 36.5 Cg_endo -62.52 98.88 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . 0.566 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 57.5 t30 -60.9 -118.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.126 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . 0.479 ' C ' ' CG ' ' R' ' 48' ' ' HIS . 0.5 OUTLIER -128.43 89.31 2.88 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.479 -1.388 . . . . 0.0 110.893 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' R' ' 46' ' ' ASN . 0.9 OUTLIER 166.62 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.041 0.448 . . . . 0.0 109.795 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' R' ' 95' ' ' HIS . 12.6 m-20 58.68 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.107 -0.996 . . . . 0.0 109.07 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . 0.597 ' HB3' ' CG2' ' R' ' 79' ' ' THR . 3.4 p30 -141.09 -2.64 1.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.53 -0.731 . . . . 0.0 109.576 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . 0.257 . . -61.94 -35.8 79.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.417 ' CD2' ' O ' ' R' ' 97' ' ' GLY . 15.3 m95 -61.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 117.355 -1.738 . . . . 0.0 106.478 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.732 HD12 HD11 ' R' ' 83' ' ' ILE . 12.0 mt -68.75 -42.02 78.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . 0.501 ' HB3' ' HE2' ' R' ' 151' ' ' PHE . 45.5 t-20 -50.65 -28.0 8.05 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.67 -71.8 0.19 Allowed 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . 0.666 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -59.54 -34.64 55.49 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 O-C-N 120.467 -1.396 . . . . 0.0 110.003 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' R' ' 53' ' ' LEU . 3.9 mm? -64.1 -66.72 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.795 . . . . 0.0 111.125 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . 0.811 ' HG3' HD23 ' R' ' 59' ' ' LEU . 0.1 OUTLIER -59.85 -29.26 68.16 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.811 HD23 ' HG3' ' R' ' 58' ' ' GLN . 3.7 mm? -70.02 -38.98 76.06 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.666 ' HB3' ' O ' ' R' ' 56' ' ' ILE . 0.0 OUTLIER -66.48 -40.96 89.62 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.592 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . 0.535 ' HG2' ' CE2' ' R' ' 60' ' ' PHE . 1.3 mtp180 -56.5 -41.61 76.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.824 -1.173 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' R' ' 59' ' ' LEU . 2.4 p90 -86.39 -47.12 9.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.264 -1.523 . . . . 0.0 111.981 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . 0.486 ' CG2' ' CZ ' ' R' ' 62' ' ' TYR . 24.7 t -70.63 -16.77 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.877 -1.764 . . . . 0.0 109.018 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 71.4 tt0 74.75 42.38 0.28 Allowed 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' R' ' 60' ' ' PHE . 7.4 mt-10 -140.28 90.74 10.19 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.945 -1.097 . . . . 0.0 108.751 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.542 ' HB3' ' CE1' ' R' ' 60' ' ' PHE . 46.5 Cg_endo -75.53 95.06 0.99 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.393 1.207 . . . . 0.0 112.401 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . 0.582 ' CG ' ' CD2' ' R' ' 111' ' ' LEU . 14.4 m-85 -76.78 -27.19 55.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . 0.619 ' CD1' HG13 ' R' ' 56' ' ' ILE . 32.3 m-85 -104.99 50.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.696 1.236 . . . . 0.0 108.643 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.541 ' HA ' ' CD1' ' R' ' 72' ' ' TYR . 38.0 m-20 -45.13 -34.28 2.59 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.713 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -63.0 -34.99 78.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.706 -1.247 . . . . 0.0 109.917 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.666 ' CG1' ' HG ' ' R' ' 57' ' ' LEU . 59.4 t -66.22 -58.44 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.674 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . 0.541 ' CD1' ' HA ' ' R' ' 69' ' ' ASP . 1.3 p90 -69.15 -31.4 70.03 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.864 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -63.23 -25.86 68.52 Favored 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.906 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 74' ' ' SER . . . . . 0.542 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 1.0 OUTLIER -79.32 134.41 58.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.55 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.24 -24.8 31.65 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.644 1.339 . . . . 0.0 110.125 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -117.71 -158.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.435 -0.791 . . . . 0.0 109.906 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -85.22 103.55 14.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.504 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mm? -122.58 47.88 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 79' ' ' THR . . . . . 0.597 ' CG2' ' HB3' ' R' ' 50' ' ' ASN . 0.0 OUTLIER -61.51 -59.25 5.52 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.687 -0.633 . . . . 0.0 110.461 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' R' ' 84' ' ' LYS . 1.0 OUTLIER -49.56 -51.65 35.47 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.789 -178.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.95 -32.48 70.84 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.826 -1.796 . . . . 0.0 109.532 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . 0.545 ' CB ' ' CG2' ' R' ' 71' ' ' VAL . . . -66.18 -58.31 5.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . 0.732 HD11 HD12 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -87.26 -35.62 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.032 -177.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' R' ' 80' ' ' LEU . 25.7 tptt -49.2 -36.35 19.58 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 63.2 tt0 -68.38 -42.03 79.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . 0.655 HD12 HG22 ' R' ' 90' ' ' THR . 2.8 tm? -62.26 -37.84 87.01 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . 0.54 ' HB2' HD13 ' R' ' 94' ' ' LEU . 85.0 tt0 -56.13 -38.56 70.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 108.465 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 89.4 m-20 -58.36 -30.36 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.241 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . 0.55 HD23 HG22 ' R' ' 90' ' ' THR . 4.9 tt -91.1 -53.68 4.26 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.498 -0.751 . . . . 0.0 112.434 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 90' ' ' THR . . . . . 0.655 HG22 HD12 ' R' ' 86' ' ' LEU . 36.1 p -80.14 -31.58 39.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 64.78 30.04 76.89 Favored Glycine 0 N--CA 1.505 3.28 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.906 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' R' ' 102' ' ' LEU . 0.4 OUTLIER -119.5 9.79 11.64 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.961 -1.317 . . . . 0.0 113.131 -177.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . 0.745 ' C ' ' HG ' ' R' ' 94' ' ' LEU . 93.8 mt-10 68.21 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.162 -0.961 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.745 ' HG ' ' C ' ' R' ' 93' ' ' GLU . 0.0 OUTLIER -138.57 -62.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . 0.53 ' C ' ' O ' ' R' ' 94' ' ' LEU . 3.9 p80 -42.5 -37.06 1.51 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' R' ' 93' ' ' GLU . 22.5 pt-20 -104.5 -16.57 15.02 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' R' ' 94' ' ' LEU . . . -93.22 -141.78 11.12 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' R' ' 101' ' ' ALA . . . -130.71 175.16 19.51 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . 0.646 ' HB3' ' HB2' ' R' ' 55' ' ' ALA . 34.4 Cg_endo -70.76 -58.68 0.08 OUTLIER 'Trans proline' 0 CA--C 1.556 1.581 0 O-C-N 123.773 1.407 . . . . 0.0 114.799 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . 0.947 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.2 Cg_endo -59.07 -22.68 65.21 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . 0.837 ' O ' ' N ' ' R' ' 103' ' ' VAL . . . -31.34 58.92 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.083 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' R' ' 100' ' ' PRO . 71.1 mt 36.46 3.27 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.248 -174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . 0.837 ' N ' ' O ' ' R' ' 101' ' ' ALA . 2.7 t -55.02 -39.6 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . 0.514 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 85.8 mt -68.34 -37.45 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.872 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.603 ' HB3' ' HB3' ' R' ' 102' ' ' LEU . 68.1 t-105 -63.36 -46.9 84.39 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.876 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . 0.612 ' HB2' HG23 ' R' ' 90' ' ' THR . 69.6 m-80 -76.32 -30.04 57.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.716 -1.24 . . . . 0.0 111.107 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . 0.581 ' CG2' ' HB2' ' R' ' 110' ' ' LEU . 54.8 mt -81.58 7.22 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.702 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.448 ' HG3' ' CG ' ' R' ' 112' ' ' HIS . 24.2 tttm -34.37 -53.14 0.5 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.559 ' C ' HD11 ' R' ' 110' ' ' LEU . 0.5 OUTLIER -60.02 -14.39 16.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.093 -2.255 . . . . 0.0 111.675 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.581 ' HB2' ' CG2' ' R' ' 107' ' ' ILE . 0.3 OUTLIER -106.49 -40.89 5.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.954 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -74.88 -106.18 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.668 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . 0.589 ' HA ' ' O ' ' R' ' 122' ' ' SER . 30.1 m-70 -25.1 73.56 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 123.833 1.778 . . . . 0.0 109.901 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.954 ' N ' ' O ' ' R' ' 111' ' ' LEU . 3.0 t -60.39 -105.31 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.398 -2.183 . . . . 0.0 110.612 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . 0.645 ' O ' HD12 ' R' ' 115' ' ' ILE . . . -134.92 82.15 0.29 Allowed Glycine 0 N--CA 1.505 3.247 1 N-CA-C 102.877 -4.089 . . . . 0.0 102.877 177.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 1.23 HG22 ' O ' ' R' ' 124' ' ' VAL 0.356 32.4 mm -126.33 162.14 30.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -170.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.12 75.6 0.37 Allowed Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.221 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 117' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' R' ' 120' ' ' ARG . 8.1 m -72.74 149.21 43.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . 0.512 ' HB2' ' OG1' ' R' ' 130' ' ' THR . . . -63.85 -24.79 67.88 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.552 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 60.5 p -97.38 -22.25 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 111.097 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . 0.674 ' O ' ' HB ' ' R' ' 117' ' ' THR . 0.0 OUTLIER -178.12 -164.51 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 O-C-N 120.96 -1.087 . . . . 0.0 110.607 -178.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' R' ' 120' ' ' ARG . 49.1 Cg_endo -85.52 161.99 10.97 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 120.671 0.914 . . . . 0.0 110.295 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.767 ' H ' ' HB ' ' R' ' 115' ' ' ILE . 19.9 m -164.96 -134.78 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.07 -1.019 . . . . 0.0 113.216 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.888 ' CA ' HG13 ' R' ' 115' ' ' ILE . 82.5 tt0 -103.8 -19.18 14.37 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 124.726 1.21 . . . . 0.0 112.886 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . 1.23 ' O ' HG22 ' R' ' 115' ' ' ILE . 10.4 m -161.93 -157.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-O 122.573 1.177 . . . . 0.0 111.74 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.535 ' HB2' ' HG3' ' R' ' 182' ' ' PRO . 48.7 t -95.12 137.31 34.35 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.525 -1.984 . . . . 0.0 107.275 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . 0.667 ' HB ' ' HA ' ' R' ' 117' ' ' THR . 77.5 t -102.51 154.22 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 -174.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.7 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 33.0 m -83.19 -21.42 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 112.905 -1.952 . . . . 0.0 114.14 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -45.3 87.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.094 -1.004 . . . . 0.0 111.437 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 51.6 25.15 13.5 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 130' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' R' ' 118' ' ' ALA . 0.0 OUTLIER -109.88 152.11 26.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.324 -1.104 . . . . 0.0 112.306 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 40.43 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.041 0.924 . . . . 0.0 112.98 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.499 ' HB2' ' HB2' ' R' ' 136' ' ' ASP . 89.6 mtp -90.4 174.19 7.7 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' R' ' 135' ' ' ALA . 62.4 m -100.87 -174.99 2.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.341 -0.85 . . . . 0.0 112.682 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . 0.498 ' CD2' ' CG2' ' R' ' 171' ' ' THR . 0.4 OUTLIER 31.3 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.098 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . 0.462 ' O ' ' OH ' ' R' ' 183' ' ' TYR . . . -62.29 -26.75 68.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.119 -0.988 . . . . 0.0 112.841 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' R' ' 132' ' ' MET . 19.2 t70 -55.99 -42.67 76.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.105 -0.997 . . . . 0.0 112.278 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . 0.685 ' CG ' ' CD1' ' R' ' 180' ' ' PHE . 52.5 p90 -155.23 159.59 40.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.788 -1.195 . . . . 0.0 109.479 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . 0.651 ' CG ' ' CE3' ' R' ' 159' ' ' TRP . 68.5 m-70 -143.76 79.18 1.62 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.139 -1.424 . . . . 0.0 110.857 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' R' ' 181' ' ' VAL . . . 174.88 162.04 0.22 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.175 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 130.06 -170.56 20.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.212 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . 0.501 ' CG1' ' HG ' ' R' ' 59' ' ' LEU . 70.1 mt -104.23 124.61 58.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.742 -0.858 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.992 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 4.2 m-85 -113.76 151.53 31.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.662 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' R' ' 176' ' ' ASP . 26.1 tp -101.66 124.14 46.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.715 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' R' ' 148' ' ' HIS . 38.1 tttt -108.85 113.54 26.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.073 -1.017 . . . . 0.0 110.422 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' R' ' 146' ' ' GLN . . . 50.23 25.63 8.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 95.2 mt-30 54.62 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -1.01 . . . . 0.0 110.631 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.41 23.57 2.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 83.2 m-70 -144.7 131.68 20.36 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.896 . . . . 0.0 108.882 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . 0.445 ' CB ' ' HZ ' ' R' ' 151' ' ' PHE . . . -104.5 115.82 31.03 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.67 ' O ' ' CD1' ' R' ' 151' ' ' PHE . 34.9 m -129.27 152.18 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.67 ' CD1' ' O ' ' R' ' 150' ' ' VAL . 7.7 m-85 -149.89 129.69 13.3 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.791 -1.564 . . . . 0.0 112.012 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.877 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -110.56 167.65 10.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.593 -1.317 . . . . 0.0 110.735 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.466 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 38.0 t -169.63 134.49 1.41 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.581 ' O ' ' CB ' ' R' ' 33' ' ' LEU . 36.9 t -53.38 102.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.383 -1.448 . . . . 0.0 111.283 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 155' ' ' THR . . . . . 0.621 ' CG2' ' HB2' ' R' ' 160' ' ' TYR . 25.1 p -78.82 -165.36 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.713 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 156' ' ' SER . . . . . 0.472 ' N ' ' O ' ' R' ' 32' ' ' THR . 81.1 p -65.41 -18.69 65.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . 0.466 ' CB ' ' CZ ' ' R' ' 160' ' ' TYR . 83.0 m-20 -102.03 2.9 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.273 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . 0.468 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 112.93 -166.14 12.11 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.151 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.651 ' CE3' ' CG ' ' R' ' 138' ' ' HIS . 0.0 OUTLIER -55.58 99.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.495 1.14 . . . . 0.0 108.685 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . 0.626 ' O ' ' HB3' ' R' ' 152' ' ' ALA . 4.0 m-85 -121.83 -178.39 3.82 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . 0.877 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -158.07 136.37 10.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.751 -1.843 . . . . 0.0 110.987 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.684 HD12 HD22 ' R' ' 31' ' ' LEU . 0.6 OUTLIER -75.79 88.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.526 1.155 . . . . 0.0 109.188 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.539 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -94.98 122.83 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' R' ' 44' ' ' ARG . 78.0 m-20 28.19 74.51 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.365 -0.834 . . . . 0.0 112.968 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.654 ' CB ' ' N ' ' R' ' 44' ' ' ARG . 0.1 OUTLIER 68.66 -15.31 0.24 Allowed 'General case' 0 N--CA 1.522 3.149 0 O-C-N 119.597 -1.939 . . . . 0.0 113.448 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.74 134.29 45.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.83 -1.794 . . . . 0.0 112.694 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.675 ' CD1' HG13 ' R' ' 162' ' ' ILE . 6.4 m-85 -101.62 121.66 42.42 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . 0.599 ' CE2' ' CD1' ' R' ' 170' ' ' TRP . 2.8 p90 -150.67 162.05 28.39 Favored Pre-proline 0 C--N 1.281 -2.406 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.314 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' R' ' 160' ' ' TYR . 39.5 Cg_endo -66.62 114.71 3.21 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.231 1.648 . . . . 0.0 109.044 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.599 ' CD1' ' CE2' ' R' ' 168' ' ' TYR . 0.1 OUTLIER -126.4 150.18 48.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 171' ' ' THR . . . . . 0.498 ' CG2' ' CD2' ' R' ' 134' ' ' LEU . 2.3 m -94.26 108.26 34.8 Favored Pre-proline 0 C--N 1.271 -2.816 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.053 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.627 ' CG ' ' HA ' ' R' ' 138' ' ' HIS . 46.1 Cg_endo -72.94 67.03 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 124.048 1.552 . . . . 0.0 110.823 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' R' ' 175' ' ' SER . 8.6 t70 -81.86 139.13 46.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.406 -0.809 . . . . 0.0 109.097 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . 0.586 ' HA ' HG12 ' R' ' 177' ' ' VAL . 44.3 Cg_endo -70.72 35.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.223 1.117 . . . . 0.0 109.95 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 175' ' ' SER . . . . . 0.524 ' H ' ' C ' ' R' ' 173' ' ' ASP . 83.4 p -81.34 -43.38 19.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 111.323 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' R' ' 143' ' ' LEU . 86.4 m-20 -126.16 1.6 7.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.017 -1.052 . . . . 0.0 109.934 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.992 ' HB ' ' CG ' ' R' ' 142' ' ' PHE . 0.2 OUTLIER -95.1 169.37 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.059 0.933 . . . . 0.0 110.464 -178.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . 0.7 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.7 OUTLIER -128.48 -91.45 0.48 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -177.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.43 124.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.685 ' CD1' ' CG ' ' R' ' 137' ' ' PHE . 0.3 OUTLIER -130.45 178.14 6.83 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -175.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -127.26 127.24 24.27 Favored Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.952 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . 0.535 ' HG3' ' HB2' ' R' ' 125' ' ' CYS . 56.2 Cg_endo -87.47 131.93 2.99 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.384 1.202 . . . . 0.0 109.998 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 1.1 p90 -64.6 -34.06 77.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.096 -1.003 . . . . 0.0 109.709 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.0 t0 . . . . . 0 N--CA 1.5 2.031 0 O-C-N 121.416 -0.802 . . . . 0.0 111.62 179.038 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.151 0.501 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 22.7 pt-20 -93.86 120.37 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.382 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' R' ' 41' ' ' PHE . 0.7 OUTLIER -94.04 127.96 40.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 111.3 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 32' ' ' THR . . . . . 0.55 ' O ' ' N ' ' R' ' 156' ' ' SER . 92.6 m -102.19 146.76 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -139.64 167.83 21.2 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.007 -178.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . 0.55 ' HB2' ' CG1' ' R' ' 154' ' ' VAL . 63.6 t80 -41.19 -44.27 2.54 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -75.93 15.47 0.53 Allowed 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 122.594 2.452 . . . . 0.0 113.927 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 -5.92 42.41 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 119.87 -1.769 . . . . 0.0 112.963 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . 0.631 ' HB3' HD23 ' R' ' 33' ' ' LEU . 82.9 tt0 -79.97 137.7 36.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.504 -1.586 . . . . 0.0 110.354 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -120.13 113.96 21.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 109.392 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.476 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 22.2 tptt -122.93 131.74 53.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 40' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' R' ' 30' ' ' GLU . 0.9 OUTLIER -85.9 122.72 30.36 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.924 0.868 . . . . 0.0 112.203 -177.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.921 ' CD1' HD12 ' R' ' 31' ' ' LEU . 0.5 OUTLIER -107.54 159.91 16.07 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' R' ' 42' ' ' TYR . 68.2 m-85 -98.94 134.1 42.28 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.414 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 43' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' R' ' 164' ' ' ASP . 7.0 m -112.7 94.75 5.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.362 -0.836 . . . . 0.0 110.498 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.67 136.09 9.79 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.283 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.58 126.83 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.374 1.197 . . . . 0.0 110.008 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . 0.426 ' CB ' ' HB3' ' R' ' 50' ' ' ASN . 0.3 OUTLIER -97.35 -120.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 109.396 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . 0.41 ' H ' ' HB3' ' R' ' 46' ' ' ASN . 1.2 p-10 -128.61 77.23 1.76 Allowed 'General case' 0 N--CA 1.512 2.634 0 O-C-N 120.242 -1.536 . . . . 0.0 111.262 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 74.6 m80 48.44 16.98 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.801 -0.562 . . . . 0.0 112.345 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.538 ' HB3' ' HA ' ' R' ' 96' ' ' GLU . 37.3 m-20 -146.66 47.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.024 . . . . 0.0 108.725 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . 0.712 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 24.1 p30 -114.72 -21.68 10.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' O ' ' R' ' 149' ' ' ALA 0.282 . . -66.32 -41.93 88.97 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.282 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.672 ' CG ' ' HA2' ' R' ' 97' ' ' GLY . 39.6 m95 -59.71 -34.78 73.35 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.912 -1.515 . . . . 0.0 107.256 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.688 HD13 HG13 ' R' ' 83' ' ' ILE . 20.2 mt -68.18 -35.2 77.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . 0.568 ' OD1' ' NE2' ' R' ' 58' ' ' GLN . 56.6 t-20 -48.92 -28.11 3.59 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . 0.866 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.13 -64.72 0.8 Allowed 'General case' 0 C--O 1.203 -1.371 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . 0.534 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -57.13 -36.32 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.751 178.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . 0.845 ' N ' HD22 ' R' ' 57' ' ' LEU . 3.9 mm? -68.61 -72.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.623 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . 0.568 ' NE2' ' OD1' ' R' ' 54' ' ' ASN . 0.7 OUTLIER -57.85 -29.68 65.19 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.637 -1.289 . . . . 0.0 108.536 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.866 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 0.2 OUTLIER -70.43 -37.26 74.35 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.852 ' HA ' ' HD3' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -50.68 -53.02 34.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . 0.614 ' N ' ' CG ' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -55.87 -48.46 75.52 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.104 -1.039 . . . . 0.0 113.343 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' HB2' ' R' ' 153' ' ' CYS . 0.1 OUTLIER -90.69 -47.7 7.5 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 119.962 -1.711 . . . . 0.0 113.921 -176.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . 0.776 ' O ' ' CB ' ' R' ' 64' ' ' GLU . 47.7 t -77.76 -24.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.169 -0.957 . . . . 0.0 111.811 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . 0.776 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 88.2 tt0 124.33 117.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.131 0.967 . . . . 0.0 109.346 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.579 ' HA ' ' HB2' ' R' ' 60' ' ' PHE . 0.1 OUTLIER -44.28 100.32 0.23 Allowed Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.852 ' HD3' ' HA ' ' R' ' 60' ' ' PHE . 51.8 Cg_endo -85.45 -162.12 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.589 2.192 . . . . 0.0 107.399 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' R' ' 69' ' ' ASP . 34.4 t80 -45.0 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 O-C-N 121.769 -0.582 . . . . 0.0 112.022 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . 0.716 ' HD1' ' O ' ' R' ' 66' ' ' PRO . 0.7 OUTLIER -37.52 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.008 -1.057 . . . . 0.0 113.031 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' R' ' 67' ' ' PHE . 51.0 m-20 -49.12 -34.34 13.87 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.62 -0.675 . . . . 0.0 112.234 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' R' ' 82' ' ' ALA . 70.2 m95 -64.43 -31.24 72.37 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.572 -1.33 . . . . 0.0 109.858 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.584 HG22 ' CB ' ' R' ' 82' ' ' ALA . 46.9 t -70.81 -67.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . 0.528 ' CD1' HG13 ' R' ' 71' ' ' VAL . 13.3 m-30 -77.42 -30.36 53.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.739 . . . . 0.0 111.878 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 73' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 22.4 t -60.83 -19.34 59.66 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.318 -1.353 . . . . 0.0 109.049 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 74' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 38.5 m -77.2 139.87 65.18 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.771 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 -27.55 39.77 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.92 164.76 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.79 . . . . 0.0 109.679 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -52.59 110.26 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.197 -0.94 . . . . 0.0 110.088 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mp -126.81 47.36 2.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.677 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 79' ' ' THR . . . . . 0.712 ' OG1' ' HA ' ' R' ' 50' ' ' ASN . 0.5 OUTLIER -65.99 -52.19 51.63 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.009 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' R' ' 79' ' ' THR . 0.0 OUTLIER -51.04 -59.39 4.21 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.678 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.38 -28.0 69.69 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.498 -1.376 . . . . 0.0 109.736 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . 0.584 ' CB ' HG22 ' R' ' 71' ' ' VAL . . . -56.29 -51.1 69.43 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.48 -0.762 . . . . 0.0 111.624 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . 0.688 HG13 HD13 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -85.41 -36.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.045 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' R' ' 87' ' ' GLU . 32.9 tttt -49.82 -33.52 16.97 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . 0.419 ' HG2' ' CE2' ' R' ' 70' ' ' TRP . 50.9 tp60 -77.15 -36.4 55.28 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . 0.585 ' CD2' HG23 ' R' ' 90' ' ' THR . 2.7 tm? -66.75 -40.62 88.38 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.807 -0.558 . . . . 0.0 110.176 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' R' ' 91' ' ' GLY . 10.7 pt-20 -66.08 -31.73 72.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.944 -1.098 . . . . 0.0 108.27 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.06 -31.36 69.91 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.389 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . 0.472 HD21 HG23 ' R' ' 90' ' ' THR . 1.1 tt -93.59 -48.89 6.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.581 -0.699 . . . . 0.0 111.042 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 90' ' ' THR . . . . . 0.585 HG23 ' CD2' ' R' ' 86' ' ' LEU . 68.1 p -74.89 -24.06 58.47 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' R' ' 87' ' ' GLU . . . 68.95 26.35 74.73 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.033 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . 0.559 HD21 ' O ' ' R' ' 101' ' ' ALA . 0.3 OUTLIER -105.94 -17.53 14.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.823 -1.398 . . . . 0.0 111.354 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' R' ' 92' ' ' LEU . 81.6 tt0 65.44 122.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' R' ' 83' ' ' ILE . 0.3 OUTLIER -166.39 12.5 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . 0.535 ' HA ' HD11 ' R' ' 83' ' ' ILE . 0.7 OUTLIER -42.39 -29.12 0.25 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.607 -0.683 . . . . 0.0 109.234 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.538 ' HA ' ' HB3' ' R' ' 49' ' ' ASP . 98.5 mt-10 -116.15 23.33 12.25 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.647 -0.658 . . . . 0.0 110.854 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.672 ' HA2' ' CG ' ' R' ' 52' ' ' TRP . . . 156.08 128.56 1.11 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.651 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' R' ' 101' ' ' ALA . . . 152.02 75.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.686 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.843 ' HG2' ' HD2' ' R' ' 100' ' ' PRO . 33.5 Cg_endo -86.13 -90.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.564 1.999 0 C-N-CA 121.32 1.347 . . . . 0.0 110.406 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.843 ' HD2' ' HG2' ' R' ' 99' ' ' PRO . 37.1 Cg_endo -62.55 -16.97 55.78 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 106.108 -2.305 . . . . 0.0 106.108 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.789 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.263 . . -30.87 61.82 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 113.61 -1.632 . . . . 0.0 112.587 175.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . 0.837 ' N ' ' O ' ' R' ' 100' ' ' PRO . 48.2 mt 39.38 0.74 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.671 -175.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . 0.789 ' N ' ' O ' ' R' ' 101' ' ' ALA . 21.8 t -52.68 -40.58 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . 0.576 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 32.3 pt -75.56 -36.54 34.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.373 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.62 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 61.5 t90 -64.63 -43.0 95.1 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.579 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . 0.456 ' HB3' ' HA ' ' R' ' 90' ' ' THR . 27.3 m120 -78.35 -27.08 46.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.723 -1.236 . . . . 0.0 112.066 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . 0.637 ' CG2' ' HB2' ' R' ' 110' ' ' LEU . 63.3 mt -78.18 16.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 111.762 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' R' ' 105' ' ' TRP . 80.4 mttt -30.49 -52.22 0.16 Allowed 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.525 ' CD2' ' CD2' ' R' ' 110' ' ' LEU . 36.9 p-80 -57.51 -26.98 62.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.143 -2.223 . . . . 0.0 112.458 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.637 ' HB2' ' CG2' ' R' ' 107' ' ' ILE . 0.2 OUTLIER -100.43 -39.49 7.93 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 176.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.1 OUTLIER -78.49 -96.91 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 111.523 -2.581 . . . . 0.0 114.608 -176.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . 0.658 ' C ' ' O ' ' R' ' 111' ' ' LEU . 85.4 t60 -13.62 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 123.897 1.808 . . . . 0.0 109.986 -173.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.823 ' N ' ' O ' ' R' ' 111' ' ' LEU . 7.2 t -97.85 -173.43 2.61 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.446 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' R' ' 123' ' ' GLU . . . -68.66 105.8 1.57 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.617 HD12 HG21 ' R' ' 124' ' ' VAL . 3.5 mm -109.88 143.55 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.539 -1.565 . . . . 0.0 110.581 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.11 -154.65 6.19 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.183 -1.484 . . . . 0.0 112.114 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 117' ' ' THR . . . . . 0.517 ' HA ' ' CG2' ' R' ' 126' ' ' VAL . 5.1 m -133.03 165.08 25.56 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . 0.609 ' CB ' ' CG2' ' R' ' 130' ' ' THR . . . -53.21 -36.35 60.91 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.38 -1.45 . . . . 0.0 110.369 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.2 m -64.59 -36.28 83.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -124.19 94.18 45.67 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.502 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.44 134.32 30.56 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.753 1.396 . . . . 0.0 112.061 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 122' ' ' SER . . . . . . . . . . . . . 3.5 m -134.11 -162.88 1.29 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' R' ' 114' ' ' GLY . 77.1 mm-40 -55.01 -41.24 71.04 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.567 -1.333 . . . . 0.0 108.377 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . 0.617 HG21 HD12 ' R' ' 115' ' ' ILE . 0.9 OUTLIER -129.07 147.35 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.484 ' SG ' ' CZ ' ' R' ' 180' ' ' PHE . 5.9 t -127.74 159.35 35.04 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.218 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . 0.739 ' C ' ' HA ' ' R' ' 179' ' ' VAL . 15.7 m -85.2 -163.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.898 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 1.1 p -60.68 -160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.726 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' R' ' 130' ' ' THR . 28.9 p-10 -96.55 -74.91 0.55 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.746 -1.221 . . . . 0.0 113.21 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . 0.502 ' H ' ' CG ' ' R' ' 128' ' ' ASP . . . 58.7 5.38 2.72 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 130' ' ' THR . . . . . 0.609 ' CG2' ' CB ' ' R' ' 118' ' ' ALA . 11.3 t -127.93 167.33 16.78 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.279 0.632 . . . . 0.0 109.355 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.4 74.44 2.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.466 ' HG3' HG21 ' R' ' 130' ' ' THR . 56.2 mtt -127.88 167.0 17.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.85 -170.87 3.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.281 -0.887 . . . . 0.0 111.381 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . 0.609 ' CD1' ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -38.87 -56.36 1.38 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 121.591 0.71 . . . . 0.0 112.538 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.57 -19.96 62.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' R' ' 183' ' ' TYR . 0.8 OUTLIER -55.71 -38.37 69.63 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.455 -1.403 . . . . 0.0 112.369 -178.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . 0.55 ' CB ' ' CD1' ' R' ' 180' ' ' PHE . 0.3 OUTLIER -142.38 168.69 19.15 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.947 -1.095 . . . . 0.0 108.173 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . 0.554 ' O ' ' HA ' ' R' ' 153' ' ' CYS . 14.8 m-70 -134.8 63.58 1.62 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.272 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.724 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . 166.52 165.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.786 -0.571 . . . . 0.0 110.119 175.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.02 -178.97 32.28 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.216 -1.468 . . . . 0.0 111.954 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . 0.638 ' HB ' ' CG1' ' R' ' 179' ' ' VAL . 10.7 mt -112.05 119.23 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 122.015 -0.697 . . . . 0.0 110.392 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.766 ' CD2' HG13 ' R' ' 177' ' ' VAL . 8.0 m-85 -109.28 134.94 51.15 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.097 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' R' ' 143' ' ' LEU . 4.6 mm? -85.72 101.23 12.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -93.55 124.53 37.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 110.934 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.69 -145.32 8.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -111.52 138.98 47.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.996 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' R' ' 147' ' ' GLU . 79.7 tt0 54.67 44.34 28.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.41 122.03 14.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.595 ' O ' ' HB1' ' R' ' 51' ' ' ALA . . . -109.56 139.26 44.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 110.641 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.662 ' C ' ' CD1' ' R' ' 151' ' ' PHE . 35.7 m -139.52 153.27 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.055 -1.028 . . . . 0.0 109.174 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.804 ' CE2' ' HA ' ' R' ' 55' ' ' ALA . 82.0 m-85 -147.19 124.68 11.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.769 -1.207 . . . . 0.0 110.438 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.999 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.03 171.93 7.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.365 -1.459 . . . . 0.0 112.743 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.569 ' HB2' ' CZ ' ' R' ' 62' ' ' TYR . 9.1 t -167.3 136.05 2.65 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.587 ' O ' ' CB ' ' R' ' 33' ' ' LEU . 53.2 t -56.5 109.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.354 -1.466 . . . . 0.0 111.654 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 155' ' ' THR . . . . . 0.677 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 77.2 p -89.63 -169.59 2.52 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 156' ' ' SER . . . . . 0.55 ' N ' ' O ' ' R' ' 32' ' ' THR . 44.7 t -60.34 -21.25 61.84 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.777 -1.202 . . . . 0.0 108.428 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CE1' ' R' ' 160' ' ' TYR . 79.4 m-20 -95.96 3.71 53.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . 0.451 ' HA2' HG12 ' R' ' 154' ' ' VAL . . . 106.23 -160.78 14.46 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.537 ' HB3' ' HD3' ' R' ' 172' ' ' PRO . 5.5 m-90 -57.36 101.58 0.07 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.625 -0.927 . . . . 0.0 108.687 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . 0.677 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 4.2 m-85 -127.52 131.47 50.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . 0.999 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -106.27 146.73 29.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 119.979 -1.701 . . . . 0.0 110.937 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' R' ' 41' ' ' PHE . 96.9 mt -102.66 90.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' R' ' 164' ' ' ASP . 3.6 t0 -88.58 122.46 32.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' R' ' 163' ' ' ASP . 26.0 t0 -3.45 -64.69 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' R' ' 163' ' ' ASP . 97.1 mt-10 -59.34 -42.21 90.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.696 -1.253 . . . . 0.0 114.37 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -167.26 172.92 9.4 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 119.811 -1.806 . . . . 0.0 113.215 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.57 ' CD1' HG12 ' R' ' 162' ' ' ILE . 3.5 m-30 -98.43 129.13 45.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . 0.637 ' CE1' ' HB1' ' R' ' 161' ' ' ALA . 2.1 p90 -141.15 163.86 39.39 Favored Pre-proline 0 C--N 1.29 -2.01 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.94 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . 0.452 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.3 Cg_endo -69.84 108.52 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . 0.5 OUTLIER -138.9 153.81 48.31 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 171' ' ' THR . . . . . 0.609 ' CG2' ' CD1' ' R' ' 134' ' ' LEU . 1.0 OUTLIER -101.93 151.23 37.95 Favored Pre-proline 0 C--N 1.278 -2.541 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.29 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.582 ' HD2' HD11 ' R' ' 134' ' ' LEU . 45.3 Cg_endo -94.37 32.97 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.865 1.71 . . . . 0.0 109.411 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . 0.582 ' O ' ' CG1' ' R' ' 177' ' ' VAL . 0.6 OUTLIER -76.77 153.27 83.17 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.357 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . 0.435 ' HA ' HG12 ' R' ' 177' ' ' VAL . 49.5 Cg_endo -75.67 26.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.968 1.51 . . . . 0.0 111.206 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 175' ' ' SER . . . . . 0.401 ' H ' ' C ' ' R' ' 173' ' ' ASP . 23.3 t -69.89 -48.3 59.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.985 -1.072 . . . . 0.0 110.897 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -125.6 13.45 8.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.766 HG13 ' CD2' ' R' ' 142' ' ' PHE . 0.1 OUTLIER -121.48 153.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.832 . . . . 0.0 109.736 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.898 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 2.1 mm? -127.63 46.6 2.52 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.062 -1.455 . . . . 0.0 108.932 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.739 ' HA ' ' C ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.61 124.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.55 ' CD1' ' CB ' ' R' ' 137' ' ' PHE . 4.2 p90 -125.12 168.17 13.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.544 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' R' ' 139' ' ' ALA . 1.0 OUTLIER -122.87 111.99 30.73 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.122 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' R' ' 125' ' ' CYS . 47.7 Cg_endo -76.04 156.14 38.34 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.615 1.324 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' R' ' 138' ' ' HIS . 1.1 p90 -91.43 -2.21 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.517 -0.739 . . . . 0.0 110.873 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 53.64 48.34 21.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 111.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -100.58 130.12 46.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -116.31 163.86 20.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.347 -0.845 . . . . 0.0 110.205 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.33 143.81 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.796 1.419 . . . . 0.0 110.522 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.1 1.44 54.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.42 -0.8 . . . . 0.0 110.75 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -102.04 131.42 48.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.364 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.37 -175.24 47.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 50.84 94.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.448 -1.03 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -112.24 139.23 47.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.149 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -80.56 133.33 35.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.86 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.4 145.54 30.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 19.0 tptt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.19 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.05 0.452 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -117.5 119.43 35.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.16 -0.962 . . . . 0.0 111.282 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . 0.715 HD12 ' CE1' ' R' ' 160' ' ' TYR . 3.8 mm? -94.8 166.81 11.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.392 -0.817 . . . . 0.0 109.546 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 32' ' ' THR . . . . . 0.561 ' CB ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -126.47 140.23 52.63 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -173.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.897 ' HA ' ' HA ' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -17.64 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.84 0 CA-C-N 111.837 -2.438 . . . . 0.0 116.463 176.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . 0.776 ' C ' ' O ' ' R' ' 33' ' ' LEU . 92.5 m-85 -19.58 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.977 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' R' ' 33' ' ' LEU . 7.0 m120 -131.84 62.41 1.63 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . 1.216 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 141.75 36.8 0.09 OUTLIER Glycine 0 N--CA 1.479 1.521 0 C-N-CA 117.055 -2.498 . . . . 0.0 110.465 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . 1.216 ' O ' ' O ' ' R' ' 36' ' ' GLY . 80.7 mm-40 -11.68 -167.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 122.455 0.302 . . . . 0.0 110.848 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.33 92.73 0.29 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 116.23 -2.188 . . . . 0.0 106.809 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' R' ' 37' ' ' GLU . 36.2 mmtt -123.76 119.87 31.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 40' ' ' THR . . . . . 0.44 ' O ' ' NH2' ' R' ' 61' ' ' ARG . 0.9 OUTLIER -91.29 115.08 27.74 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.452 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.713 ' CD1' ' CD2' ' R' ' 31' ' ' LEU . 3.0 m-85 -98.42 162.83 12.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . 0.772 ' O ' ' HB3' ' R' ' 165' ' ' GLU . 97.4 m-85 -95.4 158.58 15.4 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 46.7 m -115.57 94.9 4.9 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . 0.504 ' H ' ' CB ' ' R' ' 165' ' ' GLU . 0.0 OUTLIER -167.64 124.16 0.89 Allowed Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.306 -0.871 . . . . 0.0 109.096 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.18 126.35 13.59 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 N-CA-C 108.625 -1.336 . . . . 0.0 108.625 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 74.4 m-20 -88.12 152.97 21.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.149 -0.97 . . . . 0.0 109.033 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.39 80.24 1.82 Allowed 'General case' 0 N--CA 1.507 2.387 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.257 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . 0.6 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 5.3 p-80 178.62 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 1.5 p30 157.16 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . 0.491 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 8.4 p30 -142.88 -25.75 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.911 -1.118 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.615 ' HA ' ' HB3' ' R' ' 54' ' ' ASN 0.271 . . -64.98 -44.24 89.96 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.056 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.477 ' CE2' ' HA2' ' R' ' 97' ' ' GLY . 75.3 m95 -58.01 -36.17 72.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.898 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.737 HD11 HD12 ' R' ' 83' ' ' ILE . 11.6 mt -69.38 -44.73 70.92 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . 0.618 ' O ' ' HB2' ' R' ' 58' ' ' GLN . 0.0 OUTLIER -43.28 -32.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 108.921 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . 0.865 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -64.93 -67.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.591 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . 0.569 ' H ' HD11 ' R' ' 56' ' ' ILE . 0.2 OUTLIER -84.19 -41.74 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 117.884 -1.527 . . . . 0.0 109.885 178.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . 0.67 ' CB ' ' O ' ' R' ' 53' ' ' LEU 0.265 1.5 tm? -48.25 -61.87 1.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.604 0.716 . . . . 0.0 111.207 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . 0.618 ' HB2' ' O ' ' R' ' 54' ' ' ASN . 73.4 mt-30 -70.06 -27.77 64.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.865 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 3.4 tp -55.93 -38.51 70.38 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.64 ' CE2' ' HB3' ' R' ' 67' ' ' PHE . 22.9 m-30 -58.41 -41.18 84.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.144 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . 0.51 ' CB ' ' CZ ' ' R' ' 41' ' ' PHE . 0.0 OUTLIER -64.88 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.344 -1.472 . . . . 0.0 114.473 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.637 ' CD1' ' O ' ' R' ' 59' ' ' LEU . 1.4 p90 -82.78 -42.39 17.99 Favored 'General case' 0 N--CA 1.516 2.826 0 O-C-N 119.575 -1.953 . . . . 0.0 114.731 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . 0.698 ' O ' ' CB ' ' R' ' 64' ' ' GLU . 24.5 t -73.77 -14.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 119.825 -1.797 . . . . 0.0 111.179 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . 0.698 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 65.0 tt0 98.91 29.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.569 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 1.8 tp10 -132.33 90.15 34.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.663 -1.273 . . . . 0.0 107.788 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' R' ' 60' ' ' PHE . 48.3 Cg_endo -78.09 83.55 2.18 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.706 1.372 . . . . 0.0 113.966 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . 0.64 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 48.0 t80 -83.35 -19.11 36.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . 0.633 ' HB2' ' CD1' ' R' ' 57' ' ' LEU . 0.0 OUTLIER -62.38 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.012 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.656 ' O ' ' HB3' ' R' ' 73' ' ' SER . 94.8 m-20 -46.8 -39.37 11.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.457 -0.777 . . . . 0.0 111.775 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.443 ' O ' ' HB2' ' R' ' 77' ' ' ASN . 35.3 m95 -69.82 -37.28 76.19 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.766 -1.208 . . . . 0.0 109.635 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.56 ' CG2' HD22 ' R' ' 57' ' ' LEU 0.252 43.5 t -70.34 -75.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . 0.51 ' HB2' ' CE2' ' R' ' 68' ' ' PHE . 18.8 m-30 -86.65 -35.96 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 111.737 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 73' ' ' SER . . . . . 0.656 ' HB3' ' O ' ' R' ' 69' ' ' ASP . 9.6 t -71.03 -17.33 62.63 Favored 'General case' 0 N--CA 1.509 2.511 0 C-N-CA 117.702 -1.599 . . . . 0.0 108.909 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 74' ' ' SER . . . . . 0.425 ' HB2' ' HA ' ' R' ' 70' ' ' TRP . 0.4 OUTLIER -117.47 114.41 38.22 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.366 -0.834 . . . . 0.0 109.334 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.34 -11.65 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.539 1.283 . . . . 0.0 110.528 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -104.84 -64.47 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 111.169 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . 0.459 ' CA ' ' HB2' ' R' ' 81' ' ' GLU . 11.6 m120 -44.54 -44.18 8.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 112.047 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . 0.474 ' C ' ' HA ' ' R' ' 71' ' ' VAL . 6.1 mp 49.57 -154.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.893 -1.129 . . . . 0.0 111.008 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 79' ' ' THR . . . . . 0.669 ' HA ' ' CD1' ' R' ' 53' ' ' LEU . 2.0 t -68.67 -59.23 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.899 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . 0.432 ' H ' ' CG2' ' R' ' 79' ' ' THR . 0.4 OUTLIER -50.13 -52.26 36.59 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . 0.459 ' HB2' ' CA ' ' R' ' 77' ' ' ASN . 72.2 mt-10 -69.75 -27.92 65.35 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.077 -1.639 . . . . 0.0 109.302 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' R' ' 79' ' ' THR . . . -58.9 -53.7 55.49 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.683 -0.636 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . 0.737 HD12 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -86.4 -33.62 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.44 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' R' ' 83' ' ' ILE . 16.4 tttt -49.81 -36.36 26.11 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.89 -41.01 92.07 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . 0.664 ' HB3' ' HG1' ' R' ' 90' ' ' THR . 13.2 mt -67.03 -34.29 77.4 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.804 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . 0.592 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -51.63 -42.06 61.74 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.8 -36.03 82.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.551 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . 0.518 ' CD2' HG23 ' R' ' 90' ' ' THR . 5.1 tt -99.07 -52.45 3.54 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.695 -1.253 . . . . 0.0 111.824 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 90' ' ' THR . . . . . 0.753 ' HA ' ' CB ' ' R' ' 106' ' ' ASN . 64.8 p -70.72 -24.74 62.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . 0.592 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 61.83 21.89 61.52 Favored Glycine 0 N--CA 1.502 3.052 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.673 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . 0.664 HD12 HD21 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -93.59 -16.09 24.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.225 -1.162 . . . . 0.0 111.193 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . 0.48 ' H ' HD11 ' R' ' 92' ' ' LEU . 95.9 mt-10 52.13 93.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.387 -0.821 . . . . 0.0 108.835 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.664 HD21 HD12 ' R' ' 92' ' ' LEU . 2.5 pp -145.09 4.94 1.1 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.977 -1.077 . . . . 0.0 109.91 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . 0.58 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.9 OUTLIER -39.31 -33.87 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.422 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.49 21.82 11.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.568 -0.707 . . . . 0.0 110.658 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.644 ' O ' ' HB2' ' R' ' 94' ' ' LEU . . . 160.16 -115.26 0.65 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.087 -1.53 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' R' ' 97' ' ' GLY . . . 55.81 166.48 0.05 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.474 ' HG2' ' CG ' ' R' ' 102' ' ' LEU . 47.9 Cg_endo -79.43 125.23 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.73 1.384 . . . . 0.0 110.575 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.539 ' O ' HG23 ' R' ' 56' ' ' ILE . 39.3 Cg_endo -64.71 -34.35 51.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.487 1.257 . . . . 0.0 109.859 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.566 ' O ' HG12 ' R' ' 104' ' ' ILE 0.251 . . -57.6 -39.73 77.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.956 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . 0.474 ' CG ' ' HG2' ' R' ' 99' ' ' PRO . 3.5 mm? -56.08 -31.75 63.5 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.027 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' R' ' 107' ' ' ILE . 14.8 t -59.18 -52.85 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . 0.566 HG12 ' O ' ' R' ' 101' ' ' ALA . 43.5 pt -66.04 -34.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 111.108 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.484 ' N ' HG13 ' R' ' 104' ' ' ILE . 8.4 m95 -60.7 -38.97 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 111.816 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . 0.753 ' CB ' ' HA ' ' R' ' 90' ' ' THR . 71.3 m-80 -82.26 -34.56 28.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.702 -1.249 . . . . 0.0 113.265 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' R' ' 110' ' ' LEU . 0.2 OUTLIER -92.76 22.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.601 -1.312 . . . . 0.0 110.368 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' R' ' 112' ' ' HIS . 32.3 tttt -29.58 -58.99 0.16 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.616 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.3 m-70 -63.12 -13.59 38.5 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.129 2.24 . . . . 0.0 111.232 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.616 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -111.11 -7.46 14.49 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.749 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -142.99 -111.34 0.12 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.197 -1.365 . . . . 0.0 114.449 -173.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . 0.626 ' C ' ' O ' ' R' ' 111' ' ' LEU . 82.8 t60 -19.47 81.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 123.768 1.747 . . . . 0.0 109.871 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.749 ' N ' ' O ' ' R' ' 111' ' ' LEU 0.25 4.5 t -70.12 -162.55 0.06 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.14 177.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -68.1 97.84 0.46 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.631 ' CD1' HG22 ' R' ' 113' ' ' THR . 3.3 mm -113.01 145.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.784 -1.421 . . . . 0.0 110.601 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . 0.433 ' N ' ' HB2' ' R' ' 122' ' ' SER . . . -124.92 -143.99 6.23 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.925 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 117' ' ' THR . . . . . 0.54 ' HA ' ' CG2' ' R' ' 126' ' ' VAL . 24.9 m -138.05 174.5 10.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . 0.59 ' HB1' ' HB ' ' R' ' 130' ' ' THR . . . -55.66 -29.45 59.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.389 -1.325 . . . . 0.0 109.62 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 39.6 m -87.11 -33.19 19.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -101.16 119.8 56.89 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.247 -0.908 . . . . 0.0 110.384 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.79 124.91 4.68 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.627 1.33 . . . . 0.0 112.228 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.433 ' HB2' ' N ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER -140.74 -170.08 2.94 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' R' ' 114' ' ' GLY . 52.7 mt-10 -55.59 -44.74 77.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.52 -1.362 . . . . 0.0 107.862 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . 0.618 HG22 HD13 ' R' ' 115' ' ' ILE . 1.9 m -120.25 138.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.542 ' O ' ' O ' ' R' ' 180' ' ' PHE . 43.1 t -123.05 135.22 54.34 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.237 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . 0.922 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 10.4 m -80.64 -173.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.417 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.862 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 3.6 m -117.16 -42.01 2.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.802 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . 0.418 ' N ' ' CG2' ' R' ' 127' ' ' VAL . 89.2 m-20 42.55 37.12 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.566 -1.334 . . . . 0.0 111.021 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.33 39.92 91.83 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 130' ' ' THR . . . . . 0.59 ' HB ' ' HB1' ' R' ' 118' ' ' ALA . 90.7 m -113.34 152.62 29.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.694 -0.886 . . . . 0.0 111.627 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' R' ' 130' ' ' THR . 65.6 m-20 70.73 -166.88 0.15 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.864 0.84 . . . . 0.0 111.987 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.522 ' O ' ' OD2' ' R' ' 173' ' ' ASP . 87.2 mtp -83.83 177.5 8.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.889 -0.507 . . . . 0.0 111.111 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' R' ' 134' ' ' LEU . 0.5 OUTLIER -89.22 -171.22 3.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.69 -0.631 . . . . 0.0 111.253 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . 1.038 ' CA ' ' HB2' ' R' ' 173' ' ' ASP . 0.3 OUTLIER -3.76 -70.35 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' R' ' 133' ' ' CYS . . . -54.19 3.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . 0.607 ' O ' ' CZ ' ' R' ' 183' ' ' TYR . 14.5 t70 -84.98 -90.47 0.1 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 119.396 -2.065 . . . . 0.0 111.598 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . 0.797 ' CE1' ' HB2' ' R' ' 180' ' ' PHE . 14.3 p90 -102.47 -176.19 3.03 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . 0.694 ' HB2' ' CG2' ' R' ' 154' ' ' VAL . 0.0 OUTLIER -149.53 79.96 1.39 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.183 -1.807 . . . . 0.0 111.196 176.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.78 ' HB2' ' CG1' ' R' ' 181' ' ' VAL . . . 176.96 161.29 0.41 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.656 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 131.45 -165.62 23.17 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.826 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . 0.56 ' O ' ' CB ' ' R' ' 177' ' ' VAL . 62.0 mt -106.8 119.18 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.8 -0.823 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.736 ' CD2' HG11 ' R' ' 177' ' ' VAL . 0.4 OUTLIER -109.72 140.01 44.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.718 0.771 . . . . 0.0 109.688 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.42 119.36 38.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.33 -0.857 . . . . 0.0 108.978 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -100.73 121.26 41.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.751 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.75 -124.08 32.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -133.92 154.64 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.8 31.0 2.88 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.99 125.23 20.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.508 -0.745 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' R' ' 51' ' ' ALA . . . -112.43 142.91 44.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 110.233 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.556 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.3 m -142.15 167.63 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.0 109.7 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.525 ' O ' ' N ' ' R' ' 162' ' ' ILE . 52.2 t80 -150.35 121.68 7.86 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.257 -0.902 . . . . 0.0 112.214 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 1.089 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.44 168.0 10.23 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 119.985 -1.697 . . . . 0.0 110.264 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.753 ' HB2' ' CE2' ' R' ' 160' ' ' TYR . 0.5 OUTLIER -168.56 144.82 3.7 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.361 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.694 ' CG2' ' HB2' ' R' ' 138' ' ' HIS . 41.4 t -55.55 123.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.081 -1.637 . . . . 0.0 114.028 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 155' ' ' THR . . . . . 0.585 ' CG2' ' HB3' ' R' ' 160' ' ' TYR . 21.9 p -126.88 -179.56 4.89 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.127 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 42.1 m -56.36 -20.29 18.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.169 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . 0.492 ' HB3' ' HG3' ' R' ' 169' ' ' PRO . 79.1 m-20 -92.66 -5.2 51.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.576 -0.702 . . . . 0.0 111.855 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 116.96 -135.44 11.96 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.996 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.793 ' O ' ' HA ' ' R' ' 169' ' ' PRO . 0.0 OUTLIER -82.34 82.17 7.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . 0.753 ' CE2' ' HB2' ' R' ' 153' ' ' CYS . 0.0 OUTLIER -64.22 160.04 19.42 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . 1.089 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -147.12 113.23 5.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.687 ' CG2' ' O ' ' R' ' 162' ' ' ILE . 0.7 OUTLIER -72.43 83.69 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 123.103 1.43 . . . . 0.0 111.101 -175.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -80.01 131.0 35.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' R' ' 163' ' ' ASP . 92.6 m-20 32.82 65.16 0.24 Allowed 'General case' 0 N--CA 1.518 2.94 0 O-C-N 120.884 -1.135 . . . . 0.0 112.465 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.772 ' HB3' ' O ' ' R' ' 42' ' ' TYR . 5.3 mt-10 58.75 8.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.232 -1.542 . . . . 0.0 112.129 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 74.5 m-20 -109.44 152.54 25.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 119.977 -1.702 . . . . 0.0 108.754 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.584 ' HB2' ' CD1' ' R' ' 160' ' ' TYR . 19.5 p90 -124.7 130.39 52.33 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.868 1.318 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' R' ' 161' ' ' ALA . 2.0 p90 -159.42 144.03 11.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.685 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . 0.793 ' HA ' ' O ' ' R' ' 159' ' ' TRP . 50.3 Cg_endo -72.89 107.7 2.41 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 O-C-N 123.088 1.046 . . . . 0.0 112.802 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.576 ' O ' ' CG2' ' R' ' 171' ' ' THR . 0.6 OUTLIER -135.3 18.28 3.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 117.123 -1.831 . . . . 0.0 112.66 175.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 171' ' ' THR . . . . . 0.576 ' CG2' ' O ' ' R' ' 170' ' ' TRP . 0.1 OUTLIER 167.43 121.01 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.965 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 175.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.677 ' HB3' ' CD1' ' R' ' 159' ' ' TRP . 42.2 Cg_endo -101.65 16.76 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.235 1.29 . . . . 0.0 113.421 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . 1.038 ' HB2' ' CA ' ' R' ' 134' ' ' LEU . 0.1 OUTLIER -144.48 -173.1 0.34 Allowed Pre-proline 0 N--CA 1.511 2.583 0 O-C-N 118.216 -2.802 . . . . 0.0 114.923 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . 0.864 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.4 Cg_endo -86.39 34.07 0.45 Allowed 'Trans proline' 0 C--O 1.217 -0.57 0 O-C-N 124.29 1.679 . . . . 0.0 112.143 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 175' ' ' SER . . . . . 0.418 ' OG ' HD22 ' R' ' 134' ' ' LEU . 15.0 m -62.18 -43.45 98.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.816 -1.178 . . . . 0.0 108.436 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -123.09 0.82 9.13 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.63 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.864 HG13 ' HA ' ' R' ' 174' ' ' PRO . 0.2 OUTLIER -109.34 157.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.304 -0.873 . . . . 0.0 109.838 -178.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.862 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.5 OUTLIER -132.1 38.34 3.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 117.529 -1.668 . . . . 0.0 110.606 177.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.922 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 7.7 p -165.63 129.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.797 ' HB2' ' CE1' ' R' ' 137' ' ' PHE . 7.1 p90 -136.72 179.44 6.37 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.174 -1.41 . . . . 0.0 111.227 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . 0.78 ' CG1' ' HB2' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -112.21 137.98 21.67 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.395 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.49 141.34 60.88 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.5 1.263 . . . . 0.0 111.866 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 15.7 p90 -138.35 172.74 12.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -154.29 164.27 38.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.18 -0.95 . . . . 0.0 110.947 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -131.25 158.19 41.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.557 -0.715 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.51 106.51 46.53 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 150.9 64.01 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.68 1.358 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 25.2 tp -97.56 126.01 42.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.252 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -125.81 116.44 21.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.243 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -167.38 150.85 17.91 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 48.28 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.517 -0.99 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -139.12 163.26 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.398 -0.814 . . . . 0.0 110.209 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.16 110.05 22.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.077 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -102.63 144.5 30.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.887 . . . . 0.0 110.344 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.257 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' R' R ' 29' ' ' MET . . . . . 0.521 ' HB2' ' CE2' ' R' ' 167' ' ' PHE . 89.2 mtp . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.291 0.567 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 93.2 mt-10 -97.77 114.71 26.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 111.372 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . 0.757 ' HB3' ' CD2' ' R' ' 167' ' ' PHE . 1.2 pt? -122.9 135.52 54.53 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.49 -1.284 . . . . 0.0 111.025 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 32' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' R' ' 38' ' ' LYS . 8.8 t -91.58 156.24 17.79 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.574 ' H ' HD21 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -106.26 -173.97 2.42 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.655 -0.653 . . . . 0.0 110.595 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . 0.713 ' N ' ' O ' ' R' ' 154' ' ' VAL . 19.2 p90 -48.14 -49.8 31.01 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' R' ' 34' ' ' TYR . 12.4 p-10 -76.57 17.99 0.36 Allowed 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 122.417 2.371 . . . . 0.0 114.303 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -13.74 40.47 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 120.07 -1.644 . . . . 0.0 112.795 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . 0.542 ' HB3' HD22 ' R' ' 33' ' ' LEU . 81.2 tt0 -61.18 131.88 51.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.637 1.718 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' R' ' 32' ' ' THR . 52.6 pttt -100.93 113.03 25.63 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.925 0.869 . . . . 0.0 111.062 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' R' ' 61' ' ' ARG . 67.1 mttm -113.21 117.77 32.81 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 40' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' R' ' 40' ' ' THR . 1.3 t -94.69 133.0 38.82 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.358 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.944 ' CZ ' HD13 ' R' ' 162' ' ' ILE . 0.1 OUTLIER -145.67 166.73 24.95 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.739 176.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . 0.512 ' O ' ' OG ' ' R' ' 43' ' ' SER . 87.0 m-85 -79.35 175.86 10.21 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.964 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 43' ' ' SER . . . . . 0.689 ' O ' ' O ' ' R' ' 44' ' ' ARG . 0.8 OUTLIER 169.62 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . 0.689 ' O ' ' O ' ' R' ' 43' ' ' SER . 5.7 ptt180 -32.87 163.97 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.019 -1.05 . . . . 0.0 111.483 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 29.3 Cg_endo -52.28 104.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.347 1.183 . . . . 0.0 110.874 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' R' ' 76' ' ' GLU . 7.3 t-20 -92.63 -127.67 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.555 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . 0.553 ' O ' ' HB2' ' R' ' 48' ' ' HIS . 0.4 OUTLIER -134.55 138.12 44.36 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.613 -1.304 . . . . 0.0 111.661 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . 0.553 ' HB2' ' O ' ' R' ' 47' ' ' ASN . 92.9 m-70 72.52 42.98 0.5 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.423 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' R' ' 48' ' ' HIS . 80.1 m-20 55.26 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.439 -0.788 . . . . 0.0 109.357 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -111.63 1.98 17.06 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.623 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.438 ' O ' ' HB1' ' R' ' 149' ' ' ALA 0.253 . . -68.51 -41.86 79.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.696 -0.628 . . . . 0.0 111.716 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.503 ' CD2' ' O ' ' R' ' 97' ' ' GLY . 33.2 m95 -60.13 -33.64 72.42 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.08 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.948 ' CD1' HG12 ' R' ' 83' ' ' ILE . 2.3 mt -79.53 -40.37 29.75 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . 0.555 ' O ' ' HG3' ' R' ' 58' ' ' GLN . 8.3 t30 -55.15 -28.79 55.31 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . 0.792 ' HA ' ' CD1' ' R' ' 151' ' ' PHE . . . -64.43 -64.37 0.9 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . 0.65 ' HB ' ' CE2' ' R' ' 68' ' ' PHE . 0.6 OUTLIER -67.27 -29.2 45.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 O-C-N 120.231 -1.543 . . . . 0.0 108.174 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' R' ' 71' ' ' VAL . 1.8 mm? -52.62 -54.57 31.31 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 109.139 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' R' ' 54' ' ' ASN . 1.8 mt-30 -55.03 -31.73 61.31 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.616 HD11 ' CE1' ' R' ' 62' ' ' TYR . 1.4 tp -67.84 -40.71 83.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.728 ' HB2' ' HD2' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -54.14 -47.28 72.09 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.955 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . 0.575 ' HG2' ' CZ ' ' R' ' 60' ' ' PHE . 16.2 mmt180 -57.8 -54.32 48.22 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.884 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.616 ' CE1' HD11 ' R' ' 59' ' ' LEU . 21.6 p90 -92.6 -31.76 15.04 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 119.598 -1.939 . . . . 0.0 114.016 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . 0.73 ' O ' ' CB ' ' R' ' 64' ' ' GLU . 56.1 t -77.18 -24.85 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 120.137 -1.602 . . . . 0.0 110.233 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . 0.73 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 87.3 tt0 123.22 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.546 ' HB3' ' HD1' ' R' ' 60' ' ' PHE . 3.5 pt-20 -50.44 100.92 0.24 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.728 ' HD2' ' HB2' ' R' ' 60' ' ' PHE . 46.7 Cg_endo -86.69 -165.23 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 N-CA-C 106.023 -2.337 . . . . 0.0 106.023 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' R' ' 69' ' ' ASP . 76.6 m-85 -41.95 -19.35 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . 0.65 ' CE2' ' HB ' ' R' ' 56' ' ' ILE . 3.2 m-30 -58.24 -3.01 0.22 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.286 -1.509 . . . . 0.0 110.452 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.523 ' HA ' ' CE2' ' R' ' 72' ' ' TYR . 19.8 t70 -58.35 -30.39 66.71 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.717 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.429 ' CB ' ' HA ' ' R' ' 82' ' ' ALA . 85.2 m95 -61.58 -33.51 74.01 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.848 -1.158 . . . . 0.0 108.886 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.756 ' HB ' HD12 ' R' ' 57' ' ' LEU . 55.5 t -68.39 -62.2 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.535 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' R' ' 69' ' ' ASP . 0.8 OUTLIER -71.98 -30.75 65.58 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.207 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 73' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 34.0 t -63.99 -23.24 67.26 Favored 'General case' 0 N--CA 1.51 2.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.434 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 148.93 80.45 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' R' ' 42' ' ' TYR . 38.8 Cg_endo -65.03 -17.46 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.712 1.375 . . . . 0.0 110.025 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' R' ' 78' ' ' LEU . 96.1 mt-10 -141.28 58.84 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.5 -0.75 . . . . 0.0 109.499 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' R' ' 78' ' ' LEU . 28.7 t-20 57.38 -84.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.818 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . 0.525 ' CB ' ' O ' ' R' ' 77' ' ' ASN . 0.1 OUTLIER 78.33 67.28 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 79' ' ' THR . . . . . 0.578 ' O ' ' CG1' ' R' ' 83' ' ' ILE . 5.3 t -65.25 -52.64 53.14 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.834 -0.541 . . . . 0.0 110.573 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . 0.471 ' O ' ' HG3' ' R' ' 84' ' ' LYS . 0.4 OUTLIER -49.85 -53.12 27.65 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.56 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -68.12 -28.22 67.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.059 -1.651 . . . . 0.0 110.277 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' CB ' ' CG2' ' R' ' 71' ' ' VAL . . . -66.61 -46.74 74.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.768 0.794 . . . . 0.0 112.436 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . 0.948 HG12 ' CD1' ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.36 -39.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.565 -176.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' R' ' 80' ' ' LEU . 35.4 mttm -49.74 -35.86 23.63 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . 0.738 ' O ' HD11 ' R' ' 89' ' ' LEU . 68.3 tp60 -70.93 -44.57 65.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . 0.591 HD13 HG22 ' R' ' 103' ' ' VAL . 1.4 tm? -55.11 -38.4 68.12 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . 0.552 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.8 tt0 -59.37 -33.22 70.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.915 -1.115 . . . . 0.0 108.15 177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 82.0 m-20 -55.14 -32.49 62.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.956 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . 0.738 HD11 ' O ' ' R' ' 85' ' ' GLN . 0.3 OUTLIER -102.61 -49.1 3.93 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.938 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 90' ' ' THR . . . . . 0.885 ' OG1' HD23 ' R' ' 92' ' ' LEU . 35.0 p -78.6 -27.79 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 73.12 23.61 77.32 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.154 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . 0.885 HD23 ' OG1' ' R' ' 90' ' ' THR . 0.3 OUTLIER -108.12 -160.88 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.063 -1.257 . . . . 0.0 112.042 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . 0.591 ' C ' HD13 ' R' ' 94' ' ' LEU . 95.5 mt-10 -144.56 104.79 4.09 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.725 HD23 HG22 ' R' ' 103' ' ' VAL . 0.3 OUTLIER -105.28 9.97 33.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.853 -1.155 . . . . 0.0 110.762 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' R' ' 94' ' ' LEU . 17.0 m170 -45.29 -29.75 1.09 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' R' ' 94' ' ' LEU . 80.4 tt0 -150.49 33.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' R' ' 52' ' ' TRP . . . -95.64 -111.58 2.59 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.02 -1.05 . . . . 0.0 110.731 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . 178.14 -161.44 28.32 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.661 ' CD ' ' HD2' ' R' ' 100' ' ' PRO . 31.3 Cg_endo -72.69 -64.84 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 O-C-N 123.849 1.447 . . . . 0.0 114.108 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.932 ' O ' ' N ' ' R' ' 102' ' ' LEU . 33.6 Cg_endo -57.22 -28.32 78.9 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 N-CA-C 107.181 -1.892 . . . . 0.0 107.181 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.251 . . -29.35 60.44 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.197 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . 0.932 ' N ' ' O ' ' R' ' 100' ' ' PRO . 7.3 mp 35.45 -4.74 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -175.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . 0.949 ' O ' ' HB ' ' R' ' 107' ' ' ILE . 34.3 t -61.74 -44.99 99.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 C-N-CA 114.855 -2.738 . . . . 0.0 105.641 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' R' ' 100' ' ' PRO . 19.0 pt -84.14 -36.09 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.339 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.711 ' HB3' ' HA ' ' R' ' 102' ' ' LEU . 48.0 t-105 -60.27 -45.26 93.91 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.152 -1.419 . . . . 0.0 111.419 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -84.88 -22.53 29.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.891 -1.131 . . . . 0.0 111.794 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . 0.949 ' HB ' ' O ' ' R' ' 103' ' ' VAL . 0.2 OUTLIER -67.48 -14.43 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 111.33 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 107' ' ' ILE . 75.2 tttt -33.96 -59.73 0.41 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -84.0 -7.67 59.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.274 -2.141 . . . . 0.0 111.451 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.692 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.1 OUTLIER -84.26 -30.85 25.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.516 -1.365 . . . . 0.0 109.199 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' R' ' 107' ' ' ILE 0.281 57.6 mt -68.11 161.03 27.79 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.692 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -117.14 60.13 0.75 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.516 ' CG2' HD13 ' R' ' 115' ' ' ILE . 97.4 m -145.12 138.36 26.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.395 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -74.67 98.4 1.05 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 105.615 -2.994 . . . . 0.0 105.615 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.551 HD12 ' CG2' ' R' ' 124' ' ' VAL . 31.1 mm -93.24 142.5 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.814 -1.404 . . . . 0.0 109.828 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' R' ' 122' ' ' SER . . . -133.46 -165.78 11.18 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.869 -1.634 . . . . 0.0 111.952 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 117' ' ' THR . . . . . 0.573 ' HA ' HG21 ' R' ' 126' ' ' VAL . 7.2 m -134.63 -175.43 3.88 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . 0.562 ' HB1' ' OG1' ' R' ' 130' ' ' THR . . . -64.58 -37.86 89.0 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.795 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -66.71 -36.35 82.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.67 101.79 36.26 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.022 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.07 135.73 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.621 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.471 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 0.2 OUTLIER -145.22 -158.99 0.94 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.637 -0.665 . . . . 0.0 109.426 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.409 ' HB2' HG23 ' R' ' 113' ' ' THR . 77.0 mm-40 -56.13 -43.9 78.67 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.796 -1.19 . . . . 0.0 108.433 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . 0.551 ' CG2' HD12 ' R' ' 115' ' ' ILE . 10.7 m -115.95 135.14 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.446 ' O ' ' CD1' ' R' ' 180' ' ' PHE . 7.0 t -134.3 136.9 43.83 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.966 0.888 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . 0.929 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 6.1 m -82.53 -179.92 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.31 1.053 . . . . 0.0 111.18 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.907 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 5.0 m -121.55 -1.01 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . 0.428 ' CA ' ' CD1' ' R' ' 178' ' ' LEU . 55.9 t0 -60.49 92.96 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.764 -1.21 . . . . 0.0 110.374 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.49 67.45 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 130' ' ' THR . . . . . 0.562 ' OG1' ' HB1' ' R' ' 118' ' ' ALA . 1.4 m -97.38 146.71 24.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.685 -0.891 . . . . 0.0 111.267 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -66.32 -32.39 73.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.461 ' HB3' ' CZ ' ' R' ' 180' ' ' PHE . 64.0 mtt -90.34 141.62 28.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.0 110.962 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.31 -165.32 1.78 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.71 -0.619 . . . . 0.0 110.228 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . 0.609 ' CD1' ' CG2' ' R' ' 171' ' ' THR . 0.9 OUTLIER -45.67 -30.0 1.42 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.77 -41.45 32.36 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . 0.644 ' O ' ' CD2' ' R' ' 137' ' ' PHE . 94.0 m-20 -71.15 -140.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . 0.681 ' HB2' ' CE2' ' R' ' 183' ' ' TYR . 0.4 OUTLIER -173.37 101.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 116.593 -2.043 . . . . 0.0 112.266 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . 0.952 ' HB3' ' O ' ' R' ' 181' ' ' VAL . 0.2 OUTLIER -163.32 -138.63 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.214 1.007 . . . . 0.0 109.857 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.777 ' H ' HG11 ' R' ' 181' ' ' VAL 0.261 . . -104.81 179.69 4.2 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.744 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 161.52 -178.68 37.33 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . 0.629 HG12 ' CZ ' ' R' ' 151' ' ' PHE . 3.6 mt -108.35 115.69 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.627 -0.925 . . . . 0.0 110.616 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 1.047 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 3.0 m-85 -114.82 154.64 28.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.8 129.37 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' R' ' 148' ' ' HIS . 36.1 tttp -109.12 122.37 47.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.24 -130.6 49.73 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.49 -129.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.353 -1.087 . . . . 0.0 109.554 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.63 92.65 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 109.802 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' R' ' 144' ' ' LYS . 1.9 t60 -146.47 122.15 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.462 -0.773 . . . . 0.0 108.92 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.453 ' CB ' ' CE3' ' R' ' 52' ' ' TRP . . . -94.47 118.87 32.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.797 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.608 ' CG2' ' O ' ' R' ' 142' ' ' PHE . 34.7 m -133.62 147.63 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.005 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.792 ' CD1' ' HA ' ' R' ' 55' ' ' ALA . 3.3 m-85 -136.11 131.78 35.23 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.867 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.63 169.91 8.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.597 -1.314 . . . . 0.0 111.29 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.422 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 3.9 t -163.37 133.09 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' R' ' 34' ' ' TYR . 48.3 t -50.91 117.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.101 -1.44 . . . . 0.0 111.919 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 155' ' ' THR . . . . . 0.742 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 66.4 p -104.4 -158.34 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 83.5 p -65.73 -15.47 62.86 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.672 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 86.0 m-20 -113.01 9.47 18.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.358 -0.839 . . . . 0.0 111.969 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' R' ' 160' ' ' TYR . . . 100.92 -153.96 19.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.757 ' CG ' ' O ' ' R' ' 171' ' ' THR . 0.0 OUTLIER -57.91 94.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.322 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . 0.742 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 0.2 OUTLIER -115.79 119.04 34.72 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . 0.867 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -109.94 147.99 32.42 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.44 -1.413 . . . . 0.0 110.114 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.944 HD13 ' CZ ' ' R' ' 41' ' ' PHE . 6.0 pt -117.51 91.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-O 124.191 1.948 . . . . 0.0 112.029 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.666 ' O ' ' C ' ' R' ' 164' ' ' ASP . 63.6 m-20 -83.0 120.26 25.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 111.784 -2.462 . . . . 0.0 106.169 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . 0.666 ' C ' ' O ' ' R' ' 163' ' ' ASP . 96.8 m-20 11.93 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.113 0.959 . . . . 0.0 111.553 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' R' ' 163' ' ' ASP . 98.6 mt-10 -31.41 -52.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 19.8 t0 -172.5 177.9 2.88 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 119.339 -2.101 . . . . 0.0 113.496 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.849 ' HA ' HG22 ' R' ' 162' ' ' ILE . 2.1 m-30 -93.52 129.35 39.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' R' ' 161' ' ' ALA . 36.9 p90 -155.42 170.18 9.13 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.556 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 41.3 Cg_endo -68.61 113.38 3.15 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.748 -1.674 . . . . 0.0 107.748 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.685 ' HA ' ' HE3' ' R' ' 170' ' ' TRP . 0.0 OUTLIER -117.66 -129.24 0.29 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 123.361 1.553 . . . . 0.0 111.956 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 171' ' ' THR . . . . . 0.757 ' O ' ' CG ' ' R' ' 159' ' ' TRP 0.319 1.4 m -32.22 97.74 0.11 Allowed Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 112.904 -1.953 . . . . 0.0 115.389 -174.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.482 ' HD2' ' H ' ' R' ' 173' ' ' ASP . 53.2 Cg_endo -92.93 -30.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.53 1.805 . . . . 0.0 108.037 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . 0.532 ' CA ' ' HG ' ' R' ' 134' ' ' LEU . 18.0 p30 -148.15 170.43 7.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.448 -0.783 . . . . 0.0 108.915 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' R' ' 134' ' ' LEU . 49.5 Cg_endo -85.64 51.36 2.87 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 83.4 p -82.15 -34.13 29.28 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -125.41 6.11 7.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.557 -1.339 . . . . 0.0 111.054 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 1.047 ' HB ' ' CG ' ' R' ' 142' ' ' PHE 0.259 2.3 p -112.31 148.49 15.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.231 -0.918 . . . . 0.0 110.687 -177.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.907 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.4 OUTLIER -133.05 46.26 2.63 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.893 175.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.929 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.43 131.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' R' ' 182' ' ' PRO . 2.3 p90 -132.46 178.53 6.76 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.686 1.231 . . . . 0.0 108.987 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . 0.952 ' O ' ' HB3' ' R' ' 138' ' ' HIS . 0.8 OUTLIER -121.64 93.3 48.73 Favored Pre-proline 0 C--N 1.265 -3.088 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . 0.506 ' HB3' ' CE2' ' R' ' 180' ' ' PHE . 36.5 Cg_endo -60.05 109.29 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 120.862 1.041 . . . . 0.0 113.629 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.681 ' CE2' ' HB2' ' R' ' 137' ' ' PHE . 0.0 OUTLIER -67.12 -151.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.036 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -74.81 123.18 24.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.109 -0.994 . . . . 0.0 110.483 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -85.74 155.26 21.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.454 -0.779 . . . . 0.0 110.098 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -54.9 138.6 63.88 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.455 -0.778 . . . . 0.0 110.394 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.6 154.75 64.2 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.752 1.396 . . . . 0.0 110.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 75.1 mt -84.5 146.14 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 109.976 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -100.6 137.56 38.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -85.08 -173.48 49.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 51.77 -162.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.361 -1.082 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 98.2 m95 52.09 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -80.62 135.23 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.44 154.27 45.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.202 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' R' R ' 29' ' ' MET . . . . . 0.429 ' HB2' ' CZ ' ' R' ' 167' ' ' PHE . 88.0 mtp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.162 0.506 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 84.1 tt0 -110.44 126.95 54.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.822 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . 0.647 ' CD1' ' CG2' ' R' ' 162' ' ' ILE . 1.7 pt? -139.02 163.4 32.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.459 -0.776 . . . . 0.0 109.632 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 32' ' ' THR . . . . . 0.415 ' CG2' ' HB3' ' R' ' 38' ' ' LYS . 31.8 p -104.78 129.26 53.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.145 . . . . 0.0 111.973 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.682 ' CD1' ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -130.68 136.03 48.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.41 -0.806 . . . . 0.0 109.773 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . 0.465 ' CB ' HG13 ' R' ' 154' ' ' VAL . 58.2 t80 -33.48 -36.18 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' R' ' 62' ' ' TYR . 97.4 m-20 -105.34 65.13 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.837 -1.789 . . . . 0.0 111.287 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . 0.972 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 128.33 35.27 0.51 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . 0.972 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.0 mt-10 -13.82 -150.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' R' ' 38' ' ' LYS . 9.5 pttm -52.29 109.1 0.35 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.356 -1.465 . . . . 0.0 112.518 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.51 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 30.0 mmtm -150.09 147.19 27.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.315 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 40' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' R' ' 72' ' ' TYR . 0.8 OUTLIER -85.4 125.42 32.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.126 -0.984 . . . . 0.0 110.019 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.714 ' CD2' ' CE2' ' R' ' 151' ' ' PHE . 84.2 m-85 -110.09 154.02 23.85 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.934 1.349 . . . . 0.0 114.42 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . 0.634 ' O ' ' CB ' ' R' ' 43' ' ' SER . 76.2 m-85 -116.45 164.22 14.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.256 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 43' ' ' SER . . . . . 0.728 ' HA ' ' HA ' ' R' ' 51' ' ' ALA . 0.6 OUTLIER 155.71 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 119.446 1.021 . . . . 0.0 113.304 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . 0.576 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 4.5 mtt180 -72.28 175.74 2.92 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 109.24 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . 0.45 ' HD2' ' CB ' ' R' ' 44' ' ' ARG . 37.5 Cg_endo -61.65 100.59 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.286 1.15 . . . . 0.0 113.204 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . 0.424 ' H ' ' H ' ' R' ' 47' ' ' ASN . 2.1 m-20 -150.73 -11.85 0.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . 0.424 ' H ' ' H ' ' R' ' 46' ' ' ASN . 0.2 OUTLIER -135.78 -178.67 5.24 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . 0.455 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 77.4 m80 -92.7 -6.93 48.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.639 -1.288 . . . . 0.0 109.824 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 12.5 p30 172.17 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 109.605 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . 0.451 ' CG ' ' HB ' ' R' ' 79' ' ' THR . 0.2 OUTLIER -138.58 -3.13 1.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' R' ' 43' ' ' SER 0.255 . . -66.3 -44.54 83.18 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.712 -0.617 . . . . 0.0 110.718 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.633 ' CD2' ' HA2' ' R' ' 97' ' ' GLY . 55.2 m95 -61.1 -36.63 80.21 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.555 -1.658 . . . . 0.0 107.795 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.914 ' CD1' HG12 ' R' ' 83' ' ' ILE . 2.4 mt -68.49 -34.86 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . 0.608 ' HB2' ' O ' ' R' ' 42' ' ' TYR . 0.0 OUTLIER -47.6 -26.98 1.64 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . 0.826 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.52 -56.98 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . 0.626 ' O ' ' CG ' ' R' ' 60' ' ' PHE 0.291 1.2 mp -62.58 -42.39 95.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 122.379 1.085 . . . . 0.0 108.311 177.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . 0.861 HD13 ' CD1' ' R' ' 72' ' ' TYR . 4.2 mm? -65.03 -60.7 2.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.953 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . 0.678 ' HB2' ' CD1' ' R' ' 151' ' ' PHE . 4.6 pt20 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.826 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 1.6 mp -70.97 -48.54 52.77 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.566 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.626 ' CG ' ' O ' ' R' ' 56' ' ' ILE . 12.7 m-30 -61.51 -45.93 92.12 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.474 -1.29 . . . . 0.0 110.59 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . 0.51 ' HD3' ' HB3' ' R' ' 39' ' ' LYS . 1.5 tpm_? -58.3 -31.23 67.29 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 119.67 -1.894 . . . . 0.0 110.139 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.725 ' HB3' HG21 ' R' ' 181' ' ' VAL . 22.0 m-30 -61.7 -54.01 48.32 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.541 -1.35 . . . . 0.0 111.986 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . 0.492 ' CG1' HG22 ' R' ' 113' ' ' THR . 3.9 t -85.79 3.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.363 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 74.4 tt0 67.04 44.91 1.85 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.515 ' CG ' ' CE1' ' R' ' 112' ' ' HIS . 4.4 mp0 -133.88 89.18 30.46 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.521 ' HA ' ' CE2' ' R' ' 68' ' ' PHE . 53.1 Cg_endo -79.27 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.543 1.286 . . . . 0.0 113.757 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . 0.53 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 55.1 t80 -82.98 -25.71 32.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . 0.709 ' HB2' HD11 ' R' ' 57' ' ' LEU . 2.0 p90 -72.6 19.15 0.08 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.991 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' R' ' 73' ' ' SER . 95.5 m-20 -38.2 -37.29 0.27 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.451 -0.781 . . . . 0.0 112.868 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.498 ' HB2' ' HA ' ' R' ' 82' ' ' ALA . 84.8 m95 -62.03 -30.44 70.97 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.24 -1.538 . . . . 0.0 110.113 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.647 HG13 ' HG ' ' R' ' 57' ' ' LEU . 65.5 t -78.7 -67.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . 0.861 ' CD1' HD13 ' R' ' 57' ' ' LEU . 9.9 m-30 -67.89 -38.8 83.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.239 -0.913 . . . . 0.0 110.94 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 73' ' ' SER . . . . . 0.56 ' HB2' ' O ' ' R' ' 69' ' ' ASP . 6.1 m -63.35 -21.62 66.38 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.739 -1.185 . . . . 0.0 109.561 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 74' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 16.4 t -99.6 119.71 59.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.957 . . . . 0.0 110.513 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.97 -19.25 46.2 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.569 1.299 . . . . 0.0 110.279 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.61 165.19 11.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.449 -0.782 . . . . 0.0 109.849 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -58.52 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.825 . . . . 0.0 110.728 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . 0.415 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.4 mm? -107.82 21.81 16.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 79' ' ' THR . . . . . 0.541 ' O ' ' CG1' ' R' ' 83' ' ' ILE . 3.1 t -55.48 -52.64 62.97 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.506 -0.746 . . . . 0.0 109.956 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . 0.45 ' H ' ' CG2' ' R' ' 79' ' ' THR . 1.2 pp -49.86 -50.84 44.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.692 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . 0.409 ' OE2' ' CZ3' ' R' ' 70' ' ' TRP . 84.8 tt0 -67.08 -28.63 68.34 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.28 -1.513 . . . . 0.0 110.104 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . 0.526 ' CB ' HG23 ' R' ' 71' ' ' VAL . . . -67.01 -48.45 68.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.93 0.871 . . . . 0.0 111.572 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . 0.914 HG12 ' CD1' ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.76 -38.52 11.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.443 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 83' ' ' ILE . 36.7 tttm -50.49 -35.34 28.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -73.55 -36.56 65.65 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . 0.636 HD13 ' CG2' ' R' ' 90' ' ' THR . 2.6 tm? -63.13 -38.18 90.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . 0.57 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 83.0 tt0 -60.9 -39.71 90.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 108.824 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.08 -32.3 72.82 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.273 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . 0.47 ' CD2' HG23 ' R' ' 90' ' ' THR . 2.6 tt -94.91 -51.25 4.76 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.08 -1.013 . . . . 0.0 111.805 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 90' ' ' THR . . . . . 0.636 ' CG2' HD13 ' R' ' 86' ' ' LEU . 69.7 p -76.58 -25.64 54.21 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . 0.57 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 67.29 26.15 73.52 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.692 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . 0.608 HD11 HD22 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -104.54 -17.98 14.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.02 -1.283 . . . . 0.0 111.756 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . 0.518 ' O ' ' O ' ' R' ' 92' ' ' LEU . 84.1 tt0 58.42 115.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.608 HD22 HD11 ' R' ' 92' ' ' LEU . 3.7 pp -156.75 21.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.688 -1.257 . . . . 0.0 111.181 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' R' ' 94' ' ' LEU . 5.7 p80 -42.42 -28.35 0.2 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.2 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.451 ' C ' ' CD1' ' R' ' 52' ' ' TRP . 23.1 pt-20 -120.39 36.11 4.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.633 ' HA2' ' CD2' ' R' ' 52' ' ' TRP . . . 145.87 110.78 0.67 Allowed Glycine 0 N--CA 1.504 3.182 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.329 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' R' ' 94' ' ' LEU . . . -170.68 65.29 0.16 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.023 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.834 ' HB2' ' CD ' ' R' ' 100' ' ' PRO . 42.8 Cg_endo -84.56 -108.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.965 0 O-C-N 123.322 1.169 . . . . 0.0 109.211 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.881 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.3 Cg_endo -60.18 -17.88 48.49 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 N-CA-C 106.845 -2.021 . . . . 0.0 106.845 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.254 . . -31.22 61.27 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.195 175.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . 0.881 ' N ' ' O ' ' R' ' 100' ' ' PRO . 80.8 mt 41.0 -3.42 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.369 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.008 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . 0.892 ' O ' HG12 ' R' ' 107' ' ' ILE . 13.4 t -56.98 -47.75 82.85 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 C-N-CA 114.335 -2.946 . . . . 0.0 104.079 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.46 -39.36 85.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.932 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.615 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 51.9 t90 -63.02 -36.31 83.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.12 -1.432 . . . . 0.0 111.25 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . 0.494 ' CB ' HG23 ' R' ' 90' ' ' THR . 22.3 m120 -84.87 -23.19 29.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.086 -1.009 . . . . 0.0 113.26 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . 0.892 HG12 ' O ' ' R' ' 103' ' ' VAL . 3.4 mm -70.6 -10.95 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.242 -1.536 . . . . 0.0 110.02 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' R' ' 107' ' ' ILE . 62.1 mttt -33.47 -57.93 0.41 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.587 ' C ' HD11 ' R' ' 110' ' ' LEU . 4.1 m-70 -72.91 -9.68 58.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 119.181 -2.199 . . . . 0.0 111.506 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.587 HD11 ' C ' ' R' ' 109' ' ' HIS . 0.2 OUTLIER -106.54 -16.82 14.43 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' R' ' 107' ' ' ILE 0.323 0.1 OUTLIER -109.71 127.62 54.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.835 -176.52 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' CG ' ' R' ' 65' ' ' GLU . 55.4 p-80 -115.37 76.91 1.03 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.633 HG23 HD12 ' R' ' 115' ' ' ILE . 18.0 m -132.14 136.42 47.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.278 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' R' ' 123' ' ' GLU . . . -75.73 104.36 1.78 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.727 HD13 HG21 ' R' ' 124' ' ' VAL . 3.3 mm -90.9 144.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.634 -1.509 . . . . 0.0 109.358 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . 0.746 ' O ' ' HB3' ' R' ' 125' ' ' CYS . . . -145.42 -118.79 1.2 Allowed Glycine 0 N--CA 1.509 3.562 0 C-N-CA 118.408 -1.853 . . . . 0.0 112.462 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 117' ' ' THR . . . . . 0.406 ' C ' HG23 ' R' ' 126' ' ' VAL . 0.0 OUTLIER -178.95 -175.2 0.38 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.204 -1.174 . . . . 0.0 108.814 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . 0.687 ' HB3' ' CB ' ' R' ' 130' ' ' THR 0.278 . . -66.84 -43.62 83.22 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.31 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -37.77 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 108.889 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.22 104.11 35.28 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.33 131.17 27.38 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.524 1.276 . . . . 0.0 111.224 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.442 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 46.7 m -146.05 -168.91 3.12 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.541 ' O ' HG23 ' R' ' 181' ' ' VAL . 76.8 mm-40 -63.18 -43.16 99.02 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.8 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . 0.727 HG21 HD13 ' R' ' 115' ' ' ILE . 0.6 OUTLIER -149.17 122.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.337 -1.477 . . . . 0.0 112.566 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.746 ' HB3' ' O ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER 152.74 138.03 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.061 176.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . 0.734 HG23 ' O ' ' R' ' 125' ' ' CYS . 1.1 t -176.55 -172.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 1.06 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 33.4 m 36.91 -3.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 127.779 2.432 . . . . 0.0 116.863 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' R' ' 126' ' ' VAL . 44.9 t0 -57.22 55.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.659 -1.276 . . . . 0.0 111.752 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 105.28 15.56 19.12 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 130' ' ' THR . . . . . 0.687 ' CB ' ' HB3' ' R' ' 118' ' ' ALA . 87.1 m -116.53 154.32 30.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -1.175 . . . . 0.0 112.164 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -58.78 159.59 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.773 -0.579 . . . . 0.0 109.52 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.432 ' HG2' ' HB2' ' R' ' 174' ' ' PRO . 28.2 mtt -123.81 136.36 54.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.283 -0.885 . . . . 0.0 111.326 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.3 134.64 36.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.027 -1.045 . . . . 0.0 111.086 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . 0.669 HD12 ' OD1' ' R' ' 173' ' ' ASP . 0.2 OUTLIER -59.89 -42.22 93.34 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.244 1.021 . . . . 0.0 110.587 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.4 0.52 9.95 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -73.31 -65.74 0.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.106 . . . . 0.0 111.827 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . 0.714 ' CG ' ' CD2' ' R' ' 180' ' ' PHE . 19.5 p90 -146.85 178.23 8.5 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.091 -1.006 . . . . 0.0 110.2 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . 0.56 ' HA ' ' O ' ' R' ' 172' ' ' PRO . 29.3 m80 -143.14 72.66 1.37 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.245 -1.382 . . . . 0.0 112.212 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' R' ' 181' ' ' VAL . . . 171.81 153.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.626 ' O ' ' OE1' ' R' ' 58' ' ' GLN . . . 144.16 -176.23 23.53 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.283 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . 0.703 ' CG1' ' HA ' ' R' ' 55' ' ' ALA . 0.5 OUTLIER -98.8 128.91 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.841 ' HA ' ' HA ' ' R' ' 177' ' ' VAL . 0.2 OUTLIER -111.48 141.56 44.89 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.501 -1.279 . . . . 0.0 109.021 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' R' ' 143' ' ' LEU . 4.6 mm? -88.95 109.38 20.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.934 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -108.79 120.3 42.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.17 -137.72 44.16 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . 0.435 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 93.9 mt-30 -126.52 150.73 48.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -1.034 . . . . 0.0 110.16 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 51.27 37.56 18.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.435 ' CD2' ' O ' ' R' ' 146' ' ' GLN . 56.1 m-70 -142.86 123.61 14.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.31 -0.869 . . . . 0.0 109.672 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' ND2' ' R' ' 54' ' ' ASN . . . -105.33 136.27 45.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' R' ' 142' ' ' PHE . 31.2 m -127.9 165.72 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.025 -1.047 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.714 ' CE2' ' CD2' ' R' ' 41' ' ' PHE 0.26 0.0 OUTLIER -148.11 125.22 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.736 -1.186 . . . . 0.0 113.494 -177.613 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.895 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -132.81 164.29 27.16 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.606 -1.309 . . . . 0.0 109.238 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.541 ' HB3' ' CE1' ' R' ' 62' ' ' TYR . 22.6 p -176.29 176.39 1.68 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' R' ' 158' ' ' GLY . 64.9 t -63.59 103.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 CA-C-O 121.684 0.754 . . . . 0.0 110.992 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 155' ' ' THR . . . . . 0.693 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 41.7 p -88.75 -160.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 84.5 p -61.82 -18.65 60.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . 0.5 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 90.4 m-20 -111.39 2.69 17.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.7 . . . . 0.0 111.502 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 92.91 -118.15 5.55 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 120.704 -1.248 . . . . 0.0 112.124 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.642 ' HB3' ' HD2' ' R' ' 172' ' ' PRO . 0.0 OUTLIER -60.79 92.5 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.645 1.212 . . . . 0.0 108.89 -177.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . 0.727 ' HA ' ' H ' ' R' ' 170' ' ' TRP . 3.3 m-85 -145.0 163.47 34.1 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . 0.895 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -134.72 131.24 37.4 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.774 -1.204 . . . . 0.0 107.767 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.65 HG22 ' CD1' ' R' ' 167' ' ' PHE . 1.2 pt -122.53 92.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-O 123.981 1.848 . . . . 0.0 112.811 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.628 ' O ' ' C ' ' R' ' 164' ' ' ASP . 74.8 m-20 -96.06 129.0 43.46 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.105 -2.316 . . . . 0.0 108.637 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . 0.699 ' O ' ' CB ' ' R' ' 165' ' ' GLU . 11.2 t0 -34.37 117.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.699 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 42.9 tp10 135.06 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -169.19 161.14 10.12 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.32 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' R' ' 162' ' ' ILE . 10.1 m-30 -107.38 122.07 45.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' R' ' 168' ' ' TYR . 9.7 p90 -141.63 160.54 56.11 Favored Pre-proline 0 C--N 1.294 -1.817 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.835 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . 0.495 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.1 Cg_endo -69.52 113.45 3.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.36 1.716 . . . . 0.0 108.591 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.727 ' H ' ' HA ' ' R' ' 160' ' ' TYR . 0.0 OUTLIER -142.47 169.73 17.02 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 171' ' ' THR . . . . . 0.598 ' CG2' HD12 ' R' ' 134' ' ' LEU . 0.2 OUTLIER -100.27 99.83 10.49 Favored Pre-proline 0 C--N 1.274 -2.684 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.433 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.642 ' HD2' ' HB3' ' R' ' 159' ' ' TRP . 52.0 Cg_endo -75.61 55.67 4.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.884 1.465 . . . . 0.0 108.639 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . 0.669 ' OD1' HD12 ' R' ' 134' ' ' LEU . 3.7 m-20 -115.39 -176.76 0.39 Allowed Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.89 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' R' ' 173' ' ' ASP . 52.8 Cg_endo -79.81 31.36 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.568 1.299 . . . . 0.0 112.352 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 20.2 t -63.3 -51.19 67.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.733 -1.229 . . . . 0.0 109.387 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -131.86 13.99 4.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.708 . . . . 0.0 110.284 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.841 ' HA ' ' HA ' ' R' ' 142' ' ' PHE . 0.5 OUTLIER -102.69 168.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.894 -1.129 . . . . 0.0 113.221 -177.518 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 1.06 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 1.1 mm? -100.59 -95.12 0.27 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.939 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.666 ' HA ' ' N ' ' R' ' 126' ' ' VAL . 28.6 m -80.69 135.42 25.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.714 ' CD2' ' CG ' ' R' ' 137' ' ' PHE 0.261 2.9 p90 -128.85 -178.81 4.77 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.549 1.166 . . . . 0.0 112.315 -173.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' R' ' 62' ' ' TYR . 0.5 OUTLIER -134.19 122.42 16.12 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.554 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . 0.433 ' HD3' ' CE2' ' R' ' 180' ' ' PHE . 50.1 Cg_endo -76.34 161.35 34.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.49 1.258 . . . . 0.0 112.142 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.564 ' CD2' ' HA ' ' R' ' 137' ' ' PHE . 25.4 p90 -127.14 -173.97 3.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -138.99 145.41 39.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 0.0 111.434 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -126.43 166.0 18.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.27 70.2 8.25 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.502 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.82 149.88 54.73 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.716 1.377 . . . . 0.0 110.395 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.41 -36.89 76.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -109.21 136.93 47.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.382 -0.824 . . . . 0.0 110.267 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.49 104.39 3.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -136.26 162.22 33.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -1.06 . . . . 0.0 110.317 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 192' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' R' ' 192' ' ' TRP . 49.8 m0 -99.6 143.78 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 110.027 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -125.46 134.96 51.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.387 -0.82 . . . . 0.0 110.354 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.92 -174.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 52.9 mttp . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.238 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.054 0.454 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.89 137.39 53.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . 0.684 HD22 HD12 ' R' ' 162' ' ' ILE . 1.3 pt? -145.63 153.0 40.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 32' ' ' THR . . . . . 0.472 ' O ' ' N ' ' R' ' 156' ' ' SER . 1.9 p -112.26 142.88 44.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.202 -0.936 . . . . 0.0 109.562 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.666 ' CD1' ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -134.37 141.91 47.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.268 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' R' ' 154' ' ' VAL . 45.3 t80 -37.56 -38.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' R' ' 62' ' ' TYR . 24.0 m120 -104.21 66.1 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.736 -1.852 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . 0.94 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 129.63 35.25 0.46 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . 0.94 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.3 mt-10 -11.37 -159.14 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' R' ' 38' ' ' LYS . 5.1 pttt -44.98 110.96 0.27 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.053 1.406 . . . . 0.0 113.845 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.508 ' HG2' ' CA ' ' R' ' 61' ' ' ARG . 32.2 tptt -141.49 135.54 30.33 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.26 125.57 32.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 113.609 -176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.651 ' CD1' ' CD2' ' R' ' 31' ' ' LEU . 31.3 m-85 -100.95 169.82 8.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . 0.426 ' OH ' ' HA ' ' R' ' 72' ' ' TYR . 85.6 m-85 -101.04 161.2 13.76 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.641 0.734 . . . . 0.0 111.759 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 43' ' ' SER . . . . . 0.616 ' CA ' ' HB2' ' R' ' 165' ' ' GLU . 36.9 m -55.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.648 0.737 . . . . 0.0 111.696 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' R' ' 164' ' ' ASP . 0.4 OUTLIER -74.49 168.71 24.32 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.48 -0.762 . . . . 0.0 109.373 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 36.5 Cg_endo -62.52 98.88 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . 0.566 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 57.5 t30 -60.9 -118.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.126 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . 0.479 ' C ' ' CG ' ' R' ' 48' ' ' HIS . 0.5 OUTLIER -128.43 89.31 2.88 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.479 -1.388 . . . . 0.0 110.893 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . 0.566 ' CE1' ' HB3' ' R' ' 46' ' ' ASN . 0.9 OUTLIER 166.62 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.041 0.448 . . . . 0.0 109.795 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' R' ' 95' ' ' HIS . 12.6 m-20 58.68 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.107 -0.996 . . . . 0.0 109.07 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . 0.597 ' HB3' ' CG2' ' R' ' 79' ' ' THR . 3.4 p30 -141.09 -2.64 1.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.53 -0.731 . . . . 0.0 109.576 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . . . . . . . . 0.257 . . -61.94 -35.8 79.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.417 ' CD2' ' O ' ' R' ' 97' ' ' GLY . 15.3 m95 -61.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 117.355 -1.738 . . . . 0.0 106.478 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.732 HD12 HD11 ' R' ' 83' ' ' ILE . 12.0 mt -68.75 -42.02 78.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . 0.501 ' HB3' ' HE2' ' R' ' 151' ' ' PHE . 45.5 t-20 -50.65 -28.0 8.05 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . 0.71 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.67 -71.8 0.19 Allowed 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . 0.666 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -59.54 -34.64 55.49 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 O-C-N 120.467 -1.396 . . . . 0.0 110.003 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' R' ' 53' ' ' LEU . 3.9 mm? -64.1 -66.72 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.795 . . . . 0.0 111.125 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . 0.811 ' HG3' HD23 ' R' ' 59' ' ' LEU . 0.1 OUTLIER -59.85 -29.26 68.16 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.811 HD23 ' HG3' ' R' ' 58' ' ' GLN . 3.7 mm? -70.02 -38.98 76.06 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.666 ' HB3' ' O ' ' R' ' 56' ' ' ILE . 0.0 OUTLIER -66.48 -40.96 89.62 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.592 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . 0.535 ' HG2' ' CE2' ' R' ' 60' ' ' PHE . 1.3 mtp180 -56.5 -41.61 76.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.824 -1.173 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.562 ' CD1' ' O ' ' R' ' 59' ' ' LEU . 2.4 p90 -86.39 -47.12 9.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.264 -1.523 . . . . 0.0 111.981 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . 0.486 ' CG2' ' CZ ' ' R' ' 62' ' ' TYR . 24.7 t -70.63 -16.77 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.877 -1.764 . . . . 0.0 109.018 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 71.4 tt0 74.75 42.38 0.28 Allowed 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' R' ' 60' ' ' PHE . 7.4 mt-10 -140.28 90.74 10.19 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.945 -1.097 . . . . 0.0 108.751 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.542 ' HB3' ' CE1' ' R' ' 60' ' ' PHE . 46.5 Cg_endo -75.53 95.06 0.99 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.393 1.207 . . . . 0.0 112.401 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . 0.582 ' CG ' ' CD2' ' R' ' 111' ' ' LEU . 14.4 m-85 -76.78 -27.19 55.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . 0.619 ' CD1' HG13 ' R' ' 56' ' ' ILE . 32.3 m-85 -104.99 50.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.696 1.236 . . . . 0.0 108.643 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.541 ' HA ' ' CD1' ' R' ' 72' ' ' TYR . 38.0 m-20 -45.13 -34.28 2.59 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.713 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -63.0 -34.99 78.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.706 -1.247 . . . . 0.0 109.917 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.666 ' CG1' ' HG ' ' R' ' 57' ' ' LEU . 59.4 t -66.22 -58.44 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.674 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . 0.541 ' CD1' ' HA ' ' R' ' 69' ' ' ASP . 1.3 p90 -69.15 -31.4 70.03 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.864 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -63.23 -25.86 68.52 Favored 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.906 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 74' ' ' SER . . . . . 0.542 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 1.0 OUTLIER -79.32 134.41 58.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.55 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.24 -24.8 31.65 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.644 1.339 . . . . 0.0 110.125 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -117.71 -158.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.435 -0.791 . . . . 0.0 109.906 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -85.22 103.55 14.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.504 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . 0.542 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mm? -122.58 47.88 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 79' ' ' THR . . . . . 0.597 ' CG2' ' HB3' ' R' ' 50' ' ' ASN . 0.0 OUTLIER -61.51 -59.25 5.52 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.687 -0.633 . . . . 0.0 110.461 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' R' ' 84' ' ' LYS . 1.0 OUTLIER -49.56 -51.65 35.47 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.789 -178.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.95 -32.48 70.84 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.826 -1.796 . . . . 0.0 109.532 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . 0.545 ' CB ' ' CG2' ' R' ' 71' ' ' VAL . . . -66.18 -58.31 5.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . 0.732 HD11 HD12 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -87.26 -35.62 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.032 -177.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' R' ' 80' ' ' LEU . 25.7 tptt -49.2 -36.35 19.58 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 63.2 tt0 -68.38 -42.03 79.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . 0.655 HD12 HG22 ' R' ' 90' ' ' THR . 2.8 tm? -62.26 -37.84 87.01 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . 0.54 ' HB2' HD13 ' R' ' 94' ' ' LEU . 85.0 tt0 -56.13 -38.56 70.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 108.465 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 89.4 m-20 -58.36 -30.36 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.241 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . 0.55 HD23 HG22 ' R' ' 90' ' ' THR . 4.9 tt -91.1 -53.68 4.26 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.498 -0.751 . . . . 0.0 112.434 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 90' ' ' THR . . . . . 0.655 HG22 HD12 ' R' ' 86' ' ' LEU . 36.1 p -80.14 -31.58 39.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 64.78 30.04 76.89 Favored Glycine 0 N--CA 1.505 3.28 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.906 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' R' ' 102' ' ' LEU . 0.4 OUTLIER -119.5 9.79 11.64 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.961 -1.317 . . . . 0.0 113.131 -177.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . 0.745 ' C ' ' HG ' ' R' ' 94' ' ' LEU . 93.8 mt-10 68.21 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.162 -0.961 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.745 ' HG ' ' C ' ' R' ' 93' ' ' GLU . 0.0 OUTLIER -138.57 -62.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . 0.53 ' C ' ' O ' ' R' ' 94' ' ' LEU . 3.9 p80 -42.5 -37.06 1.51 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.401 ' CG ' ' HB3' ' R' ' 93' ' ' GLU . 22.5 pt-20 -104.5 -16.57 15.02 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' R' ' 94' ' ' LEU . . . -93.22 -141.78 11.12 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' R' ' 101' ' ' ALA . . . -130.71 175.16 19.51 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.646 ' HB3' ' HB2' ' R' ' 55' ' ' ALA . 34.4 Cg_endo -70.76 -58.68 0.08 OUTLIER 'Trans proline' 0 CA--C 1.556 1.581 0 O-C-N 123.773 1.407 . . . . 0.0 114.799 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.947 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.2 Cg_endo -59.07 -22.68 65.21 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.837 ' O ' ' N ' ' R' ' 103' ' ' VAL . . . -31.34 58.92 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.083 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' R' ' 100' ' ' PRO . 71.1 mt 36.46 3.27 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.248 -174.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . 0.837 ' N ' ' O ' ' R' ' 101' ' ' ALA . 2.7 t -55.02 -39.6 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . 0.514 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 85.8 mt -68.34 -37.45 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.872 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.603 ' HB3' ' HB3' ' R' ' 102' ' ' LEU . 68.1 t-105 -63.36 -46.9 84.39 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.876 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . 0.612 ' HB2' HG23 ' R' ' 90' ' ' THR . 69.6 m-80 -76.32 -30.04 57.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.716 -1.24 . . . . 0.0 111.107 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . 0.581 ' CG2' ' HB2' ' R' ' 110' ' ' LEU . 54.8 mt -81.58 7.22 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.702 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.448 ' HG3' ' CG ' ' R' ' 112' ' ' HIS . 24.2 tttm -34.37 -53.14 0.5 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.559 ' C ' HD11 ' R' ' 110' ' ' LEU . 0.5 OUTLIER -60.02 -14.39 16.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.093 -2.255 . . . . 0.0 111.675 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.581 ' HB2' ' CG2' ' R' ' 107' ' ' ILE . 0.3 OUTLIER -106.49 -40.89 5.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.954 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -74.88 -106.18 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.668 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . 0.589 ' HA ' ' O ' ' R' ' 122' ' ' SER . 30.1 m-70 -25.1 73.56 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 123.833 1.778 . . . . 0.0 109.901 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.954 ' N ' ' O ' ' R' ' 111' ' ' LEU . 3.0 t -60.39 -105.31 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.398 -2.183 . . . . 0.0 110.612 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . 0.645 ' O ' HD12 ' R' ' 115' ' ' ILE . . . -134.92 82.15 0.29 Allowed Glycine 0 N--CA 1.505 3.247 1 N-CA-C 102.877 -4.089 . . . . 0.0 102.877 177.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 1.23 HG22 ' O ' ' R' ' 124' ' ' VAL 0.356 32.4 mm -126.33 162.14 30.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -170.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.12 75.6 0.37 Allowed Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.221 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 117' ' ' THR . . . . . 0.674 ' HB ' ' O ' ' R' ' 120' ' ' ARG . 8.1 m -72.74 149.21 43.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . 0.512 ' HB2' ' OG1' ' R' ' 130' ' ' THR . . . -63.85 -24.79 67.88 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.552 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 60.5 p -97.38 -22.25 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 111.097 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . 0.674 ' O ' ' HB ' ' R' ' 117' ' ' THR . 0.0 OUTLIER -178.12 -164.51 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 O-C-N 120.96 -1.087 . . . . 0.0 110.607 -178.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' R' ' 120' ' ' ARG . 49.1 Cg_endo -85.52 161.99 10.97 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 120.671 0.914 . . . . 0.0 110.295 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.767 ' H ' ' HB ' ' R' ' 115' ' ' ILE . 19.9 m -164.96 -134.78 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.07 -1.019 . . . . 0.0 113.216 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.888 ' CA ' HG13 ' R' ' 115' ' ' ILE . 82.5 tt0 -103.8 -19.18 14.37 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 124.726 1.21 . . . . 0.0 112.886 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . 1.23 ' O ' HG22 ' R' ' 115' ' ' ILE . 10.4 m -161.93 -157.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-O 122.573 1.177 . . . . 0.0 111.74 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.535 ' HB2' ' HG3' ' R' ' 182' ' ' PRO . 48.7 t -95.12 137.31 34.35 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.525 -1.984 . . . . 0.0 107.275 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . 0.667 ' HB ' ' HA ' ' R' ' 117' ' ' THR . 77.5 t -102.51 154.22 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 -174.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.7 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 33.0 m -83.19 -21.42 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 112.905 -1.952 . . . . 0.0 114.14 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -45.3 87.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.094 -1.004 . . . . 0.0 111.437 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 51.6 25.15 13.5 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 130' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' R' ' 118' ' ' ALA . 0.0 OUTLIER -109.88 152.11 26.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.324 -1.104 . . . . 0.0 112.306 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 40.43 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.041 0.924 . . . . 0.0 112.98 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.499 ' HB2' ' HB2' ' R' ' 136' ' ' ASP . 89.6 mtp -90.4 174.19 7.7 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' R' ' 135' ' ' ALA . 62.4 m -100.87 -174.99 2.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.341 -0.85 . . . . 0.0 112.682 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . 0.498 ' CD2' ' CG2' ' R' ' 171' ' ' THR . 0.4 OUTLIER 31.3 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.098 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . 0.462 ' O ' ' OH ' ' R' ' 183' ' ' TYR . . . -62.29 -26.75 68.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.119 -0.988 . . . . 0.0 112.841 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . 0.499 ' HB2' ' HB2' ' R' ' 132' ' ' MET . 19.2 t70 -55.99 -42.67 76.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.105 -0.997 . . . . 0.0 112.278 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . 0.685 ' CG ' ' CD1' ' R' ' 180' ' ' PHE . 52.5 p90 -155.23 159.59 40.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.788 -1.195 . . . . 0.0 109.479 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . 0.651 ' CG ' ' CE3' ' R' ' 159' ' ' TRP . 68.5 m-70 -143.76 79.18 1.62 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.139 -1.424 . . . . 0.0 110.857 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' R' ' 181' ' ' VAL . . . 174.88 162.04 0.22 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.175 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 130.06 -170.56 20.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.212 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . 0.501 ' CG1' ' HG ' ' R' ' 59' ' ' LEU . 70.1 mt -104.23 124.61 58.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.742 -0.858 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.992 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 4.2 m-85 -113.76 151.53 31.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.662 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' R' ' 176' ' ' ASP . 26.1 tp -101.66 124.14 46.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.715 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' R' ' 148' ' ' HIS . 38.1 tttt -108.85 113.54 26.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.073 -1.017 . . . . 0.0 110.422 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' R' ' 146' ' ' GLN . . . 50.23 25.63 8.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . 0.428 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 95.2 mt-30 54.62 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -1.01 . . . . 0.0 110.631 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.41 23.57 2.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 83.2 m-70 -144.7 131.68 20.36 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.896 . . . . 0.0 108.882 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.445 ' CB ' ' HZ ' ' R' ' 151' ' ' PHE . . . -104.5 115.82 31.03 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.67 ' O ' ' CD1' ' R' ' 151' ' ' PHE . 34.9 m -129.27 152.18 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.67 ' CD1' ' O ' ' R' ' 150' ' ' VAL . 7.7 m-85 -149.89 129.69 13.3 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.791 -1.564 . . . . 0.0 112.012 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.877 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -110.56 167.65 10.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.593 -1.317 . . . . 0.0 110.735 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.466 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 38.0 t -169.63 134.49 1.41 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.581 ' O ' ' CB ' ' R' ' 33' ' ' LEU . 36.9 t -53.38 102.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.383 -1.448 . . . . 0.0 111.283 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 155' ' ' THR . . . . . 0.621 ' CG2' ' HB2' ' R' ' 160' ' ' TYR . 25.1 p -78.82 -165.36 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.713 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 156' ' ' SER . . . . . 0.472 ' N ' ' O ' ' R' ' 32' ' ' THR . 81.1 p -65.41 -18.69 65.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . 0.466 ' CB ' ' CZ ' ' R' ' 160' ' ' TYR . 83.0 m-20 -102.03 2.9 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.273 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . 0.468 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 112.93 -166.14 12.11 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.151 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.651 ' CE3' ' CG ' ' R' ' 138' ' ' HIS . 0.0 OUTLIER -55.58 99.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.495 1.14 . . . . 0.0 108.685 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . 0.626 ' O ' ' HB3' ' R' ' 152' ' ' ALA . 4.0 m-85 -121.83 -178.39 3.82 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . 0.877 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -158.07 136.37 10.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.751 -1.843 . . . . 0.0 110.987 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.684 HD12 HD22 ' R' ' 31' ' ' LEU . 0.6 OUTLIER -75.79 88.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.526 1.155 . . . . 0.0 109.188 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.539 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -94.98 122.83 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' R' ' 44' ' ' ARG . 78.0 m-20 28.19 74.51 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.365 -0.834 . . . . 0.0 112.968 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.654 ' CB ' ' N ' ' R' ' 44' ' ' ARG . 0.1 OUTLIER 68.66 -15.31 0.24 Allowed 'General case' 0 N--CA 1.522 3.149 0 O-C-N 119.597 -1.939 . . . . 0.0 113.448 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.74 134.29 45.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.83 -1.794 . . . . 0.0 112.694 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.675 ' CD1' HG13 ' R' ' 162' ' ' ILE . 6.4 m-85 -101.62 121.66 42.42 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . 0.599 ' CE2' ' CD1' ' R' ' 170' ' ' TRP . 2.8 p90 -150.67 162.05 28.39 Favored Pre-proline 0 C--N 1.281 -2.406 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.314 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' R' ' 160' ' ' TYR . 39.5 Cg_endo -66.62 114.71 3.21 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.231 1.648 . . . . 0.0 109.044 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.599 ' CD1' ' CE2' ' R' ' 168' ' ' TYR . 0.1 OUTLIER -126.4 150.18 48.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 171' ' ' THR . . . . . 0.498 ' CG2' ' CD2' ' R' ' 134' ' ' LEU . 2.3 m -94.26 108.26 34.8 Favored Pre-proline 0 C--N 1.271 -2.816 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.053 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.627 ' CG ' ' HA ' ' R' ' 138' ' ' HIS . 46.1 Cg_endo -72.94 67.03 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 124.048 1.552 . . . . 0.0 110.823 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' R' ' 175' ' ' SER . 8.6 t70 -81.86 139.13 46.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.406 -0.809 . . . . 0.0 109.097 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . 0.586 ' HA ' HG12 ' R' ' 177' ' ' VAL . 44.3 Cg_endo -70.72 35.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.223 1.117 . . . . 0.0 109.95 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 175' ' ' SER . . . . . 0.524 ' H ' ' C ' ' R' ' 173' ' ' ASP . 83.4 p -81.34 -43.38 19.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 111.323 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . 0.437 ' HB3' ' O ' ' R' ' 143' ' ' LEU . 86.4 m-20 -126.16 1.6 7.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.017 -1.052 . . . . 0.0 109.934 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.992 ' HB ' ' CG ' ' R' ' 142' ' ' PHE . 0.2 OUTLIER -95.1 169.37 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.059 0.933 . . . . 0.0 110.464 -178.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.7 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.7 OUTLIER -128.48 -91.45 0.48 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -177.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.43 124.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.685 ' CD1' ' CG ' ' R' ' 137' ' ' PHE . 0.3 OUTLIER -130.45 178.14 6.83 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -175.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -127.26 127.24 24.27 Favored Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.952 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . 0.535 ' HG3' ' HB2' ' R' ' 125' ' ' CYS . 56.2 Cg_endo -87.47 131.93 2.99 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.384 1.202 . . . . 0.0 109.998 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 1.1 p90 -64.6 -34.06 77.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.096 -1.003 . . . . 0.0 109.709 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.0 t0 47.9 46.32 18.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.416 -0.802 . . . . 0.0 111.62 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -94.67 19.54 9.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.224 -0.923 . . . . 0.0 110.772 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -117.38 78.7 11.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.913 . . . . 0.0 110.137 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.16 -12.88 35.1 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.869 1.457 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 83.0 mt -58.34 -33.23 69.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -75.03 172.9 11.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.69 138.1 7.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 50.54 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.479 -1.012 . . . . 0.0 110.674 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -104.04 140.05 38.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.138 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -131.73 132.29 43.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -145.29 -44.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.472 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.269 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.151 0.501 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' R' R ' 30' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 22.7 pt-20 -93.86 120.37 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.382 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 31' ' ' LEU . . . . . 0.931 HD11 ' CZ ' ' R' ' 167' ' ' PHE . 0.7 OUTLIER -94.04 127.96 40.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 111.3 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 32' ' ' THR . . . . . 0.55 ' O ' ' N ' ' R' ' 156' ' ' SER . 92.6 m -102.19 146.76 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.701 ' H ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -139.64 167.83 21.2 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.007 -178.523 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 34' ' ' TYR . . . . . 0.62 ' HB2' HG11 ' R' ' 154' ' ' VAL . 63.6 t80 -41.19 -44.27 2.54 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -75.93 15.47 0.53 Allowed 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 122.594 2.452 . . . . 0.0 113.927 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 -5.92 42.41 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 119.87 -1.769 . . . . 0.0 112.963 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 37' ' ' GLU . . . . . 0.643 ' HB3' HD21 ' R' ' 33' ' ' LEU . 82.9 tt0 -79.97 137.7 36.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.504 -1.586 . . . . 0.0 110.354 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -120.13 113.96 21.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 109.392 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 22.2 tptt -122.93 131.74 53.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 40' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' R' ' 30' ' ' GLU . 0.9 OUTLIER -85.9 122.72 30.36 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.924 0.868 . . . . 0.0 112.203 -177.727 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.717 ' CD2' HD13 ' R' ' 162' ' ' ILE . 0.5 OUTLIER -107.54 159.91 16.07 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 42' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' R' ' 42' ' ' TYR . 68.2 m-85 -98.94 134.1 42.28 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.414 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 43' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' R' ' 164' ' ' ASP . 7.0 m -112.7 94.75 5.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.362 -0.836 . . . . 0.0 110.498 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 44' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' R' ' 77' ' ' ASN . 0.4 OUTLIER -152.67 136.09 9.79 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.283 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.58 126.83 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.374 1.197 . . . . 0.0 110.008 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' R' ' 50' ' ' ASN . 0.3 OUTLIER -97.35 -120.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 109.396 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 47' ' ' ASN . . . . . 0.524 ' ND2' HD23 ' R' ' 80' ' ' LEU . 1.2 p-10 -128.61 77.23 1.76 Allowed 'General case' 0 N--CA 1.512 2.634 0 O-C-N 120.242 -1.536 . . . . 0.0 111.262 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 74.6 m80 48.44 16.98 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.801 -0.562 . . . . 0.0 112.345 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 49' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' R' ' 96' ' ' GLU . 37.3 m-20 -146.66 47.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.024 . . . . 0.0 108.725 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.743 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 24.1 p30 -114.72 -21.68 10.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 51' ' ' ALA . . . . . 0.693 ' CB ' ' HB3' ' R' ' 149' ' ' ALA 0.282 . . -66.32 -41.93 88.97 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.282 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.705 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 39.6 m95 -59.71 -34.78 73.35 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.912 -1.515 . . . . 0.0 107.256 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.825 HD11 HG13 ' R' ' 83' ' ' ILE . 20.2 mt -68.18 -35.2 77.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 54' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' R' ' 51' ' ' ALA . 56.6 t-20 -48.92 -28.11 3.59 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 55' ' ' ALA . . . . . 0.873 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.13 -64.72 0.8 Allowed 'General case' 0 C--O 1.203 -1.371 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.594 ' N ' HD13 ' R' ' 56' ' ' ILE . 0.0 OUTLIER -57.13 -36.32 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.751 178.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 57' ' ' LEU . . . . . 0.987 HD21 HG21 ' R' ' 71' ' ' VAL . 3.9 mm? -68.61 -72.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.623 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 58' ' ' GLN . . . . . 0.568 ' NE2' ' OD1' ' R' ' 54' ' ' ASN . 0.7 OUTLIER -57.85 -29.68 65.19 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.637 -1.289 . . . . 0.0 108.536 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.873 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 0.2 OUTLIER -70.43 -37.26 74.35 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.908 ' HA ' ' HD3' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -50.68 -53.02 34.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.249 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 61' ' ' ARG . . . . . 0.614 ' N ' ' CG ' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -55.87 -48.46 75.52 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.104 -1.039 . . . . 0.0 113.343 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' R' ' 153' ' ' CYS . 0.1 OUTLIER -90.69 -47.7 7.5 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 119.962 -1.711 . . . . 0.0 113.921 -176.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.888 HG22 HG12 ' R' ' 124' ' ' VAL . 47.7 t -77.76 -24.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.169 -0.957 . . . . 0.0 111.811 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 64' ' ' GLU . . . . . 0.776 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 88.2 tt0 124.33 117.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.131 0.967 . . . . 0.0 109.346 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' R' ' 68' ' ' PHE . 0.1 OUTLIER -44.28 100.32 0.23 Allowed Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.908 ' HD3' ' HA ' ' R' ' 60' ' ' PHE . 51.8 Cg_endo -85.45 -162.12 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.589 2.192 . . . . 0.0 107.399 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 67' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' R' ' 69' ' ' ASP . 34.4 t80 -45.0 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 O-C-N 121.769 -0.582 . . . . 0.0 112.022 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 68' ' ' PHE . . . . . 0.942 ' HD2' HD13 ' R' ' 57' ' ' LEU . 0.7 OUTLIER -37.52 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.008 -1.057 . . . . 0.0 113.031 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' R' ' 67' ' ' PHE . 51.0 m-20 -49.12 -34.34 13.87 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.62 -0.675 . . . . 0.0 112.234 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.616 ' HB3' ' HA ' ' R' ' 82' ' ' ALA . 70.2 m95 -64.43 -31.24 72.37 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.572 -1.33 . . . . 0.0 109.858 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.987 HG21 HD21 ' R' ' 57' ' ' LEU . 46.9 t -70.81 -67.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 72' ' ' TYR . . . . . 0.925 ' CE2' HD12 ' R' ' 57' ' ' LEU . 13.3 m-30 -77.42 -30.36 53.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.739 . . . . 0.0 111.878 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 73' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 22.4 t -60.83 -19.34 59.66 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.318 -1.353 . . . . 0.0 109.049 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 74' ' ' SER . . . . . 0.687 ' OG ' HD22 ' R' ' 78' ' ' LEU . 38.5 m -77.2 139.87 65.18 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.771 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 -27.55 39.77 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.92 164.76 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.79 . . . . 0.0 109.679 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 77' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' R' ' 44' ' ' ARG . 36.1 p-10 -52.59 110.26 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.197 -0.94 . . . . 0.0 110.088 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 78' ' ' LEU . . . . . 0.687 HD22 ' OG ' ' R' ' 74' ' ' SER . 1.5 mp -126.81 47.36 2.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.677 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 79' ' ' THR . . . . . 0.745 ' OG1' HD12 ' R' ' 53' ' ' LEU . 0.5 OUTLIER -65.99 -52.19 51.63 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.009 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.524 HD23 ' ND2' ' R' ' 47' ' ' ASN . 0.0 OUTLIER -51.04 -59.39 4.21 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.678 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.38 -28.0 69.69 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.498 -1.376 . . . . 0.0 109.736 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.813 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -56.29 -51.1 69.43 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.48 -0.762 . . . . 0.0 111.624 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.825 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -85.41 -36.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.045 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 84' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' R' ' 87' ' ' GLU . 32.9 tttt -49.82 -33.52 16.97 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' R' ' 70' ' ' TRP . 50.9 tp60 -77.15 -36.4 55.28 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 86' ' ' LEU . . . . . 1.013 HD11 HG13 ' R' ' 103' ' ' VAL . 2.7 tm? -66.75 -40.62 88.38 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.807 -0.558 . . . . 0.0 110.176 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 87' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' R' ' 91' ' ' GLY . 10.7 pt-20 -66.08 -31.73 72.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.944 -1.098 . . . . 0.0 108.27 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.06 -31.36 69.91 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.389 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.833 HD23 ' N ' ' R' ' 90' ' ' THR . 1.1 tt -93.59 -48.89 6.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.581 -0.699 . . . . 0.0 111.042 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 90' ' ' THR . . . . . 0.833 ' N ' HD23 ' R' ' 89' ' ' LEU . 68.1 p -74.89 -24.06 58.47 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 91' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' R' ' 87' ' ' GLU . . . 68.95 26.35 74.73 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.033 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 92' ' ' LEU . . . . . 0.795 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.3 OUTLIER -105.94 -17.53 14.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.823 -1.398 . . . . 0.0 111.354 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 93' ' ' GLU . . . . . 0.532 ' H ' ' HB2' ' R' ' 87' ' ' GLU . 81.6 tt0 65.44 122.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.813 HD13 ' CG2' ' R' ' 83' ' ' ILE . 0.3 OUTLIER -166.39 12.5 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 95' ' ' HIS . . . . . 0.728 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.7 OUTLIER -42.39 -29.12 0.25 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.607 -0.683 . . . . 0.0 109.234 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 96' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' R' ' 49' ' ' ASP . 98.5 mt-10 -116.15 23.33 12.25 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.647 -0.658 . . . . 0.0 110.854 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 97' ' ' GLY . . . . . 0.683 ' HA2' ' CG ' ' R' ' 52' ' ' TRP . . . 156.08 128.56 1.11 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.651 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 98' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' R' ' 101' ' ' ALA . . . 152.02 75.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.686 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.889 ' HG2' ' HD2' ' R' ' 100' ' ' PRO . 33.5 Cg_endo -86.13 -90.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.564 1.999 0 C-N-CA 121.32 1.347 . . . . 0.0 110.406 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.889 ' HD2' ' HG2' ' R' ' 99' ' ' PRO . 37.1 Cg_endo -62.55 -16.97 55.78 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 106.108 -2.305 . . . . 0.0 106.108 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.795 ' O ' HD22 ' R' ' 92' ' ' LEU 0.263 . . -30.87 61.82 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 113.61 -1.632 . . . . 0.0 112.587 175.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.837 ' N ' ' O ' ' R' ' 100' ' ' PRO . 48.2 mt 39.38 0.74 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.671 -175.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 1.013 HG13 HD11 ' R' ' 86' ' ' LEU . 21.8 t -52.68 -40.58 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.64 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 32.3 pt -75.56 -36.54 34.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.373 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.632 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 61.5 t90 -64.63 -43.0 95.1 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.579 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.705 ' HB2' HG22 ' R' ' 90' ' ' THR . 27.3 m120 -78.35 -27.08 46.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.723 -1.236 . . . . 0.0 112.066 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 107' ' ' ILE . . . . . 0.743 HG23 HD23 ' R' ' 110' ' ' LEU . 63.3 mt -78.18 16.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 111.762 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' R' ' 112' ' ' HIS . 80.4 mttt -30.49 -52.22 0.16 Allowed 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.588 ' CD2' HD22 ' R' ' 110' ' ' LEU . 36.9 p-80 -57.51 -26.98 62.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.143 -2.223 . . . . 0.0 112.458 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.743 HD23 HG23 ' R' ' 107' ' ' ILE . 0.2 OUTLIER -100.43 -39.49 7.93 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 176.382 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.1 OUTLIER -78.49 -96.91 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 111.523 -2.581 . . . . 0.0 114.608 -176.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 112' ' ' HIS . . . . . 0.67 ' H ' ' HA ' ' R' ' 108' ' ' LYS . 85.4 t60 -13.62 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 123.897 1.808 . . . . 0.0 109.986 -173.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.994 HG23 HD11 ' R' ' 115' ' ' ILE . 7.2 t -97.85 -173.43 2.61 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.446 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.824 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.66 105.8 1.57 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 1.0 HD12 HG22 ' R' ' 124' ' ' VAL . 3.5 mm -109.88 143.55 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.539 -1.565 . . . . 0.0 110.581 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 116' ' ' GLY . . . . . 0.585 ' O ' HG13 ' R' ' 126' ' ' VAL . . . -143.11 -154.65 6.19 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.183 -1.484 . . . . 0.0 112.114 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.934 ' HA ' HG22 ' R' ' 126' ' ' VAL . 5.1 m -133.03 165.08 25.56 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 1.01 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -53.21 -36.35 60.91 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.38 -1.45 . . . . 0.0 110.369 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.2 m -64.59 -36.28 83.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -124.19 94.18 45.67 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.502 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.44 134.32 30.56 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.753 1.396 . . . . 0.0 112.061 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 122' ' ' SER . . . . . . . . . . . . . 3.5 m -134.11 -162.88 1.29 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' R' ' 114' ' ' GLY . 77.1 mm-40 -55.01 -41.24 71.04 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.567 -1.333 . . . . 0.0 108.377 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 1.0 HG22 HD12 ' R' ' 115' ' ' ILE . 0.9 OUTLIER -129.07 147.35 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' R' ' 182' ' ' PRO . 5.9 t -127.74 159.35 35.04 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.218 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.934 HG22 ' HA ' ' R' ' 117' ' ' THR . 15.7 m -85.2 -163.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.938 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 1.1 p -60.68 -160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.726 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.743 ' HA ' ' HB2' ' R' ' 118' ' ' ALA . 28.9 p-10 -96.55 -74.91 0.55 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.746 -1.221 . . . . 0.0 113.21 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 129' ' ' GLY . . . . . 0.457 ' H ' ' CG ' ' R' ' 128' ' ' ASP . . . 58.7 5.38 2.72 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 130' ' ' THR . . . . . 1.01 HG21 ' HB1' ' R' ' 118' ' ' ALA . 11.3 t -127.93 167.33 16.78 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.279 0.632 . . . . 0.0 109.355 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.4 74.44 2.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.585 ' HG3' HG23 ' R' ' 130' ' ' THR . 56.2 mtt -127.88 167.0 17.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.85 -170.87 3.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.281 -0.887 . . . . 0.0 111.381 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 1.07 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -38.87 -56.36 1.38 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 121.591 0.71 . . . . 0.0 112.538 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.57 -19.96 62.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 136' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' R' ' 183' ' ' TYR . 0.8 OUTLIER -55.71 -38.37 69.63 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.455 -1.403 . . . . 0.0 112.369 -178.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 137' ' ' PHE . . . . . 0.55 ' CB ' ' CD1' ' R' ' 180' ' ' PHE . 0.3 OUTLIER -142.38 168.69 19.15 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.947 -1.095 . . . . 0.0 108.173 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' R' ' 139' ' ' ALA . 14.8 m-70 -134.8 63.58 1.62 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.272 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 166.52 165.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.786 -0.571 . . . . 0.0 110.119 175.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.02 -178.97 32.28 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.216 -1.468 . . . . 0.0 111.954 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 141' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' R' ' 151' ' ' PHE . 10.7 mt -112.05 119.23 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 122.015 -0.697 . . . . 0.0 110.392 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.84 ' CZ ' HG11 ' R' ' 177' ' ' VAL . 8.0 m-85 -109.28 134.94 51.15 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.097 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' R' ' 143' ' ' LEU . 4.6 mm? -85.72 101.23 12.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.523 ' HD2' HG11 ' R' ' 150' ' ' VAL . 33.9 tttm -93.55 124.53 37.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 110.934 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.69 -145.32 8.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -111.52 138.98 47.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.996 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 147' ' ' GLU . . . . . 0.413 ' HA ' ' CH2' ' R' ' 52' ' ' TRP . 79.7 tt0 54.67 44.34 28.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 0.1 OUTLIER -141.41 122.03 14.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 149' ' ' ALA . . . . . 0.705 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -109.56 139.26 44.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 110.641 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 150' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.7 m -139.52 153.27 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.055 -1.028 . . . . 0.0 109.174 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' R' ' 141' ' ' ILE . 82.0 m-85 -147.19 124.68 11.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.769 -1.207 . . . . 0.0 110.438 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.03 171.93 7.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.365 -1.459 . . . . 0.0 112.743 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 153' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 9.1 t -167.3 136.05 2.65 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' R' ' 34' ' ' TYR . 53.2 t -56.5 109.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.354 -1.466 . . . . 0.0 111.654 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 155' ' ' THR . . . . . 0.693 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 77.2 p -89.63 -169.59 2.52 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 156' ' ' SER . . . . . 0.55 ' N ' ' O ' ' R' ' 32' ' ' THR . 44.7 t -60.34 -21.25 61.84 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.777 -1.202 . . . . 0.0 108.428 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CE1' ' R' ' 160' ' ' TYR . 79.4 m-20 -95.96 3.71 53.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 158' ' ' GLY . . . . . 0.497 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 106.23 -160.78 14.46 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.625 ' CE2' HD12 ' R' ' 134' ' ' LEU . 5.5 m-90 -57.36 101.58 0.07 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.625 -0.927 . . . . 0.0 108.687 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 160' ' ' TYR . . . . . 0.693 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 4.2 m-85 -127.52 131.47 50.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 161' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -106.27 146.73 29.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 119.979 -1.701 . . . . 0.0 110.937 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 162' ' ' ILE . . . . . 0.913 ' CD1' HD13 ' R' ' 31' ' ' LEU . 96.9 mt -102.66 90.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' R' ' 164' ' ' ASP . 3.6 t0 -88.58 122.46 32.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 164' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' R' ' 163' ' ' ASP . 26.0 t0 -3.45 -64.69 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' R' ' 163' ' ' ASP . 97.1 mt-10 -59.34 -42.21 90.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.696 -1.253 . . . . 0.0 114.37 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -167.26 172.92 9.4 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 119.811 -1.806 . . . . 0.0 113.215 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 167' ' ' PHE . . . . . 0.931 ' CZ ' HD11 ' R' ' 31' ' ' LEU . 3.5 m-30 -98.43 129.13 45.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 168' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' R' ' 161' ' ' ALA . 2.1 p90 -141.15 163.86 39.39 Favored Pre-proline 0 C--N 1.29 -2.01 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.94 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 169' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 42.3 Cg_endo -69.84 108.52 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.525 ' CD1' ' CD1' ' R' ' 168' ' ' TYR . 0.5 OUTLIER -138.9 153.81 48.31 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 171' ' ' THR . . . . . 1.07 ' CG2' HD11 ' R' ' 134' ' ' LEU . 1.0 OUTLIER -101.93 151.23 37.95 Favored Pre-proline 0 C--N 1.278 -2.541 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.29 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.749 ' HD2' HD13 ' R' ' 134' ' ' LEU . 45.3 Cg_endo -94.37 32.97 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.865 1.71 . . . . 0.0 109.411 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 173' ' ' ASP . . . . . 0.582 ' O ' ' CG1' ' R' ' 177' ' ' VAL . 0.6 OUTLIER -76.77 153.27 83.17 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.357 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' R' ' 177' ' ' VAL . 49.5 Cg_endo -75.67 26.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.968 1.51 . . . . 0.0 111.206 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 23.3 t -69.89 -48.3 59.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.985 -1.072 . . . . 0.0 110.897 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 176' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' R' ' 143' ' ' LEU . 91.1 m-20 -125.6 13.45 8.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.84 HG11 ' CZ ' ' R' ' 142' ' ' PHE . 0.1 OUTLIER -121.48 153.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.832 . . . . 0.0 109.736 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.938 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 2.1 mm? -127.63 46.6 2.52 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.062 -1.455 . . . . 0.0 108.932 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.733 ' HA ' ' C ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.61 124.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.55 ' CD1' ' CB ' ' R' ' 137' ' ' PHE . 4.2 p90 -125.12 168.17 13.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.544 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 181' ' ' VAL . . . . . 0.867 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 1.0 OUTLIER -122.87 111.99 30.73 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.122 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 182' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' R' ' 125' ' ' CYS . 47.7 Cg_endo -76.04 156.14 38.34 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.615 1.324 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' R' ' 138' ' ' HIS . 1.1 p90 -91.43 -2.21 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.517 -0.739 . . . . 0.0 110.873 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 111.2 179.313 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.05 0.452 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' R' R ' 30' ' ' GLU . . . . . 0.482 ' C ' HD22 ' R' ' 31' ' ' LEU . 44.9 tp10 -117.5 119.43 35.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.16 -0.962 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 31' ' ' LEU . . . . . 0.961 HD23 ' CD1' ' R' ' 41' ' ' PHE . 3.8 mm? -94.8 166.81 11.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.392 -0.817 . . . . 0.0 109.546 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 32' ' ' THR . . . . . 0.88 ' C ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -126.47 140.23 52.63 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -173.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 1.111 ' N ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -17.64 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.84 0 CA-C-N 111.837 -2.438 . . . . 0.0 116.463 176.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 34' ' ' TYR . . . . . 0.776 ' C ' ' O ' ' R' ' 33' ' ' LEU . 92.5 m-85 -19.58 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.977 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' R' ' 33' ' ' LEU . 7.0 m120 -131.84 62.41 1.63 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 36' ' ' GLY . . . . . 1.216 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 141.75 36.8 0.09 OUTLIER Glycine 0 N--CA 1.479 1.521 0 C-N-CA 117.055 -2.498 . . . . 0.0 110.465 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 37' ' ' GLU . . . . . 1.216 ' O ' ' O ' ' R' ' 36' ' ' GLY . 80.7 mm-40 -11.68 -167.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 122.455 0.302 . . . . 0.0 110.848 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.33 92.73 0.29 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 116.23 -2.188 . . . . 0.0 106.809 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' R' ' 37' ' ' GLU . 36.2 mmtt -123.76 119.87 31.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 40' ' ' THR . . . . . 0.588 ' O ' HG22 ' R' ' 40' ' ' THR . 0.9 OUTLIER -91.29 115.08 27.74 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.452 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.961 ' CD1' HD23 ' R' ' 31' ' ' LEU . 3.0 m-85 -98.42 162.83 12.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 42' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' R' ' 165' ' ' GLU . 97.4 m-85 -95.4 158.58 15.4 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' R' ' 165' ' ' GLU . 46.7 m -115.57 94.9 4.9 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 44' ' ' ARG . . . . . 0.529 ' H ' ' CB ' ' R' ' 165' ' ' GLU . 0.0 OUTLIER -167.64 124.16 0.89 Allowed Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.306 -0.871 . . . . 0.0 109.096 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.18 126.35 13.59 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 N-CA-C 108.625 -1.336 . . . . 0.0 108.625 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 31.1 m120 -88.12 152.97 21.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.149 -0.97 . . . . 0.0 109.033 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.39 80.24 1.82 Allowed 'General case' 0 N--CA 1.507 2.387 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.257 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.586 ' CD2' HD23 ' R' ' 80' ' ' LEU . 5.3 p-80 178.62 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 49' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 1.5 p30 157.16 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 8.4 p30 -142.88 -25.75 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.911 -1.118 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 51' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' R' ' 54' ' ' ASN 0.271 . . -64.98 -44.24 89.96 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.056 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.498 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 75.3 m95 -58.01 -36.17 72.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.898 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.877 HD11 HG13 ' R' ' 83' ' ' ILE . 11.6 mt -69.38 -44.73 70.92 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 54' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' R' ' 51' ' ' ALA . 0.0 OUTLIER -43.28 -32.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 108.921 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 55' ' ' ALA . . . . . 0.866 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -64.93 -67.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.591 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.733 HG21 ' O ' ' R' ' 100' ' ' PRO . 0.2 OUTLIER -84.19 -41.74 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 117.884 -1.527 . . . . 0.0 109.885 178.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 57' ' ' LEU . . . . . 0.917 ' CD2' HG21 ' R' ' 71' ' ' VAL 0.265 1.5 tm? -48.25 -61.87 1.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.604 0.716 . . . . 0.0 111.207 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 58' ' ' GLN . . . . . 0.653 ' CD ' HG21 ' R' ' 162' ' ' ILE . 73.4 mt-30 -70.06 -27.77 64.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.866 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 3.4 tp -55.93 -38.51 70.38 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.923 ' CE1' HD21 ' R' ' 111' ' ' LEU . 22.9 m-30 -58.41 -41.18 84.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.144 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 61' ' ' ARG . . . . . 0.51 ' CB ' ' CZ ' ' R' ' 41' ' ' PHE . 0.0 OUTLIER -64.88 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.344 -1.472 . . . . 0.0 114.473 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.769 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 1.4 p90 -82.78 -42.39 17.99 Favored 'General case' 0 N--CA 1.516 2.826 0 O-C-N 119.575 -1.953 . . . . 0.0 114.731 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.769 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.5 t -73.77 -14.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 119.825 -1.797 . . . . 0.0 111.179 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 64' ' ' GLU . . . . . 0.698 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 65.0 tt0 98.91 29.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 1.8 tp10 -132.33 90.15 34.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.663 -1.273 . . . . 0.0 107.788 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' R' ' 60' ' ' PHE . 48.3 Cg_endo -78.09 83.55 2.18 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.706 1.372 . . . . 0.0 113.966 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 67' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 48.0 t80 -83.35 -19.11 36.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 68' ' ' PHE . . . . . 0.671 ' HB2' ' CD1' ' R' ' 57' ' ' LEU . 0.0 OUTLIER -62.38 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.012 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' R' ' 73' ' ' SER . 94.8 m-20 -46.8 -39.37 11.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.457 -0.777 . . . . 0.0 111.775 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.504 ' HA ' ' HB2' ' R' ' 74' ' ' SER . 35.3 m95 -69.82 -37.28 76.19 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.766 -1.208 . . . . 0.0 109.635 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' R' ' 57' ' ' LEU 0.252 43.5 t -70.34 -75.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 72' ' ' TYR . . . . . 0.632 ' CD1' HG12 ' R' ' 71' ' ' VAL . 18.8 m-30 -86.65 -35.96 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 111.737 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 73' ' ' SER . . . . . 0.664 ' HB3' ' O ' ' R' ' 69' ' ' ASP . 9.6 t -71.03 -17.33 62.63 Favored 'General case' 0 N--CA 1.509 2.511 0 C-N-CA 117.702 -1.599 . . . . 0.0 108.909 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 74' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' R' ' 70' ' ' TRP . 0.4 OUTLIER -117.47 114.41 38.22 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.366 -0.834 . . . . 0.0 109.334 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.34 -11.65 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.539 1.283 . . . . 0.0 110.528 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 76' ' ' GLU . . . . . 0.514 ' O ' HD13 ' R' ' 78' ' ' LEU . 84.6 tt0 -104.84 -64.47 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 77' ' ' ASN . . . . . 0.479 ' CA ' ' HB2' ' R' ' 81' ' ' GLU . 11.6 m120 -44.54 -44.18 8.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 112.047 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 78' ' ' LEU . . . . . 0.709 ' O ' ' HB2' ' R' ' 82' ' ' ALA . 6.1 mp 49.57 -154.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.893 -1.129 . . . . 0.0 111.008 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 79' ' ' THR . . . . . 0.832 ' OG1' HD12 ' R' ' 53' ' ' LEU . 2.0 t -68.67 -59.23 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.899 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.65 ' H ' HG23 ' R' ' 79' ' ' THR . 0.4 OUTLIER -50.13 -52.26 36.59 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 81' ' ' GLU . . . . . 0.589 ' HG3' HD12 ' R' ' 80' ' ' LEU . 72.2 mt-10 -69.75 -27.92 65.35 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.077 -1.639 . . . . 0.0 109.302 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.749 ' CB ' HG23 ' R' ' 71' ' ' VAL . . . -58.9 -53.7 55.49 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.683 -0.636 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 1.12 HG21 HD11 ' R' ' 94' ' ' LEU . 0.2 OUTLIER -86.4 -33.62 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.44 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 84' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' R' ' 83' ' ' ILE . 16.4 tttt -49.81 -36.36 26.11 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.89 -41.01 92.07 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 86' ' ' LEU . . . . . 0.978 HD13 HG13 ' R' ' 103' ' ' VAL . 13.2 mt -67.03 -34.29 77.4 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.804 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 87' ' ' GLU . . . . . 0.591 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -51.63 -42.06 61.74 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.8 -36.03 82.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.551 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.691 ' CD2' HG23 ' R' ' 107' ' ' ILE . 5.1 tt -99.07 -52.45 3.54 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.695 -1.253 . . . . 0.0 111.824 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 90' ' ' THR . . . . . 0.963 ' CG2' HD22 ' R' ' 86' ' ' LEU . 64.8 p -70.72 -24.74 62.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 91' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 61.83 21.89 61.52 Favored Glycine 0 N--CA 1.502 3.052 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.673 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 92' ' ' LEU . . . . . 1.04 ' CD1' HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -93.59 -16.09 24.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.225 -1.162 . . . . 0.0 111.193 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 93' ' ' GLU . . . . . 0.741 ' N ' HD12 ' R' ' 92' ' ' LEU . 95.9 mt-10 52.13 93.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.387 -0.821 . . . . 0.0 108.835 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 1.12 HD11 HG21 ' R' ' 83' ' ' ILE . 2.5 pp -145.09 4.94 1.1 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.977 -1.077 . . . . 0.0 109.91 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 95' ' ' HIS . . . . . 0.841 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.9 OUTLIER -39.31 -33.87 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.422 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.49 21.82 11.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.568 -0.707 . . . . 0.0 110.658 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 97' ' ' GLY . . . . . 0.652 ' O ' ' HB2' ' R' ' 94' ' ' LEU . . . 160.16 -115.26 0.65 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.087 -1.53 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 98' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' R' ' 97' ' ' GLY . . . 55.81 166.48 0.05 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' R' ' 102' ' ' LEU . 47.9 Cg_endo -79.43 125.23 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.73 1.384 . . . . 0.0 110.575 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.733 ' O ' HG21 ' R' ' 56' ' ' ILE . 39.3 Cg_endo -64.71 -34.35 51.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.487 1.257 . . . . 0.0 109.859 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' R' ' 104' ' ' ILE 0.251 . . -57.6 -39.73 77.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.956 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' R' ' 92' ' ' LEU . 3.5 mm? -56.08 -31.75 63.5 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.027 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.978 HG13 HD13 ' R' ' 86' ' ' LEU . 14.8 t -59.18 -52.85 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.705 HG22 HD11 ' R' ' 111' ' ' LEU . 43.5 pt -66.04 -34.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 111.108 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.498 ' N ' HG13 ' R' ' 104' ' ' ILE . 8.4 m95 -60.7 -38.97 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 111.816 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.787 ' CB ' ' HA ' ' R' ' 90' ' ' THR . 71.3 m-80 -82.26 -34.56 28.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.702 -1.249 . . . . 0.0 113.265 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 107' ' ' ILE . . . . . 0.728 HG22 HD23 ' R' ' 110' ' ' LEU . 0.2 OUTLIER -92.76 22.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.601 -1.312 . . . . 0.0 110.368 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' R' ' 112' ' ' HIS . 32.3 tttt -29.58 -58.99 0.16 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.848 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.3 m-70 -63.12 -13.59 38.5 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.129 2.24 . . . . 0.0 111.232 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.848 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -111.11 -7.46 14.49 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.923 HD21 ' CE1' ' R' ' 60' ' ' PHE . 0.2 OUTLIER -142.99 -111.34 0.12 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.197 -1.365 . . . . 0.0 114.449 -173.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 112' ' ' HIS . . . . . 0.626 ' C ' ' O ' ' R' ' 111' ' ' LEU . 53.6 t-80 -19.47 81.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 123.768 1.747 . . . . 0.0 109.871 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 113' ' ' THR . . . . . 1.094 ' CG2' HD11 ' R' ' 115' ' ' ILE 0.25 4.5 t -70.12 -162.55 0.06 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.14 177.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.837 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.1 97.84 0.46 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 1.094 HD11 ' CG2' ' R' ' 113' ' ' THR . 3.3 mm -113.01 145.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.784 -1.421 . . . . 0.0 110.601 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 116' ' ' GLY . . . . . 0.453 ' N ' ' HB2' ' R' ' 122' ' ' SER . . . -124.92 -143.99 6.23 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.925 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.977 ' HA ' HG22 ' R' ' 126' ' ' VAL . 24.9 m -138.05 174.5 10.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.889 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -55.66 -29.45 59.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.389 -1.325 . . . . 0.0 109.62 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 39.6 m -87.11 -33.19 19.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -101.16 119.8 56.89 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.247 -0.908 . . . . 0.0 110.384 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.79 124.91 4.68 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.627 1.33 . . . . 0.0 112.228 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER -140.74 -170.08 2.94 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' R' ' 114' ' ' GLY . 52.7 mt-10 -55.59 -44.74 77.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.52 -1.362 . . . . 0.0 107.862 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 1.008 ' CG2' HD12 ' R' ' 115' ' ' ILE . 1.9 m -120.25 138.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.542 ' O ' ' O ' ' R' ' 180' ' ' PHE . 43.1 t -123.05 135.22 54.34 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.237 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' R' ' 117' ' ' THR . 10.4 m -80.64 -173.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.417 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.931 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 3.6 m -117.16 -42.01 2.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.802 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.526 ' N ' HG23 ' R' ' 127' ' ' VAL . 89.2 m-20 42.55 37.12 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.566 -1.334 . . . . 0.0 111.021 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.33 39.92 91.83 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 130' ' ' THR . . . . . 0.889 HG21 ' HB1' ' R' ' 118' ' ' ALA . 90.7 m -113.34 152.62 29.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.694 -0.886 . . . . 0.0 111.627 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 131' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' R' ' 130' ' ' THR . 65.6 m-20 70.73 -166.88 0.15 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.864 0.84 . . . . 0.0 111.987 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.522 ' O ' ' OD2' ' R' ' 173' ' ' ASP . 87.2 mtp -83.83 177.5 8.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.889 -0.507 . . . . 0.0 111.111 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' R' ' 134' ' ' LEU . 0.5 OUTLIER -89.22 -171.22 3.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.69 -0.631 . . . . 0.0 111.253 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 1.077 ' HA ' ' HB2' ' R' ' 173' ' ' ASP . 0.3 OUTLIER -3.76 -70.35 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 135' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' R' ' 133' ' ' CYS . . . -54.19 3.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 136' ' ' ASP . . . . . 0.607 ' O ' ' CZ ' ' R' ' 183' ' ' TYR . 14.5 t70 -84.98 -90.47 0.1 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 119.396 -2.065 . . . . 0.0 111.598 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 137' ' ' PHE . . . . . 0.84 ' CE1' ' HB2' ' R' ' 180' ' ' PHE . 14.3 p90 -102.47 -176.19 3.03 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.888 ' HB2' HG23 ' R' ' 154' ' ' VAL . 0.0 OUTLIER -149.53 79.96 1.39 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.183 -1.807 . . . . 0.0 111.196 176.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.767 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 176.96 161.29 0.41 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.656 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 131.45 -165.62 23.17 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.826 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 141' ' ' ILE . . . . . 0.794 HD11 ' CD2' ' R' ' 59' ' ' LEU . 62.0 mt -106.8 119.18 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.8 -0.823 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.826 ' HB2' HG23 ' R' ' 150' ' ' VAL . 0.4 OUTLIER -109.72 140.01 44.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.718 0.771 . . . . 0.0 109.688 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.42 119.36 38.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.33 -0.857 . . . . 0.0 108.978 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -100.73 121.26 41.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.751 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.75 -124.08 32.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -133.92 154.64 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.8 31.0 2.88 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.99 125.23 20.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.508 -0.745 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 149' ' ' ALA . . . . . 0.747 ' HB3' ' C ' ' R' ' 51' ' ' ALA . . . -112.43 142.91 44.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 110.233 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 150' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.3 m -142.15 167.63 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.0 109.7 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' R' ' 59' ' ' LEU . 52.2 t80 -150.35 121.68 7.86 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.257 -0.902 . . . . 0.0 112.214 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.44 168.0 10.23 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 119.985 -1.697 . . . . 0.0 110.264 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 153' ' ' CYS . . . . . 0.79 ' HB2' ' CE2' ' R' ' 160' ' ' TYR . 0.5 OUTLIER -168.56 144.82 3.7 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.361 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' R' ' 138' ' ' HIS . 41.4 t -55.55 123.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.081 -1.637 . . . . 0.0 114.028 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 155' ' ' THR . . . . . 0.608 ' CG2' ' HB3' ' R' ' 160' ' ' TYR . 21.9 p -126.88 -179.56 4.89 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.127 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 42.1 m -56.36 -20.29 18.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.169 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 157' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' R' ' 169' ' ' PRO . 79.1 m-20 -92.66 -5.2 51.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.576 -0.702 . . . . 0.0 111.855 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 158' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 116.96 -135.44 11.96 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.996 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.857 ' O ' ' HA ' ' R' ' 169' ' ' PRO . 0.0 OUTLIER -82.34 82.17 7.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 160' ' ' TYR . . . . . 0.982 ' O ' ' HB1' ' R' ' 152' ' ' ALA . 0.0 OUTLIER -64.22 160.04 19.42 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 161' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -147.12 113.23 5.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 162' ' ' ILE . . . . . 0.866 HG23 ' O ' ' R' ' 162' ' ' ILE . 0.7 OUTLIER -72.43 83.69 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 123.103 1.43 . . . . 0.0 111.101 -175.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -80.01 131.0 35.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 164' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' R' ' 163' ' ' ASP . 92.6 m-20 32.82 65.16 0.24 Allowed 'General case' 0 N--CA 1.518 2.94 0 O-C-N 120.884 -1.135 . . . . 0.0 112.465 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' R' ' 42' ' ' TYR . 5.3 mt-10 58.75 8.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.232 -1.542 . . . . 0.0 112.129 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 166' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 74.5 m-20 -109.44 152.54 25.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 119.977 -1.702 . . . . 0.0 108.754 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 167' ' ' PHE . . . . . 0.662 ' CB ' HD11 ' R' ' 31' ' ' LEU . 19.5 p90 -124.7 130.39 52.33 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.868 1.318 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 168' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' R' ' 161' ' ' ALA . 2.0 p90 -159.42 144.03 11.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.685 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 169' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' R' ' 159' ' ' TRP . 50.3 Cg_endo -72.89 107.7 2.41 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 O-C-N 123.088 1.046 . . . . 0.0 112.802 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.79 ' O ' HG23 ' R' ' 171' ' ' THR . 0.6 OUTLIER -135.3 18.28 3.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 117.123 -1.831 . . . . 0.0 112.66 175.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 171' ' ' THR . . . . . 1.029 HG22 HD11 ' R' ' 134' ' ' LEU . 0.1 OUTLIER 167.43 121.01 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.965 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 175.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 1.037 ' CD ' HD13 ' R' ' 134' ' ' LEU . 42.2 Cg_endo -101.65 16.76 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.235 1.29 . . . . 0.0 113.421 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 173' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' R' ' 134' ' ' LEU . 0.1 OUTLIER -144.48 -173.1 0.34 Allowed Pre-proline 0 N--CA 1.511 2.583 0 O-C-N 118.216 -2.802 . . . . 0.0 114.923 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 1.06 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.4 Cg_endo -86.39 34.07 0.45 Allowed 'Trans proline' 0 C--O 1.217 -0.57 0 O-C-N 124.29 1.679 . . . . 0.0 112.143 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 175' ' ' SER . . . . . 0.729 ' OG ' HD23 ' R' ' 134' ' ' LEU . 15.0 m -62.18 -43.45 98.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.816 -1.178 . . . . 0.0 108.436 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -123.09 0.82 9.13 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.63 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 1.06 HG13 ' HA ' ' R' ' 174' ' ' PRO . 0.2 OUTLIER -109.34 157.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.304 -0.873 . . . . 0.0 109.838 -178.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.931 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.5 OUTLIER -132.1 38.34 3.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 117.529 -1.668 . . . . 0.0 110.606 177.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.974 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 7.7 p -165.63 129.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.84 ' HB2' ' CE1' ' R' ' 137' ' ' PHE . 7.1 p90 -136.72 179.44 6.37 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.174 -1.41 . . . . 0.0 111.227 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 181' ' ' VAL . . . . . 0.767 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -112.21 137.98 21.67 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.395 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 182' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' R' ' 181' ' ' VAL . 41.0 Cg_endo -66.49 141.34 60.88 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.5 1.263 . . . . 0.0 111.866 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 15.7 p90 -138.35 172.74 12.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 50.4 p30 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.18 -0.95 . . . . 0.0 110.947 -179.914 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' R' R ' 29' ' ' MET . . . . . 0.54 ' HB2' ' CE2' ' R' ' 167' ' ' PHE . 89.2 mtp . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.291 0.567 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 30' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' R' ' 40' ' ' THR . 93.2 mt-10 -97.77 114.71 26.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 111.372 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 31' ' ' LEU . . . . . 1.028 HD13 HG21 ' R' ' 162' ' ' ILE . 1.2 pt? -122.9 135.52 54.53 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.49 -1.284 . . . . 0.0 111.025 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 32' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' R' ' 38' ' ' LYS . 8.8 t -91.58 156.24 17.79 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -106.26 -173.97 2.42 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.655 -0.653 . . . . 0.0 110.595 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 34' ' ' TYR . . . . . 0.713 ' N ' ' O ' ' R' ' 154' ' ' VAL . 19.2 p90 -48.14 -49.8 31.01 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 35' ' ' ASN . . . . . 0.629 ' OD1' HD23 ' R' ' 33' ' ' LEU . 12.4 p-10 -76.57 17.99 0.36 Allowed 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 122.417 2.371 . . . . 0.0 114.303 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -13.74 40.47 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 120.07 -1.644 . . . . 0.0 112.795 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 37' ' ' GLU . . . . . 0.791 ' HB3' HD21 ' R' ' 33' ' ' LEU . 81.2 tt0 -61.18 131.88 51.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.637 1.718 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 38' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' R' ' 38' ' ' LYS . 52.6 pttt -100.93 113.03 25.63 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.925 0.869 . . . . 0.0 111.062 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' HD2' ' R' ' 61' ' ' ARG . 67.1 mttm -113.21 117.77 32.81 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 40' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' R' ' 40' ' ' THR . 1.3 t -94.69 133.0 38.82 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.358 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 1.179 ' CE2' HD11 ' R' ' 162' ' ' ILE . 0.1 OUTLIER -145.67 166.73 24.95 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.739 176.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 42' ' ' TYR . . . . . 0.512 ' O ' ' OG ' ' R' ' 43' ' ' SER . 87.0 m-85 -79.35 175.86 10.21 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.964 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 43' ' ' SER . . . . . 0.689 ' O ' ' O ' ' R' ' 44' ' ' ARG . 0.8 OUTLIER 169.62 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 44' ' ' ARG . . . . . 0.689 ' O ' ' O ' ' R' ' 43' ' ' SER . 5.7 ptt180 -32.87 163.97 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.019 -1.05 . . . . 0.0 111.483 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 45' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 29.3 Cg_endo -52.28 104.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.347 1.183 . . . . 0.0 110.874 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' R' ' 76' ' ' GLU . 7.3 t-20 -92.63 -127.67 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.555 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' R' ' 48' ' ' HIS . 0.4 OUTLIER -134.55 138.12 44.36 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.613 -1.304 . . . . 0.0 111.661 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' R' ' 47' ' ' ASN . 51.3 m80 72.52 42.98 0.5 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.423 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 49' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' R' ' 48' ' ' HIS . 80.1 m-20 55.26 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.439 -0.788 . . . . 0.0 109.357 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' R' ' 77' ' ' ASN . 31.1 p-10 -111.63 1.98 17.06 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.623 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.253 . . -68.51 -41.86 79.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.696 -0.628 . . . . 0.0 111.716 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 1.006 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 33.2 m95 -60.13 -33.64 72.42 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.08 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 1.074 HD11 HG12 ' R' ' 83' ' ' ILE . 2.3 mt -79.53 -40.37 29.75 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 54' ' ' ASN . . . . . 0.569 ' O ' ' HG3' ' R' ' 58' ' ' GLN . 8.3 t30 -55.15 -28.79 55.31 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 55' ' ' ALA . . . . . 0.942 ' HB1' ' CE1' ' R' ' 151' ' ' PHE . . . -64.43 -64.37 0.9 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.856 HD12 HG11 ' R' ' 103' ' ' VAL . 0.6 OUTLIER -67.27 -29.2 45.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 O-C-N 120.231 -1.543 . . . . 0.0 108.174 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 57' ' ' LEU . . . . . 0.997 ' HG ' HG11 ' R' ' 71' ' ' VAL . 1.8 mm? -52.62 -54.57 31.31 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 109.139 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 58' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' R' ' 54' ' ' ASN . 1.8 mt-30 -55.03 -31.73 61.31 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' R' ' 151' ' ' PHE . 1.4 tp -67.84 -40.71 83.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.783 ' HB2' ' HD2' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -54.14 -47.28 72.09 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.955 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 61' ' ' ARG . . . . . 0.581 ' HG2' ' CZ ' ' R' ' 60' ' ' PHE . 16.2 mmt180 -57.8 -54.32 48.22 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.884 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.806 ' CZ ' ' HB1' ' R' ' 139' ' ' ALA . 21.6 p90 -92.6 -31.76 15.04 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 119.598 -1.939 . . . . 0.0 114.016 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.74 HG22 HG12 ' R' ' 124' ' ' VAL . 56.1 t -77.18 -24.85 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 120.137 -1.602 . . . . 0.0 110.233 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 64' ' ' GLU . . . . . 0.73 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 87.3 tt0 123.22 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' HD1' ' R' ' 60' ' ' PHE . 3.5 pt-20 -50.44 100.92 0.24 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' R' ' 60' ' ' PHE . 46.7 Cg_endo -86.69 -165.23 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 N-CA-C 106.023 -2.337 . . . . 0.0 106.023 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 67' ' ' PHE . . . . . 0.593 ' CE1' HD21 ' R' ' 89' ' ' LEU . 76.6 m-85 -41.95 -19.35 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 68' ' ' PHE . . . . . 0.802 ' HB3' HD22 ' R' ' 57' ' ' LEU . 3.2 m-30 -58.24 -3.01 0.22 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.286 -1.509 . . . . 0.0 110.452 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' R' ' 72' ' ' TYR . 19.8 t70 -58.35 -30.39 66.71 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.717 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -61.58 -33.51 74.01 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.848 -1.158 . . . . 0.0 108.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.997 HG11 ' HG ' ' R' ' 57' ' ' LEU . 55.5 t -68.39 -62.2 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.535 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 72' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' R' ' 69' ' ' ASP . 0.8 OUTLIER -71.98 -30.75 65.58 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.207 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 73' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 34.0 t -63.99 -23.24 67.26 Favored 'General case' 0 N--CA 1.51 2.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.434 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 148.93 80.45 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 75' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' R' ' 42' ' ' TYR . 38.8 Cg_endo -65.03 -17.46 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.712 1.375 . . . . 0.0 110.025 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 76' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' R' ' 78' ' ' LEU . 96.1 mt-10 -141.28 58.84 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.5 -0.75 . . . . 0.0 109.499 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 77' ' ' ASN . . . . . 0.539 ' ND2' HG13 ' R' ' 71' ' ' VAL . 28.7 t-20 57.38 -84.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.818 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 78' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' R' ' 81' ' ' GLU . 0.1 OUTLIER 78.33 67.28 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 79' ' ' THR . . . . . 0.646 ' O ' HG12 ' R' ' 83' ' ' ILE . 5.3 t -65.25 -52.64 53.14 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.834 -0.541 . . . . 0.0 110.573 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' R' ' 81' ' ' GLU . 0.4 OUTLIER -49.85 -53.12 27.65 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.56 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 81' ' ' GLU . . . . . 0.593 ' HG3' HD12 ' R' ' 80' ' ' LEU . 95.4 mt-10 -68.12 -28.22 67.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.059 -1.651 . . . . 0.0 110.277 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.921 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.61 -46.74 74.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.768 0.794 . . . . 0.0 112.436 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 1.074 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.36 -39.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.565 -176.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' R' ' 80' ' ' LEU . 35.4 mttm -49.74 -35.86 23.63 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 68.3 tp60 -70.93 -44.57 65.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 86' ' ' LEU . . . . . 0.806 HD13 ' OG1' ' R' ' 90' ' ' THR . 1.4 tm? -55.11 -38.4 68.12 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 87' ' ' GLU . . . . . 0.554 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.8 tt0 -59.37 -33.22 70.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.915 -1.115 . . . . 0.0 108.15 177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 88' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 82.0 m-20 -55.14 -32.49 62.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.956 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.905 ' H ' HD12 ' R' ' 89' ' ' LEU . 0.3 OUTLIER -102.61 -49.1 3.93 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.938 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 90' ' ' THR . . . . . 0.887 ' OG1' HD22 ' R' ' 92' ' ' LEU . 35.0 p -78.6 -27.79 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 91' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 73.12 23.61 77.32 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.154 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 92' ' ' LEU . . . . . 1.017 HD11 HD21 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -108.12 -160.88 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.063 -1.257 . . . . 0.0 112.042 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 93' ' ' GLU . . . . . 0.83 ' C ' HD13 ' R' ' 94' ' ' LEU . 95.5 mt-10 -144.56 104.79 4.09 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 1.017 HD21 HD11 ' R' ' 92' ' ' LEU . 0.3 OUTLIER -105.28 9.97 33.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.853 -1.155 . . . . 0.0 110.762 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 95' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' R' ' 94' ' ' LEU . 17.0 m170 -45.29 -29.75 1.09 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 96' ' ' GLU . . . . . 0.451 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 80.4 tt0 -150.49 33.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 97' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' R' ' 52' ' ' TRP . . . -95.64 -111.58 2.59 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.02 -1.05 . . . . 0.0 110.731 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 98' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . 178.14 -161.44 28.32 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.696 ' CD ' ' HD2' ' R' ' 100' ' ' PRO . 31.3 Cg_endo -72.69 -64.84 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 O-C-N 123.849 1.447 . . . . 0.0 114.108 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.932 ' O ' ' N ' ' R' ' 102' ' ' LEU . 33.6 Cg_endo -57.22 -28.32 78.9 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 N-CA-C 107.181 -1.892 . . . . 0.0 107.181 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.971 ' O ' HD12 ' R' ' 92' ' ' LEU 0.251 . . -29.35 60.44 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.197 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.932 ' N ' ' O ' ' R' ' 100' ' ' PRO . 7.3 mp 35.45 -4.74 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.959 ' O ' ' HB ' ' R' ' 107' ' ' ILE . 34.3 t -61.74 -44.99 99.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 C-N-CA 114.855 -2.738 . . . . 0.0 105.641 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' R' ' 100' ' ' PRO . 19.0 pt -84.14 -36.09 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.339 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.73 ' HB3' ' HA ' ' R' ' 102' ' ' LEU . 48.0 t-105 -60.27 -45.26 93.91 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.152 -1.419 . . . . 0.0 111.419 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.457 ' HB2' HG22 ' R' ' 90' ' ' THR . 9.1 m120 -84.88 -22.53 29.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.891 -1.131 . . . . 0.0 111.794 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 107' ' ' ILE . . . . . 0.959 ' HB ' ' O ' ' R' ' 103' ' ' VAL . 0.2 OUTLIER -67.48 -14.43 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 111.33 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 107' ' ' ILE . 75.2 tttt -33.96 -59.73 0.41 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.425 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.0 m80 -84.0 -7.67 59.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.274 -2.141 . . . . 0.0 111.451 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.761 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.1 OUTLIER -84.26 -30.85 25.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.516 -1.365 . . . . 0.0 109.199 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.815 ' CG ' HG23 ' R' ' 107' ' ' ILE 0.281 57.6 mt -68.11 161.03 27.79 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.692 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -117.14 60.13 0.75 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.623 HG22 HD13 ' R' ' 115' ' ' ILE . 97.4 m -145.12 138.36 26.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.395 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -74.67 98.4 1.05 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 105.615 -2.994 . . . . 0.0 105.615 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.948 HG23 ' CG2' ' R' ' 124' ' ' VAL . 31.1 mm -93.24 142.5 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.814 -1.404 . . . . 0.0 109.828 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' R' ' 122' ' ' SER . . . -133.46 -165.78 11.18 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.869 -1.634 . . . . 0.0 111.952 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.691 ' HA ' HG22 ' R' ' 126' ' ' VAL . 7.2 m -134.63 -175.43 3.88 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' R' ' 130' ' ' THR . . . -64.58 -37.86 89.0 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.795 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -66.71 -36.35 82.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.67 101.79 36.26 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.022 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.07 135.73 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.621 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.499 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 0.2 OUTLIER -145.22 -158.99 0.94 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.637 -0.665 . . . . 0.0 109.426 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.403 ' HB2' HG22 ' R' ' 113' ' ' THR . 77.0 mm-40 -56.13 -43.9 78.67 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.796 -1.19 . . . . 0.0 108.433 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.948 ' CG2' HG23 ' R' ' 115' ' ' ILE . 10.7 m -115.95 135.14 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.446 ' O ' ' CD1' ' R' ' 180' ' ' PHE . 7.0 t -134.3 136.9 43.83 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.966 0.888 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 6.1 m -82.53 -179.92 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.31 1.053 . . . . 0.0 111.18 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.973 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 5.0 m -121.55 -1.01 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' R' ' 178' ' ' LEU . 55.9 t0 -60.49 92.96 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.764 -1.21 . . . . 0.0 110.374 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.49 67.45 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 130' ' ' THR . . . . . 0.756 HG23 ' CB ' ' R' ' 118' ' ' ALA . 1.4 m -97.38 146.71 24.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.685 -0.891 . . . . 0.0 111.267 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -66.32 -32.39 73.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.491 ' HB3' ' CZ ' ' R' ' 180' ' ' PHE . 64.0 mtt -90.34 141.62 28.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.0 110.962 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.31 -165.32 1.78 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.71 -0.619 . . . . 0.0 110.228 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 1.085 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.9 OUTLIER -45.67 -30.0 1.42 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.77 -41.45 32.36 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 136' ' ' ASP . . . . . 0.644 ' O ' ' CD2' ' R' ' 137' ' ' PHE . 94.0 m-20 -71.15 -140.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 137' ' ' PHE . . . . . 0.715 ' HB2' ' CE2' ' R' ' 183' ' ' TYR . 0.4 OUTLIER -173.37 101.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 116.593 -2.043 . . . . 0.0 112.266 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.973 ' HB3' ' O ' ' R' ' 181' ' ' VAL . 1.3 t-160 -163.32 -138.63 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.214 1.007 . . . . 0.0 109.857 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' SG ' ' R' ' 153' ' ' CYS 0.261 . . -104.81 179.69 4.2 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.744 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 161.52 -178.68 37.33 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 141' ' ' ILE . . . . . 1.094 HG23 ' CE1' ' R' ' 151' ' ' PHE . 3.6 mt -108.35 115.69 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.627 -0.925 . . . . 0.0 110.616 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 1.045 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 3.0 m-85 -114.82 154.64 28.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.8 129.37 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.468 ' HB2' HG11 ' R' ' 150' ' ' VAL . 36.1 tttp -109.12 122.37 47.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.24 -130.6 49.73 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.49 -129.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.353 -1.087 . . . . 0.0 109.554 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.63 92.65 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 109.802 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' R' ' 144' ' ' LYS . 6.3 t-80 -146.47 122.15 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.462 -0.773 . . . . 0.0 108.92 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 149' ' ' ALA . . . . . 1.006 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -94.47 118.87 32.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.797 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 150' ' ' VAL . . . . . 0.618 HG22 ' O ' ' R' ' 142' ' ' PHE . 34.7 m -133.62 147.63 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.005 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 1.094 ' CE1' HG23 ' R' ' 141' ' ' ILE . 3.3 m-85 -136.11 131.78 35.23 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.63 169.91 8.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.597 -1.314 . . . . 0.0 111.29 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 153' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' R' ' 139' ' ' ALA . 3.9 t -163.37 133.09 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' R' ' 34' ' ' TYR . 48.3 t -50.91 117.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.101 -1.44 . . . . 0.0 111.919 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 155' ' ' THR . . . . . 0.764 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 66.4 p -104.4 -158.34 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 83.5 p -65.73 -15.47 62.86 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.672 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 157' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 86.0 m-20 -113.01 9.47 18.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.358 -0.839 . . . . 0.0 111.969 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 158' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 100.92 -153.96 19.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.757 ' CG ' ' O ' ' R' ' 171' ' ' THR . 0.0 OUTLIER -57.91 94.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.322 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 160' ' ' TYR . . . . . 0.764 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 0.2 OUTLIER -115.79 119.04 34.72 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 161' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -109.94 147.99 32.42 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.44 -1.413 . . . . 0.0 110.114 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 162' ' ' ILE . . . . . 1.179 HD11 ' CE2' ' R' ' 41' ' ' PHE . 6.0 pt -117.51 91.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-O 124.191 1.948 . . . . 0.0 112.029 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.666 ' O ' ' C ' ' R' ' 164' ' ' ASP . 63.6 m-20 -83.0 120.26 25.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 111.784 -2.462 . . . . 0.0 106.169 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 164' ' ' ASP . . . . . 0.675 ' HA ' ' C ' ' R' ' 43' ' ' SER . 96.8 m-20 11.93 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.113 0.959 . . . . 0.0 111.553 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' R' ' 163' ' ' ASP . 98.6 mt-10 -31.41 -52.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 166' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 19.8 t0 -172.5 177.9 2.88 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 119.339 -2.101 . . . . 0.0 113.496 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 167' ' ' PHE . . . . . 1.132 ' HA ' HG22 ' R' ' 162' ' ' ILE . 2.1 m-30 -93.52 129.35 39.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 168' ' ' TYR . . . . . 0.521 ' HB2' ' HD2' ' R' ' 169' ' ' PRO . 36.9 p90 -155.42 170.18 9.13 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.556 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 169' ' ' PRO . . . . . 0.521 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 41.3 Cg_endo -68.61 113.38 3.15 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.748 -1.674 . . . . 0.0 107.748 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.696 ' HA ' ' HE3' ' R' ' 170' ' ' TRP . 0.0 OUTLIER -117.66 -129.24 0.29 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 123.361 1.553 . . . . 0.0 111.956 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 171' ' ' THR . . . . . 1.085 ' CG2' HD11 ' R' ' 134' ' ' LEU 0.319 1.4 m -32.22 97.74 0.11 Allowed Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 112.904 -1.953 . . . . 0.0 115.389 -174.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' R' ' 173' ' ' ASP . 53.2 Cg_endo -92.93 -30.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.53 1.805 . . . . 0.0 108.037 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 173' ' ' ASP . . . . . 0.55 ' CA ' ' HG ' ' R' ' 134' ' ' LEU . 18.0 p30 -148.15 170.43 7.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.448 -0.783 . . . . 0.0 108.915 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' R' ' 134' ' ' LEU . 49.5 Cg_endo -85.64 51.36 2.87 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 83.4 p -82.15 -34.13 29.28 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -125.41 6.11 7.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.557 -1.339 . . . . 0.0 111.054 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 1.045 ' HB ' ' CG ' ' R' ' 142' ' ' PHE 0.259 2.3 p -112.31 148.49 15.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.231 -0.918 . . . . 0.0 110.687 -177.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.973 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.4 OUTLIER -133.05 46.26 2.63 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.893 175.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.43 131.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' R' ' 182' ' ' PRO . 2.3 p90 -132.46 178.53 6.76 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.686 1.231 . . . . 0.0 108.987 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 181' ' ' VAL . . . . . 0.973 ' O ' ' HB3' ' R' ' 138' ' ' HIS . 0.8 OUTLIER -121.64 93.3 48.73 Favored Pre-proline 0 C--N 1.265 -3.088 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 182' ' ' PRO . . . . . 0.495 ' HB3' ' CE2' ' R' ' 180' ' ' PHE . 36.5 Cg_endo -60.05 109.29 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 120.862 1.041 . . . . 0.0 113.629 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.715 ' CE2' ' HB2' ' R' ' 137' ' ' PHE . 0.0 OUTLIER -67.12 -151.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.036 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.2 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.109 -0.994 . . . . 0.0 110.483 -179.565 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' R' R ' 29' ' ' MET . . . . . 0.432 ' HB2' ' CZ ' ' R' ' 167' ' ' PHE . 88.0 mtp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.162 0.506 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 30' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 84.1 tt0 -110.44 126.95 54.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.822 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 31' ' ' LEU . . . . . 1.078 ' CD1' HG21 ' R' ' 162' ' ' ILE . 1.7 pt? -139.02 163.4 32.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.459 -0.776 . . . . 0.0 109.632 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 32' ' ' THR . . . . . 0.784 HG22 ' HB3' ' R' ' 38' ' ' LYS . 31.8 p -104.78 129.26 53.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.145 . . . . 0.0 111.973 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.97 HD13 ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -130.68 136.03 48.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.41 -0.806 . . . . 0.0 109.773 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 34' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' R' ' 33' ' ' LEU . 58.2 t80 -33.48 -36.18 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 35' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' R' ' 62' ' ' TYR . 97.4 m-20 -105.34 65.13 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.837 -1.789 . . . . 0.0 111.287 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 36' ' ' GLY . . . . . 0.972 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 128.33 35.27 0.51 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 37' ' ' GLU . . . . . 0.972 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.0 mt-10 -13.82 -150.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 38' ' ' LYS . . . . . 0.784 ' HB3' HG22 ' R' ' 32' ' ' THR . 9.5 pttm -52.29 109.1 0.35 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.356 -1.465 . . . . 0.0 112.518 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 30.0 mmtm -150.09 147.19 27.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.315 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 40' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' R' ' 72' ' ' TYR . 0.8 OUTLIER -85.4 125.42 32.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.126 -0.984 . . . . 0.0 110.019 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.714 ' CD2' ' CE2' ' R' ' 151' ' ' PHE . 84.2 m-85 -110.09 154.02 23.85 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.934 1.349 . . . . 0.0 114.42 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 42' ' ' TYR . . . . . 0.686 ' HA ' ' HB2' ' R' ' 164' ' ' ASP . 76.2 m-85 -116.45 164.22 14.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.256 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 43' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' R' ' 51' ' ' ALA . 0.6 OUTLIER 155.71 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 119.446 1.021 . . . . 0.0 113.304 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 44' ' ' ARG . . . . . 0.576 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 4.5 mtt180 -72.28 175.74 2.92 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 109.24 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 45' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' R' ' 44' ' ' ARG . 37.5 Cg_endo -61.65 100.59 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.286 1.15 . . . . 0.0 113.204 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 47' ' ' ASN . 2.1 m-20 -150.73 -11.85 0.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 47' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 46' ' ' ASN . 0.2 OUTLIER -135.78 -178.67 5.24 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 77.4 m80 -92.7 -6.93 48.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.639 -1.288 . . . . 0.0 109.824 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 49' ' ' ASP . . . . . 0.749 ' O ' HG21 ' R' ' 79' ' ' THR . 12.5 p30 172.17 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 109.605 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.465 ' CG ' ' HB ' ' R' ' 79' ' ' THR . 0.2 OUTLIER -138.58 -3.13 1.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 51' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.255 . . -66.3 -44.54 83.18 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.712 -0.617 . . . . 0.0 110.718 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.656 ' CD2' ' HA2' ' R' ' 97' ' ' GLY . 55.2 m95 -61.1 -36.63 80.21 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.555 -1.658 . . . . 0.0 107.795 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 1.086 HD11 HG12 ' R' ' 83' ' ' ILE . 2.4 mt -68.49 -34.86 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 54' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' R' ' 42' ' ' TYR . 0.0 OUTLIER -47.6 -26.98 1.64 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 55' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.52 -56.98 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.953 HG23 ' CE2' ' R' ' 60' ' ' PHE 0.291 1.2 mp -62.58 -42.39 95.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 122.379 1.085 . . . . 0.0 108.311 177.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 57' ' ' LEU . . . . . 1.014 HD12 ' CE1' ' R' ' 72' ' ' TYR . 4.2 mm? -65.03 -60.7 2.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.953 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 58' ' ' GLN . . . . . 0.779 ' NE2' ' O ' ' R' ' 140' ' ' GLY . 6.2 pt20 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.834 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 1.6 mp -70.97 -48.54 52.77 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.566 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.953 ' CE2' HG23 ' R' ' 56' ' ' ILE . 12.7 m-30 -61.51 -45.93 92.12 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.474 -1.29 . . . . 0.0 110.59 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 61' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' R' ' 39' ' ' LYS . 1.5 tpm_? -58.3 -31.23 67.29 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 119.67 -1.894 . . . . 0.0 110.139 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 1.016 ' HB3' HG21 ' R' ' 181' ' ' VAL . 22.0 m-30 -61.7 -54.01 48.32 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.541 -1.35 . . . . 0.0 111.986 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.811 HG11 HG23 ' R' ' 113' ' ' THR . 3.9 t -85.79 3.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.363 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 64' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 74.4 tt0 67.04 44.91 1.85 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 4.4 mp0 -133.88 89.18 30.46 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' CZ ' ' R' ' 68' ' ' PHE . 53.1 Cg_endo -79.27 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.543 1.286 . . . . 0.0 113.757 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 67' ' ' PHE . . . . . 0.554 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 55.1 t80 -82.98 -25.71 32.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 68' ' ' PHE . . . . . 0.869 ' CG ' HD13 ' R' ' 57' ' ' LEU . 2.0 p90 -72.6 19.15 0.08 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.991 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' R' ' 73' ' ' SER . 95.5 m-20 -38.2 -37.29 0.27 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.451 -0.781 . . . . 0.0 112.868 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.463 ' HB2' ' HA ' ' R' ' 82' ' ' ALA . 84.8 m95 -62.03 -30.44 70.97 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.24 -1.538 . . . . 0.0 110.113 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' R' ' 57' ' ' LEU . 65.5 t -78.7 -67.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 72' ' ' TYR . . . . . 1.014 ' CE1' HD12 ' R' ' 57' ' ' LEU . 9.9 m-30 -67.89 -38.8 83.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.239 -0.913 . . . . 0.0 110.94 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 73' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' R' ' 69' ' ' ASP . 6.1 m -63.35 -21.62 66.38 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.739 -1.185 . . . . 0.0 109.561 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 74' ' ' SER . . . . . 0.585 ' OG ' HD23 ' R' ' 78' ' ' LEU . 16.4 t -99.6 119.71 59.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.957 . . . . 0.0 110.513 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.97 -19.25 46.2 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.569 1.299 . . . . 0.0 110.279 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.61 165.19 11.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.449 -0.782 . . . . 0.0 109.849 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -58.52 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.825 . . . . 0.0 110.728 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 78' ' ' LEU . . . . . 0.585 HD23 ' OG ' ' R' ' 74' ' ' SER . 1.4 mm? -107.82 21.81 16.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 79' ' ' THR . . . . . 0.749 HG21 ' O ' ' R' ' 49' ' ' ASP . 3.1 t -55.48 -52.64 62.97 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.506 -0.746 . . . . 0.0 109.956 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.606 ' H ' HG23 ' R' ' 79' ' ' THR . 1.2 pp -49.86 -50.84 44.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.692 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 81' ' ' GLU . . . . . 0.553 ' N ' HD12 ' R' ' 80' ' ' LEU . 84.8 tt0 -67.08 -28.63 68.34 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.28 -1.513 . . . . 0.0 110.104 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -67.01 -48.45 68.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.93 0.871 . . . . 0.0 111.572 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 1.086 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.76 -38.52 11.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.443 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 84' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 83' ' ' ILE . 36.7 tttm -50.49 -35.34 28.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -73.55 -36.56 65.65 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 86' ' ' LEU . . . . . 1.019 HD12 HD21 ' R' ' 94' ' ' LEU . 2.6 tm? -63.13 -38.18 90.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 87' ' ' GLU . . . . . 0.571 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 83.0 tt0 -60.9 -39.71 90.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 108.824 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.08 -32.3 72.82 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.273 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.808 HD23 ' N ' ' R' ' 90' ' ' THR . 2.6 tt -94.91 -51.25 4.76 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.08 -1.013 . . . . 0.0 111.805 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 90' ' ' THR . . . . . 0.838 HG22 ' HB2' ' R' ' 106' ' ' ASN . 69.7 p -76.58 -25.64 54.21 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 91' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 67.29 26.15 73.52 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.692 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 92' ' ' LEU . . . . . 1.098 HD13 HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -104.54 -17.98 14.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.02 -1.283 . . . . 0.0 111.756 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 93' ' ' GLU . . . . . 0.74 ' N ' HD12 ' R' ' 92' ' ' LEU . 84.1 tt0 58.42 115.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 1.098 HD23 HD13 ' R' ' 92' ' ' LEU . 3.7 pp -156.75 21.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.688 -1.257 . . . . 0.0 111.181 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 95' ' ' HIS . . . . . 0.839 ' HA ' HD12 ' R' ' 83' ' ' ILE . 5.7 p80 -42.42 -28.35 0.2 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.2 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 96' ' ' GLU . . . . . 0.485 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 23.1 pt-20 -120.39 36.11 4.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 97' ' ' GLY . . . . . 0.656 ' HA2' ' CD2' ' R' ' 52' ' ' TRP . . . 145.87 110.78 0.67 Allowed Glycine 0 N--CA 1.504 3.182 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.329 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 98' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' R' ' 94' ' ' LEU . . . -170.68 65.29 0.16 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.023 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.843 ' HB2' ' CD ' ' R' ' 100' ' ' PRO . 42.8 Cg_endo -84.56 -108.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.965 0 O-C-N 123.322 1.169 . . . . 0.0 109.211 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.881 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.3 Cg_endo -60.18 -17.88 48.49 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 N-CA-C 106.845 -2.021 . . . . 0.0 106.845 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.254 . . -31.22 61.27 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.195 175.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.881 ' N ' ' O ' ' R' ' 100' ' ' PRO . 80.8 mt 41.0 -3.42 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.369 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.008 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.968 HG13 HD11 ' R' ' 86' ' ' LEU . 13.4 t -56.98 -47.75 82.85 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 C-N-CA 114.335 -2.946 . . . . 0.0 104.079 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.46 -39.36 85.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.932 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.635 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 51.9 t90 -63.02 -36.31 83.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.12 -1.432 . . . . 0.0 111.25 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.838 ' HB2' HG22 ' R' ' 90' ' ' THR . 22.3 m120 -84.87 -23.19 29.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.086 -1.009 . . . . 0.0 113.26 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 107' ' ' ILE . . . . . 0.905 HG12 ' O ' ' R' ' 103' ' ' VAL . 3.4 mm -70.6 -10.95 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.242 -1.536 . . . . 0.0 110.02 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' R' ' 107' ' ' ILE . 62.1 mttt -33.47 -57.93 0.41 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.827 ' C ' HD13 ' R' ' 110' ' ' LEU . 4.1 m-70 -72.91 -9.68 58.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 119.181 -2.199 . . . . 0.0 111.506 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.838 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.2 OUTLIER -106.54 -16.82 14.43 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.859 HD23 HG21 ' R' ' 107' ' ' ILE 0.323 0.1 OUTLIER -109.71 127.62 54.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.835 -176.52 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' R' R ' 112' ' ' HIS . . . . . 0.546 ' N ' HD13 ' R' ' 111' ' ' LEU . 17.8 p80 -115.37 76.91 1.03 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.886 HG22 ' CD1' ' R' ' 115' ' ' ILE . 18.0 m -132.14 136.42 47.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.278 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.539 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -75.73 104.36 1.78 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 1.1 HD12 HG22 ' R' ' 124' ' ' VAL . 3.3 mm -90.9 144.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.634 -1.509 . . . . 0.0 109.358 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 116' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' R' ' 125' ' ' CYS . . . -145.42 -118.79 1.2 Allowed Glycine 0 N--CA 1.509 3.562 0 C-N-CA 118.408 -1.853 . . . . 0.0 112.462 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.53 HG23 ' O ' ' R' ' 116' ' ' GLY . 0.0 OUTLIER -178.95 -175.2 0.38 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.204 -1.174 . . . . 0.0 108.814 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.702 ' CA ' HG22 ' R' ' 126' ' ' VAL 0.278 . . -66.84 -43.62 83.22 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.31 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -37.77 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 108.889 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 120' ' ' ARG . . . . . 0.427 ' HA ' ' HD2' ' R' ' 121' ' ' PRO . 0.0 OUTLIER -123.22 104.11 35.28 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' R' ' 120' ' ' ARG . 39.8 Cg_endo -65.33 131.17 27.38 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.524 1.276 . . . . 0.0 111.224 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 46.7 m -146.05 -168.91 3.12 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.569 ' O ' HG23 ' R' ' 181' ' ' VAL . 76.8 mm-40 -63.18 -43.16 99.02 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.8 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 1.1 HG22 HD12 ' R' ' 115' ' ' ILE . 0.6 OUTLIER -149.17 122.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.337 -1.477 . . . . 0.0 112.566 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.784 ' HB3' ' O ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER 152.74 138.03 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.061 176.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.995 ' CG1' HG13 ' R' ' 127' ' ' VAL . 1.1 t -176.55 -172.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 1.095 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.4 m 36.91 -3.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 127.779 2.432 . . . . 0.0 116.863 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' R' ' 126' ' ' VAL . 44.9 t0 -57.22 55.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.659 -1.276 . . . . 0.0 111.752 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 129' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 105.28 15.56 19.12 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 130' ' ' THR . . . . . 0.661 HG21 ' CB ' ' R' ' 118' ' ' ALA . 87.1 m -116.53 154.32 30.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -1.175 . . . . 0.0 112.164 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -58.78 159.59 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.773 -0.579 . . . . 0.0 109.52 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.447 ' HG2' HG12 ' R' ' 127' ' ' VAL . 28.2 mtt -123.81 136.36 54.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.283 -0.885 . . . . 0.0 111.326 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.415 ' N ' ' HG2' ' R' ' 174' ' ' PRO . 49.1 t -137.3 134.64 36.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.027 -1.045 . . . . 0.0 111.086 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 1.006 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -59.89 -42.22 93.34 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.244 1.021 . . . . 0.0 110.587 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.4 0.52 9.95 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' R' ' 133' ' ' CYS . 47.4 t0 -73.31 -65.74 0.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.106 . . . . 0.0 111.827 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 137' ' ' PHE . . . . . 0.714 ' CG ' ' CD2' ' R' ' 180' ' ' PHE . 19.5 p90 -146.85 178.23 8.5 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.091 -1.006 . . . . 0.0 110.2 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' R' ' 172' ' ' PRO . 29.3 m80 -143.14 72.66 1.37 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.245 -1.382 . . . . 0.0 112.212 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.968 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 171.81 153.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.779 ' O ' ' NE2' ' R' ' 58' ' ' GLN . . . 144.16 -176.23 23.53 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.283 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 141' ' ' ILE . . . . . 0.71 ' CG1' ' HA ' ' R' ' 55' ' ' ALA . 0.5 OUTLIER -98.8 128.91 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.829 ' HA ' ' HA ' ' R' ' 177' ' ' VAL . 0.2 OUTLIER -111.48 141.56 44.89 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.501 -1.279 . . . . 0.0 109.021 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.487 ' N ' HD22 ' R' ' 143' ' ' LEU . 4.6 mm? -88.95 109.38 20.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.934 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.519 ' HD2' HG11 ' R' ' 150' ' ' VAL . 24.6 tttt -108.79 120.3 42.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.17 -137.72 44.16 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 146' ' ' GLN . . . . . 0.435 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 93.9 mt-30 -126.52 150.73 48.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -1.034 . . . . 0.0 110.16 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 51.27 37.56 18.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.435 ' CD2' ' O ' ' R' ' 146' ' ' GLN . 56.1 m-70 -142.86 123.61 14.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.31 -0.869 . . . . 0.0 109.672 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 149' ' ' ALA . . . . . 0.796 ' HB3' ' HB1' ' R' ' 51' ' ' ALA . . . -105.33 136.27 45.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 150' ' ' VAL . . . . . 0.706 HG22 ' O ' ' R' ' 142' ' ' PHE . 31.2 m -127.9 165.72 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.025 -1.047 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.714 ' CE2' ' CD2' ' R' ' 41' ' ' PHE 0.26 0.0 OUTLIER -148.11 125.22 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.736 -1.186 . . . . 0.0 113.494 -177.613 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -132.81 164.29 27.16 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.606 -1.309 . . . . 0.0 109.238 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 153' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 22.6 p -176.29 176.39 1.68 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' R' ' 158' ' ' GLY . 64.9 t -63.59 103.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 CA-C-O 121.684 0.754 . . . . 0.0 110.992 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 155' ' ' THR . . . . . 0.712 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 41.7 p -88.75 -160.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 84.5 p -61.82 -18.65 60.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 157' ' ' ASN . . . . . 0.529 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 90.4 m-20 -111.39 2.69 17.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.7 . . . . 0.0 111.502 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 158' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 92.91 -118.15 5.55 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 120.704 -1.248 . . . . 0.0 112.124 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.674 ' HB3' ' HD2' ' R' ' 172' ' ' PRO . 0.0 OUTLIER -60.79 92.5 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.645 1.212 . . . . 0.0 108.89 -177.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 160' ' ' TYR . . . . . 0.763 ' HA ' ' H ' ' R' ' 170' ' ' TRP . 3.3 m-85 -145.0 163.47 34.1 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 161' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -134.72 131.24 37.4 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.774 -1.204 . . . . 0.0 107.767 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 162' ' ' ILE . . . . . 1.078 HG21 ' CD1' ' R' ' 31' ' ' LEU . 1.2 pt -122.53 92.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-O 123.981 1.848 . . . . 0.0 112.811 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.697 ' HA ' ' CB ' ' R' ' 43' ' ' SER . 74.8 m-20 -96.06 129.0 43.46 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.105 -2.316 . . . . 0.0 108.637 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 164' ' ' ASP . . . . . 0.699 ' O ' ' CB ' ' R' ' 165' ' ' GLU . 11.2 t0 -34.37 117.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.699 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 42.9 tp10 135.06 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -169.19 161.14 10.12 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.32 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 167' ' ' PHE . . . . . 1.017 ' HA ' HG22 ' R' ' 162' ' ' ILE . 10.1 m-30 -107.38 122.07 45.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 168' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' R' ' 168' ' ' TYR . 9.7 p90 -141.63 160.54 56.11 Favored Pre-proline 0 C--N 1.294 -1.817 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.835 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 169' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.1 Cg_endo -69.52 113.45 3.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.36 1.716 . . . . 0.0 108.591 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.763 ' H ' ' HA ' ' R' ' 160' ' ' TYR . 0.0 OUTLIER -142.47 169.73 17.02 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 171' ' ' THR . . . . . 1.006 ' CG2' HD11 ' R' ' 134' ' ' LEU . 0.2 OUTLIER -100.27 99.83 10.49 Favored Pre-proline 0 C--N 1.274 -2.684 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.433 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' R' ' 159' ' ' TRP . 52.0 Cg_endo -75.61 55.67 4.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.884 1.465 . . . . 0.0 108.639 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 173' ' ' ASP . . . . . 0.755 ' CG ' HD13 ' R' ' 134' ' ' LEU . 3.7 m-20 -115.39 -176.76 0.39 Allowed Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.89 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' R' ' 173' ' ' ASP . 52.8 Cg_endo -79.81 31.36 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.568 1.299 . . . . 0.0 112.352 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 20.2 t -63.3 -51.19 67.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.733 -1.229 . . . . 0.0 109.387 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -131.86 13.99 4.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.708 . . . . 0.0 110.284 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 1.095 ' O ' HG21 ' R' ' 127' ' ' VAL . 0.5 OUTLIER -102.69 168.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.894 -1.129 . . . . 0.0 113.221 -177.518 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 1.089 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 1.1 mm? -100.59 -95.12 0.27 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.939 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.661 ' HA ' ' N ' ' R' ' 126' ' ' VAL . 28.6 m -80.69 135.42 25.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.714 ' CD2' ' CG ' ' R' ' 137' ' ' PHE 0.261 2.9 p90 -128.85 -178.81 4.77 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.549 1.166 . . . . 0.0 112.315 -173.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 181' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' R' ' 62' ' ' TYR . 0.5 OUTLIER -134.19 122.42 16.12 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.554 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 182' ' ' PRO . . . . . 0.429 ' N ' ' CE2' ' R' ' 180' ' ' PHE . 50.1 Cg_endo -76.34 161.35 34.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.49 1.258 . . . . 0.0 112.142 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' R' ' 137' ' ' PHE . 25.4 p90 -127.14 -173.97 3.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 56.5 t0 . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 0.0 111.434 -179.295 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.054 0.454 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.89 137.39 53.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 31' ' ' LEU . . . . . 0.981 HD11 ' CD1' ' R' ' 162' ' ' ILE . 1.3 pt? -145.63 153.0 40.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' R' ' 38' ' ' LYS . 1.9 p -112.26 142.88 44.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.202 -0.936 . . . . 0.0 109.562 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.927 HD13 ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -134.37 141.91 47.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.268 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 34' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' R' ' 154' ' ' VAL . 45.3 t80 -37.56 -38.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 35' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' R' ' 62' ' ' TYR . 24.0 m120 -104.21 66.1 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.736 -1.852 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 36' ' ' GLY . . . . . 0.94 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 129.63 35.25 0.46 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 37' ' ' GLU . . . . . 0.94 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.3 mt-10 -11.37 -159.14 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 38' ' ' LYS . . . . . 0.536 ' HA ' HG22 ' R' ' 32' ' ' THR . 5.1 pttt -44.98 110.96 0.27 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.053 1.406 . . . . 0.0 113.845 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.527 ' HG2' ' CA ' ' R' ' 61' ' ' ARG . 32.2 tptt -141.49 135.54 30.33 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 40' ' ' THR . . . . . 0.522 ' O ' HG22 ' R' ' 40' ' ' THR . 0.9 OUTLIER -84.26 125.57 32.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 113.609 -176.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.853 ' CD1' HD21 ' R' ' 31' ' ' LEU . 31.3 m-85 -100.95 169.82 8.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 42' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' R' ' 72' ' ' TYR . 85.6 m-85 -101.04 161.2 13.76 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.641 0.734 . . . . 0.0 111.759 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 43' ' ' SER . . . . . 0.635 ' CA ' ' HB2' ' R' ' 165' ' ' GLU . 36.9 m -55.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.648 0.737 . . . . 0.0 111.696 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 44' ' ' ARG . . . . . 0.867 ' HA ' ' HA ' ' R' ' 164' ' ' ASP . 0.4 OUTLIER -74.49 168.71 24.32 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.48 -0.762 . . . . 0.0 109.373 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 45' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 36.5 Cg_endo -62.52 98.88 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.457 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 57.5 t30 -60.9 -118.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.126 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 47' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' R' ' 48' ' ' HIS . 0.5 OUTLIER -128.43 89.31 2.88 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.479 -1.388 . . . . 0.0 110.893 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' R' ' 47' ' ' ASN . 2.5 p80 166.62 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.041 0.448 . . . . 0.0 109.795 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 49' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' R' ' 95' ' ' HIS . 12.6 m-20 58.68 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.107 -0.996 . . . . 0.0 109.07 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.833 ' HB3' HG21 ' R' ' 79' ' ' THR . 3.4 p30 -141.09 -2.64 1.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.53 -0.731 . . . . 0.0 109.576 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 51' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.257 . . -61.94 -35.8 79.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.615 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 15.3 m95 -61.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 117.355 -1.738 . . . . 0.0 106.478 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.913 HD13 HG22 ' R' ' 71' ' ' VAL . 12.0 mt -68.75 -42.02 78.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 54' ' ' ASN . . . . . 0.504 ' HB3' ' HE2' ' R' ' 151' ' ' PHE . 45.5 t-20 -50.65 -28.0 8.05 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 55' ' ' ALA . . . . . 0.949 ' O ' HD23 ' R' ' 59' ' ' LEU . . . -67.67 -71.8 0.19 Allowed 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -59.54 -34.64 55.49 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 O-C-N 120.467 -1.396 . . . . 0.0 110.003 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 57' ' ' LEU . . . . . 1.024 HD11 ' HB ' ' R' ' 71' ' ' VAL . 3.9 mm? -64.1 -66.72 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.795 . . . . 0.0 111.125 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 58' ' ' GLN . . . . . 0.599 ' HG3' HD22 ' R' ' 59' ' ' LEU . 0.0 OUTLIER -59.85 -29.26 68.16 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.949 HD23 ' O ' ' R' ' 55' ' ' ALA . 3.7 mm? -70.02 -38.98 76.06 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.683 ' HB3' ' O ' ' R' ' 56' ' ' ILE . 0.0 OUTLIER -66.48 -40.96 89.62 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.592 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 61' ' ' ARG . . . . . 0.546 ' HG2' ' CE2' ' R' ' 60' ' ' PHE . 1.3 mtp180 -56.5 -41.61 76.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.824 -1.173 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.881 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 2.4 p90 -86.39 -47.12 9.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.264 -1.523 . . . . 0.0 111.981 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.881 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.7 t -70.63 -16.77 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.877 -1.764 . . . . 0.0 109.018 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 64' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 71.4 tt0 74.75 42.38 0.28 Allowed 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' R' ' 60' ' ' PHE . 7.4 mt-10 -140.28 90.74 10.19 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.945 -1.097 . . . . 0.0 108.751 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' R' ' 60' ' ' PHE . 46.5 Cg_endo -75.53 95.06 0.99 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.393 1.207 . . . . 0.0 112.401 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 67' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' R' ' 111' ' ' LEU . 14.4 m-85 -76.78 -27.19 55.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' R' ' 103' ' ' VAL . 32.3 m-85 -104.99 50.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.696 1.236 . . . . 0.0 108.643 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.605 ' HA ' ' CD1' ' R' ' 72' ' ' TYR . 38.0 m-20 -45.13 -34.28 2.59 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.713 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -63.0 -34.99 78.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.706 -1.247 . . . . 0.0 109.917 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 1.024 ' HB ' HD11 ' R' ' 57' ' ' LEU . 59.4 t -66.22 -58.44 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.674 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 72' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' R' ' 69' ' ' ASP . 1.3 p90 -69.15 -31.4 70.03 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.864 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -63.23 -25.86 68.52 Favored 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.906 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 74' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 1.0 OUTLIER -79.32 134.41 58.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.55 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.24 -24.8 31.65 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.644 1.339 . . . . 0.0 110.125 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 76' ' ' GLU . . . . . 0.453 ' CG ' HD23 ' R' ' 78' ' ' LEU . 22.4 pt-20 -117.71 -158.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.435 -0.791 . . . . 0.0 109.906 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 77' ' ' ASN . . . . . 0.489 ' O ' HD22 ' R' ' 78' ' ' LEU . 87.6 m-20 -85.22 103.55 14.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.504 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 78' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mm? -122.58 47.88 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 79' ' ' THR . . . . . 0.833 HG21 ' HB3' ' R' ' 50' ' ' ASN . 0.0 OUTLIER -61.51 -59.25 5.52 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.687 -0.633 . . . . 0.0 110.461 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.653 ' H ' HG23 ' R' ' 79' ' ' THR . 1.0 OUTLIER -49.56 -51.65 35.47 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.789 -178.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 81' ' ' GLU . . . . . 0.512 ' OE1' HD12 ' R' ' 78' ' ' LEU . 84.3 tt0 -59.95 -32.48 70.84 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.826 -1.796 . . . . 0.0 109.532 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.824 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.18 -58.31 5.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.862 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -87.26 -35.62 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.032 -177.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 84' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' R' ' 80' ' ' LEU . 25.7 tptt -49.2 -36.35 19.58 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 63.2 tt0 -68.38 -42.03 79.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 86' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' R' ' 94' ' ' LEU . 2.8 tm? -62.26 -37.84 87.01 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 87' ' ' GLU . . . . . 0.527 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -56.13 -38.56 70.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 108.465 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 88' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 89.4 m-20 -58.36 -30.36 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.241 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.735 HD23 ' N ' ' R' ' 90' ' ' THR . 4.9 tt -91.1 -53.68 4.26 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.498 -0.751 . . . . 0.0 112.434 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 90' ' ' THR . . . . . 0.735 ' N ' HD23 ' R' ' 89' ' ' LEU . 36.1 p -80.14 -31.58 39.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 91' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 64.78 30.04 76.89 Favored Glycine 0 N--CA 1.505 3.28 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.906 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 92' ' ' LEU . . . . . 0.841 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.4 OUTLIER -119.5 9.79 11.64 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.961 -1.317 . . . . 0.0 113.131 -177.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 93' ' ' GLU . . . . . 0.754 ' C ' ' HG ' ' R' ' 94' ' ' LEU . 93.8 mt-10 68.21 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.162 -0.961 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' R' ' 86' ' ' LEU . 0.0 OUTLIER -138.57 -62.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 95' ' ' HIS . . . . . 0.534 ' HB3' HD13 ' R' ' 83' ' ' ILE . 3.9 p80 -42.5 -37.06 1.51 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 96' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' R' ' 93' ' ' GLU . 22.5 pt-20 -104.5 -16.57 15.02 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 97' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' R' ' 94' ' ' LEU . . . -93.22 -141.78 11.12 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 98' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . -130.71 175.16 19.51 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.737 ' HB3' ' HB3' ' R' ' 55' ' ' ALA . 34.4 Cg_endo -70.76 -58.68 0.08 OUTLIER 'Trans proline' 0 CA--C 1.556 1.581 0 O-C-N 123.773 1.407 . . . . 0.0 114.799 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.947 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.2 Cg_endo -59.07 -22.68 65.21 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.841 ' O ' HD22 ' R' ' 92' ' ' LEU . . . -31.34 58.92 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.083 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' R' ' 100' ' ' PRO . 71.1 mt 36.46 3.27 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.248 -174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.863 HG13 HD11 ' R' ' 86' ' ' LEU . 2.7 t -55.02 -39.6 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.825 HD12 ' HA ' ' R' ' 100' ' ' PRO . 85.8 mt -68.34 -37.45 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.872 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' R' ' 102' ' ' LEU . 68.1 t-105 -63.36 -46.9 84.39 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.876 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' R' ' 90' ' ' THR . 29.7 m120 -76.32 -30.04 57.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.716 -1.24 . . . . 0.0 111.107 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 107' ' ' ILE . . . . . 0.695 HG23 HD23 ' R' ' 110' ' ' LEU . 54.8 mt -81.58 7.22 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.702 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' R' ' 112' ' ' HIS . 24.2 tttm -34.37 -53.14 0.5 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.739 ' C ' HD13 ' R' ' 110' ' ' LEU . 0.5 OUTLIER -60.02 -14.39 16.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.093 -2.255 . . . . 0.0 111.675 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.739 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -106.49 -40.89 5.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.954 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -74.88 -106.18 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.668 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 112' ' ' HIS . . . . . 0.653 ' HA ' ' O ' ' R' ' 122' ' ' SER . 30.1 m-70 -25.1 73.56 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 123.833 1.778 . . . . 0.0 109.901 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 113' ' ' THR . . . . . 1.046 HG22 ' HA ' ' R' ' 123' ' ' GLU . 3.0 t -60.39 -105.31 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.398 -2.183 . . . . 0.0 110.612 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.769 ' O ' HD13 ' R' ' 115' ' ' ILE . . . -134.92 82.15 0.29 Allowed Glycine 0 N--CA 1.505 3.247 1 N-CA-C 102.877 -4.089 . . . . 0.0 102.877 177.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 1.288 HG23 ' O ' ' R' ' 124' ' ' VAL 0.356 32.4 mm -126.33 162.14 30.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -170.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.12 75.6 0.37 Allowed Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.221 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 117' ' ' THR . . . . . 1.037 HG23 HG21 ' R' ' 126' ' ' VAL . 8.1 m -72.74 149.21 43.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' CG2' ' R' ' 130' ' ' THR . . . -63.85 -24.79 67.88 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.552 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 60.5 p -97.38 -22.25 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 111.097 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 120' ' ' ARG . . . . . 0.695 ' O ' ' HB ' ' R' ' 117' ' ' THR . 0.0 OUTLIER -178.12 -164.51 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 O-C-N 120.96 -1.087 . . . . 0.0 110.607 -178.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' R' ' 120' ' ' ARG . 49.1 Cg_endo -85.52 161.99 10.97 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 120.671 0.914 . . . . 0.0 110.295 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.901 ' H ' ' HB ' ' R' ' 115' ' ' ILE . 19.9 m -164.96 -134.78 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.07 -1.019 . . . . 0.0 113.216 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 1.046 ' HA ' HG22 ' R' ' 113' ' ' THR . 82.5 tt0 -103.8 -19.18 14.37 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 124.726 1.21 . . . . 0.0 112.886 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 1.288 ' O ' HG23 ' R' ' 115' ' ' ILE . 10.4 m -161.93 -157.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-O 122.573 1.177 . . . . 0.0 111.74 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.584 ' HB2' ' HG3' ' R' ' 182' ' ' PRO . 48.7 t -95.12 137.31 34.35 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.525 -1.984 . . . . 0.0 107.275 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 1.037 HG21 HG23 ' R' ' 117' ' ' THR . 77.5 t -102.51 154.22 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 -174.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.924 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.0 m -83.19 -21.42 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 112.905 -1.952 . . . . 0.0 114.14 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.748 ' H ' HG12 ' R' ' 126' ' ' VAL . 56.2 t0 -45.3 87.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.094 -1.004 . . . . 0.0 111.437 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 129' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 51.6 25.15 13.5 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 130' ' ' THR . . . . . 0.825 ' CG2' ' HB2' ' R' ' 118' ' ' ALA . 0.0 OUTLIER -109.88 152.11 26.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.324 -1.104 . . . . 0.0 112.306 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 40.43 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.041 0.924 . . . . 0.0 112.98 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.507 ' HB2' ' HB2' ' R' ' 136' ' ' ASP . 89.6 mtp -90.4 174.19 7.7 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' R' ' 135' ' ' ALA . 62.4 m -100.87 -174.99 2.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.341 -0.85 . . . . 0.0 112.682 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 1.089 HD11 HG23 ' R' ' 171' ' ' THR . 0.4 OUTLIER 31.3 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.098 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 135' ' ' ALA . . . . . 0.465 ' HA ' ' NE2' ' R' ' 138' ' ' HIS . . . -62.29 -26.75 68.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.119 -0.988 . . . . 0.0 112.841 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 136' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' R' ' 132' ' ' MET . 19.2 t70 -55.99 -42.67 76.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.105 -0.997 . . . . 0.0 112.278 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 137' ' ' PHE . . . . . 0.685 ' CG ' ' CD1' ' R' ' 180' ' ' PHE . 52.5 p90 -155.23 159.59 40.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.788 -1.195 . . . . 0.0 109.479 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.651 ' CG ' ' CE3' ' R' ' 159' ' ' TRP . 68.5 m-70 -143.76 79.18 1.62 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.139 -1.424 . . . . 0.0 110.857 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 174.88 162.04 0.22 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.175 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 130.06 -170.56 20.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.212 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 141' ' ' ILE . . . . . 0.73 HG23 ' CE1' ' R' ' 151' ' ' PHE . 70.1 mt -104.23 124.61 58.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.742 -0.858 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.989 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 4.2 m-85 -113.76 151.53 31.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.662 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.646 HD21 ' HG2' ' R' ' 146' ' ' GLN . 26.1 tp -101.66 124.14 46.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.715 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' R' ' 148' ' ' HIS . 38.1 tttt -108.85 113.54 26.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.073 -1.017 . . . . 0.0 110.422 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' R' ' 146' ' ' GLN . . . 50.23 25.63 8.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 146' ' ' GLN . . . . . 0.646 ' HG2' HD21 ' R' ' 143' ' ' LEU . 95.2 mt-30 54.62 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -1.01 . . . . 0.0 110.631 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.41 23.57 2.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 83.2 m-70 -144.7 131.68 20.36 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.896 . . . . 0.0 108.882 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 149' ' ' ALA . . . . . 0.935 ' HB1' ' HZ ' ' R' ' 151' ' ' PHE . . . -104.5 115.82 31.03 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 150' ' ' VAL . . . . . 0.67 ' O ' ' CD1' ' R' ' 151' ' ' PHE . 34.9 m -129.27 152.18 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.935 ' HZ ' ' HB1' ' R' ' 149' ' ' ALA . 7.7 m-85 -149.89 129.69 13.3 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.791 -1.564 . . . . 0.0 112.012 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -110.56 167.65 10.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.593 -1.317 . . . . 0.0 110.735 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 153' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 38.0 t -169.63 134.49 1.41 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' R' ' 138' ' ' HIS . 36.9 t -53.38 102.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.383 -1.448 . . . . 0.0 111.283 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 155' ' ' THR . . . . . 0.661 ' CG2' ' HB2' ' R' ' 160' ' ' TYR . 25.1 p -78.82 -165.36 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.713 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 156' ' ' SER . . . . . 0.472 ' N ' ' O ' ' R' ' 32' ' ' THR . 81.1 p -65.41 -18.69 65.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 157' ' ' ASN . . . . . 0.466 ' CB ' ' CZ ' ' R' ' 160' ' ' TYR . 83.0 m-20 -102.03 2.9 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.273 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 158' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 112.93 -166.14 12.11 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.151 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.651 ' CE3' ' CG ' ' R' ' 138' ' ' HIS . 0.0 OUTLIER -55.58 99.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.495 1.14 . . . . 0.0 108.685 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 160' ' ' TYR . . . . . 0.661 ' HB2' ' CG2' ' R' ' 155' ' ' THR . 4.0 m-85 -121.83 -178.39 3.82 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 161' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -158.07 136.37 10.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.751 -1.843 . . . . 0.0 110.987 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 162' ' ' ILE . . . . . 0.981 ' CD1' HD11 ' R' ' 31' ' ' LEU . 0.6 OUTLIER -75.79 88.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.526 1.155 . . . . 0.0 109.188 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -94.98 122.83 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 164' ' ' ASP . . . . . 0.867 ' HA ' ' HA ' ' R' ' 44' ' ' ARG . 78.0 m-20 28.19 74.51 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.365 -0.834 . . . . 0.0 112.968 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.654 ' CB ' ' N ' ' R' ' 44' ' ' ARG . 0.1 OUTLIER 68.66 -15.31 0.24 Allowed 'General case' 0 N--CA 1.522 3.149 0 O-C-N 119.597 -1.939 . . . . 0.0 113.448 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.74 134.29 45.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.83 -1.794 . . . . 0.0 112.694 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 167' ' ' PHE . . . . . 0.699 ' CD1' HG13 ' R' ' 162' ' ' ILE . 6.4 m-85 -101.62 121.66 42.42 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 168' ' ' TYR . . . . . 0.599 ' CE2' ' CD1' ' R' ' 170' ' ' TRP . 2.8 p90 -150.67 162.05 28.39 Favored Pre-proline 0 C--N 1.281 -2.406 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.314 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 169' ' ' PRO . . . . . 0.471 ' HA ' ' CD1' ' R' ' 160' ' ' TYR . 39.5 Cg_endo -66.62 114.71 3.21 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.231 1.648 . . . . 0.0 109.044 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.599 ' CD1' ' CE2' ' R' ' 168' ' ' TYR . 0.1 OUTLIER -126.4 150.18 48.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 171' ' ' THR . . . . . 1.089 HG23 HD11 ' R' ' 134' ' ' LEU . 2.3 m -94.26 108.26 34.8 Favored Pre-proline 0 C--N 1.271 -2.816 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.053 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' R' ' 138' ' ' HIS . 46.1 Cg_endo -72.94 67.03 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 124.048 1.552 . . . . 0.0 110.823 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 173' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' R' ' 134' ' ' LEU . 8.6 t70 -81.86 139.13 46.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.406 -0.809 . . . . 0.0 109.097 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.783 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.3 Cg_endo -70.72 35.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.223 1.117 . . . . 0.0 109.95 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 175' ' ' SER . . . . . 0.494 ' H ' ' C ' ' R' ' 173' ' ' ASP . 83.4 p -81.34 -43.38 19.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 111.323 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 176' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' R' ' 143' ' ' LEU . 86.4 m-20 -126.16 1.6 7.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.017 -1.052 . . . . 0.0 109.934 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.989 ' HB ' ' CG ' ' R' ' 142' ' ' PHE . 0.2 OUTLIER -95.1 169.37 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.059 0.933 . . . . 0.0 110.464 -178.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.797 HD22 ' O ' ' R' ' 177' ' ' VAL . 0.7 OUTLIER -128.48 -91.45 0.48 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -177.317 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' R' ' 126' ' ' VAL . 34.7 m -72.43 124.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.685 ' CD1' ' CG ' ' R' ' 137' ' ' PHE . 0.3 OUTLIER -130.45 178.14 6.83 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -175.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 181' ' ' VAL . . . . . 0.874 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -127.26 127.24 24.27 Favored Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.952 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 182' ' ' PRO . . . . . 0.584 ' HG3' ' HB2' ' R' ' 125' ' ' CYS . 56.2 Cg_endo -87.47 131.93 2.99 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.384 1.202 . . . . 0.0 109.998 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 1.1 p90 -64.6 -34.06 77.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.096 -1.003 . . . . 0.0 109.709 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.0 t0 . . . . . 0 N--CA 1.5 2.031 0 O-C-N 121.416 -0.802 . . . . 0.0 111.62 179.038 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.151 0.501 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' R' R ' 30' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 22.7 pt-20 -93.86 120.37 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.382 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 31' ' ' LEU . . . . . 0.931 HD11 ' CZ ' ' R' ' 167' ' ' PHE . 0.7 OUTLIER -94.04 127.96 40.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 111.3 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 32' ' ' THR . . . . . 0.55 ' O ' ' N ' ' R' ' 156' ' ' SER . 92.6 m -102.19 146.76 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.701 ' H ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -139.64 167.83 21.2 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.007 -178.523 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 34' ' ' TYR . . . . . 0.62 ' HB2' HG11 ' R' ' 154' ' ' VAL . 63.6 t80 -41.19 -44.27 2.54 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -75.93 15.47 0.53 Allowed 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 122.594 2.452 . . . . 0.0 113.927 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 -5.92 42.41 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 119.87 -1.769 . . . . 0.0 112.963 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 37' ' ' GLU . . . . . 0.643 ' HB3' HD21 ' R' ' 33' ' ' LEU . 82.9 tt0 -79.97 137.7 36.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.504 -1.586 . . . . 0.0 110.354 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -120.13 113.96 21.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 109.392 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 22.2 tptt -122.93 131.74 53.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 40' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' R' ' 30' ' ' GLU . 0.9 OUTLIER -85.9 122.72 30.36 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.924 0.868 . . . . 0.0 112.203 -177.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.717 ' CD2' HD13 ' R' ' 162' ' ' ILE . 0.5 OUTLIER -107.54 159.91 16.07 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 42' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' R' ' 42' ' ' TYR . 68.2 m-85 -98.94 134.1 42.28 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.414 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 43' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' R' ' 164' ' ' ASP . 7.0 m -112.7 94.75 5.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.362 -0.836 . . . . 0.0 110.498 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 44' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' R' ' 77' ' ' ASN . 0.4 OUTLIER -152.67 136.09 9.79 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.283 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.58 126.83 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.374 1.197 . . . . 0.0 110.008 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' R' ' 50' ' ' ASN . 0.3 OUTLIER -97.35 -120.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 109.396 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 47' ' ' ASN . . . . . 0.524 ' ND2' HD23 ' R' ' 80' ' ' LEU . 1.2 p-10 -128.61 77.23 1.76 Allowed 'General case' 0 N--CA 1.512 2.634 0 O-C-N 120.242 -1.536 . . . . 0.0 111.262 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 74.6 m80 48.44 16.98 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.801 -0.562 . . . . 0.0 112.345 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' R' ' 96' ' ' GLU . 37.3 m-20 -146.66 47.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.024 . . . . 0.0 108.725 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.743 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 24.1 p30 -114.72 -21.68 10.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.693 ' CB ' ' HB3' ' R' ' 149' ' ' ALA 0.282 . . -66.32 -41.93 88.97 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.282 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.705 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 39.6 m95 -59.71 -34.78 73.35 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.912 -1.515 . . . . 0.0 107.256 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.825 HD11 HG13 ' R' ' 83' ' ' ILE . 20.2 mt -68.18 -35.2 77.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 54' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' R' ' 51' ' ' ALA . 56.6 t-20 -48.92 -28.11 3.59 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 55' ' ' ALA . . . . . 0.873 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.13 -64.72 0.8 Allowed 'General case' 0 C--O 1.203 -1.371 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.594 ' N ' HD13 ' R' ' 56' ' ' ILE . 0.0 OUTLIER -57.13 -36.32 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.751 178.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 57' ' ' LEU . . . . . 0.987 HD21 HG21 ' R' ' 71' ' ' VAL . 3.9 mm? -68.61 -72.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.623 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 58' ' ' GLN . . . . . 0.568 ' NE2' ' OD1' ' R' ' 54' ' ' ASN . 0.7 OUTLIER -57.85 -29.68 65.19 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.637 -1.289 . . . . 0.0 108.536 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.873 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 0.2 OUTLIER -70.43 -37.26 74.35 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.908 ' HA ' ' HD3' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -50.68 -53.02 34.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 61' ' ' ARG . . . . . 0.614 ' N ' ' CG ' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -55.87 -48.46 75.52 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.104 -1.039 . . . . 0.0 113.343 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' R' ' 153' ' ' CYS . 0.1 OUTLIER -90.69 -47.7 7.5 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 119.962 -1.711 . . . . 0.0 113.921 -176.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.888 HG22 HG12 ' R' ' 124' ' ' VAL . 47.7 t -77.76 -24.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.169 -0.957 . . . . 0.0 111.811 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 64' ' ' GLU . . . . . 0.776 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 88.2 tt0 124.33 117.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.131 0.967 . . . . 0.0 109.346 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' R' ' 68' ' ' PHE . 0.1 OUTLIER -44.28 100.32 0.23 Allowed Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.908 ' HD3' ' HA ' ' R' ' 60' ' ' PHE . 51.8 Cg_endo -85.45 -162.12 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.589 2.192 . . . . 0.0 107.399 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 67' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' R' ' 69' ' ' ASP . 34.4 t80 -45.0 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 O-C-N 121.769 -0.582 . . . . 0.0 112.022 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 68' ' ' PHE . . . . . 0.942 ' HD2' HD13 ' R' ' 57' ' ' LEU . 0.7 OUTLIER -37.52 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.008 -1.057 . . . . 0.0 113.031 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' R' ' 67' ' ' PHE . 51.0 m-20 -49.12 -34.34 13.87 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.62 -0.675 . . . . 0.0 112.234 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.616 ' HB3' ' HA ' ' R' ' 82' ' ' ALA . 70.2 m95 -64.43 -31.24 72.37 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.572 -1.33 . . . . 0.0 109.858 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.987 HG21 HD21 ' R' ' 57' ' ' LEU . 46.9 t -70.81 -67.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 72' ' ' TYR . . . . . 0.925 ' CE2' HD12 ' R' ' 57' ' ' LEU . 13.3 m-30 -77.42 -30.36 53.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.739 . . . . 0.0 111.878 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 73' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 22.4 t -60.83 -19.34 59.66 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.318 -1.353 . . . . 0.0 109.049 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 74' ' ' SER . . . . . 0.687 ' OG ' HD22 ' R' ' 78' ' ' LEU . 38.5 m -77.2 139.87 65.18 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.771 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 -27.55 39.77 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.92 164.76 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.79 . . . . 0.0 109.679 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 77' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' R' ' 44' ' ' ARG . 36.1 p-10 -52.59 110.26 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.197 -0.94 . . . . 0.0 110.088 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 78' ' ' LEU . . . . . 0.687 HD22 ' OG ' ' R' ' 74' ' ' SER . 1.5 mp -126.81 47.36 2.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.677 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 79' ' ' THR . . . . . 0.745 ' OG1' HD12 ' R' ' 53' ' ' LEU . 0.5 OUTLIER -65.99 -52.19 51.63 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.009 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.524 HD23 ' ND2' ' R' ' 47' ' ' ASN . 0.0 OUTLIER -51.04 -59.39 4.21 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.678 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.38 -28.0 69.69 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.498 -1.376 . . . . 0.0 109.736 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.813 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -56.29 -51.1 69.43 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.48 -0.762 . . . . 0.0 111.624 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.825 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -85.41 -36.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.045 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 84' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' R' ' 87' ' ' GLU . 32.9 tttt -49.82 -33.52 16.97 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' R' ' 70' ' ' TRP . 50.9 tp60 -77.15 -36.4 55.28 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 86' ' ' LEU . . . . . 1.013 HD11 HG13 ' R' ' 103' ' ' VAL . 2.7 tm? -66.75 -40.62 88.38 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.807 -0.558 . . . . 0.0 110.176 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 87' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' R' ' 91' ' ' GLY . 10.7 pt-20 -66.08 -31.73 72.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.944 -1.098 . . . . 0.0 108.27 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.06 -31.36 69.91 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.389 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.833 HD23 ' N ' ' R' ' 90' ' ' THR . 1.1 tt -93.59 -48.89 6.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.581 -0.699 . . . . 0.0 111.042 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 90' ' ' THR . . . . . 0.833 ' N ' HD23 ' R' ' 89' ' ' LEU . 68.1 p -74.89 -24.06 58.47 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 91' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' R' ' 87' ' ' GLU . . . 68.95 26.35 74.73 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.033 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 92' ' ' LEU . . . . . 0.795 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.3 OUTLIER -105.94 -17.53 14.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.823 -1.398 . . . . 0.0 111.354 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 93' ' ' GLU . . . . . 0.532 ' H ' ' HB2' ' R' ' 87' ' ' GLU . 81.6 tt0 65.44 122.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.813 HD13 ' CG2' ' R' ' 83' ' ' ILE . 0.3 OUTLIER -166.39 12.5 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 95' ' ' HIS . . . . . 0.728 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.7 OUTLIER -42.39 -29.12 0.25 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.607 -0.683 . . . . 0.0 109.234 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' R' ' 49' ' ' ASP . 98.5 mt-10 -116.15 23.33 12.25 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.647 -0.658 . . . . 0.0 110.854 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.683 ' HA2' ' CG ' ' R' ' 52' ' ' TRP . . . 156.08 128.56 1.11 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.651 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 98' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' R' ' 101' ' ' ALA . . . 152.02 75.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.686 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.889 ' HG2' ' HD2' ' R' ' 100' ' ' PRO . 33.5 Cg_endo -86.13 -90.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.564 1.999 0 C-N-CA 121.32 1.347 . . . . 0.0 110.406 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.889 ' HD2' ' HG2' ' R' ' 99' ' ' PRO . 37.1 Cg_endo -62.55 -16.97 55.78 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 106.108 -2.305 . . . . 0.0 106.108 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.795 ' O ' HD22 ' R' ' 92' ' ' LEU 0.263 . . -30.87 61.82 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 113.61 -1.632 . . . . 0.0 112.587 175.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.837 ' N ' ' O ' ' R' ' 100' ' ' PRO . 48.2 mt 39.38 0.74 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.671 -175.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 1.013 HG13 HD11 ' R' ' 86' ' ' LEU . 21.8 t -52.68 -40.58 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.64 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 32.3 pt -75.56 -36.54 34.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.373 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.632 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 61.5 t90 -64.63 -43.0 95.1 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.579 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.705 ' HB2' HG22 ' R' ' 90' ' ' THR . 27.3 m120 -78.35 -27.08 46.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.723 -1.236 . . . . 0.0 112.066 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 107' ' ' ILE . . . . . 0.743 HG23 HD23 ' R' ' 110' ' ' LEU . 63.3 mt -78.18 16.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 111.762 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' R' ' 112' ' ' HIS . 80.4 mttt -30.49 -52.22 0.16 Allowed 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.588 ' CD2' HD22 ' R' ' 110' ' ' LEU . 36.9 p-80 -57.51 -26.98 62.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.143 -2.223 . . . . 0.0 112.458 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.743 HD23 HG23 ' R' ' 107' ' ' ILE . 0.2 OUTLIER -100.43 -39.49 7.93 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 176.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.1 OUTLIER -78.49 -96.91 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 111.523 -2.581 . . . . 0.0 114.608 -176.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 112' ' ' HIS . . . . . 0.67 ' H ' ' HA ' ' R' ' 108' ' ' LYS . 85.4 t60 -13.62 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 123.897 1.808 . . . . 0.0 109.986 -173.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.994 HG23 HD11 ' R' ' 115' ' ' ILE . 7.2 t -97.85 -173.43 2.61 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.446 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.824 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.66 105.8 1.57 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 1.0 HD12 HG22 ' R' ' 124' ' ' VAL . 3.5 mm -109.88 143.55 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.539 -1.565 . . . . 0.0 110.581 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 116' ' ' GLY . . . . . 0.585 ' O ' HG13 ' R' ' 126' ' ' VAL . . . -143.11 -154.65 6.19 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.183 -1.484 . . . . 0.0 112.114 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.934 ' HA ' HG22 ' R' ' 126' ' ' VAL . 5.1 m -133.03 165.08 25.56 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 1.01 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -53.21 -36.35 60.91 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.38 -1.45 . . . . 0.0 110.369 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.2 m -64.59 -36.28 83.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -124.19 94.18 45.67 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.502 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.44 134.32 30.56 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.753 1.396 . . . . 0.0 112.061 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 122' ' ' SER . . . . . . . . . . . . . 3.5 m -134.11 -162.88 1.29 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' R' ' 114' ' ' GLY . 77.1 mm-40 -55.01 -41.24 71.04 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.567 -1.333 . . . . 0.0 108.377 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 1.0 HG22 HD12 ' R' ' 115' ' ' ILE . 0.9 OUTLIER -129.07 147.35 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' R' ' 182' ' ' PRO . 5.9 t -127.74 159.35 35.04 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.218 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.934 HG22 ' HA ' ' R' ' 117' ' ' THR . 15.7 m -85.2 -163.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.938 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 1.1 p -60.68 -160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.726 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.743 ' HA ' ' HB2' ' R' ' 118' ' ' ALA . 28.9 p-10 -96.55 -74.91 0.55 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.746 -1.221 . . . . 0.0 113.21 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 129' ' ' GLY . . . . . 0.457 ' H ' ' CG ' ' R' ' 128' ' ' ASP . . . 58.7 5.38 2.72 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 130' ' ' THR . . . . . 1.01 HG21 ' HB1' ' R' ' 118' ' ' ALA . 11.3 t -127.93 167.33 16.78 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.279 0.632 . . . . 0.0 109.355 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.4 74.44 2.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.585 ' HG3' HG23 ' R' ' 130' ' ' THR . 56.2 mtt -127.88 167.0 17.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.85 -170.87 3.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.281 -0.887 . . . . 0.0 111.381 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 1.07 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -38.87 -56.36 1.38 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 121.591 0.71 . . . . 0.0 112.538 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.57 -19.96 62.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 136' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' R' ' 183' ' ' TYR . 0.8 OUTLIER -55.71 -38.37 69.63 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.455 -1.403 . . . . 0.0 112.369 -178.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 137' ' ' PHE . . . . . 0.55 ' CB ' ' CD1' ' R' ' 180' ' ' PHE . 0.3 OUTLIER -142.38 168.69 19.15 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.947 -1.095 . . . . 0.0 108.173 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' R' ' 139' ' ' ALA . 14.8 m-70 -134.8 63.58 1.62 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.272 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 166.52 165.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.786 -0.571 . . . . 0.0 110.119 175.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.02 -178.97 32.28 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.216 -1.468 . . . . 0.0 111.954 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 141' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' R' ' 151' ' ' PHE . 10.7 mt -112.05 119.23 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 122.015 -0.697 . . . . 0.0 110.392 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.84 ' CZ ' HG11 ' R' ' 177' ' ' VAL . 8.0 m-85 -109.28 134.94 51.15 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.097 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' R' ' 143' ' ' LEU . 4.6 mm? -85.72 101.23 12.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.523 ' HD2' HG11 ' R' ' 150' ' ' VAL . 33.9 tttm -93.55 124.53 37.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 110.934 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.69 -145.32 8.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -111.52 138.98 47.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.996 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.413 ' HA ' ' CH2' ' R' ' 52' ' ' TRP . 79.7 tt0 54.67 44.34 28.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 0.1 OUTLIER -141.41 122.03 14.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.705 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -109.56 139.26 44.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 110.641 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 150' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.7 m -139.52 153.27 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.055 -1.028 . . . . 0.0 109.174 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' R' ' 141' ' ' ILE . 82.0 m-85 -147.19 124.68 11.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.769 -1.207 . . . . 0.0 110.438 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.03 171.93 7.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.365 -1.459 . . . . 0.0 112.743 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 153' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 9.1 t -167.3 136.05 2.65 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' R' ' 34' ' ' TYR . 53.2 t -56.5 109.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.354 -1.466 . . . . 0.0 111.654 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 155' ' ' THR . . . . . 0.693 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 77.2 p -89.63 -169.59 2.52 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 156' ' ' SER . . . . . 0.55 ' N ' ' O ' ' R' ' 32' ' ' THR . 44.7 t -60.34 -21.25 61.84 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.777 -1.202 . . . . 0.0 108.428 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CE1' ' R' ' 160' ' ' TYR . 79.4 m-20 -95.96 3.71 53.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 158' ' ' GLY . . . . . 0.497 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 106.23 -160.78 14.46 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.625 ' CE2' HD12 ' R' ' 134' ' ' LEU . 5.5 m-90 -57.36 101.58 0.07 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.625 -0.927 . . . . 0.0 108.687 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 160' ' ' TYR . . . . . 0.693 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 4.2 m-85 -127.52 131.47 50.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 161' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -106.27 146.73 29.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 119.979 -1.701 . . . . 0.0 110.937 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 162' ' ' ILE . . . . . 0.913 ' CD1' HD13 ' R' ' 31' ' ' LEU . 96.9 mt -102.66 90.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' R' ' 164' ' ' ASP . 3.6 t0 -88.58 122.46 32.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 164' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' R' ' 163' ' ' ASP . 26.0 t0 -3.45 -64.69 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' R' ' 163' ' ' ASP . 97.1 mt-10 -59.34 -42.21 90.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.696 -1.253 . . . . 0.0 114.37 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -167.26 172.92 9.4 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 119.811 -1.806 . . . . 0.0 113.215 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 167' ' ' PHE . . . . . 0.931 ' CZ ' HD11 ' R' ' 31' ' ' LEU . 3.5 m-30 -98.43 129.13 45.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 168' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' R' ' 161' ' ' ALA . 2.1 p90 -141.15 163.86 39.39 Favored Pre-proline 0 C--N 1.29 -2.01 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.94 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 169' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 42.3 Cg_endo -69.84 108.52 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.525 ' CD1' ' CD1' ' R' ' 168' ' ' TYR . 0.5 OUTLIER -138.9 153.81 48.31 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 171' ' ' THR . . . . . 1.07 ' CG2' HD11 ' R' ' 134' ' ' LEU . 1.0 OUTLIER -101.93 151.23 37.95 Favored Pre-proline 0 C--N 1.278 -2.541 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.29 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.749 ' HD2' HD13 ' R' ' 134' ' ' LEU . 45.3 Cg_endo -94.37 32.97 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.865 1.71 . . . . 0.0 109.411 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 173' ' ' ASP . . . . . 0.582 ' O ' ' CG1' ' R' ' 177' ' ' VAL . 0.6 OUTLIER -76.77 153.27 83.17 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.357 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' R' ' 177' ' ' VAL . 49.5 Cg_endo -75.67 26.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.968 1.51 . . . . 0.0 111.206 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 23.3 t -69.89 -48.3 59.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.985 -1.072 . . . . 0.0 110.897 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 176' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' R' ' 143' ' ' LEU . 91.1 m-20 -125.6 13.45 8.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.84 HG11 ' CZ ' ' R' ' 142' ' ' PHE . 0.1 OUTLIER -121.48 153.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.832 . . . . 0.0 109.736 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.938 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 2.1 mm? -127.63 46.6 2.52 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.062 -1.455 . . . . 0.0 108.932 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.733 ' HA ' ' C ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.61 124.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.55 ' CD1' ' CB ' ' R' ' 137' ' ' PHE . 4.2 p90 -125.12 168.17 13.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.544 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 181' ' ' VAL . . . . . 0.867 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 1.0 OUTLIER -122.87 111.99 30.73 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.122 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 182' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' R' ' 125' ' ' CYS . 47.7 Cg_endo -76.04 156.14 38.34 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.615 1.324 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' R' ' 138' ' ' HIS . 1.1 p90 -91.43 -2.21 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.517 -0.739 . . . . 0.0 110.873 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 53.64 48.34 21.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 111.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -100.58 130.12 46.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -116.31 163.86 20.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.347 -0.845 . . . . 0.0 110.205 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.33 143.81 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.796 1.419 . . . . 0.0 110.522 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.1 1.44 54.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.42 -0.8 . . . . 0.0 110.75 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -102.04 131.42 48.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.364 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.37 -175.24 47.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 50.84 94.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.448 -1.03 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -112.24 139.23 47.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.149 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -80.56 133.33 35.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.86 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.4 145.54 30.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 19.0 tptt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.19 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.05 0.452 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' R' R ' 30' ' ' GLU . . . . . 0.482 ' C ' HD22 ' R' ' 31' ' ' LEU . 44.9 tp10 -117.5 119.43 35.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.16 -0.962 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 31' ' ' LEU . . . . . 0.961 HD23 ' CD1' ' R' ' 41' ' ' PHE . 3.8 mm? -94.8 166.81 11.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.392 -0.817 . . . . 0.0 109.546 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 32' ' ' THR . . . . . 0.88 ' C ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -126.47 140.23 52.63 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -173.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 1.111 ' N ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -17.64 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.84 0 CA-C-N 111.837 -2.438 . . . . 0.0 116.463 176.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 34' ' ' TYR . . . . . 0.776 ' C ' ' O ' ' R' ' 33' ' ' LEU . 92.5 m-85 -19.58 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.977 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' R' ' 33' ' ' LEU . 7.0 m120 -131.84 62.41 1.63 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 36' ' ' GLY . . . . . 1.216 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 141.75 36.8 0.09 OUTLIER Glycine 0 N--CA 1.479 1.521 0 C-N-CA 117.055 -2.498 . . . . 0.0 110.465 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 37' ' ' GLU . . . . . 1.216 ' O ' ' O ' ' R' ' 36' ' ' GLY . 80.7 mm-40 -11.68 -167.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 122.455 0.302 . . . . 0.0 110.848 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.33 92.73 0.29 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 116.23 -2.188 . . . . 0.0 106.809 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' R' ' 37' ' ' GLU . 36.2 mmtt -123.76 119.87 31.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 40' ' ' THR . . . . . 0.588 ' O ' HG22 ' R' ' 40' ' ' THR . 0.9 OUTLIER -91.29 115.08 27.74 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.452 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.961 ' CD1' HD23 ' R' ' 31' ' ' LEU . 3.0 m-85 -98.42 162.83 12.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 42' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' R' ' 165' ' ' GLU . 97.4 m-85 -95.4 158.58 15.4 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' R' ' 165' ' ' GLU . 46.7 m -115.57 94.9 4.9 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 44' ' ' ARG . . . . . 0.529 ' H ' ' CB ' ' R' ' 165' ' ' GLU . 0.0 OUTLIER -167.64 124.16 0.89 Allowed Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.306 -0.871 . . . . 0.0 109.096 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.18 126.35 13.59 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 N-CA-C 108.625 -1.336 . . . . 0.0 108.625 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 31.1 m120 -88.12 152.97 21.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.149 -0.97 . . . . 0.0 109.033 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.39 80.24 1.82 Allowed 'General case' 0 N--CA 1.507 2.387 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.257 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.586 ' CD2' HD23 ' R' ' 80' ' ' LEU . 5.3 p-80 178.62 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 1.5 p30 157.16 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 8.4 p30 -142.88 -25.75 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.911 -1.118 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' R' ' 54' ' ' ASN 0.271 . . -64.98 -44.24 89.96 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.056 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.498 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 75.3 m95 -58.01 -36.17 72.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.898 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.877 HD11 HG13 ' R' ' 83' ' ' ILE . 11.6 mt -69.38 -44.73 70.92 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 54' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' R' ' 51' ' ' ALA . 0.0 OUTLIER -43.28 -32.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 108.921 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 55' ' ' ALA . . . . . 0.866 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -64.93 -67.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.591 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.733 HG21 ' O ' ' R' ' 100' ' ' PRO . 0.2 OUTLIER -84.19 -41.74 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 117.884 -1.527 . . . . 0.0 109.885 178.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 57' ' ' LEU . . . . . 0.917 ' CD2' HG21 ' R' ' 71' ' ' VAL 0.265 1.5 tm? -48.25 -61.87 1.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.604 0.716 . . . . 0.0 111.207 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 58' ' ' GLN . . . . . 0.653 ' CD ' HG21 ' R' ' 162' ' ' ILE . 73.4 mt-30 -70.06 -27.77 64.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.866 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 3.4 tp -55.93 -38.51 70.38 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.923 ' CE1' HD21 ' R' ' 111' ' ' LEU . 22.9 m-30 -58.41 -41.18 84.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.144 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 61' ' ' ARG . . . . . 0.51 ' CB ' ' CZ ' ' R' ' 41' ' ' PHE . 0.0 OUTLIER -64.88 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.344 -1.472 . . . . 0.0 114.473 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.769 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 1.4 p90 -82.78 -42.39 17.99 Favored 'General case' 0 N--CA 1.516 2.826 0 O-C-N 119.575 -1.953 . . . . 0.0 114.731 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.769 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.5 t -73.77 -14.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 119.825 -1.797 . . . . 0.0 111.179 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 64' ' ' GLU . . . . . 0.698 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 65.0 tt0 98.91 29.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 1.8 tp10 -132.33 90.15 34.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.663 -1.273 . . . . 0.0 107.788 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' R' ' 60' ' ' PHE . 48.3 Cg_endo -78.09 83.55 2.18 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.706 1.372 . . . . 0.0 113.966 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 67' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 48.0 t80 -83.35 -19.11 36.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 68' ' ' PHE . . . . . 0.671 ' HB2' ' CD1' ' R' ' 57' ' ' LEU . 0.0 OUTLIER -62.38 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.012 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' R' ' 73' ' ' SER . 94.8 m-20 -46.8 -39.37 11.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.457 -0.777 . . . . 0.0 111.775 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.504 ' HA ' ' HB2' ' R' ' 74' ' ' SER . 35.3 m95 -69.82 -37.28 76.19 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.766 -1.208 . . . . 0.0 109.635 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' R' ' 57' ' ' LEU 0.252 43.5 t -70.34 -75.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 72' ' ' TYR . . . . . 0.632 ' CD1' HG12 ' R' ' 71' ' ' VAL . 18.8 m-30 -86.65 -35.96 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 111.737 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 73' ' ' SER . . . . . 0.664 ' HB3' ' O ' ' R' ' 69' ' ' ASP . 9.6 t -71.03 -17.33 62.63 Favored 'General case' 0 N--CA 1.509 2.511 0 C-N-CA 117.702 -1.599 . . . . 0.0 108.909 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 74' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' R' ' 70' ' ' TRP . 0.4 OUTLIER -117.47 114.41 38.22 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.366 -0.834 . . . . 0.0 109.334 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.34 -11.65 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.539 1.283 . . . . 0.0 110.528 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 76' ' ' GLU . . . . . 0.514 ' O ' HD13 ' R' ' 78' ' ' LEU . 84.6 tt0 -104.84 -64.47 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 77' ' ' ASN . . . . . 0.479 ' CA ' ' HB2' ' R' ' 81' ' ' GLU . 11.6 m120 -44.54 -44.18 8.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 112.047 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 78' ' ' LEU . . . . . 0.709 ' O ' ' HB2' ' R' ' 82' ' ' ALA . 6.1 mp 49.57 -154.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.893 -1.129 . . . . 0.0 111.008 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 79' ' ' THR . . . . . 0.832 ' OG1' HD12 ' R' ' 53' ' ' LEU . 2.0 t -68.67 -59.23 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.899 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.65 ' H ' HG23 ' R' ' 79' ' ' THR . 0.4 OUTLIER -50.13 -52.26 36.59 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 81' ' ' GLU . . . . . 0.589 ' HG3' HD12 ' R' ' 80' ' ' LEU . 72.2 mt-10 -69.75 -27.92 65.35 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.077 -1.639 . . . . 0.0 109.302 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.749 ' CB ' HG23 ' R' ' 71' ' ' VAL . . . -58.9 -53.7 55.49 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.683 -0.636 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 1.12 HG21 HD11 ' R' ' 94' ' ' LEU . 0.2 OUTLIER -86.4 -33.62 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.44 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 84' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' R' ' 83' ' ' ILE . 16.4 tttt -49.81 -36.36 26.11 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.89 -41.01 92.07 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 86' ' ' LEU . . . . . 0.978 HD13 HG13 ' R' ' 103' ' ' VAL . 13.2 mt -67.03 -34.29 77.4 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.804 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 87' ' ' GLU . . . . . 0.591 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -51.63 -42.06 61.74 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.8 -36.03 82.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.551 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.691 ' CD2' HG23 ' R' ' 107' ' ' ILE . 5.1 tt -99.07 -52.45 3.54 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.695 -1.253 . . . . 0.0 111.824 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 90' ' ' THR . . . . . 0.963 ' CG2' HD22 ' R' ' 86' ' ' LEU . 64.8 p -70.72 -24.74 62.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 91' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 61.83 21.89 61.52 Favored Glycine 0 N--CA 1.502 3.052 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.673 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 92' ' ' LEU . . . . . 1.04 ' CD1' HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -93.59 -16.09 24.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.225 -1.162 . . . . 0.0 111.193 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 93' ' ' GLU . . . . . 0.741 ' N ' HD12 ' R' ' 92' ' ' LEU . 95.9 mt-10 52.13 93.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.387 -0.821 . . . . 0.0 108.835 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 1.12 HD11 HG21 ' R' ' 83' ' ' ILE . 2.5 pp -145.09 4.94 1.1 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.977 -1.077 . . . . 0.0 109.91 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 95' ' ' HIS . . . . . 0.841 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.9 OUTLIER -39.31 -33.87 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.422 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.49 21.82 11.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.568 -0.707 . . . . 0.0 110.658 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.652 ' O ' ' HB2' ' R' ' 94' ' ' LEU . . . 160.16 -115.26 0.65 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.087 -1.53 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 98' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' R' ' 97' ' ' GLY . . . 55.81 166.48 0.05 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' R' ' 102' ' ' LEU . 47.9 Cg_endo -79.43 125.23 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.73 1.384 . . . . 0.0 110.575 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.733 ' O ' HG21 ' R' ' 56' ' ' ILE . 39.3 Cg_endo -64.71 -34.35 51.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.487 1.257 . . . . 0.0 109.859 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' R' ' 104' ' ' ILE 0.251 . . -57.6 -39.73 77.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.956 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' R' ' 92' ' ' LEU . 3.5 mm? -56.08 -31.75 63.5 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.027 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.978 HG13 HD13 ' R' ' 86' ' ' LEU . 14.8 t -59.18 -52.85 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.705 HG22 HD11 ' R' ' 111' ' ' LEU . 43.5 pt -66.04 -34.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 111.108 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.498 ' N ' HG13 ' R' ' 104' ' ' ILE . 8.4 m95 -60.7 -38.97 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 111.816 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.787 ' CB ' ' HA ' ' R' ' 90' ' ' THR . 71.3 m-80 -82.26 -34.56 28.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.702 -1.249 . . . . 0.0 113.265 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 107' ' ' ILE . . . . . 0.728 HG22 HD23 ' R' ' 110' ' ' LEU . 0.2 OUTLIER -92.76 22.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.601 -1.312 . . . . 0.0 110.368 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' R' ' 112' ' ' HIS . 32.3 tttt -29.58 -58.99 0.16 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.848 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.3 m-70 -63.12 -13.59 38.5 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.129 2.24 . . . . 0.0 111.232 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.848 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -111.11 -7.46 14.49 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.923 HD21 ' CE1' ' R' ' 60' ' ' PHE . 0.2 OUTLIER -142.99 -111.34 0.12 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.197 -1.365 . . . . 0.0 114.449 -173.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 112' ' ' HIS . . . . . 0.626 ' C ' ' O ' ' R' ' 111' ' ' LEU . 53.6 t-80 -19.47 81.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 123.768 1.747 . . . . 0.0 109.871 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 113' ' ' THR . . . . . 1.094 ' CG2' HD11 ' R' ' 115' ' ' ILE 0.25 4.5 t -70.12 -162.55 0.06 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.14 177.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.837 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.1 97.84 0.46 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 1.094 HD11 ' CG2' ' R' ' 113' ' ' THR . 3.3 mm -113.01 145.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.784 -1.421 . . . . 0.0 110.601 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 116' ' ' GLY . . . . . 0.453 ' N ' ' HB2' ' R' ' 122' ' ' SER . . . -124.92 -143.99 6.23 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.925 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.977 ' HA ' HG22 ' R' ' 126' ' ' VAL . 24.9 m -138.05 174.5 10.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.889 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -55.66 -29.45 59.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.389 -1.325 . . . . 0.0 109.62 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 39.6 m -87.11 -33.19 19.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -101.16 119.8 56.89 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.247 -0.908 . . . . 0.0 110.384 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.79 124.91 4.68 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.627 1.33 . . . . 0.0 112.228 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER -140.74 -170.08 2.94 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' R' ' 114' ' ' GLY . 52.7 mt-10 -55.59 -44.74 77.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.52 -1.362 . . . . 0.0 107.862 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 1.008 ' CG2' HD12 ' R' ' 115' ' ' ILE . 1.9 m -120.25 138.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.542 ' O ' ' O ' ' R' ' 180' ' ' PHE . 43.1 t -123.05 135.22 54.34 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.237 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' R' ' 117' ' ' THR . 10.4 m -80.64 -173.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.417 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.931 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 3.6 m -117.16 -42.01 2.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.802 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.526 ' N ' HG23 ' R' ' 127' ' ' VAL . 89.2 m-20 42.55 37.12 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.566 -1.334 . . . . 0.0 111.021 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.33 39.92 91.83 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 130' ' ' THR . . . . . 0.889 HG21 ' HB1' ' R' ' 118' ' ' ALA . 90.7 m -113.34 152.62 29.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.694 -0.886 . . . . 0.0 111.627 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 131' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' R' ' 130' ' ' THR . 65.6 m-20 70.73 -166.88 0.15 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.864 0.84 . . . . 0.0 111.987 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.522 ' O ' ' OD2' ' R' ' 173' ' ' ASP . 87.2 mtp -83.83 177.5 8.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.889 -0.507 . . . . 0.0 111.111 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' R' ' 134' ' ' LEU . 0.5 OUTLIER -89.22 -171.22 3.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.69 -0.631 . . . . 0.0 111.253 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 1.077 ' HA ' ' HB2' ' R' ' 173' ' ' ASP . 0.3 OUTLIER -3.76 -70.35 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 135' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' R' ' 133' ' ' CYS . . . -54.19 3.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 136' ' ' ASP . . . . . 0.607 ' O ' ' CZ ' ' R' ' 183' ' ' TYR . 14.5 t70 -84.98 -90.47 0.1 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 119.396 -2.065 . . . . 0.0 111.598 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 137' ' ' PHE . . . . . 0.84 ' CE1' ' HB2' ' R' ' 180' ' ' PHE . 14.3 p90 -102.47 -176.19 3.03 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.888 ' HB2' HG23 ' R' ' 154' ' ' VAL . 0.0 OUTLIER -149.53 79.96 1.39 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.183 -1.807 . . . . 0.0 111.196 176.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.767 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 176.96 161.29 0.41 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.656 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 131.45 -165.62 23.17 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.826 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 141' ' ' ILE . . . . . 0.794 HD11 ' CD2' ' R' ' 59' ' ' LEU . 62.0 mt -106.8 119.18 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.8 -0.823 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.826 ' HB2' HG23 ' R' ' 150' ' ' VAL . 0.4 OUTLIER -109.72 140.01 44.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.718 0.771 . . . . 0.0 109.688 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.42 119.36 38.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.33 -0.857 . . . . 0.0 108.978 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -100.73 121.26 41.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.751 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.75 -124.08 32.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -133.92 154.64 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.8 31.0 2.88 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.99 125.23 20.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.508 -0.745 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.747 ' HB3' ' C ' ' R' ' 51' ' ' ALA . . . -112.43 142.91 44.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 110.233 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 150' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.3 m -142.15 167.63 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.0 109.7 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' R' ' 59' ' ' LEU . 52.2 t80 -150.35 121.68 7.86 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.257 -0.902 . . . . 0.0 112.214 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.44 168.0 10.23 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 119.985 -1.697 . . . . 0.0 110.264 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 153' ' ' CYS . . . . . 0.79 ' HB2' ' CE2' ' R' ' 160' ' ' TYR . 0.5 OUTLIER -168.56 144.82 3.7 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.361 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' R' ' 138' ' ' HIS . 41.4 t -55.55 123.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.081 -1.637 . . . . 0.0 114.028 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 155' ' ' THR . . . . . 0.608 ' CG2' ' HB3' ' R' ' 160' ' ' TYR . 21.9 p -126.88 -179.56 4.89 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.127 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 42.1 m -56.36 -20.29 18.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.169 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 157' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' R' ' 169' ' ' PRO . 79.1 m-20 -92.66 -5.2 51.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.576 -0.702 . . . . 0.0 111.855 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 158' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 116.96 -135.44 11.96 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.996 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.857 ' O ' ' HA ' ' R' ' 169' ' ' PRO . 0.0 OUTLIER -82.34 82.17 7.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 160' ' ' TYR . . . . . 0.982 ' O ' ' HB1' ' R' ' 152' ' ' ALA . 0.0 OUTLIER -64.22 160.04 19.42 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 161' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -147.12 113.23 5.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 162' ' ' ILE . . . . . 0.866 HG23 ' O ' ' R' ' 162' ' ' ILE . 0.7 OUTLIER -72.43 83.69 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 123.103 1.43 . . . . 0.0 111.101 -175.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -80.01 131.0 35.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 164' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' R' ' 163' ' ' ASP . 92.6 m-20 32.82 65.16 0.24 Allowed 'General case' 0 N--CA 1.518 2.94 0 O-C-N 120.884 -1.135 . . . . 0.0 112.465 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' R' ' 42' ' ' TYR . 5.3 mt-10 58.75 8.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.232 -1.542 . . . . 0.0 112.129 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 166' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 74.5 m-20 -109.44 152.54 25.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 119.977 -1.702 . . . . 0.0 108.754 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 167' ' ' PHE . . . . . 0.662 ' CB ' HD11 ' R' ' 31' ' ' LEU . 19.5 p90 -124.7 130.39 52.33 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.868 1.318 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 168' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' R' ' 161' ' ' ALA . 2.0 p90 -159.42 144.03 11.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.685 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 169' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' R' ' 159' ' ' TRP . 50.3 Cg_endo -72.89 107.7 2.41 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 O-C-N 123.088 1.046 . . . . 0.0 112.802 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.79 ' O ' HG23 ' R' ' 171' ' ' THR . 0.6 OUTLIER -135.3 18.28 3.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 117.123 -1.831 . . . . 0.0 112.66 175.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 171' ' ' THR . . . . . 1.029 HG22 HD11 ' R' ' 134' ' ' LEU . 0.1 OUTLIER 167.43 121.01 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.965 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 175.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 1.037 ' CD ' HD13 ' R' ' 134' ' ' LEU . 42.2 Cg_endo -101.65 16.76 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.235 1.29 . . . . 0.0 113.421 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 173' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' R' ' 134' ' ' LEU . 0.1 OUTLIER -144.48 -173.1 0.34 Allowed Pre-proline 0 N--CA 1.511 2.583 0 O-C-N 118.216 -2.802 . . . . 0.0 114.923 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 1.06 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.4 Cg_endo -86.39 34.07 0.45 Allowed 'Trans proline' 0 C--O 1.217 -0.57 0 O-C-N 124.29 1.679 . . . . 0.0 112.143 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 175' ' ' SER . . . . . 0.729 ' OG ' HD23 ' R' ' 134' ' ' LEU . 15.0 m -62.18 -43.45 98.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.816 -1.178 . . . . 0.0 108.436 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -123.09 0.82 9.13 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.63 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 1.06 HG13 ' HA ' ' R' ' 174' ' ' PRO . 0.2 OUTLIER -109.34 157.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.304 -0.873 . . . . 0.0 109.838 -178.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.931 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.5 OUTLIER -132.1 38.34 3.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 117.529 -1.668 . . . . 0.0 110.606 177.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.974 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 7.7 p -165.63 129.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.84 ' HB2' ' CE1' ' R' ' 137' ' ' PHE . 7.1 p90 -136.72 179.44 6.37 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.174 -1.41 . . . . 0.0 111.227 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 181' ' ' VAL . . . . . 0.767 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -112.21 137.98 21.67 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.395 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 182' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' R' ' 181' ' ' VAL . 41.0 Cg_endo -66.49 141.34 60.88 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.5 1.263 . . . . 0.0 111.866 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 15.7 p90 -138.35 172.74 12.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -154.29 164.27 38.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.18 -0.95 . . . . 0.0 110.947 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -131.25 158.19 41.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.557 -0.715 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.51 106.51 46.53 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 150.9 64.01 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.68 1.358 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 25.2 tp -97.56 126.01 42.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.252 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -125.81 116.44 21.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.243 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -167.38 150.85 17.91 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 48.28 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.517 -0.99 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -139.12 163.26 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.398 -0.814 . . . . 0.0 110.209 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.16 110.05 22.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.077 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -102.63 144.5 30.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.887 . . . . 0.0 110.344 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.257 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' R' R ' 29' ' ' MET . . . . . 0.54 ' HB2' ' CE2' ' R' ' 167' ' ' PHE . 89.2 mtp . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.291 0.567 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 30' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' R' ' 40' ' ' THR . 93.2 mt-10 -97.77 114.71 26.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 111.372 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 31' ' ' LEU . . . . . 1.028 HD13 HG21 ' R' ' 162' ' ' ILE . 1.2 pt? -122.9 135.52 54.53 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.49 -1.284 . . . . 0.0 111.025 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 32' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' R' ' 38' ' ' LYS . 8.8 t -91.58 156.24 17.79 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -106.26 -173.97 2.42 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.655 -0.653 . . . . 0.0 110.595 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 34' ' ' TYR . . . . . 0.713 ' N ' ' O ' ' R' ' 154' ' ' VAL . 19.2 p90 -48.14 -49.8 31.01 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 35' ' ' ASN . . . . . 0.629 ' OD1' HD23 ' R' ' 33' ' ' LEU . 12.4 p-10 -76.57 17.99 0.36 Allowed 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 122.417 2.371 . . . . 0.0 114.303 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -13.74 40.47 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 120.07 -1.644 . . . . 0.0 112.795 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 37' ' ' GLU . . . . . 0.791 ' HB3' HD21 ' R' ' 33' ' ' LEU . 81.2 tt0 -61.18 131.88 51.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.637 1.718 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 38' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' R' ' 38' ' ' LYS . 52.6 pttt -100.93 113.03 25.63 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.925 0.869 . . . . 0.0 111.062 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' HD2' ' R' ' 61' ' ' ARG . 67.1 mttm -113.21 117.77 32.81 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 40' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' R' ' 40' ' ' THR . 1.3 t -94.69 133.0 38.82 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.358 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 1.179 ' CE2' HD11 ' R' ' 162' ' ' ILE . 0.1 OUTLIER -145.67 166.73 24.95 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.739 176.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 42' ' ' TYR . . . . . 0.512 ' O ' ' OG ' ' R' ' 43' ' ' SER . 87.0 m-85 -79.35 175.86 10.21 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.964 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 43' ' ' SER . . . . . 0.689 ' O ' ' O ' ' R' ' 44' ' ' ARG . 0.8 OUTLIER 169.62 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 44' ' ' ARG . . . . . 0.689 ' O ' ' O ' ' R' ' 43' ' ' SER . 5.7 ptt180 -32.87 163.97 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.019 -1.05 . . . . 0.0 111.483 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 45' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 29.3 Cg_endo -52.28 104.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.347 1.183 . . . . 0.0 110.874 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' R' ' 76' ' ' GLU . 7.3 t-20 -92.63 -127.67 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.555 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' R' ' 48' ' ' HIS . 0.4 OUTLIER -134.55 138.12 44.36 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.613 -1.304 . . . . 0.0 111.661 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.546 ' HB2' ' O ' ' R' ' 47' ' ' ASN . 51.3 m80 72.52 42.98 0.5 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.423 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' R' ' 48' ' ' HIS . 80.1 m-20 55.26 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.439 -0.788 . . . . 0.0 109.357 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' R' ' 77' ' ' ASN . 31.1 p-10 -111.63 1.98 17.06 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.623 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.253 . . -68.51 -41.86 79.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.696 -0.628 . . . . 0.0 111.716 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 1.006 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 33.2 m95 -60.13 -33.64 72.42 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.08 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 1.074 HD11 HG12 ' R' ' 83' ' ' ILE . 2.3 mt -79.53 -40.37 29.75 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 54' ' ' ASN . . . . . 0.569 ' O ' ' HG3' ' R' ' 58' ' ' GLN . 8.3 t30 -55.15 -28.79 55.31 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 55' ' ' ALA . . . . . 0.942 ' HB1' ' CE1' ' R' ' 151' ' ' PHE . . . -64.43 -64.37 0.9 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.856 HD12 HG11 ' R' ' 103' ' ' VAL . 0.6 OUTLIER -67.27 -29.2 45.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 O-C-N 120.231 -1.543 . . . . 0.0 108.174 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 57' ' ' LEU . . . . . 0.997 ' HG ' HG11 ' R' ' 71' ' ' VAL . 1.8 mm? -52.62 -54.57 31.31 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 109.139 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 58' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' R' ' 54' ' ' ASN . 1.8 mt-30 -55.03 -31.73 61.31 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' R' ' 151' ' ' PHE . 1.4 tp -67.84 -40.71 83.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.783 ' HB2' ' HD2' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -54.14 -47.28 72.09 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.955 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 61' ' ' ARG . . . . . 0.581 ' HG2' ' CZ ' ' R' ' 60' ' ' PHE . 16.2 mmt180 -57.8 -54.32 48.22 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.884 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.806 ' CZ ' ' HB1' ' R' ' 139' ' ' ALA . 21.6 p90 -92.6 -31.76 15.04 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 119.598 -1.939 . . . . 0.0 114.016 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.74 HG22 HG12 ' R' ' 124' ' ' VAL . 56.1 t -77.18 -24.85 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 120.137 -1.602 . . . . 0.0 110.233 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 64' ' ' GLU . . . . . 0.73 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 87.3 tt0 123.22 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' HD1' ' R' ' 60' ' ' PHE . 3.5 pt-20 -50.44 100.92 0.24 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' R' ' 60' ' ' PHE . 46.7 Cg_endo -86.69 -165.23 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 N-CA-C 106.023 -2.337 . . . . 0.0 106.023 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 67' ' ' PHE . . . . . 0.593 ' CE1' HD21 ' R' ' 89' ' ' LEU . 76.6 m-85 -41.95 -19.35 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 68' ' ' PHE . . . . . 0.802 ' HB3' HD22 ' R' ' 57' ' ' LEU . 3.2 m-30 -58.24 -3.01 0.22 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.286 -1.509 . . . . 0.0 110.452 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' R' ' 72' ' ' TYR . 19.8 t70 -58.35 -30.39 66.71 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.717 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -61.58 -33.51 74.01 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.848 -1.158 . . . . 0.0 108.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.997 HG11 ' HG ' ' R' ' 57' ' ' LEU . 55.5 t -68.39 -62.2 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.535 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 72' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' R' ' 69' ' ' ASP . 0.8 OUTLIER -71.98 -30.75 65.58 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.207 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 73' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 34.0 t -63.99 -23.24 67.26 Favored 'General case' 0 N--CA 1.51 2.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.434 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 148.93 80.45 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 75' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' R' ' 42' ' ' TYR . 38.8 Cg_endo -65.03 -17.46 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.712 1.375 . . . . 0.0 110.025 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 76' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' R' ' 78' ' ' LEU . 96.1 mt-10 -141.28 58.84 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.5 -0.75 . . . . 0.0 109.499 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 77' ' ' ASN . . . . . 0.539 ' ND2' HG13 ' R' ' 71' ' ' VAL . 28.7 t-20 57.38 -84.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.818 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 78' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' R' ' 81' ' ' GLU . 0.1 OUTLIER 78.33 67.28 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 79' ' ' THR . . . . . 0.646 ' O ' HG12 ' R' ' 83' ' ' ILE . 5.3 t -65.25 -52.64 53.14 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.834 -0.541 . . . . 0.0 110.573 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' R' ' 81' ' ' GLU . 0.4 OUTLIER -49.85 -53.12 27.65 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.56 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 81' ' ' GLU . . . . . 0.593 ' HG3' HD12 ' R' ' 80' ' ' LEU . 95.4 mt-10 -68.12 -28.22 67.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.059 -1.651 . . . . 0.0 110.277 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.921 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.61 -46.74 74.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.768 0.794 . . . . 0.0 112.436 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 1.074 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.36 -39.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.565 -176.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' R' ' 80' ' ' LEU . 35.4 mttm -49.74 -35.86 23.63 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 68.3 tp60 -70.93 -44.57 65.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 86' ' ' LEU . . . . . 0.806 HD13 ' OG1' ' R' ' 90' ' ' THR . 1.4 tm? -55.11 -38.4 68.12 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 87' ' ' GLU . . . . . 0.554 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.8 tt0 -59.37 -33.22 70.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.915 -1.115 . . . . 0.0 108.15 177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 88' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 82.0 m-20 -55.14 -32.49 62.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.956 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.905 ' H ' HD12 ' R' ' 89' ' ' LEU . 0.3 OUTLIER -102.61 -49.1 3.93 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.938 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 90' ' ' THR . . . . . 0.887 ' OG1' HD22 ' R' ' 92' ' ' LEU . 35.0 p -78.6 -27.79 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 91' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 73.12 23.61 77.32 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.154 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 92' ' ' LEU . . . . . 1.017 HD11 HD21 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -108.12 -160.88 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.063 -1.257 . . . . 0.0 112.042 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 93' ' ' GLU . . . . . 0.83 ' C ' HD13 ' R' ' 94' ' ' LEU . 95.5 mt-10 -144.56 104.79 4.09 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 1.017 HD21 HD11 ' R' ' 92' ' ' LEU . 0.3 OUTLIER -105.28 9.97 33.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.853 -1.155 . . . . 0.0 110.762 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 95' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' R' ' 94' ' ' LEU . 17.0 m170 -45.29 -29.75 1.09 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.451 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 80.4 tt0 -150.49 33.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' R' ' 52' ' ' TRP . . . -95.64 -111.58 2.59 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.02 -1.05 . . . . 0.0 110.731 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 98' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . 178.14 -161.44 28.32 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.696 ' CD ' ' HD2' ' R' ' 100' ' ' PRO . 31.3 Cg_endo -72.69 -64.84 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 O-C-N 123.849 1.447 . . . . 0.0 114.108 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.932 ' O ' ' N ' ' R' ' 102' ' ' LEU . 33.6 Cg_endo -57.22 -28.32 78.9 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 N-CA-C 107.181 -1.892 . . . . 0.0 107.181 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.971 ' O ' HD12 ' R' ' 92' ' ' LEU 0.251 . . -29.35 60.44 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.197 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.932 ' N ' ' O ' ' R' ' 100' ' ' PRO . 7.3 mp 35.45 -4.74 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -175.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.959 ' O ' ' HB ' ' R' ' 107' ' ' ILE . 34.3 t -61.74 -44.99 99.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 C-N-CA 114.855 -2.738 . . . . 0.0 105.641 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' R' ' 100' ' ' PRO . 19.0 pt -84.14 -36.09 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.339 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.73 ' HB3' ' HA ' ' R' ' 102' ' ' LEU . 48.0 t-105 -60.27 -45.26 93.91 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.152 -1.419 . . . . 0.0 111.419 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.457 ' HB2' HG22 ' R' ' 90' ' ' THR . 9.1 m120 -84.88 -22.53 29.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.891 -1.131 . . . . 0.0 111.794 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 107' ' ' ILE . . . . . 0.959 ' HB ' ' O ' ' R' ' 103' ' ' VAL . 0.2 OUTLIER -67.48 -14.43 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 111.33 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 107' ' ' ILE . 75.2 tttt -33.96 -59.73 0.41 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.425 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.0 m80 -84.0 -7.67 59.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.274 -2.141 . . . . 0.0 111.451 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.761 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.1 OUTLIER -84.26 -30.85 25.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.516 -1.365 . . . . 0.0 109.199 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.815 ' CG ' HG23 ' R' ' 107' ' ' ILE 0.281 57.6 mt -68.11 161.03 27.79 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.692 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -117.14 60.13 0.75 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.623 HG22 HD13 ' R' ' 115' ' ' ILE . 97.4 m -145.12 138.36 26.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.395 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -74.67 98.4 1.05 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 105.615 -2.994 . . . . 0.0 105.615 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.948 HG23 ' CG2' ' R' ' 124' ' ' VAL . 31.1 mm -93.24 142.5 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.814 -1.404 . . . . 0.0 109.828 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' R' ' 122' ' ' SER . . . -133.46 -165.78 11.18 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.869 -1.634 . . . . 0.0 111.952 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.691 ' HA ' HG22 ' R' ' 126' ' ' VAL . 7.2 m -134.63 -175.43 3.88 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' R' ' 130' ' ' THR . . . -64.58 -37.86 89.0 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.795 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -66.71 -36.35 82.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.67 101.79 36.26 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.022 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.07 135.73 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.621 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.499 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 0.2 OUTLIER -145.22 -158.99 0.94 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.637 -0.665 . . . . 0.0 109.426 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.403 ' HB2' HG22 ' R' ' 113' ' ' THR . 77.0 mm-40 -56.13 -43.9 78.67 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.796 -1.19 . . . . 0.0 108.433 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.948 ' CG2' HG23 ' R' ' 115' ' ' ILE . 10.7 m -115.95 135.14 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.446 ' O ' ' CD1' ' R' ' 180' ' ' PHE . 7.0 t -134.3 136.9 43.83 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.966 0.888 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 6.1 m -82.53 -179.92 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.31 1.053 . . . . 0.0 111.18 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.973 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 5.0 m -121.55 -1.01 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' R' ' 178' ' ' LEU . 55.9 t0 -60.49 92.96 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.764 -1.21 . . . . 0.0 110.374 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.49 67.45 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 130' ' ' THR . . . . . 0.756 HG23 ' CB ' ' R' ' 118' ' ' ALA . 1.4 m -97.38 146.71 24.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.685 -0.891 . . . . 0.0 111.267 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -66.32 -32.39 73.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.491 ' HB3' ' CZ ' ' R' ' 180' ' ' PHE . 64.0 mtt -90.34 141.62 28.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.0 110.962 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.31 -165.32 1.78 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.71 -0.619 . . . . 0.0 110.228 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 1.085 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.9 OUTLIER -45.67 -30.0 1.42 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.77 -41.45 32.36 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 136' ' ' ASP . . . . . 0.644 ' O ' ' CD2' ' R' ' 137' ' ' PHE . 94.0 m-20 -71.15 -140.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 137' ' ' PHE . . . . . 0.715 ' HB2' ' CE2' ' R' ' 183' ' ' TYR . 0.4 OUTLIER -173.37 101.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 116.593 -2.043 . . . . 0.0 112.266 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.973 ' HB3' ' O ' ' R' ' 181' ' ' VAL . 1.3 t-160 -163.32 -138.63 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.214 1.007 . . . . 0.0 109.857 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' SG ' ' R' ' 153' ' ' CYS 0.261 . . -104.81 179.69 4.2 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.744 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 161.52 -178.68 37.33 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 141' ' ' ILE . . . . . 1.094 HG23 ' CE1' ' R' ' 151' ' ' PHE . 3.6 mt -108.35 115.69 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.627 -0.925 . . . . 0.0 110.616 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 1.045 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 3.0 m-85 -114.82 154.64 28.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.8 129.37 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.468 ' HB2' HG11 ' R' ' 150' ' ' VAL . 36.1 tttp -109.12 122.37 47.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.24 -130.6 49.73 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.49 -129.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.353 -1.087 . . . . 0.0 109.554 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.63 92.65 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 109.802 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' R' ' 144' ' ' LYS . 6.3 t-80 -146.47 122.15 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.462 -0.773 . . . . 0.0 108.92 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 1.006 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -94.47 118.87 32.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.797 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 150' ' ' VAL . . . . . 0.618 HG22 ' O ' ' R' ' 142' ' ' PHE . 34.7 m -133.62 147.63 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.005 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 1.094 ' CE1' HG23 ' R' ' 141' ' ' ILE . 3.3 m-85 -136.11 131.78 35.23 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.63 169.91 8.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.597 -1.314 . . . . 0.0 111.29 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 153' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' R' ' 139' ' ' ALA . 3.9 t -163.37 133.09 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' R' ' 34' ' ' TYR . 48.3 t -50.91 117.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.101 -1.44 . . . . 0.0 111.919 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 155' ' ' THR . . . . . 0.764 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 66.4 p -104.4 -158.34 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 83.5 p -65.73 -15.47 62.86 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.672 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 157' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 86.0 m-20 -113.01 9.47 18.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.358 -0.839 . . . . 0.0 111.969 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 158' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 100.92 -153.96 19.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.757 ' CG ' ' O ' ' R' ' 171' ' ' THR . 0.0 OUTLIER -57.91 94.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.322 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 160' ' ' TYR . . . . . 0.764 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 0.2 OUTLIER -115.79 119.04 34.72 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 161' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -109.94 147.99 32.42 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.44 -1.413 . . . . 0.0 110.114 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 162' ' ' ILE . . . . . 1.179 HD11 ' CE2' ' R' ' 41' ' ' PHE . 6.0 pt -117.51 91.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-O 124.191 1.948 . . . . 0.0 112.029 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.666 ' O ' ' C ' ' R' ' 164' ' ' ASP . 63.6 m-20 -83.0 120.26 25.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 111.784 -2.462 . . . . 0.0 106.169 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 164' ' ' ASP . . . . . 0.675 ' HA ' ' C ' ' R' ' 43' ' ' SER . 96.8 m-20 11.93 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.113 0.959 . . . . 0.0 111.553 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' R' ' 163' ' ' ASP . 98.6 mt-10 -31.41 -52.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 166' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 19.8 t0 -172.5 177.9 2.88 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 119.339 -2.101 . . . . 0.0 113.496 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 167' ' ' PHE . . . . . 1.132 ' HA ' HG22 ' R' ' 162' ' ' ILE . 2.1 m-30 -93.52 129.35 39.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 168' ' ' TYR . . . . . 0.521 ' HB2' ' HD2' ' R' ' 169' ' ' PRO . 36.9 p90 -155.42 170.18 9.13 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.556 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 169' ' ' PRO . . . . . 0.521 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 41.3 Cg_endo -68.61 113.38 3.15 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.748 -1.674 . . . . 0.0 107.748 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.696 ' HA ' ' HE3' ' R' ' 170' ' ' TRP . 0.0 OUTLIER -117.66 -129.24 0.29 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 123.361 1.553 . . . . 0.0 111.956 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 171' ' ' THR . . . . . 1.085 ' CG2' HD11 ' R' ' 134' ' ' LEU 0.319 1.4 m -32.22 97.74 0.11 Allowed Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 112.904 -1.953 . . . . 0.0 115.389 -174.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' R' ' 173' ' ' ASP . 53.2 Cg_endo -92.93 -30.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.53 1.805 . . . . 0.0 108.037 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 173' ' ' ASP . . . . . 0.55 ' CA ' ' HG ' ' R' ' 134' ' ' LEU . 18.0 p30 -148.15 170.43 7.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.448 -0.783 . . . . 0.0 108.915 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' R' ' 134' ' ' LEU . 49.5 Cg_endo -85.64 51.36 2.87 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 83.4 p -82.15 -34.13 29.28 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -125.41 6.11 7.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.557 -1.339 . . . . 0.0 111.054 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 1.045 ' HB ' ' CG ' ' R' ' 142' ' ' PHE 0.259 2.3 p -112.31 148.49 15.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.231 -0.918 . . . . 0.0 110.687 -177.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.973 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.4 OUTLIER -133.05 46.26 2.63 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.893 175.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.43 131.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' R' ' 182' ' ' PRO . 2.3 p90 -132.46 178.53 6.76 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.686 1.231 . . . . 0.0 108.987 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 181' ' ' VAL . . . . . 0.973 ' O ' ' HB3' ' R' ' 138' ' ' HIS . 0.8 OUTLIER -121.64 93.3 48.73 Favored Pre-proline 0 C--N 1.265 -3.088 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 182' ' ' PRO . . . . . 0.495 ' HB3' ' CE2' ' R' ' 180' ' ' PHE . 36.5 Cg_endo -60.05 109.29 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 120.862 1.041 . . . . 0.0 113.629 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.715 ' CE2' ' HB2' ' R' ' 137' ' ' PHE . 0.0 OUTLIER -67.12 -151.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.036 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -74.81 123.18 24.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.109 -0.994 . . . . 0.0 110.483 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -85.74 155.26 21.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.454 -0.779 . . . . 0.0 110.098 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -54.9 138.6 63.88 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.455 -0.778 . . . . 0.0 110.394 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.6 154.75 64.2 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.752 1.396 . . . . 0.0 110.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 75.1 mt -84.5 146.14 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 109.976 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -100.6 137.56 38.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -85.08 -173.48 49.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 51.77 -162.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.361 -1.082 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 98.2 m95 52.09 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -80.62 135.23 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.44 154.27 45.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.202 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' R' R ' 29' ' ' MET . . . . . 0.432 ' HB2' ' CZ ' ' R' ' 167' ' ' PHE . 88.0 mtp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.162 0.506 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 30' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 84.1 tt0 -110.44 126.95 54.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.822 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 31' ' ' LEU . . . . . 1.078 ' CD1' HG21 ' R' ' 162' ' ' ILE . 1.7 pt? -139.02 163.4 32.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.459 -0.776 . . . . 0.0 109.632 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 32' ' ' THR . . . . . 0.784 HG22 ' HB3' ' R' ' 38' ' ' LYS . 31.8 p -104.78 129.26 53.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.145 . . . . 0.0 111.973 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.97 HD13 ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -130.68 136.03 48.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.41 -0.806 . . . . 0.0 109.773 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 34' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' R' ' 33' ' ' LEU . 58.2 t80 -33.48 -36.18 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 35' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' R' ' 62' ' ' TYR . 97.4 m-20 -105.34 65.13 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.837 -1.789 . . . . 0.0 111.287 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 36' ' ' GLY . . . . . 0.972 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 128.33 35.27 0.51 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 37' ' ' GLU . . . . . 0.972 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.0 mt-10 -13.82 -150.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 38' ' ' LYS . . . . . 0.784 ' HB3' HG22 ' R' ' 32' ' ' THR . 9.5 pttm -52.29 109.1 0.35 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.356 -1.465 . . . . 0.0 112.518 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 30.0 mmtm -150.09 147.19 27.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.315 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 40' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' R' ' 72' ' ' TYR . 0.8 OUTLIER -85.4 125.42 32.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.126 -0.984 . . . . 0.0 110.019 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.714 ' CD2' ' CE2' ' R' ' 151' ' ' PHE . 84.2 m-85 -110.09 154.02 23.85 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.934 1.349 . . . . 0.0 114.42 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 42' ' ' TYR . . . . . 0.686 ' HA ' ' HB2' ' R' ' 164' ' ' ASP . 76.2 m-85 -116.45 164.22 14.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.256 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 43' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' R' ' 51' ' ' ALA . 0.6 OUTLIER 155.71 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 119.446 1.021 . . . . 0.0 113.304 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 44' ' ' ARG . . . . . 0.576 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 4.5 mtt180 -72.28 175.74 2.92 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 109.24 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 45' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' R' ' 44' ' ' ARG . 37.5 Cg_endo -61.65 100.59 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.286 1.15 . . . . 0.0 113.204 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 47' ' ' ASN . 2.1 m-20 -150.73 -11.85 0.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 47' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 46' ' ' ASN . 0.2 OUTLIER -135.78 -178.67 5.24 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 77.4 m80 -92.7 -6.93 48.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.639 -1.288 . . . . 0.0 109.824 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.749 ' O ' HG21 ' R' ' 79' ' ' THR . 12.5 p30 172.17 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 109.605 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.465 ' CG ' ' HB ' ' R' ' 79' ' ' THR . 0.2 OUTLIER -138.58 -3.13 1.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.255 . . -66.3 -44.54 83.18 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.712 -0.617 . . . . 0.0 110.718 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.656 ' CD2' ' HA2' ' R' ' 97' ' ' GLY . 55.2 m95 -61.1 -36.63 80.21 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.555 -1.658 . . . . 0.0 107.795 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 1.086 HD11 HG12 ' R' ' 83' ' ' ILE . 2.4 mt -68.49 -34.86 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 54' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' R' ' 42' ' ' TYR . 0.0 OUTLIER -47.6 -26.98 1.64 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 55' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.52 -56.98 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.953 HG23 ' CE2' ' R' ' 60' ' ' PHE 0.291 1.2 mp -62.58 -42.39 95.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 122.379 1.085 . . . . 0.0 108.311 177.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 57' ' ' LEU . . . . . 1.014 HD12 ' CE1' ' R' ' 72' ' ' TYR . 4.2 mm? -65.03 -60.7 2.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.953 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 58' ' ' GLN . . . . . 0.779 ' NE2' ' O ' ' R' ' 140' ' ' GLY . 6.2 pt20 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.834 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 1.6 mp -70.97 -48.54 52.77 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.566 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.953 ' CE2' HG23 ' R' ' 56' ' ' ILE . 12.7 m-30 -61.51 -45.93 92.12 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.474 -1.29 . . . . 0.0 110.59 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 61' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' R' ' 39' ' ' LYS . 1.5 tpm_? -58.3 -31.23 67.29 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 119.67 -1.894 . . . . 0.0 110.139 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 1.016 ' HB3' HG21 ' R' ' 181' ' ' VAL . 22.0 m-30 -61.7 -54.01 48.32 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.541 -1.35 . . . . 0.0 111.986 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.811 HG11 HG23 ' R' ' 113' ' ' THR . 3.9 t -85.79 3.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.363 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 64' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 74.4 tt0 67.04 44.91 1.85 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 4.4 mp0 -133.88 89.18 30.46 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' CZ ' ' R' ' 68' ' ' PHE . 53.1 Cg_endo -79.27 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.543 1.286 . . . . 0.0 113.757 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 67' ' ' PHE . . . . . 0.554 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 55.1 t80 -82.98 -25.71 32.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 68' ' ' PHE . . . . . 0.869 ' CG ' HD13 ' R' ' 57' ' ' LEU . 2.0 p90 -72.6 19.15 0.08 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.991 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' R' ' 73' ' ' SER . 95.5 m-20 -38.2 -37.29 0.27 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.451 -0.781 . . . . 0.0 112.868 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.463 ' HB2' ' HA ' ' R' ' 82' ' ' ALA . 84.8 m95 -62.03 -30.44 70.97 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.24 -1.538 . . . . 0.0 110.113 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' R' ' 57' ' ' LEU . 65.5 t -78.7 -67.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 72' ' ' TYR . . . . . 1.014 ' CE1' HD12 ' R' ' 57' ' ' LEU . 9.9 m-30 -67.89 -38.8 83.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.239 -0.913 . . . . 0.0 110.94 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 73' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' R' ' 69' ' ' ASP . 6.1 m -63.35 -21.62 66.38 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.739 -1.185 . . . . 0.0 109.561 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 74' ' ' SER . . . . . 0.585 ' OG ' HD23 ' R' ' 78' ' ' LEU . 16.4 t -99.6 119.71 59.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.957 . . . . 0.0 110.513 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.97 -19.25 46.2 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.569 1.299 . . . . 0.0 110.279 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.61 165.19 11.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.449 -0.782 . . . . 0.0 109.849 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -58.52 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.825 . . . . 0.0 110.728 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 78' ' ' LEU . . . . . 0.585 HD23 ' OG ' ' R' ' 74' ' ' SER . 1.4 mm? -107.82 21.81 16.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 79' ' ' THR . . . . . 0.749 HG21 ' O ' ' R' ' 49' ' ' ASP . 3.1 t -55.48 -52.64 62.97 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.506 -0.746 . . . . 0.0 109.956 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.606 ' H ' HG23 ' R' ' 79' ' ' THR . 1.2 pp -49.86 -50.84 44.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.692 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 81' ' ' GLU . . . . . 0.553 ' N ' HD12 ' R' ' 80' ' ' LEU . 84.8 tt0 -67.08 -28.63 68.34 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.28 -1.513 . . . . 0.0 110.104 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -67.01 -48.45 68.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.93 0.871 . . . . 0.0 111.572 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 1.086 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.76 -38.52 11.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.443 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 84' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 83' ' ' ILE . 36.7 tttm -50.49 -35.34 28.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -73.55 -36.56 65.65 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 86' ' ' LEU . . . . . 1.019 HD12 HD21 ' R' ' 94' ' ' LEU . 2.6 tm? -63.13 -38.18 90.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 87' ' ' GLU . . . . . 0.571 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 83.0 tt0 -60.9 -39.71 90.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 108.824 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.08 -32.3 72.82 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.273 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.808 HD23 ' N ' ' R' ' 90' ' ' THR . 2.6 tt -94.91 -51.25 4.76 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.08 -1.013 . . . . 0.0 111.805 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 90' ' ' THR . . . . . 0.838 HG22 ' HB2' ' R' ' 106' ' ' ASN . 69.7 p -76.58 -25.64 54.21 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 91' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 67.29 26.15 73.52 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.692 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 92' ' ' LEU . . . . . 1.098 HD13 HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -104.54 -17.98 14.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.02 -1.283 . . . . 0.0 111.756 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 93' ' ' GLU . . . . . 0.74 ' N ' HD12 ' R' ' 92' ' ' LEU . 84.1 tt0 58.42 115.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 1.098 HD23 HD13 ' R' ' 92' ' ' LEU . 3.7 pp -156.75 21.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.688 -1.257 . . . . 0.0 111.181 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 95' ' ' HIS . . . . . 0.839 ' HA ' HD12 ' R' ' 83' ' ' ILE . 5.7 p80 -42.42 -28.35 0.2 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.2 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.485 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 23.1 pt-20 -120.39 36.11 4.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.656 ' HA2' ' CD2' ' R' ' 52' ' ' TRP . . . 145.87 110.78 0.67 Allowed Glycine 0 N--CA 1.504 3.182 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.329 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 98' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' R' ' 94' ' ' LEU . . . -170.68 65.29 0.16 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.023 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.843 ' HB2' ' CD ' ' R' ' 100' ' ' PRO . 42.8 Cg_endo -84.56 -108.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.965 0 O-C-N 123.322 1.169 . . . . 0.0 109.211 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.881 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.3 Cg_endo -60.18 -17.88 48.49 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 N-CA-C 106.845 -2.021 . . . . 0.0 106.845 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.254 . . -31.22 61.27 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.195 175.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.881 ' N ' ' O ' ' R' ' 100' ' ' PRO . 80.8 mt 41.0 -3.42 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.369 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.008 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.968 HG13 HD11 ' R' ' 86' ' ' LEU . 13.4 t -56.98 -47.75 82.85 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 C-N-CA 114.335 -2.946 . . . . 0.0 104.079 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.46 -39.36 85.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.932 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.635 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 51.9 t90 -63.02 -36.31 83.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.12 -1.432 . . . . 0.0 111.25 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.838 ' HB2' HG22 ' R' ' 90' ' ' THR . 22.3 m120 -84.87 -23.19 29.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.086 -1.009 . . . . 0.0 113.26 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 107' ' ' ILE . . . . . 0.905 HG12 ' O ' ' R' ' 103' ' ' VAL . 3.4 mm -70.6 -10.95 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.242 -1.536 . . . . 0.0 110.02 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' R' ' 107' ' ' ILE . 62.1 mttt -33.47 -57.93 0.41 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.827 ' C ' HD13 ' R' ' 110' ' ' LEU . 4.1 m-70 -72.91 -9.68 58.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 119.181 -2.199 . . . . 0.0 111.506 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.838 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.2 OUTLIER -106.54 -16.82 14.43 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.859 HD23 HG21 ' R' ' 107' ' ' ILE 0.323 0.1 OUTLIER -109.71 127.62 54.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.835 -176.52 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' R' R ' 112' ' ' HIS . . . . . 0.546 ' N ' HD13 ' R' ' 111' ' ' LEU . 17.8 p80 -115.37 76.91 1.03 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.886 HG22 ' CD1' ' R' ' 115' ' ' ILE . 18.0 m -132.14 136.42 47.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.278 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.539 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -75.73 104.36 1.78 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 1.1 HD12 HG22 ' R' ' 124' ' ' VAL . 3.3 mm -90.9 144.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.634 -1.509 . . . . 0.0 109.358 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 116' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' R' ' 125' ' ' CYS . . . -145.42 -118.79 1.2 Allowed Glycine 0 N--CA 1.509 3.562 0 C-N-CA 118.408 -1.853 . . . . 0.0 112.462 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.53 HG23 ' O ' ' R' ' 116' ' ' GLY . 0.0 OUTLIER -178.95 -175.2 0.38 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.204 -1.174 . . . . 0.0 108.814 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.702 ' CA ' HG22 ' R' ' 126' ' ' VAL 0.278 . . -66.84 -43.62 83.22 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.31 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -37.77 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 108.889 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 120' ' ' ARG . . . . . 0.427 ' HA ' ' HD2' ' R' ' 121' ' ' PRO . 0.0 OUTLIER -123.22 104.11 35.28 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' R' ' 120' ' ' ARG . 39.8 Cg_endo -65.33 131.17 27.38 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.524 1.276 . . . . 0.0 111.224 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 46.7 m -146.05 -168.91 3.12 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.569 ' O ' HG23 ' R' ' 181' ' ' VAL . 76.8 mm-40 -63.18 -43.16 99.02 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.8 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 1.1 HG22 HD12 ' R' ' 115' ' ' ILE . 0.6 OUTLIER -149.17 122.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.337 -1.477 . . . . 0.0 112.566 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.784 ' HB3' ' O ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER 152.74 138.03 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.061 176.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.995 ' CG1' HG13 ' R' ' 127' ' ' VAL . 1.1 t -176.55 -172.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 1.095 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.4 m 36.91 -3.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 127.779 2.432 . . . . 0.0 116.863 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' R' ' 126' ' ' VAL . 44.9 t0 -57.22 55.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.659 -1.276 . . . . 0.0 111.752 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 129' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 105.28 15.56 19.12 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 130' ' ' THR . . . . . 0.661 HG21 ' CB ' ' R' ' 118' ' ' ALA . 87.1 m -116.53 154.32 30.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -1.175 . . . . 0.0 112.164 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -58.78 159.59 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.773 -0.579 . . . . 0.0 109.52 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.447 ' HG2' HG12 ' R' ' 127' ' ' VAL . 28.2 mtt -123.81 136.36 54.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.283 -0.885 . . . . 0.0 111.326 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.415 ' N ' ' HG2' ' R' ' 174' ' ' PRO . 49.1 t -137.3 134.64 36.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.027 -1.045 . . . . 0.0 111.086 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 1.006 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -59.89 -42.22 93.34 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.244 1.021 . . . . 0.0 110.587 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.4 0.52 9.95 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' R' ' 133' ' ' CYS . 47.4 t0 -73.31 -65.74 0.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.106 . . . . 0.0 111.827 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 137' ' ' PHE . . . . . 0.714 ' CG ' ' CD2' ' R' ' 180' ' ' PHE . 19.5 p90 -146.85 178.23 8.5 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.091 -1.006 . . . . 0.0 110.2 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' R' ' 172' ' ' PRO . 29.3 m80 -143.14 72.66 1.37 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.245 -1.382 . . . . 0.0 112.212 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.968 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 171.81 153.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.779 ' O ' ' NE2' ' R' ' 58' ' ' GLN . . . 144.16 -176.23 23.53 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.283 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 141' ' ' ILE . . . . . 0.71 ' CG1' ' HA ' ' R' ' 55' ' ' ALA . 0.5 OUTLIER -98.8 128.91 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.829 ' HA ' ' HA ' ' R' ' 177' ' ' VAL . 0.2 OUTLIER -111.48 141.56 44.89 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.501 -1.279 . . . . 0.0 109.021 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.487 ' N ' HD22 ' R' ' 143' ' ' LEU . 4.6 mm? -88.95 109.38 20.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.934 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.519 ' HD2' HG11 ' R' ' 150' ' ' VAL . 24.6 tttt -108.79 120.3 42.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.17 -137.72 44.16 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 146' ' ' GLN . . . . . 0.435 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 93.9 mt-30 -126.52 150.73 48.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -1.034 . . . . 0.0 110.16 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 51.27 37.56 18.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.435 ' CD2' ' O ' ' R' ' 146' ' ' GLN . 56.1 m-70 -142.86 123.61 14.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.31 -0.869 . . . . 0.0 109.672 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.796 ' HB3' ' HB1' ' R' ' 51' ' ' ALA . . . -105.33 136.27 45.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 150' ' ' VAL . . . . . 0.706 HG22 ' O ' ' R' ' 142' ' ' PHE . 31.2 m -127.9 165.72 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.025 -1.047 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.714 ' CE2' ' CD2' ' R' ' 41' ' ' PHE 0.26 0.0 OUTLIER -148.11 125.22 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.736 -1.186 . . . . 0.0 113.494 -177.613 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -132.81 164.29 27.16 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.606 -1.309 . . . . 0.0 109.238 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 153' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 22.6 p -176.29 176.39 1.68 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' R' ' 158' ' ' GLY . 64.9 t -63.59 103.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 CA-C-O 121.684 0.754 . . . . 0.0 110.992 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 155' ' ' THR . . . . . 0.712 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 41.7 p -88.75 -160.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 84.5 p -61.82 -18.65 60.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 157' ' ' ASN . . . . . 0.529 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 90.4 m-20 -111.39 2.69 17.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.7 . . . . 0.0 111.502 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 158' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 92.91 -118.15 5.55 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 120.704 -1.248 . . . . 0.0 112.124 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.674 ' HB3' ' HD2' ' R' ' 172' ' ' PRO . 0.0 OUTLIER -60.79 92.5 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.645 1.212 . . . . 0.0 108.89 -177.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 160' ' ' TYR . . . . . 0.763 ' HA ' ' H ' ' R' ' 170' ' ' TRP . 3.3 m-85 -145.0 163.47 34.1 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 161' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -134.72 131.24 37.4 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.774 -1.204 . . . . 0.0 107.767 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 162' ' ' ILE . . . . . 1.078 HG21 ' CD1' ' R' ' 31' ' ' LEU . 1.2 pt -122.53 92.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-O 123.981 1.848 . . . . 0.0 112.811 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.697 ' HA ' ' CB ' ' R' ' 43' ' ' SER . 74.8 m-20 -96.06 129.0 43.46 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.105 -2.316 . . . . 0.0 108.637 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 164' ' ' ASP . . . . . 0.699 ' O ' ' CB ' ' R' ' 165' ' ' GLU . 11.2 t0 -34.37 117.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.699 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 42.9 tp10 135.06 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -169.19 161.14 10.12 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.32 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 167' ' ' PHE . . . . . 1.017 ' HA ' HG22 ' R' ' 162' ' ' ILE . 10.1 m-30 -107.38 122.07 45.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 168' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' R' ' 168' ' ' TYR . 9.7 p90 -141.63 160.54 56.11 Favored Pre-proline 0 C--N 1.294 -1.817 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.835 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 169' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.1 Cg_endo -69.52 113.45 3.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.36 1.716 . . . . 0.0 108.591 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.763 ' H ' ' HA ' ' R' ' 160' ' ' TYR . 0.0 OUTLIER -142.47 169.73 17.02 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 171' ' ' THR . . . . . 1.006 ' CG2' HD11 ' R' ' 134' ' ' LEU . 0.2 OUTLIER -100.27 99.83 10.49 Favored Pre-proline 0 C--N 1.274 -2.684 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.433 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' R' ' 159' ' ' TRP . 52.0 Cg_endo -75.61 55.67 4.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.884 1.465 . . . . 0.0 108.639 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 173' ' ' ASP . . . . . 0.755 ' CG ' HD13 ' R' ' 134' ' ' LEU . 3.7 m-20 -115.39 -176.76 0.39 Allowed Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.89 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' R' ' 173' ' ' ASP . 52.8 Cg_endo -79.81 31.36 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.568 1.299 . . . . 0.0 112.352 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 20.2 t -63.3 -51.19 67.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.733 -1.229 . . . . 0.0 109.387 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -131.86 13.99 4.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.708 . . . . 0.0 110.284 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 1.095 ' O ' HG21 ' R' ' 127' ' ' VAL . 0.5 OUTLIER -102.69 168.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.894 -1.129 . . . . 0.0 113.221 -177.518 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 1.089 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 1.1 mm? -100.59 -95.12 0.27 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.939 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.661 ' HA ' ' N ' ' R' ' 126' ' ' VAL . 28.6 m -80.69 135.42 25.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.714 ' CD2' ' CG ' ' R' ' 137' ' ' PHE 0.261 2.9 p90 -128.85 -178.81 4.77 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.549 1.166 . . . . 0.0 112.315 -173.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 181' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' R' ' 62' ' ' TYR . 0.5 OUTLIER -134.19 122.42 16.12 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.554 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 182' ' ' PRO . . . . . 0.429 ' N ' ' CE2' ' R' ' 180' ' ' PHE . 50.1 Cg_endo -76.34 161.35 34.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.49 1.258 . . . . 0.0 112.142 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' R' ' 137' ' ' PHE . 25.4 p90 -127.14 -173.97 3.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -138.99 145.41 39.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 0.0 111.434 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -126.43 166.0 18.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.27 70.2 8.25 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.502 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.82 149.88 54.73 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.716 1.377 . . . . 0.0 110.395 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 188' ' ' LEU . . . . . 0.724 HD13 ' O ' ' R' ' 188' ' ' LEU . 0.7 OUTLIER -59.41 -36.89 76.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -109.21 136.93 47.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.382 -0.824 . . . . 0.0 110.267 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.49 104.39 3.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -136.26 162.22 33.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -1.06 . . . . 0.0 110.317 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 192' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' R' ' 192' ' ' TRP . 49.8 m0 -99.6 143.78 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 110.027 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -125.46 134.96 51.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.387 -0.82 . . . . 0.0 110.354 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.92 -174.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 52.9 mttp . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.238 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.054 0.454 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.89 137.39 53.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 31' ' ' LEU . . . . . 0.981 HD11 ' CD1' ' R' ' 162' ' ' ILE . 1.3 pt? -145.63 153.0 40.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' R' ' 38' ' ' LYS . 1.9 p -112.26 142.88 44.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.202 -0.936 . . . . 0.0 109.562 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.927 HD13 ' N ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -134.37 141.91 47.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.268 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 34' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' R' ' 154' ' ' VAL . 45.3 t80 -37.56 -38.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 35' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' R' ' 62' ' ' TYR . 24.0 m120 -104.21 66.1 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.736 -1.852 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 36' ' ' GLY . . . . . 0.94 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 129.63 35.25 0.46 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 37' ' ' GLU . . . . . 0.94 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.3 mt-10 -11.37 -159.14 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 38' ' ' LYS . . . . . 0.536 ' HA ' HG22 ' R' ' 32' ' ' THR . 5.1 pttt -44.98 110.96 0.27 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.053 1.406 . . . . 0.0 113.845 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.527 ' HG2' ' CA ' ' R' ' 61' ' ' ARG . 32.2 tptt -141.49 135.54 30.33 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 40' ' ' THR . . . . . 0.522 ' O ' HG22 ' R' ' 40' ' ' THR . 0.9 OUTLIER -84.26 125.57 32.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 113.609 -176.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.853 ' CD1' HD21 ' R' ' 31' ' ' LEU . 31.3 m-85 -100.95 169.82 8.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 42' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' R' ' 72' ' ' TYR . 85.6 m-85 -101.04 161.2 13.76 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.641 0.734 . . . . 0.0 111.759 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 43' ' ' SER . . . . . 0.635 ' CA ' ' HB2' ' R' ' 165' ' ' GLU . 36.9 m -55.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.648 0.737 . . . . 0.0 111.696 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 44' ' ' ARG . . . . . 0.867 ' HA ' ' HA ' ' R' ' 164' ' ' ASP . 0.4 OUTLIER -74.49 168.71 24.32 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.48 -0.762 . . . . 0.0 109.373 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 45' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 36.5 Cg_endo -62.52 98.88 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.457 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 57.5 t30 -60.9 -118.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.126 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 47' ' ' ASN . . . . . 0.58 ' O ' ' CD2' ' R' ' 48' ' ' HIS . 0.5 OUTLIER -128.43 89.31 2.88 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.479 -1.388 . . . . 0.0 110.893 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' R' ' 47' ' ' ASN . 2.5 p80 166.62 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.041 0.448 . . . . 0.0 109.795 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' R' ' 95' ' ' HIS . 12.6 m-20 58.68 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.107 -0.996 . . . . 0.0 109.07 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.833 ' HB3' HG21 ' R' ' 79' ' ' THR . 3.4 p30 -141.09 -2.64 1.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.53 -0.731 . . . . 0.0 109.576 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.257 . . -61.94 -35.8 79.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.615 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 15.3 m95 -61.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 117.355 -1.738 . . . . 0.0 106.478 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.913 HD13 HG22 ' R' ' 71' ' ' VAL . 12.0 mt -68.75 -42.02 78.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 54' ' ' ASN . . . . . 0.504 ' HB3' ' HE2' ' R' ' 151' ' ' PHE . 45.5 t-20 -50.65 -28.0 8.05 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 55' ' ' ALA . . . . . 0.949 ' O ' HD23 ' R' ' 59' ' ' LEU . . . -67.67 -71.8 0.19 Allowed 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -59.54 -34.64 55.49 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 O-C-N 120.467 -1.396 . . . . 0.0 110.003 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 57' ' ' LEU . . . . . 1.024 HD11 ' HB ' ' R' ' 71' ' ' VAL . 3.9 mm? -64.1 -66.72 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.795 . . . . 0.0 111.125 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 58' ' ' GLN . . . . . 0.599 ' HG3' HD22 ' R' ' 59' ' ' LEU . 0.0 OUTLIER -59.85 -29.26 68.16 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.949 HD23 ' O ' ' R' ' 55' ' ' ALA . 3.7 mm? -70.02 -38.98 76.06 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.683 ' HB3' ' O ' ' R' ' 56' ' ' ILE . 0.0 OUTLIER -66.48 -40.96 89.62 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.592 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 61' ' ' ARG . . . . . 0.546 ' HG2' ' CE2' ' R' ' 60' ' ' PHE . 1.3 mtp180 -56.5 -41.61 76.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.824 -1.173 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.881 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 2.4 p90 -86.39 -47.12 9.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.264 -1.523 . . . . 0.0 111.981 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.881 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.7 t -70.63 -16.77 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.877 -1.764 . . . . 0.0 109.018 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 64' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 71.4 tt0 74.75 42.38 0.28 Allowed 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' R' ' 60' ' ' PHE . 7.4 mt-10 -140.28 90.74 10.19 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.945 -1.097 . . . . 0.0 108.751 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' R' ' 60' ' ' PHE . 46.5 Cg_endo -75.53 95.06 0.99 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.393 1.207 . . . . 0.0 112.401 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 67' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' R' ' 111' ' ' LEU . 14.4 m-85 -76.78 -27.19 55.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' R' ' 103' ' ' VAL . 32.3 m-85 -104.99 50.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.696 1.236 . . . . 0.0 108.643 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.605 ' HA ' ' CD1' ' R' ' 72' ' ' TYR . 38.0 m-20 -45.13 -34.28 2.59 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.713 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -63.0 -34.99 78.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.706 -1.247 . . . . 0.0 109.917 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 1.024 ' HB ' HD11 ' R' ' 57' ' ' LEU . 59.4 t -66.22 -58.44 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.674 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 72' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' R' ' 69' ' ' ASP . 1.3 p90 -69.15 -31.4 70.03 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.864 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -63.23 -25.86 68.52 Favored 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.906 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 74' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 1.0 OUTLIER -79.32 134.41 58.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.55 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.24 -24.8 31.65 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.644 1.339 . . . . 0.0 110.125 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 76' ' ' GLU . . . . . 0.453 ' CG ' HD23 ' R' ' 78' ' ' LEU . 22.4 pt-20 -117.71 -158.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.435 -0.791 . . . . 0.0 109.906 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 77' ' ' ASN . . . . . 0.489 ' O ' HD22 ' R' ' 78' ' ' LEU . 87.6 m-20 -85.22 103.55 14.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.504 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 78' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mm? -122.58 47.88 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 79' ' ' THR . . . . . 0.833 HG21 ' HB3' ' R' ' 50' ' ' ASN . 0.0 OUTLIER -61.51 -59.25 5.52 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.687 -0.633 . . . . 0.0 110.461 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.653 ' H ' HG23 ' R' ' 79' ' ' THR . 1.0 OUTLIER -49.56 -51.65 35.47 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.789 -178.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 81' ' ' GLU . . . . . 0.512 ' OE1' HD12 ' R' ' 78' ' ' LEU . 84.3 tt0 -59.95 -32.48 70.84 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.826 -1.796 . . . . 0.0 109.532 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.824 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.18 -58.31 5.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.862 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -87.26 -35.62 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.032 -177.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 84' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' R' ' 80' ' ' LEU . 25.7 tptt -49.2 -36.35 19.58 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 63.2 tt0 -68.38 -42.03 79.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 86' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' R' ' 94' ' ' LEU . 2.8 tm? -62.26 -37.84 87.01 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 87' ' ' GLU . . . . . 0.527 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -56.13 -38.56 70.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 108.465 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 88' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 89.4 m-20 -58.36 -30.36 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.241 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.735 HD23 ' N ' ' R' ' 90' ' ' THR . 4.9 tt -91.1 -53.68 4.26 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.498 -0.751 . . . . 0.0 112.434 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 90' ' ' THR . . . . . 0.735 ' N ' HD23 ' R' ' 89' ' ' LEU . 36.1 p -80.14 -31.58 39.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 91' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 64.78 30.04 76.89 Favored Glycine 0 N--CA 1.505 3.28 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.906 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 92' ' ' LEU . . . . . 0.841 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.4 OUTLIER -119.5 9.79 11.64 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.961 -1.317 . . . . 0.0 113.131 -177.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 93' ' ' GLU . . . . . 0.754 ' C ' ' HG ' ' R' ' 94' ' ' LEU . 93.8 mt-10 68.21 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.162 -0.961 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' R' ' 86' ' ' LEU . 0.0 OUTLIER -138.57 -62.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 95' ' ' HIS . . . . . 0.534 ' HB3' HD13 ' R' ' 83' ' ' ILE . 3.9 p80 -42.5 -37.06 1.51 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' R' ' 93' ' ' GLU . 22.5 pt-20 -104.5 -16.57 15.02 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' R' ' 94' ' ' LEU . . . -93.22 -141.78 11.12 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 98' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . -130.71 175.16 19.51 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.737 ' HB3' ' HB3' ' R' ' 55' ' ' ALA . 34.4 Cg_endo -70.76 -58.68 0.08 OUTLIER 'Trans proline' 0 CA--C 1.556 1.581 0 O-C-N 123.773 1.407 . . . . 0.0 114.799 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.947 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.2 Cg_endo -59.07 -22.68 65.21 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.841 ' O ' HD22 ' R' ' 92' ' ' LEU . . . -31.34 58.92 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.083 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' R' ' 100' ' ' PRO . 71.1 mt 36.46 3.27 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.248 -174.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.863 HG13 HD11 ' R' ' 86' ' ' LEU . 2.7 t -55.02 -39.6 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.825 HD12 ' HA ' ' R' ' 100' ' ' PRO . 85.8 mt -68.34 -37.45 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.872 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' R' ' 102' ' ' LEU . 68.1 t-105 -63.36 -46.9 84.39 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.876 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' R' ' 90' ' ' THR . 29.7 m120 -76.32 -30.04 57.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.716 -1.24 . . . . 0.0 111.107 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 107' ' ' ILE . . . . . 0.695 HG23 HD23 ' R' ' 110' ' ' LEU . 54.8 mt -81.58 7.22 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.702 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' R' ' 112' ' ' HIS . 24.2 tttm -34.37 -53.14 0.5 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.739 ' C ' HD13 ' R' ' 110' ' ' LEU . 0.5 OUTLIER -60.02 -14.39 16.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.093 -2.255 . . . . 0.0 111.675 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.739 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -106.49 -40.89 5.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.954 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -74.88 -106.18 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.668 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 112' ' ' HIS . . . . . 0.653 ' HA ' ' O ' ' R' ' 122' ' ' SER . 30.1 m-70 -25.1 73.56 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 123.833 1.778 . . . . 0.0 109.901 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 113' ' ' THR . . . . . 1.046 HG22 ' HA ' ' R' ' 123' ' ' GLU . 3.0 t -60.39 -105.31 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.398 -2.183 . . . . 0.0 110.612 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.769 ' O ' HD13 ' R' ' 115' ' ' ILE . . . -134.92 82.15 0.29 Allowed Glycine 0 N--CA 1.505 3.247 1 N-CA-C 102.877 -4.089 . . . . 0.0 102.877 177.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 1.288 HG23 ' O ' ' R' ' 124' ' ' VAL 0.356 32.4 mm -126.33 162.14 30.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -170.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.12 75.6 0.37 Allowed Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.221 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 117' ' ' THR . . . . . 1.037 HG23 HG21 ' R' ' 126' ' ' VAL . 8.1 m -72.74 149.21 43.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' CG2' ' R' ' 130' ' ' THR . . . -63.85 -24.79 67.88 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.552 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 60.5 p -97.38 -22.25 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 111.097 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 120' ' ' ARG . . . . . 0.695 ' O ' ' HB ' ' R' ' 117' ' ' THR . 0.0 OUTLIER -178.12 -164.51 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 O-C-N 120.96 -1.087 . . . . 0.0 110.607 -178.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' R' ' 120' ' ' ARG . 49.1 Cg_endo -85.52 161.99 10.97 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 120.671 0.914 . . . . 0.0 110.295 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.901 ' H ' ' HB ' ' R' ' 115' ' ' ILE . 19.9 m -164.96 -134.78 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.07 -1.019 . . . . 0.0 113.216 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 1.046 ' HA ' HG22 ' R' ' 113' ' ' THR . 82.5 tt0 -103.8 -19.18 14.37 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 124.726 1.21 . . . . 0.0 112.886 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 1.288 ' O ' HG23 ' R' ' 115' ' ' ILE . 10.4 m -161.93 -157.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-O 122.573 1.177 . . . . 0.0 111.74 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.584 ' HB2' ' HG3' ' R' ' 182' ' ' PRO . 48.7 t -95.12 137.31 34.35 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.525 -1.984 . . . . 0.0 107.275 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 1.037 HG21 HG23 ' R' ' 117' ' ' THR . 77.5 t -102.51 154.22 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 -174.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.924 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.0 m -83.19 -21.42 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 112.905 -1.952 . . . . 0.0 114.14 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.748 ' H ' HG12 ' R' ' 126' ' ' VAL . 56.2 t0 -45.3 87.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.094 -1.004 . . . . 0.0 111.437 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 129' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 51.6 25.15 13.5 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 130' ' ' THR . . . . . 0.825 ' CG2' ' HB2' ' R' ' 118' ' ' ALA . 0.0 OUTLIER -109.88 152.11 26.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.324 -1.104 . . . . 0.0 112.306 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 40.43 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.041 0.924 . . . . 0.0 112.98 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.507 ' HB2' ' HB2' ' R' ' 136' ' ' ASP . 89.6 mtp -90.4 174.19 7.7 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' R' ' 135' ' ' ALA . 62.4 m -100.87 -174.99 2.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.341 -0.85 . . . . 0.0 112.682 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 1.089 HD11 HG23 ' R' ' 171' ' ' THR . 0.4 OUTLIER 31.3 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.098 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 135' ' ' ALA . . . . . 0.465 ' HA ' ' NE2' ' R' ' 138' ' ' HIS . . . -62.29 -26.75 68.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.119 -0.988 . . . . 0.0 112.841 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 136' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' R' ' 132' ' ' MET . 19.2 t70 -55.99 -42.67 76.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.105 -0.997 . . . . 0.0 112.278 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 137' ' ' PHE . . . . . 0.685 ' CG ' ' CD1' ' R' ' 180' ' ' PHE . 52.5 p90 -155.23 159.59 40.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.788 -1.195 . . . . 0.0 109.479 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.651 ' CG ' ' CE3' ' R' ' 159' ' ' TRP . 68.5 m-70 -143.76 79.18 1.62 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.139 -1.424 . . . . 0.0 110.857 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 174.88 162.04 0.22 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.175 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 130.06 -170.56 20.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.212 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 141' ' ' ILE . . . . . 0.73 HG23 ' CE1' ' R' ' 151' ' ' PHE . 70.1 mt -104.23 124.61 58.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.742 -0.858 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.989 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 4.2 m-85 -113.76 151.53 31.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.662 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.646 HD21 ' HG2' ' R' ' 146' ' ' GLN . 26.1 tp -101.66 124.14 46.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.715 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' R' ' 148' ' ' HIS . 38.1 tttt -108.85 113.54 26.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.073 -1.017 . . . . 0.0 110.422 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' R' ' 146' ' ' GLN . . . 50.23 25.63 8.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 146' ' ' GLN . . . . . 0.646 ' HG2' HD21 ' R' ' 143' ' ' LEU . 95.2 mt-30 54.62 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -1.01 . . . . 0.0 110.631 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.41 23.57 2.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 83.2 m-70 -144.7 131.68 20.36 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.896 . . . . 0.0 108.882 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.935 ' HB1' ' HZ ' ' R' ' 151' ' ' PHE . . . -104.5 115.82 31.03 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 150' ' ' VAL . . . . . 0.67 ' O ' ' CD1' ' R' ' 151' ' ' PHE . 34.9 m -129.27 152.18 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.935 ' HZ ' ' HB1' ' R' ' 149' ' ' ALA . 7.7 m-85 -149.89 129.69 13.3 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.791 -1.564 . . . . 0.0 112.012 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -110.56 167.65 10.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.593 -1.317 . . . . 0.0 110.735 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 153' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 38.0 t -169.63 134.49 1.41 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' R' ' 138' ' ' HIS . 36.9 t -53.38 102.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.383 -1.448 . . . . 0.0 111.283 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 155' ' ' THR . . . . . 0.661 ' CG2' ' HB2' ' R' ' 160' ' ' TYR . 25.1 p -78.82 -165.36 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.713 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 156' ' ' SER . . . . . 0.472 ' N ' ' O ' ' R' ' 32' ' ' THR . 81.1 p -65.41 -18.69 65.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 157' ' ' ASN . . . . . 0.466 ' CB ' ' CZ ' ' R' ' 160' ' ' TYR . 83.0 m-20 -102.03 2.9 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.273 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 158' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 112.93 -166.14 12.11 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.151 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.651 ' CE3' ' CG ' ' R' ' 138' ' ' HIS . 0.0 OUTLIER -55.58 99.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.495 1.14 . . . . 0.0 108.685 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 160' ' ' TYR . . . . . 0.661 ' HB2' ' CG2' ' R' ' 155' ' ' THR . 4.0 m-85 -121.83 -178.39 3.82 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 161' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -158.07 136.37 10.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.751 -1.843 . . . . 0.0 110.987 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 162' ' ' ILE . . . . . 0.981 ' CD1' HD11 ' R' ' 31' ' ' LEU . 0.6 OUTLIER -75.79 88.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.526 1.155 . . . . 0.0 109.188 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -94.98 122.83 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 164' ' ' ASP . . . . . 0.867 ' HA ' ' HA ' ' R' ' 44' ' ' ARG . 78.0 m-20 28.19 74.51 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.365 -0.834 . . . . 0.0 112.968 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.654 ' CB ' ' N ' ' R' ' 44' ' ' ARG . 0.1 OUTLIER 68.66 -15.31 0.24 Allowed 'General case' 0 N--CA 1.522 3.149 0 O-C-N 119.597 -1.939 . . . . 0.0 113.448 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.74 134.29 45.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.83 -1.794 . . . . 0.0 112.694 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 167' ' ' PHE . . . . . 0.699 ' CD1' HG13 ' R' ' 162' ' ' ILE . 6.4 m-85 -101.62 121.66 42.42 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 168' ' ' TYR . . . . . 0.599 ' CE2' ' CD1' ' R' ' 170' ' ' TRP . 2.8 p90 -150.67 162.05 28.39 Favored Pre-proline 0 C--N 1.281 -2.406 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.314 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 169' ' ' PRO . . . . . 0.471 ' HA ' ' CD1' ' R' ' 160' ' ' TYR . 39.5 Cg_endo -66.62 114.71 3.21 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.231 1.648 . . . . 0.0 109.044 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.599 ' CD1' ' CE2' ' R' ' 168' ' ' TYR . 0.1 OUTLIER -126.4 150.18 48.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 171' ' ' THR . . . . . 1.089 HG23 HD11 ' R' ' 134' ' ' LEU . 2.3 m -94.26 108.26 34.8 Favored Pre-proline 0 C--N 1.271 -2.816 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.053 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' R' ' 138' ' ' HIS . 46.1 Cg_endo -72.94 67.03 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 124.048 1.552 . . . . 0.0 110.823 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 173' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' R' ' 134' ' ' LEU . 8.6 t70 -81.86 139.13 46.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.406 -0.809 . . . . 0.0 109.097 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.783 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.3 Cg_endo -70.72 35.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.223 1.117 . . . . 0.0 109.95 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 175' ' ' SER . . . . . 0.494 ' H ' ' C ' ' R' ' 173' ' ' ASP . 83.4 p -81.34 -43.38 19.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 111.323 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 176' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' R' ' 143' ' ' LEU . 86.4 m-20 -126.16 1.6 7.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.017 -1.052 . . . . 0.0 109.934 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.989 ' HB ' ' CG ' ' R' ' 142' ' ' PHE . 0.2 OUTLIER -95.1 169.37 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.059 0.933 . . . . 0.0 110.464 -178.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.797 HD22 ' O ' ' R' ' 177' ' ' VAL . 0.7 OUTLIER -128.48 -91.45 0.48 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -177.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' R' ' 126' ' ' VAL . 34.7 m -72.43 124.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.685 ' CD1' ' CG ' ' R' ' 137' ' ' PHE . 0.3 OUTLIER -130.45 178.14 6.83 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -175.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 181' ' ' VAL . . . . . 0.874 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -127.26 127.24 24.27 Favored Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.952 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 182' ' ' PRO . . . . . 0.584 ' HG3' ' HB2' ' R' ' 125' ' ' CYS . 56.2 Cg_endo -87.47 131.93 2.99 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.384 1.202 . . . . 0.0 109.998 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 1.1 p90 -64.6 -34.06 77.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.096 -1.003 . . . . 0.0 109.709 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.0 t0 47.9 46.32 18.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.416 -0.802 . . . . 0.0 111.62 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 185' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' R' ' 183' ' ' TYR . 99.8 mm-40 -94.67 19.54 9.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.224 -0.923 . . . . 0.0 110.772 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -117.38 78.7 11.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.913 . . . . 0.0 110.137 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.16 -12.88 35.1 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.869 1.457 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 83.0 mt -58.34 -33.23 69.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -75.03 172.9 11.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.69 138.1 7.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 50.54 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.479 -1.012 . . . . 0.0 110.674 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -104.04 140.05 38.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.138 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -131.73 132.29 43.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -145.29 -44.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.472 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.269 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.151 0.501 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 22.7 pt-20 -93.86 120.37 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.382 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . 0.931 HD11 ' CZ ' ' R' ' 167' ' ' PHE . 0.7 OUTLIER -94.04 127.96 40.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 111.3 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . 0.55 ' O ' ' N ' ' R' ' 156' ' ' SER . 92.6 m -102.19 146.76 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.701 HD22 ' H ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -139.64 167.83 21.2 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.007 -178.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . 0.62 ' HB2' HG11 ' R' ' 154' ' ' VAL . 63.6 t80 -41.19 -44.27 2.54 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -75.93 15.47 0.53 Allowed 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 122.594 2.452 . . . . 0.0 113.927 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 -5.92 42.41 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 119.87 -1.769 . . . . 0.0 112.963 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . 0.643 ' HB3' HD21 ' R' ' 33' ' ' LEU . 82.9 tt0 -79.97 137.7 36.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.504 -1.586 . . . . 0.0 110.354 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -120.13 113.96 21.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 109.392 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 22.2 tptt -122.93 131.74 53.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' R' ' 30' ' ' GLU . 0.9 OUTLIER -85.9 122.72 30.36 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.924 0.868 . . . . 0.0 112.203 -177.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.717 ' CD2' HD13 ' R' ' 162' ' ' ILE . 0.5 OUTLIER -107.54 159.91 16.07 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' R' ' 42' ' ' TYR . 68.2 m-85 -98.94 134.1 42.28 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.414 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' R' ' 164' ' ' ASP . 7.0 m -112.7 94.75 5.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.362 -0.836 . . . . 0.0 110.498 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' R' ' 77' ' ' ASN . 0.4 OUTLIER -152.67 136.09 9.79 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.283 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.58 126.83 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.374 1.197 . . . . 0.0 110.008 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' R' ' 50' ' ' ASN . 0.3 OUTLIER -97.35 -120.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 109.396 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . 0.524 ' ND2' HD23 ' R' ' 80' ' ' LEU . 1.2 p-10 -128.61 77.23 1.76 Allowed 'General case' 0 N--CA 1.512 2.634 0 O-C-N 120.242 -1.536 . . . . 0.0 111.262 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 74.6 m80 48.44 16.98 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.801 -0.562 . . . . 0.0 112.345 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' R' ' 96' ' ' GLU . 37.3 m-20 -146.66 47.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.024 . . . . 0.0 108.725 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.743 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 24.1 p30 -114.72 -21.68 10.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . 0.693 ' CB ' ' HB3' ' R' ' 149' ' ' ALA 0.282 . . -66.32 -41.93 88.97 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.282 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.705 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 39.6 m95 -59.71 -34.78 73.35 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.912 -1.515 . . . . 0.0 107.256 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.825 HD11 HG13 ' R' ' 83' ' ' ILE . 20.2 mt -68.18 -35.2 77.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' R' ' 51' ' ' ALA . 56.6 t-20 -48.92 -28.11 3.59 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . 0.873 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.13 -64.72 0.8 Allowed 'General case' 0 C--O 1.203 -1.371 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.594 ' N ' HD13 ' R' ' 56' ' ' ILE . 0.0 OUTLIER -57.13 -36.32 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.751 178.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . 0.987 HD21 HG21 ' R' ' 71' ' ' VAL . 3.9 mm? -68.61 -72.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.623 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . 0.568 ' NE2' ' OD1' ' R' ' 54' ' ' ASN . 0.7 OUTLIER -57.85 -29.68 65.19 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.637 -1.289 . . . . 0.0 108.536 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.873 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 0.2 OUTLIER -70.43 -37.26 74.35 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.908 ' HA ' ' HD3' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -50.68 -53.02 34.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . 0.614 ' N ' ' CG ' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -55.87 -48.46 75.52 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.104 -1.039 . . . . 0.0 113.343 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' R' ' 153' ' ' CYS . 0.1 OUTLIER -90.69 -47.7 7.5 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 119.962 -1.711 . . . . 0.0 113.921 -176.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.888 HG22 HG12 ' R' ' 124' ' ' VAL . 47.7 t -77.76 -24.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.169 -0.957 . . . . 0.0 111.811 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . 0.776 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 88.2 tt0 124.33 117.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.131 0.967 . . . . 0.0 109.346 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' R' ' 68' ' ' PHE . 0.1 OUTLIER -44.28 100.32 0.23 Allowed Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.908 ' HD3' ' HA ' ' R' ' 60' ' ' PHE . 51.8 Cg_endo -85.45 -162.12 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.589 2.192 . . . . 0.0 107.399 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' R' ' 69' ' ' ASP . 34.4 t80 -45.0 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 O-C-N 121.769 -0.582 . . . . 0.0 112.022 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . 0.942 ' HD2' HD13 ' R' ' 57' ' ' LEU . 0.7 OUTLIER -37.52 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.008 -1.057 . . . . 0.0 113.031 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' R' ' 67' ' ' PHE . 51.0 m-20 -49.12 -34.34 13.87 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.62 -0.675 . . . . 0.0 112.234 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.616 ' HB3' ' HA ' ' R' ' 82' ' ' ALA . 70.2 m95 -64.43 -31.24 72.37 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.572 -1.33 . . . . 0.0 109.858 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.987 HG21 HD21 ' R' ' 57' ' ' LEU . 46.9 t -70.81 -67.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . 0.925 ' CE2' HD12 ' R' ' 57' ' ' LEU . 13.3 m-30 -77.42 -30.36 53.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.739 . . . . 0.0 111.878 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 22.4 t -60.83 -19.34 59.66 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.318 -1.353 . . . . 0.0 109.049 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . 0.687 ' OG ' HD22 ' R' ' 78' ' ' LEU . 38.5 m -77.2 139.87 65.18 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.771 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 -27.55 39.77 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.92 164.76 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.79 . . . . 0.0 109.679 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' R' ' 44' ' ' ARG . 36.1 p-10 -52.59 110.26 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.197 -0.94 . . . . 0.0 110.088 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . 0.687 HD22 ' OG ' ' R' ' 74' ' ' SER . 1.5 mp -126.81 47.36 2.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.677 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . 0.745 ' OG1' HD12 ' R' ' 53' ' ' LEU . 0.5 OUTLIER -65.99 -52.19 51.63 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.009 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.524 HD23 ' ND2' ' R' ' 47' ' ' ASN . 0.0 OUTLIER -51.04 -59.39 4.21 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.678 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.38 -28.0 69.69 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.498 -1.376 . . . . 0.0 109.736 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.813 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -56.29 -51.1 69.43 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.48 -0.762 . . . . 0.0 111.624 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.825 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -85.41 -36.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.045 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' R' ' 87' ' ' GLU . 32.9 tttt -49.82 -33.52 16.97 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' R' ' 70' ' ' TRP . 50.9 tp60 -77.15 -36.4 55.28 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . 1.013 HD11 HG13 ' R' ' 103' ' ' VAL . 2.7 tm? -66.75 -40.62 88.38 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.807 -0.558 . . . . 0.0 110.176 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' R' ' 91' ' ' GLY . 10.7 pt-20 -66.08 -31.73 72.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.944 -1.098 . . . . 0.0 108.27 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.06 -31.36 69.91 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.389 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.833 HD23 ' N ' ' R' ' 90' ' ' THR . 1.1 tt -93.59 -48.89 6.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.581 -0.699 . . . . 0.0 111.042 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . 0.833 ' N ' HD23 ' R' ' 89' ' ' LEU . 68.1 p -74.89 -24.06 58.47 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' R' ' 87' ' ' GLU . . . 68.95 26.35 74.73 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.033 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . 0.795 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.3 OUTLIER -105.94 -17.53 14.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.823 -1.398 . . . . 0.0 111.354 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . 0.532 ' H ' ' HB2' ' R' ' 87' ' ' GLU . 81.6 tt0 65.44 122.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.813 HD13 ' CG2' ' R' ' 83' ' ' ILE . 0.3 OUTLIER -166.39 12.5 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . 0.728 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.7 OUTLIER -42.39 -29.12 0.25 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.607 -0.683 . . . . 0.0 109.234 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' R' ' 49' ' ' ASP . 98.5 mt-10 -116.15 23.33 12.25 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.647 -0.658 . . . . 0.0 110.854 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . 0.683 ' HA2' ' CG ' ' R' ' 52' ' ' TRP . . . 156.08 128.56 1.11 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.651 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' R' ' 101' ' ' ALA . . . 152.02 75.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.686 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.889 ' HG2' ' HD2' ' R' ' 100' ' ' PRO . 33.5 Cg_endo -86.13 -90.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.564 1.999 0 C-N-CA 121.32 1.347 . . . . 0.0 110.406 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.889 ' HD2' ' HG2' ' R' ' 99' ' ' PRO . 37.1 Cg_endo -62.55 -16.97 55.78 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 106.108 -2.305 . . . . 0.0 106.108 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.795 ' O ' HD22 ' R' ' 92' ' ' LEU 0.263 . . -30.87 61.82 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 113.61 -1.632 . . . . 0.0 112.587 175.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.837 ' N ' ' O ' ' R' ' 100' ' ' PRO . 48.2 mt 39.38 0.74 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.671 -175.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 1.013 HG13 HD11 ' R' ' 86' ' ' LEU . 21.8 t -52.68 -40.58 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.64 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 32.3 pt -75.56 -36.54 34.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.373 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.632 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 61.5 t90 -64.63 -43.0 95.1 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.579 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.705 ' HB2' HG22 ' R' ' 90' ' ' THR . 27.3 m120 -78.35 -27.08 46.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.723 -1.236 . . . . 0.0 112.066 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . 0.743 HG23 HD23 ' R' ' 110' ' ' LEU . 63.3 mt -78.18 16.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 111.762 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' R' ' 112' ' ' HIS . 80.4 mttt -30.49 -52.22 0.16 Allowed 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.588 ' CD2' HD22 ' R' ' 110' ' ' LEU . 36.9 p-80 -57.51 -26.98 62.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.143 -2.223 . . . . 0.0 112.458 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.743 HD23 HG23 ' R' ' 107' ' ' ILE . 0.2 OUTLIER -100.43 -39.49 7.93 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 176.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.1 OUTLIER -78.49 -96.91 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 111.523 -2.581 . . . . 0.0 114.608 -176.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . 0.67 ' H ' ' HA ' ' R' ' 108' ' ' LYS . 85.4 t60 -13.62 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 123.897 1.808 . . . . 0.0 109.986 -173.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.994 HG23 HD11 ' R' ' 115' ' ' ILE . 7.2 t -97.85 -173.43 2.61 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.446 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.824 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.66 105.8 1.57 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 1.0 HD12 HG22 ' R' ' 124' ' ' VAL . 3.5 mm -109.88 143.55 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.539 -1.565 . . . . 0.0 110.581 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . 0.585 ' O ' HG13 ' R' ' 126' ' ' VAL . . . -143.11 -154.65 6.19 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.183 -1.484 . . . . 0.0 112.114 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.934 ' HA ' HG22 ' R' ' 126' ' ' VAL . 5.1 m -133.03 165.08 25.56 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 1.01 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -53.21 -36.35 60.91 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.38 -1.45 . . . . 0.0 110.369 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.2 m -64.59 -36.28 83.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -124.19 94.18 45.67 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.502 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.44 134.32 30.56 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.753 1.396 . . . . 0.0 112.061 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . . . . . . . . . 3.5 m -134.11 -162.88 1.29 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' R' ' 114' ' ' GLY . 77.1 mm-40 -55.01 -41.24 71.04 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.567 -1.333 . . . . 0.0 108.377 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 1.0 HG22 HD12 ' R' ' 115' ' ' ILE . 0.9 OUTLIER -129.07 147.35 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' R' ' 182' ' ' PRO . 5.9 t -127.74 159.35 35.04 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.218 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.934 HG22 ' HA ' ' R' ' 117' ' ' THR . 15.7 m -85.2 -163.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.938 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 1.1 p -60.68 -160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.726 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.743 ' HA ' ' HB2' ' R' ' 118' ' ' ALA . 28.9 p-10 -96.55 -74.91 0.55 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.746 -1.221 . . . . 0.0 113.21 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . 0.457 ' H ' ' CG ' ' R' ' 128' ' ' ASP . . . 58.7 5.38 2.72 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . 1.01 HG21 ' HB1' ' R' ' 118' ' ' ALA . 11.3 t -127.93 167.33 16.78 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.279 0.632 . . . . 0.0 109.355 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.4 74.44 2.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.585 ' HG3' HG23 ' R' ' 130' ' ' THR . 56.2 mtt -127.88 167.0 17.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.85 -170.87 3.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.281 -0.887 . . . . 0.0 111.381 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 1.07 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -38.87 -56.36 1.38 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 121.591 0.71 . . . . 0.0 112.538 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.57 -19.96 62.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' R' ' 183' ' ' TYR . 0.8 OUTLIER -55.71 -38.37 69.63 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.455 -1.403 . . . . 0.0 112.369 -178.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . 0.55 ' CB ' ' CD1' ' R' ' 180' ' ' PHE . 0.3 OUTLIER -142.38 168.69 19.15 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.947 -1.095 . . . . 0.0 108.173 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' R' ' 139' ' ' ALA . 14.8 m-70 -134.8 63.58 1.62 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.272 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 166.52 165.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.786 -0.571 . . . . 0.0 110.119 175.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.02 -178.97 32.28 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.216 -1.468 . . . . 0.0 111.954 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' R' ' 151' ' ' PHE . 10.7 mt -112.05 119.23 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 122.015 -0.697 . . . . 0.0 110.392 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.84 ' CZ ' HG11 ' R' ' 177' ' ' VAL . 8.0 m-85 -109.28 134.94 51.15 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.097 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' R' ' 143' ' ' LEU . 4.6 mm? -85.72 101.23 12.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.523 ' HD2' HG11 ' R' ' 150' ' ' VAL . 33.9 tttm -93.55 124.53 37.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 110.934 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.69 -145.32 8.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -111.52 138.98 47.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.996 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . 0.413 ' HA ' ' CH2' ' R' ' 52' ' ' TRP . 79.7 tt0 54.67 44.34 28.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 0.1 OUTLIER -141.41 122.03 14.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . 0.705 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -109.56 139.26 44.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 110.641 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.7 m -139.52 153.27 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.055 -1.028 . . . . 0.0 109.174 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' R' ' 141' ' ' ILE . 82.0 m-85 -147.19 124.68 11.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.769 -1.207 . . . . 0.0 110.438 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.03 171.93 7.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.365 -1.459 . . . . 0.0 112.743 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 9.1 t -167.3 136.05 2.65 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' R' ' 34' ' ' TYR . 53.2 t -56.5 109.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.354 -1.466 . . . . 0.0 111.654 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . 0.693 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 77.2 p -89.63 -169.59 2.52 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . 0.55 ' N ' ' O ' ' R' ' 32' ' ' THR . 44.7 t -60.34 -21.25 61.84 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.777 -1.202 . . . . 0.0 108.428 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CE1' ' R' ' 160' ' ' TYR . 79.4 m-20 -95.96 3.71 53.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . 0.497 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 106.23 -160.78 14.46 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.625 ' CE2' HD12 ' R' ' 134' ' ' LEU . 5.5 m-90 -57.36 101.58 0.07 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.625 -0.927 . . . . 0.0 108.687 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . 0.693 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 4.2 m-85 -127.52 131.47 50.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -106.27 146.73 29.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 119.979 -1.701 . . . . 0.0 110.937 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . 0.913 ' CD1' HD13 ' R' ' 31' ' ' LEU . 96.9 mt -102.66 90.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' R' ' 164' ' ' ASP . 3.6 t0 -88.58 122.46 32.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' R' ' 163' ' ' ASP . 26.0 t0 -3.45 -64.69 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' R' ' 163' ' ' ASP . 97.1 mt-10 -59.34 -42.21 90.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.696 -1.253 . . . . 0.0 114.37 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -167.26 172.92 9.4 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 119.811 -1.806 . . . . 0.0 113.215 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . 0.931 ' CZ ' HD11 ' R' ' 31' ' ' LEU . 3.5 m-30 -98.43 129.13 45.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' R' ' 161' ' ' ALA . 2.1 p90 -141.15 163.86 39.39 Favored Pre-proline 0 C--N 1.29 -2.01 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.94 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 42.3 Cg_endo -69.84 108.52 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.525 ' CD1' ' CD1' ' R' ' 168' ' ' TYR . 0.5 OUTLIER -138.9 153.81 48.31 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . 1.07 ' CG2' HD11 ' R' ' 134' ' ' LEU . 1.0 OUTLIER -101.93 151.23 37.95 Favored Pre-proline 0 C--N 1.278 -2.541 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.29 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.749 ' HD2' HD13 ' R' ' 134' ' ' LEU . 45.3 Cg_endo -94.37 32.97 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.865 1.71 . . . . 0.0 109.411 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . 0.582 ' O ' ' CG1' ' R' ' 177' ' ' VAL . 0.6 OUTLIER -76.77 153.27 83.17 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.357 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' R' ' 177' ' ' VAL . 49.5 Cg_endo -75.67 26.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.968 1.51 . . . . 0.0 111.206 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 23.3 t -69.89 -48.3 59.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.985 -1.072 . . . . 0.0 110.897 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' R' ' 143' ' ' LEU . 91.1 m-20 -125.6 13.45 8.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.84 HG11 ' CZ ' ' R' ' 142' ' ' PHE . 0.1 OUTLIER -121.48 153.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.832 . . . . 0.0 109.736 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.938 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 2.1 mm? -127.63 46.6 2.52 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.062 -1.455 . . . . 0.0 108.932 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.733 ' HA ' ' C ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.61 124.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.55 ' CD1' ' CB ' ' R' ' 137' ' ' PHE . 4.2 p90 -125.12 168.17 13.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.544 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . 0.867 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 1.0 OUTLIER -122.87 111.99 30.73 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.122 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' R' ' 125' ' ' CYS . 47.7 Cg_endo -76.04 156.14 38.34 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.615 1.324 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' R' ' 138' ' ' HIS . 1.1 p90 -91.43 -2.21 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.517 -0.739 . . . . 0.0 110.873 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 111.2 179.313 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.05 0.452 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . 0.482 ' C ' HD22 ' R' ' 31' ' ' LEU . 44.9 tp10 -117.5 119.43 35.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.16 -0.962 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . 0.961 HD23 ' CD1' ' R' ' 41' ' ' PHE . 3.8 mm? -94.8 166.81 11.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.392 -0.817 . . . . 0.0 109.546 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . 0.88 ' C ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -126.47 140.23 52.63 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -173.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 1.111 ' N ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -17.64 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.84 0 CA-C-N 111.837 -2.438 . . . . 0.0 116.463 176.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . 0.776 ' C ' ' O ' ' R' ' 33' ' ' LEU . 92.5 m-85 -19.58 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.977 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' R' ' 33' ' ' LEU . 7.0 m120 -131.84 62.41 1.63 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . 1.216 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 141.75 36.8 0.09 OUTLIER Glycine 0 N--CA 1.479 1.521 0 C-N-CA 117.055 -2.498 . . . . 0.0 110.465 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . 1.216 ' O ' ' O ' ' R' ' 36' ' ' GLY . 80.7 mm-40 -11.68 -167.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 122.455 0.302 . . . . 0.0 110.848 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.33 92.73 0.29 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 116.23 -2.188 . . . . 0.0 106.809 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' R' ' 37' ' ' GLU . 36.2 mmtt -123.76 119.87 31.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . 0.588 HG22 ' O ' ' R' ' 40' ' ' THR . 0.9 OUTLIER -91.29 115.08 27.74 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.452 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.961 ' CD1' HD23 ' R' ' 31' ' ' LEU . 3.0 m-85 -98.42 162.83 12.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' R' ' 165' ' ' GLU . 97.4 m-85 -95.4 158.58 15.4 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' R' ' 165' ' ' GLU . 46.7 m -115.57 94.9 4.9 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . 0.529 ' H ' ' CB ' ' R' ' 165' ' ' GLU . 0.0 OUTLIER -167.64 124.16 0.89 Allowed Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.306 -0.871 . . . . 0.0 109.096 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.18 126.35 13.59 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 N-CA-C 108.625 -1.336 . . . . 0.0 108.625 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 74.4 m-20 -88.12 152.97 21.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.149 -0.97 . . . . 0.0 109.033 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.39 80.24 1.82 Allowed 'General case' 0 N--CA 1.507 2.387 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.257 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.586 ' CD2' HD23 ' R' ' 80' ' ' LEU . 5.3 p-80 178.62 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 1.5 p30 157.16 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 8.4 p30 -142.88 -25.75 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.911 -1.118 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' R' ' 54' ' ' ASN 0.271 . . -64.98 -44.24 89.96 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.056 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.498 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 75.3 m95 -58.01 -36.17 72.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.898 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.877 HD11 HG13 ' R' ' 83' ' ' ILE . 11.6 mt -69.38 -44.73 70.92 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' R' ' 51' ' ' ALA . 0.0 OUTLIER -43.28 -32.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 108.921 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . 0.866 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -64.93 -67.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.591 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.733 HG21 ' O ' ' R' ' 100' ' ' PRO . 0.2 OUTLIER -84.19 -41.74 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 117.884 -1.527 . . . . 0.0 109.885 178.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . 0.917 ' CD2' HG21 ' R' ' 71' ' ' VAL 0.265 1.5 tm? -48.25 -61.87 1.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.604 0.716 . . . . 0.0 111.207 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . 0.653 ' CD ' HG21 ' R' ' 162' ' ' ILE . 73.4 mt-30 -70.06 -27.77 64.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.866 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 3.4 tp -55.93 -38.51 70.38 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.923 ' CE1' HD21 ' R' ' 111' ' ' LEU . 22.9 m-30 -58.41 -41.18 84.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.144 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . 0.51 ' CB ' ' CZ ' ' R' ' 41' ' ' PHE . 0.0 OUTLIER -64.88 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.344 -1.472 . . . . 0.0 114.473 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.769 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 1.4 p90 -82.78 -42.39 17.99 Favored 'General case' 0 N--CA 1.516 2.826 0 O-C-N 119.575 -1.953 . . . . 0.0 114.731 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.769 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.5 t -73.77 -14.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 119.825 -1.797 . . . . 0.0 111.179 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . 0.698 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 65.0 tt0 98.91 29.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 1.8 tp10 -132.33 90.15 34.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.663 -1.273 . . . . 0.0 107.788 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' R' ' 60' ' ' PHE . 48.3 Cg_endo -78.09 83.55 2.18 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.706 1.372 . . . . 0.0 113.966 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 48.0 t80 -83.35 -19.11 36.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . 0.671 ' HB2' ' CD1' ' R' ' 57' ' ' LEU . 0.0 OUTLIER -62.38 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.012 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' R' ' 73' ' ' SER . 94.8 m-20 -46.8 -39.37 11.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.457 -0.777 . . . . 0.0 111.775 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.504 ' HA ' ' HB2' ' R' ' 74' ' ' SER . 35.3 m95 -69.82 -37.28 76.19 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.766 -1.208 . . . . 0.0 109.635 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' R' ' 57' ' ' LEU 0.252 43.5 t -70.34 -75.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . 0.632 ' CD1' HG12 ' R' ' 71' ' ' VAL . 18.8 m-30 -86.65 -35.96 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 111.737 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . 0.664 ' HB3' ' O ' ' R' ' 69' ' ' ASP . 9.6 t -71.03 -17.33 62.63 Favored 'General case' 0 N--CA 1.509 2.511 0 C-N-CA 117.702 -1.599 . . . . 0.0 108.909 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' R' ' 70' ' ' TRP . 0.4 OUTLIER -117.47 114.41 38.22 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.366 -0.834 . . . . 0.0 109.334 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.34 -11.65 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.539 1.283 . . . . 0.0 110.528 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . 0.514 ' O ' HD13 ' R' ' 78' ' ' LEU . 84.6 tt0 -104.84 -64.47 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.479 ' CA ' ' HB2' ' R' ' 81' ' ' GLU . 11.6 m120 -44.54 -44.18 8.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 112.047 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . 0.709 ' O ' ' HB2' ' R' ' 82' ' ' ALA . 6.1 mp 49.57 -154.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.893 -1.129 . . . . 0.0 111.008 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . 0.832 ' OG1' HD12 ' R' ' 53' ' ' LEU . 2.0 t -68.67 -59.23 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.899 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.65 ' H ' HG23 ' R' ' 79' ' ' THR . 0.4 OUTLIER -50.13 -52.26 36.59 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . 0.589 ' HG3' HD12 ' R' ' 80' ' ' LEU . 72.2 mt-10 -69.75 -27.92 65.35 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.077 -1.639 . . . . 0.0 109.302 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.749 ' CB ' HG23 ' R' ' 71' ' ' VAL . . . -58.9 -53.7 55.49 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.683 -0.636 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 1.12 HG21 HD11 ' R' ' 94' ' ' LEU . 0.2 OUTLIER -86.4 -33.62 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.44 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' R' ' 83' ' ' ILE . 16.4 tttt -49.81 -36.36 26.11 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.89 -41.01 92.07 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . 0.978 HD13 HG13 ' R' ' 103' ' ' VAL . 13.2 mt -67.03 -34.29 77.4 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.804 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . 0.591 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -51.63 -42.06 61.74 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.8 -36.03 82.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.551 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.691 ' CD2' HG23 ' R' ' 107' ' ' ILE . 5.1 tt -99.07 -52.45 3.54 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.695 -1.253 . . . . 0.0 111.824 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . 0.963 ' CG2' HD22 ' R' ' 86' ' ' LEU . 64.8 p -70.72 -24.74 62.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 61.83 21.89 61.52 Favored Glycine 0 N--CA 1.502 3.052 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.673 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . 1.04 ' CD1' HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -93.59 -16.09 24.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.225 -1.162 . . . . 0.0 111.193 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . 0.741 ' N ' HD12 ' R' ' 92' ' ' LEU . 95.9 mt-10 52.13 93.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.387 -0.821 . . . . 0.0 108.835 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 1.12 HD11 HG21 ' R' ' 83' ' ' ILE . 2.5 pp -145.09 4.94 1.1 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.977 -1.077 . . . . 0.0 109.91 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . 0.841 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.9 OUTLIER -39.31 -33.87 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.422 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.49 21.82 11.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.568 -0.707 . . . . 0.0 110.658 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . 0.652 ' O ' ' HB2' ' R' ' 94' ' ' LEU . . . 160.16 -115.26 0.65 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.087 -1.53 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' R' ' 97' ' ' GLY . . . 55.81 166.48 0.05 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' R' ' 102' ' ' LEU . 47.9 Cg_endo -79.43 125.23 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.73 1.384 . . . . 0.0 110.575 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.733 ' O ' HG21 ' R' ' 56' ' ' ILE . 39.3 Cg_endo -64.71 -34.35 51.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.487 1.257 . . . . 0.0 109.859 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' R' ' 104' ' ' ILE 0.251 . . -57.6 -39.73 77.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.956 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' R' ' 92' ' ' LEU . 3.5 mm? -56.08 -31.75 63.5 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.027 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.978 HG13 HD13 ' R' ' 86' ' ' LEU . 14.8 t -59.18 -52.85 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.705 HG22 HD11 ' R' ' 111' ' ' LEU . 43.5 pt -66.04 -34.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 111.108 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.498 ' N ' HG13 ' R' ' 104' ' ' ILE . 8.4 m95 -60.7 -38.97 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 111.816 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.787 ' CB ' ' HA ' ' R' ' 90' ' ' THR . 71.3 m-80 -82.26 -34.56 28.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.702 -1.249 . . . . 0.0 113.265 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . 0.728 HG22 HD23 ' R' ' 110' ' ' LEU . 0.2 OUTLIER -92.76 22.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.601 -1.312 . . . . 0.0 110.368 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' R' ' 112' ' ' HIS . 32.3 tttt -29.58 -58.99 0.16 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.848 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.3 m-70 -63.12 -13.59 38.5 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.129 2.24 . . . . 0.0 111.232 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.848 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -111.11 -7.46 14.49 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.923 HD21 ' CE1' ' R' ' 60' ' ' PHE . 0.2 OUTLIER -142.99 -111.34 0.12 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.197 -1.365 . . . . 0.0 114.449 -173.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . 0.626 ' C ' ' O ' ' R' ' 111' ' ' LEU . 82.8 t60 -19.47 81.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 123.768 1.747 . . . . 0.0 109.871 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 1.094 ' CG2' HD11 ' R' ' 115' ' ' ILE 0.25 4.5 t -70.12 -162.55 0.06 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.14 177.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.837 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.1 97.84 0.46 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 1.094 HD11 ' CG2' ' R' ' 113' ' ' THR . 3.3 mm -113.01 145.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.784 -1.421 . . . . 0.0 110.601 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . 0.453 ' N ' ' HB2' ' R' ' 122' ' ' SER . . . -124.92 -143.99 6.23 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.925 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.977 ' HA ' HG22 ' R' ' 126' ' ' VAL . 24.9 m -138.05 174.5 10.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.889 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -55.66 -29.45 59.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.389 -1.325 . . . . 0.0 109.62 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 39.6 m -87.11 -33.19 19.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -101.16 119.8 56.89 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.247 -0.908 . . . . 0.0 110.384 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.79 124.91 4.68 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.627 1.33 . . . . 0.0 112.228 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER -140.74 -170.08 2.94 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' R' ' 114' ' ' GLY . 52.7 mt-10 -55.59 -44.74 77.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.52 -1.362 . . . . 0.0 107.862 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 1.008 ' CG2' HD12 ' R' ' 115' ' ' ILE . 1.9 m -120.25 138.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.542 ' O ' ' O ' ' R' ' 180' ' ' PHE . 43.1 t -123.05 135.22 54.34 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.237 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' R' ' 117' ' ' THR . 10.4 m -80.64 -173.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.417 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.931 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 3.6 m -117.16 -42.01 2.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.802 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.526 ' N ' HG23 ' R' ' 127' ' ' VAL . 89.2 m-20 42.55 37.12 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.566 -1.334 . . . . 0.0 111.021 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.33 39.92 91.83 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . 0.889 HG21 ' HB1' ' R' ' 118' ' ' ALA . 90.7 m -113.34 152.62 29.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.694 -0.886 . . . . 0.0 111.627 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' R' ' 130' ' ' THR . 65.6 m-20 70.73 -166.88 0.15 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.864 0.84 . . . . 0.0 111.987 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.522 ' O ' ' OD2' ' R' ' 173' ' ' ASP . 87.2 mtp -83.83 177.5 8.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.889 -0.507 . . . . 0.0 111.111 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' R' ' 134' ' ' LEU . 0.5 OUTLIER -89.22 -171.22 3.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.69 -0.631 . . . . 0.0 111.253 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 1.077 ' HA ' ' HB2' ' R' ' 173' ' ' ASP . 0.3 OUTLIER -3.76 -70.35 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' R' ' 133' ' ' CYS . . . -54.19 3.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . 0.607 ' O ' ' CZ ' ' R' ' 183' ' ' TYR . 14.5 t70 -84.98 -90.47 0.1 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 119.396 -2.065 . . . . 0.0 111.598 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . 0.84 ' CE1' ' HB2' ' R' ' 180' ' ' PHE . 14.3 p90 -102.47 -176.19 3.03 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.888 ' HB2' HG23 ' R' ' 154' ' ' VAL . 0.0 OUTLIER -149.53 79.96 1.39 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.183 -1.807 . . . . 0.0 111.196 176.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.767 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 176.96 161.29 0.41 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.656 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 131.45 -165.62 23.17 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.826 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . 0.794 HD11 ' CD2' ' R' ' 59' ' ' LEU . 62.0 mt -106.8 119.18 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.8 -0.823 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.826 ' HB2' HG23 ' R' ' 150' ' ' VAL . 0.4 OUTLIER -109.72 140.01 44.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.718 0.771 . . . . 0.0 109.688 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.42 119.36 38.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.33 -0.857 . . . . 0.0 108.978 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -100.73 121.26 41.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.751 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.75 -124.08 32.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -133.92 154.64 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.8 31.0 2.88 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.99 125.23 20.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.508 -0.745 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . 0.747 ' HB3' ' C ' ' R' ' 51' ' ' ALA . . . -112.43 142.91 44.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 110.233 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.3 m -142.15 167.63 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.0 109.7 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' R' ' 59' ' ' LEU . 52.2 t80 -150.35 121.68 7.86 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.257 -0.902 . . . . 0.0 112.214 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.44 168.0 10.23 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 119.985 -1.697 . . . . 0.0 110.264 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . 0.79 ' HB2' ' CE2' ' R' ' 160' ' ' TYR . 0.5 OUTLIER -168.56 144.82 3.7 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.361 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' R' ' 138' ' ' HIS . 41.4 t -55.55 123.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.081 -1.637 . . . . 0.0 114.028 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . 0.608 ' CG2' ' HB3' ' R' ' 160' ' ' TYR . 21.9 p -126.88 -179.56 4.89 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.127 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 42.1 m -56.36 -20.29 18.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.169 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' R' ' 169' ' ' PRO . 79.1 m-20 -92.66 -5.2 51.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.576 -0.702 . . . . 0.0 111.855 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 116.96 -135.44 11.96 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.996 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.857 ' O ' ' HA ' ' R' ' 169' ' ' PRO . 0.0 OUTLIER -82.34 82.17 7.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . 0.982 ' O ' ' HB1' ' R' ' 152' ' ' ALA . 0.0 OUTLIER -64.22 160.04 19.42 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -147.12 113.23 5.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . 0.866 ' O ' HG23 ' R' ' 162' ' ' ILE . 0.7 OUTLIER -72.43 83.69 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 123.103 1.43 . . . . 0.0 111.101 -175.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -80.01 131.0 35.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' R' ' 163' ' ' ASP . 92.6 m-20 32.82 65.16 0.24 Allowed 'General case' 0 N--CA 1.518 2.94 0 O-C-N 120.884 -1.135 . . . . 0.0 112.465 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' R' ' 42' ' ' TYR . 5.3 mt-10 58.75 8.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.232 -1.542 . . . . 0.0 112.129 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 74.5 m-20 -109.44 152.54 25.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 119.977 -1.702 . . . . 0.0 108.754 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . 0.662 ' CB ' HD11 ' R' ' 31' ' ' LEU . 19.5 p90 -124.7 130.39 52.33 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.868 1.318 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' R' ' 161' ' ' ALA . 2.0 p90 -159.42 144.03 11.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.685 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' R' ' 159' ' ' TRP . 50.3 Cg_endo -72.89 107.7 2.41 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 O-C-N 123.088 1.046 . . . . 0.0 112.802 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.79 ' O ' HG23 ' R' ' 171' ' ' THR . 0.6 OUTLIER -135.3 18.28 3.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 117.123 -1.831 . . . . 0.0 112.66 175.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . 1.029 HG22 HD11 ' R' ' 134' ' ' LEU . 0.1 OUTLIER 167.43 121.01 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.965 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 175.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 1.037 ' CD ' HD13 ' R' ' 134' ' ' LEU . 42.2 Cg_endo -101.65 16.76 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.235 1.29 . . . . 0.0 113.421 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' R' ' 134' ' ' LEU . 0.1 OUTLIER -144.48 -173.1 0.34 Allowed Pre-proline 0 N--CA 1.511 2.583 0 O-C-N 118.216 -2.802 . . . . 0.0 114.923 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 1.06 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.4 Cg_endo -86.39 34.07 0.45 Allowed 'Trans proline' 0 C--O 1.217 -0.57 0 O-C-N 124.29 1.679 . . . . 0.0 112.143 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . 0.729 ' OG ' HD23 ' R' ' 134' ' ' LEU . 15.0 m -62.18 -43.45 98.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.816 -1.178 . . . . 0.0 108.436 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -123.09 0.82 9.13 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.63 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 1.06 HG13 ' HA ' ' R' ' 174' ' ' PRO . 0.2 OUTLIER -109.34 157.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.304 -0.873 . . . . 0.0 109.838 -178.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.931 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.5 OUTLIER -132.1 38.34 3.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 117.529 -1.668 . . . . 0.0 110.606 177.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.974 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 7.7 p -165.63 129.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.84 ' HB2' ' CE1' ' R' ' 137' ' ' PHE . 7.1 p90 -136.72 179.44 6.37 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.174 -1.41 . . . . 0.0 111.227 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . 0.767 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -112.21 137.98 21.67 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.395 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' R' ' 181' ' ' VAL . 41.0 Cg_endo -66.49 141.34 60.88 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.5 1.263 . . . . 0.0 111.866 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 15.7 p90 -138.35 172.74 12.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 50.4 p30 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.18 -0.95 . . . . 0.0 110.947 -179.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' R' R ' 29' ' ' MET . . . . . 0.54 ' HB2' ' CE2' ' R' ' 167' ' ' PHE . 89.2 mtp . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.291 0.567 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' R' ' 40' ' ' THR . 93.2 mt-10 -97.77 114.71 26.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 111.372 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . 1.028 HD13 HG21 ' R' ' 162' ' ' ILE . 1.2 pt? -122.9 135.52 54.53 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.49 -1.284 . . . . 0.0 111.025 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' R' ' 38' ' ' LYS . 8.8 t -91.58 156.24 17.79 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -106.26 -173.97 2.42 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.655 -0.653 . . . . 0.0 110.595 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . 0.713 ' N ' ' O ' ' R' ' 154' ' ' VAL . 19.2 p90 -48.14 -49.8 31.01 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . 0.629 ' OD1' HD23 ' R' ' 33' ' ' LEU . 12.4 p-10 -76.57 17.99 0.36 Allowed 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 122.417 2.371 . . . . 0.0 114.303 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -13.74 40.47 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 120.07 -1.644 . . . . 0.0 112.795 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . 0.791 ' HB3' HD21 ' R' ' 33' ' ' LEU . 81.2 tt0 -61.18 131.88 51.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.637 1.718 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' R' ' 38' ' ' LYS . 52.6 pttt -100.93 113.03 25.63 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.925 0.869 . . . . 0.0 111.062 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' HD2' ' R' ' 61' ' ' ARG . 67.1 mttm -113.21 117.77 32.81 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' R' ' 40' ' ' THR . 1.3 t -94.69 133.0 38.82 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.358 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 1.179 ' CE2' HD11 ' R' ' 162' ' ' ILE . 0.1 OUTLIER -145.67 166.73 24.95 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.739 176.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . 0.512 ' O ' ' OG ' ' R' ' 43' ' ' SER . 87.0 m-85 -79.35 175.86 10.21 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.964 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . 0.689 ' O ' ' O ' ' R' ' 44' ' ' ARG . 0.8 OUTLIER 169.62 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . 0.689 ' O ' ' O ' ' R' ' 43' ' ' SER . 5.7 ptt180 -32.87 163.97 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.019 -1.05 . . . . 0.0 111.483 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 29.3 Cg_endo -52.28 104.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.347 1.183 . . . . 0.0 110.874 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' R' ' 76' ' ' GLU . 7.3 t-20 -92.63 -127.67 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.555 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' R' ' 48' ' ' HIS . 0.4 OUTLIER -134.55 138.12 44.36 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.613 -1.304 . . . . 0.0 111.661 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.55 ' CD2' HD22 ' R' ' 80' ' ' LEU . 92.9 m-70 72.52 42.98 0.5 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.423 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' R' ' 48' ' ' HIS . 80.1 m-20 55.26 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.439 -0.788 . . . . 0.0 109.357 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' R' ' 77' ' ' ASN . 31.1 p-10 -111.63 1.98 17.06 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.623 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.253 . . -68.51 -41.86 79.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.696 -0.628 . . . . 0.0 111.716 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 1.006 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 33.2 m95 -60.13 -33.64 72.42 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.08 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 1.074 HD11 HG12 ' R' ' 83' ' ' ILE . 2.3 mt -79.53 -40.37 29.75 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . 0.569 ' O ' ' HG3' ' R' ' 58' ' ' GLN . 8.3 t30 -55.15 -28.79 55.31 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . 0.942 ' HB1' ' CE1' ' R' ' 151' ' ' PHE . . . -64.43 -64.37 0.9 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.856 HD12 HG11 ' R' ' 103' ' ' VAL . 0.6 OUTLIER -67.27 -29.2 45.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 O-C-N 120.231 -1.543 . . . . 0.0 108.174 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . 0.997 ' HG ' HG11 ' R' ' 71' ' ' VAL . 1.8 mm? -52.62 -54.57 31.31 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 109.139 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' R' ' 54' ' ' ASN . 1.8 mt-30 -55.03 -31.73 61.31 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' R' ' 151' ' ' PHE . 1.4 tp -67.84 -40.71 83.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.783 ' HB2' ' HD2' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -54.14 -47.28 72.09 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.955 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . 0.581 ' HG2' ' CZ ' ' R' ' 60' ' ' PHE . 16.2 mmt180 -57.8 -54.32 48.22 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.884 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.806 ' CZ ' ' HB1' ' R' ' 139' ' ' ALA . 21.6 p90 -92.6 -31.76 15.04 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 119.598 -1.939 . . . . 0.0 114.016 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.74 HG22 HG12 ' R' ' 124' ' ' VAL . 56.1 t -77.18 -24.85 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 120.137 -1.602 . . . . 0.0 110.233 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . 0.73 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 87.3 tt0 123.22 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' HD1' ' R' ' 60' ' ' PHE . 3.5 pt-20 -50.44 100.92 0.24 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' R' ' 60' ' ' PHE . 46.7 Cg_endo -86.69 -165.23 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 N-CA-C 106.023 -2.337 . . . . 0.0 106.023 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . 0.593 ' CE1' HD21 ' R' ' 89' ' ' LEU . 76.6 m-85 -41.95 -19.35 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . 0.802 ' HB3' HD22 ' R' ' 57' ' ' LEU . 3.2 m-30 -58.24 -3.01 0.22 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.286 -1.509 . . . . 0.0 110.452 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' R' ' 72' ' ' TYR . 19.8 t70 -58.35 -30.39 66.71 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.717 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -61.58 -33.51 74.01 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.848 -1.158 . . . . 0.0 108.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.997 HG11 ' HG ' ' R' ' 57' ' ' LEU . 55.5 t -68.39 -62.2 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.535 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' R' ' 69' ' ' ASP . 0.8 OUTLIER -71.98 -30.75 65.58 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.207 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 34.0 t -63.99 -23.24 67.26 Favored 'General case' 0 N--CA 1.51 2.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.434 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 148.93 80.45 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' R' ' 42' ' ' TYR . 38.8 Cg_endo -65.03 -17.46 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.712 1.375 . . . . 0.0 110.025 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' R' ' 78' ' ' LEU . 96.1 mt-10 -141.28 58.84 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.5 -0.75 . . . . 0.0 109.499 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.539 ' ND2' HG13 ' R' ' 71' ' ' VAL . 28.7 t-20 57.38 -84.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.818 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' R' ' 81' ' ' GLU . 0.1 OUTLIER 78.33 67.28 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . 0.646 ' O ' HG12 ' R' ' 83' ' ' ILE . 5.3 t -65.25 -52.64 53.14 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.834 -0.541 . . . . 0.0 110.573 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' R' ' 81' ' ' GLU . 0.4 OUTLIER -49.85 -53.12 27.65 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.56 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . 0.593 ' HG3' HD12 ' R' ' 80' ' ' LEU . 95.4 mt-10 -68.12 -28.22 67.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.059 -1.651 . . . . 0.0 110.277 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.921 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.61 -46.74 74.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.768 0.794 . . . . 0.0 112.436 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 1.074 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.36 -39.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.565 -176.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' R' ' 80' ' ' LEU . 35.4 mttm -49.74 -35.86 23.63 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 68.3 tp60 -70.93 -44.57 65.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . 0.806 HD13 ' OG1' ' R' ' 90' ' ' THR . 1.4 tm? -55.11 -38.4 68.12 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . 0.554 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.8 tt0 -59.37 -33.22 70.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.915 -1.115 . . . . 0.0 108.15 177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 82.0 m-20 -55.14 -32.49 62.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.956 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.905 HD12 ' H ' ' R' ' 89' ' ' LEU . 0.3 OUTLIER -102.61 -49.1 3.93 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.938 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . 0.887 ' OG1' HD22 ' R' ' 92' ' ' LEU . 35.0 p -78.6 -27.79 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 73.12 23.61 77.32 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.154 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . 1.017 HD11 HD21 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -108.12 -160.88 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.063 -1.257 . . . . 0.0 112.042 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . 0.83 ' C ' HD13 ' R' ' 94' ' ' LEU . 95.5 mt-10 -144.56 104.79 4.09 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 1.017 HD21 HD11 ' R' ' 92' ' ' LEU . 0.3 OUTLIER -105.28 9.97 33.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.853 -1.155 . . . . 0.0 110.762 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' R' ' 94' ' ' LEU . 17.0 m170 -45.29 -29.75 1.09 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . 0.451 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 80.4 tt0 -150.49 33.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' R' ' 52' ' ' TRP . . . -95.64 -111.58 2.59 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.02 -1.05 . . . . 0.0 110.731 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . 178.14 -161.44 28.32 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.696 ' CD ' ' HD2' ' R' ' 100' ' ' PRO . 31.3 Cg_endo -72.69 -64.84 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 O-C-N 123.849 1.447 . . . . 0.0 114.108 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.932 ' O ' ' N ' ' R' ' 102' ' ' LEU . 33.6 Cg_endo -57.22 -28.32 78.9 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 N-CA-C 107.181 -1.892 . . . . 0.0 107.181 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.971 ' O ' HD12 ' R' ' 92' ' ' LEU 0.251 . . -29.35 60.44 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.197 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.932 ' N ' ' O ' ' R' ' 100' ' ' PRO . 7.3 mp 35.45 -4.74 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.959 ' O ' ' HB ' ' R' ' 107' ' ' ILE . 34.3 t -61.74 -44.99 99.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 C-N-CA 114.855 -2.738 . . . . 0.0 105.641 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' R' ' 100' ' ' PRO . 19.0 pt -84.14 -36.09 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.339 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.73 ' HB3' ' HA ' ' R' ' 102' ' ' LEU . 48.0 t-105 -60.27 -45.26 93.91 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.152 -1.419 . . . . 0.0 111.419 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.719 HD21 HD23 ' R' ' 102' ' ' LEU . 86.4 m-20 -84.88 -22.53 29.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.891 -1.131 . . . . 0.0 111.794 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . 0.959 ' HB ' ' O ' ' R' ' 103' ' ' VAL . 0.2 OUTLIER -67.48 -14.43 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 111.33 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 107' ' ' ILE . 75.2 tttt -33.96 -59.73 0.41 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.425 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.0 m80 -84.0 -7.67 59.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.274 -2.141 . . . . 0.0 111.451 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.761 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.1 OUTLIER -84.26 -30.85 25.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.516 -1.365 . . . . 0.0 109.199 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.815 ' CG ' HG23 ' R' ' 107' ' ' ILE 0.281 57.6 mt -68.11 161.03 27.79 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.692 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -117.14 60.13 0.75 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.623 HG22 HD13 ' R' ' 115' ' ' ILE . 97.4 m -145.12 138.36 26.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.395 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -74.67 98.4 1.05 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 105.615 -2.994 . . . . 0.0 105.615 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.948 HG23 ' CG2' ' R' ' 124' ' ' VAL . 31.1 mm -93.24 142.5 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.814 -1.404 . . . . 0.0 109.828 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' R' ' 122' ' ' SER . . . -133.46 -165.78 11.18 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.869 -1.634 . . . . 0.0 111.952 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.691 ' HA ' HG22 ' R' ' 126' ' ' VAL . 7.2 m -134.63 -175.43 3.88 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' R' ' 130' ' ' THR . . . -64.58 -37.86 89.0 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.795 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -66.71 -36.35 82.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.67 101.79 36.26 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.022 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.07 135.73 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.621 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.499 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 0.2 OUTLIER -145.22 -158.99 0.94 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.637 -0.665 . . . . 0.0 109.426 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.403 ' HB2' HG22 ' R' ' 113' ' ' THR . 77.0 mm-40 -56.13 -43.9 78.67 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.796 -1.19 . . . . 0.0 108.433 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.948 ' CG2' HG23 ' R' ' 115' ' ' ILE . 10.7 m -115.95 135.14 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.446 ' O ' ' CD1' ' R' ' 180' ' ' PHE . 7.0 t -134.3 136.9 43.83 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.966 0.888 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 6.1 m -82.53 -179.92 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.31 1.053 . . . . 0.0 111.18 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.973 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 5.0 m -121.55 -1.01 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' R' ' 178' ' ' LEU . 55.9 t0 -60.49 92.96 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.764 -1.21 . . . . 0.0 110.374 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.49 67.45 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . 0.756 HG23 ' CB ' ' R' ' 118' ' ' ALA . 1.4 m -97.38 146.71 24.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.685 -0.891 . . . . 0.0 111.267 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -66.32 -32.39 73.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.491 ' HB3' ' CZ ' ' R' ' 180' ' ' PHE . 64.0 mtt -90.34 141.62 28.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.0 110.962 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.31 -165.32 1.78 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.71 -0.619 . . . . 0.0 110.228 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 1.085 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.9 OUTLIER -45.67 -30.0 1.42 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.77 -41.45 32.36 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . 0.644 ' O ' ' CD2' ' R' ' 137' ' ' PHE . 94.0 m-20 -71.15 -140.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . 0.715 ' HB2' ' CE2' ' R' ' 183' ' ' TYR . 0.4 OUTLIER -173.37 101.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 116.593 -2.043 . . . . 0.0 112.266 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.973 ' HB3' ' O ' ' R' ' 181' ' ' VAL . 0.2 OUTLIER -163.32 -138.63 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.214 1.007 . . . . 0.0 109.857 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' SG ' ' R' ' 153' ' ' CYS 0.261 . . -104.81 179.69 4.2 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.744 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 161.52 -178.68 37.33 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . 1.094 HG23 ' CE1' ' R' ' 151' ' ' PHE . 3.6 mt -108.35 115.69 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.627 -0.925 . . . . 0.0 110.616 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 1.045 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 3.0 m-85 -114.82 154.64 28.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.8 129.37 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.468 ' HB2' HG11 ' R' ' 150' ' ' VAL . 36.1 tttp -109.12 122.37 47.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.24 -130.6 49.73 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.49 -129.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.353 -1.087 . . . . 0.0 109.554 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.63 92.65 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 109.802 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' R' ' 144' ' ' LYS . 1.9 t60 -146.47 122.15 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.462 -0.773 . . . . 0.0 108.92 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . 1.006 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -94.47 118.87 32.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.797 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . 0.618 HG22 ' O ' ' R' ' 142' ' ' PHE . 34.7 m -133.62 147.63 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.005 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 1.094 ' CE1' HG23 ' R' ' 141' ' ' ILE . 3.3 m-85 -136.11 131.78 35.23 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.63 169.91 8.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.597 -1.314 . . . . 0.0 111.29 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' R' ' 139' ' ' ALA . 3.9 t -163.37 133.09 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' R' ' 34' ' ' TYR . 48.3 t -50.91 117.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.101 -1.44 . . . . 0.0 111.919 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . 0.764 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 66.4 p -104.4 -158.34 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 83.5 p -65.73 -15.47 62.86 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.672 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 86.0 m-20 -113.01 9.47 18.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.358 -0.839 . . . . 0.0 111.969 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 100.92 -153.96 19.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.757 ' CG ' ' O ' ' R' ' 171' ' ' THR . 0.0 OUTLIER -57.91 94.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.322 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . 0.764 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 0.2 OUTLIER -115.79 119.04 34.72 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -109.94 147.99 32.42 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.44 -1.413 . . . . 0.0 110.114 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . 1.179 HD11 ' CE2' ' R' ' 41' ' ' PHE . 6.0 pt -117.51 91.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-O 124.191 1.948 . . . . 0.0 112.029 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.666 ' O ' ' C ' ' R' ' 164' ' ' ASP . 63.6 m-20 -83.0 120.26 25.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 111.784 -2.462 . . . . 0.0 106.169 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . 0.675 ' HA ' ' C ' ' R' ' 43' ' ' SER . 96.8 m-20 11.93 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.113 0.959 . . . . 0.0 111.553 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' R' ' 163' ' ' ASP . 98.6 mt-10 -31.41 -52.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 19.8 t0 -172.5 177.9 2.88 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 119.339 -2.101 . . . . 0.0 113.496 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . 1.132 ' HA ' HG22 ' R' ' 162' ' ' ILE . 2.1 m-30 -93.52 129.35 39.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . 0.521 ' HB2' ' HD2' ' R' ' 169' ' ' PRO . 36.9 p90 -155.42 170.18 9.13 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.556 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . 0.521 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 41.3 Cg_endo -68.61 113.38 3.15 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.748 -1.674 . . . . 0.0 107.748 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.696 ' HA ' ' HE3' ' R' ' 170' ' ' TRP . 0.0 OUTLIER -117.66 -129.24 0.29 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 123.361 1.553 . . . . 0.0 111.956 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . 1.085 ' CG2' HD11 ' R' ' 134' ' ' LEU 0.319 1.4 m -32.22 97.74 0.11 Allowed Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 112.904 -1.953 . . . . 0.0 115.389 -174.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' R' ' 173' ' ' ASP . 53.2 Cg_endo -92.93 -30.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.53 1.805 . . . . 0.0 108.037 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . 0.55 ' CA ' ' HG ' ' R' ' 134' ' ' LEU . 18.0 p30 -148.15 170.43 7.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.448 -0.783 . . . . 0.0 108.915 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' R' ' 134' ' ' LEU . 49.5 Cg_endo -85.64 51.36 2.87 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 83.4 p -82.15 -34.13 29.28 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -125.41 6.11 7.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.557 -1.339 . . . . 0.0 111.054 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 1.045 ' HB ' ' CG ' ' R' ' 142' ' ' PHE 0.259 2.3 p -112.31 148.49 15.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.231 -0.918 . . . . 0.0 110.687 -177.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.973 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.4 OUTLIER -133.05 46.26 2.63 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.893 175.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.43 131.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' R' ' 182' ' ' PRO . 2.3 p90 -132.46 178.53 6.76 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.686 1.231 . . . . 0.0 108.987 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . 0.973 ' O ' ' HB3' ' R' ' 138' ' ' HIS . 0.8 OUTLIER -121.64 93.3 48.73 Favored Pre-proline 0 C--N 1.265 -3.088 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . 0.495 ' HB3' ' CE2' ' R' ' 180' ' ' PHE . 36.5 Cg_endo -60.05 109.29 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 120.862 1.041 . . . . 0.0 113.629 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.715 ' CE2' ' HB2' ' R' ' 137' ' ' PHE . 0.0 OUTLIER -67.12 -151.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.036 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.2 t0 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.109 -0.994 . . . . 0.0 110.483 -179.565 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' R' R ' 29' ' ' MET . . . . . 0.432 ' HB2' ' CZ ' ' R' ' 167' ' ' PHE . 88.0 mtp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.162 0.506 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 84.1 tt0 -110.44 126.95 54.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.822 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . 1.078 ' CD1' HG21 ' R' ' 162' ' ' ILE . 1.7 pt? -139.02 163.4 32.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.459 -0.776 . . . . 0.0 109.632 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . 0.784 HG22 ' HB3' ' R' ' 38' ' ' LYS . 31.8 p -104.78 129.26 53.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.145 . . . . 0.0 111.973 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.97 ' N ' HD13 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -130.68 136.03 48.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.41 -0.806 . . . . 0.0 109.773 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' R' ' 33' ' ' LEU . 58.2 t80 -33.48 -36.18 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' R' ' 62' ' ' TYR . 97.4 m-20 -105.34 65.13 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.837 -1.789 . . . . 0.0 111.287 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . 0.972 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 128.33 35.27 0.51 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . 0.972 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.0 mt-10 -13.82 -150.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . 0.784 ' HB3' HG22 ' R' ' 32' ' ' THR . 9.5 pttm -52.29 109.1 0.35 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.356 -1.465 . . . . 0.0 112.518 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 30.0 mmtm -150.09 147.19 27.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.315 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' R' ' 72' ' ' TYR . 0.8 OUTLIER -85.4 125.42 32.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.126 -0.984 . . . . 0.0 110.019 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.714 ' CD2' ' CE2' ' R' ' 151' ' ' PHE . 84.2 m-85 -110.09 154.02 23.85 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.934 1.349 . . . . 0.0 114.42 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . 0.686 ' HA ' ' HB2' ' R' ' 164' ' ' ASP . 76.2 m-85 -116.45 164.22 14.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.256 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' R' ' 51' ' ' ALA . 0.6 OUTLIER 155.71 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 119.446 1.021 . . . . 0.0 113.304 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . 0.576 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 4.5 mtt180 -72.28 175.74 2.92 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 109.24 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' R' ' 44' ' ' ARG . 37.5 Cg_endo -61.65 100.59 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.286 1.15 . . . . 0.0 113.204 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 47' ' ' ASN . 2.1 m-20 -150.73 -11.85 0.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 46' ' ' ASN . 0.2 OUTLIER -135.78 -178.67 5.24 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 77.4 m80 -92.7 -6.93 48.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.639 -1.288 . . . . 0.0 109.824 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . 0.749 ' O ' HG21 ' R' ' 79' ' ' THR . 12.5 p30 172.17 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 109.605 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.465 ' CG ' ' HB ' ' R' ' 79' ' ' THR . 0.2 OUTLIER -138.58 -3.13 1.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.255 . . -66.3 -44.54 83.18 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.712 -0.617 . . . . 0.0 110.718 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.656 ' CD2' ' HA2' ' R' ' 97' ' ' GLY . 55.2 m95 -61.1 -36.63 80.21 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.555 -1.658 . . . . 0.0 107.795 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 1.086 HD11 HG12 ' R' ' 83' ' ' ILE . 2.4 mt -68.49 -34.86 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' R' ' 42' ' ' TYR . 0.0 OUTLIER -47.6 -26.98 1.64 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.52 -56.98 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.953 HG23 ' CE2' ' R' ' 60' ' ' PHE 0.291 1.2 mp -62.58 -42.39 95.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 122.379 1.085 . . . . 0.0 108.311 177.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . 1.014 HD12 ' CE1' ' R' ' 72' ' ' TYR . 4.2 mm? -65.03 -60.7 2.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.953 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . 0.702 ' HB2' ' CD1' ' R' ' 151' ' ' PHE . 4.6 pt20 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.834 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 1.6 mp -70.97 -48.54 52.77 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.566 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.953 ' CE2' HG23 ' R' ' 56' ' ' ILE . 12.7 m-30 -61.51 -45.93 92.12 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.474 -1.29 . . . . 0.0 110.59 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' R' ' 39' ' ' LYS . 1.5 tpm_? -58.3 -31.23 67.29 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 119.67 -1.894 . . . . 0.0 110.139 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 1.016 ' HB3' HG21 ' R' ' 181' ' ' VAL . 22.0 m-30 -61.7 -54.01 48.32 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.541 -1.35 . . . . 0.0 111.986 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.811 HG11 HG23 ' R' ' 113' ' ' THR . 3.9 t -85.79 3.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.363 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 74.4 tt0 67.04 44.91 1.85 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.515 ' CG ' ' CE1' ' R' ' 112' ' ' HIS . 4.4 mp0 -133.88 89.18 30.46 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' CZ ' ' R' ' 68' ' ' PHE . 53.1 Cg_endo -79.27 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.543 1.286 . . . . 0.0 113.757 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . 0.554 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 55.1 t80 -82.98 -25.71 32.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . 0.869 ' CG ' HD13 ' R' ' 57' ' ' LEU . 2.0 p90 -72.6 19.15 0.08 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.991 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' R' ' 73' ' ' SER . 95.5 m-20 -38.2 -37.29 0.27 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.451 -0.781 . . . . 0.0 112.868 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.463 ' HB2' ' HA ' ' R' ' 82' ' ' ALA . 84.8 m95 -62.03 -30.44 70.97 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.24 -1.538 . . . . 0.0 110.113 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' R' ' 57' ' ' LEU . 65.5 t -78.7 -67.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . 1.014 ' CE1' HD12 ' R' ' 57' ' ' LEU . 9.9 m-30 -67.89 -38.8 83.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.239 -0.913 . . . . 0.0 110.94 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' R' ' 69' ' ' ASP . 6.1 m -63.35 -21.62 66.38 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.739 -1.185 . . . . 0.0 109.561 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . 0.585 ' OG ' HD23 ' R' ' 78' ' ' LEU . 16.4 t -99.6 119.71 59.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.957 . . . . 0.0 110.513 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.97 -19.25 46.2 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.569 1.299 . . . . 0.0 110.279 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.61 165.19 11.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.449 -0.782 . . . . 0.0 109.849 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -58.52 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.825 . . . . 0.0 110.728 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . 0.585 HD23 ' OG ' ' R' ' 74' ' ' SER . 1.4 mm? -107.82 21.81 16.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . 0.749 HG21 ' O ' ' R' ' 49' ' ' ASP . 3.1 t -55.48 -52.64 62.97 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.506 -0.746 . . . . 0.0 109.956 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.606 ' H ' HG23 ' R' ' 79' ' ' THR . 1.2 pp -49.86 -50.84 44.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.692 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . 0.553 ' N ' HD12 ' R' ' 80' ' ' LEU . 84.8 tt0 -67.08 -28.63 68.34 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.28 -1.513 . . . . 0.0 110.104 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -67.01 -48.45 68.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.93 0.871 . . . . 0.0 111.572 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 1.086 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.76 -38.52 11.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.443 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 83' ' ' ILE . 36.7 tttm -50.49 -35.34 28.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -73.55 -36.56 65.65 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . 1.019 HD12 HD21 ' R' ' 94' ' ' LEU . 2.6 tm? -63.13 -38.18 90.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . 0.571 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 83.0 tt0 -60.9 -39.71 90.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 108.824 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.08 -32.3 72.82 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.273 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.808 HD23 ' N ' ' R' ' 90' ' ' THR . 2.6 tt -94.91 -51.25 4.76 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.08 -1.013 . . . . 0.0 111.805 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . 0.838 HG22 ' HB2' ' R' ' 106' ' ' ASN . 69.7 p -76.58 -25.64 54.21 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 67.29 26.15 73.52 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.692 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . 1.098 HD13 HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -104.54 -17.98 14.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.02 -1.283 . . . . 0.0 111.756 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . 0.74 ' N ' HD12 ' R' ' 92' ' ' LEU . 84.1 tt0 58.42 115.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 1.098 HD23 HD13 ' R' ' 92' ' ' LEU . 3.7 pp -156.75 21.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.688 -1.257 . . . . 0.0 111.181 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . 0.839 ' HA ' HD12 ' R' ' 83' ' ' ILE . 5.7 p80 -42.42 -28.35 0.2 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.2 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . 0.485 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 23.1 pt-20 -120.39 36.11 4.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . 0.656 ' HA2' ' CD2' ' R' ' 52' ' ' TRP . . . 145.87 110.78 0.67 Allowed Glycine 0 N--CA 1.504 3.182 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.329 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' R' ' 94' ' ' LEU . . . -170.68 65.29 0.16 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.023 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.843 ' HB2' ' CD ' ' R' ' 100' ' ' PRO . 42.8 Cg_endo -84.56 -108.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.965 0 O-C-N 123.322 1.169 . . . . 0.0 109.211 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.881 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.3 Cg_endo -60.18 -17.88 48.49 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 N-CA-C 106.845 -2.021 . . . . 0.0 106.845 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.254 . . -31.22 61.27 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.195 175.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.881 ' N ' ' O ' ' R' ' 100' ' ' PRO . 80.8 mt 41.0 -3.42 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.369 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.008 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.968 HG13 HD11 ' R' ' 86' ' ' LEU . 13.4 t -56.98 -47.75 82.85 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 C-N-CA 114.335 -2.946 . . . . 0.0 104.079 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.46 -39.36 85.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.932 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.635 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 51.9 t90 -63.02 -36.31 83.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.12 -1.432 . . . . 0.0 111.25 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.838 ' HB2' HG22 ' R' ' 90' ' ' THR . 22.3 m120 -84.87 -23.19 29.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.086 -1.009 . . . . 0.0 113.26 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . 0.905 HG12 ' O ' ' R' ' 103' ' ' VAL . 3.4 mm -70.6 -10.95 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.242 -1.536 . . . . 0.0 110.02 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' R' ' 107' ' ' ILE . 62.1 mttt -33.47 -57.93 0.41 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.827 ' C ' HD13 ' R' ' 110' ' ' LEU . 4.1 m-70 -72.91 -9.68 58.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 119.181 -2.199 . . . . 0.0 111.506 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.838 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.2 OUTLIER -106.54 -16.82 14.43 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.859 HD23 HG21 ' R' ' 107' ' ' ILE 0.323 0.1 OUTLIER -109.71 127.62 54.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.835 -176.52 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . 0.546 ' N ' HD13 ' R' ' 111' ' ' LEU . 55.4 p-80 -115.37 76.91 1.03 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.886 HG22 ' CD1' ' R' ' 115' ' ' ILE . 18.0 m -132.14 136.42 47.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.278 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.539 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -75.73 104.36 1.78 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 1.1 HD12 HG22 ' R' ' 124' ' ' VAL . 3.3 mm -90.9 144.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.634 -1.509 . . . . 0.0 109.358 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' R' ' 125' ' ' CYS . . . -145.42 -118.79 1.2 Allowed Glycine 0 N--CA 1.509 3.562 0 C-N-CA 118.408 -1.853 . . . . 0.0 112.462 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.53 HG23 ' O ' ' R' ' 116' ' ' GLY . 0.0 OUTLIER -178.95 -175.2 0.38 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.204 -1.174 . . . . 0.0 108.814 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.702 ' CA ' HG22 ' R' ' 126' ' ' VAL 0.278 . . -66.84 -43.62 83.22 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.31 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -37.77 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 108.889 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . 0.427 ' HA ' ' HD2' ' R' ' 121' ' ' PRO . 0.0 OUTLIER -123.22 104.11 35.28 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' R' ' 120' ' ' ARG . 39.8 Cg_endo -65.33 131.17 27.38 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.524 1.276 . . . . 0.0 111.224 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 46.7 m -146.05 -168.91 3.12 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.569 ' O ' HG23 ' R' ' 181' ' ' VAL . 76.8 mm-40 -63.18 -43.16 99.02 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.8 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 1.1 HG22 HD12 ' R' ' 115' ' ' ILE . 0.6 OUTLIER -149.17 122.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.337 -1.477 . . . . 0.0 112.566 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.784 ' HB3' ' O ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER 152.74 138.03 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.061 176.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.995 ' CG1' HG13 ' R' ' 127' ' ' VAL . 1.1 t -176.55 -172.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 1.095 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.4 m 36.91 -3.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 127.779 2.432 . . . . 0.0 116.863 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' R' ' 126' ' ' VAL . 44.9 t0 -57.22 55.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.659 -1.276 . . . . 0.0 111.752 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 105.28 15.56 19.12 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . 0.661 HG21 ' CB ' ' R' ' 118' ' ' ALA . 87.1 m -116.53 154.32 30.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -1.175 . . . . 0.0 112.164 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -58.78 159.59 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.773 -0.579 . . . . 0.0 109.52 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.447 ' HG2' HG12 ' R' ' 127' ' ' VAL . 28.2 mtt -123.81 136.36 54.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.283 -0.885 . . . . 0.0 111.326 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.415 ' N ' ' HG2' ' R' ' 174' ' ' PRO . 49.1 t -137.3 134.64 36.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.027 -1.045 . . . . 0.0 111.086 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 1.006 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -59.89 -42.22 93.34 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.244 1.021 . . . . 0.0 110.587 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.4 0.52 9.95 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' R' ' 133' ' ' CYS . 47.4 t0 -73.31 -65.74 0.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.106 . . . . 0.0 111.827 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . 0.714 ' CG ' ' CD2' ' R' ' 180' ' ' PHE . 19.5 p90 -146.85 178.23 8.5 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.091 -1.006 . . . . 0.0 110.2 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' R' ' 172' ' ' PRO . 29.3 m80 -143.14 72.66 1.37 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.245 -1.382 . . . . 0.0 112.212 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.968 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 171.81 153.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.626 ' O ' ' OE1' ' R' ' 58' ' ' GLN . . . 144.16 -176.23 23.53 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.283 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . 0.71 ' CG1' ' HA ' ' R' ' 55' ' ' ALA . 0.5 OUTLIER -98.8 128.91 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.829 ' HA ' ' HA ' ' R' ' 177' ' ' VAL . 0.2 OUTLIER -111.48 141.56 44.89 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.501 -1.279 . . . . 0.0 109.021 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.487 ' N ' HD22 ' R' ' 143' ' ' LEU . 4.6 mm? -88.95 109.38 20.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.934 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.519 ' HD2' HG11 ' R' ' 150' ' ' VAL . 24.6 tttt -108.79 120.3 42.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.17 -137.72 44.16 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . 0.435 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 93.9 mt-30 -126.52 150.73 48.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -1.034 . . . . 0.0 110.16 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 51.27 37.56 18.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.435 ' CD2' ' O ' ' R' ' 146' ' ' GLN . 56.1 m-70 -142.86 123.61 14.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.31 -0.869 . . . . 0.0 109.672 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . 0.796 ' HB3' ' HB1' ' R' ' 51' ' ' ALA . . . -105.33 136.27 45.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . 0.706 HG22 ' O ' ' R' ' 142' ' ' PHE . 31.2 m -127.9 165.72 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.025 -1.047 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.714 ' CE2' ' CD2' ' R' ' 41' ' ' PHE 0.26 0.0 OUTLIER -148.11 125.22 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.736 -1.186 . . . . 0.0 113.494 -177.613 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -132.81 164.29 27.16 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.606 -1.309 . . . . 0.0 109.238 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 22.6 p -176.29 176.39 1.68 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' R' ' 158' ' ' GLY . 64.9 t -63.59 103.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 CA-C-O 121.684 0.754 . . . . 0.0 110.992 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . 0.712 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 41.7 p -88.75 -160.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 84.5 p -61.82 -18.65 60.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . 0.529 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 90.4 m-20 -111.39 2.69 17.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.7 . . . . 0.0 111.502 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 92.91 -118.15 5.55 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 120.704 -1.248 . . . . 0.0 112.124 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.674 ' HB3' ' HD2' ' R' ' 172' ' ' PRO . 0.0 OUTLIER -60.79 92.5 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.645 1.212 . . . . 0.0 108.89 -177.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . 0.763 ' HA ' ' H ' ' R' ' 170' ' ' TRP . 3.3 m-85 -145.0 163.47 34.1 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -134.72 131.24 37.4 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.774 -1.204 . . . . 0.0 107.767 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . 1.078 HG21 ' CD1' ' R' ' 31' ' ' LEU . 1.2 pt -122.53 92.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-O 123.981 1.848 . . . . 0.0 112.811 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.697 ' HA ' ' CB ' ' R' ' 43' ' ' SER . 74.8 m-20 -96.06 129.0 43.46 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.105 -2.316 . . . . 0.0 108.637 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . 0.699 ' O ' ' CB ' ' R' ' 165' ' ' GLU . 11.2 t0 -34.37 117.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.699 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 42.9 tp10 135.06 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -169.19 161.14 10.12 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.32 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . 1.017 ' HA ' HG22 ' R' ' 162' ' ' ILE . 10.1 m-30 -107.38 122.07 45.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' R' ' 168' ' ' TYR . 9.7 p90 -141.63 160.54 56.11 Favored Pre-proline 0 C--N 1.294 -1.817 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.835 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.1 Cg_endo -69.52 113.45 3.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.36 1.716 . . . . 0.0 108.591 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.763 ' H ' ' HA ' ' R' ' 160' ' ' TYR . 0.0 OUTLIER -142.47 169.73 17.02 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . 1.006 ' CG2' HD11 ' R' ' 134' ' ' LEU . 0.2 OUTLIER -100.27 99.83 10.49 Favored Pre-proline 0 C--N 1.274 -2.684 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.433 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' R' ' 159' ' ' TRP . 52.0 Cg_endo -75.61 55.67 4.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.884 1.465 . . . . 0.0 108.639 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . 0.755 ' CG ' HD13 ' R' ' 134' ' ' LEU . 3.7 m-20 -115.39 -176.76 0.39 Allowed Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.89 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' R' ' 173' ' ' ASP . 52.8 Cg_endo -79.81 31.36 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.568 1.299 . . . . 0.0 112.352 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 20.2 t -63.3 -51.19 67.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.733 -1.229 . . . . 0.0 109.387 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -131.86 13.99 4.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.708 . . . . 0.0 110.284 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 1.095 ' O ' HG21 ' R' ' 127' ' ' VAL . 0.5 OUTLIER -102.69 168.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.894 -1.129 . . . . 0.0 113.221 -177.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 1.089 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 1.1 mm? -100.59 -95.12 0.27 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.939 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.661 ' HA ' ' N ' ' R' ' 126' ' ' VAL . 28.6 m -80.69 135.42 25.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.714 ' CD2' ' CG ' ' R' ' 137' ' ' PHE 0.261 2.9 p90 -128.85 -178.81 4.77 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.549 1.166 . . . . 0.0 112.315 -173.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' R' ' 62' ' ' TYR . 0.5 OUTLIER -134.19 122.42 16.12 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.554 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . 0.429 ' N ' ' CE2' ' R' ' 180' ' ' PHE . 50.1 Cg_endo -76.34 161.35 34.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.49 1.258 . . . . 0.0 112.142 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' R' ' 137' ' ' PHE . 25.4 p90 -127.14 -173.97 3.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 56.5 t0 . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 0.0 111.434 -179.295 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.054 0.454 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.89 137.39 53.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . 0.981 HD11 ' CD1' ' R' ' 162' ' ' ILE . 1.3 pt? -145.63 153.0 40.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' R' ' 38' ' ' LYS . 1.9 p -112.26 142.88 44.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.202 -0.936 . . . . 0.0 109.562 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.927 ' N ' HD13 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -134.37 141.91 47.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.268 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' R' ' 154' ' ' VAL . 45.3 t80 -37.56 -38.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' R' ' 62' ' ' TYR . 24.0 m120 -104.21 66.1 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.736 -1.852 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . 0.94 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 129.63 35.25 0.46 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . 0.94 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.3 mt-10 -11.37 -159.14 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . 0.536 ' HA ' HG22 ' R' ' 32' ' ' THR . 5.1 pttt -44.98 110.96 0.27 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.053 1.406 . . . . 0.0 113.845 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.527 ' HG2' ' CA ' ' R' ' 61' ' ' ARG . 32.2 tptt -141.49 135.54 30.33 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . 0.522 HG22 ' O ' ' R' ' 40' ' ' THR . 0.9 OUTLIER -84.26 125.57 32.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 113.609 -176.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.853 ' CD1' HD21 ' R' ' 31' ' ' LEU . 31.3 m-85 -100.95 169.82 8.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' R' ' 72' ' ' TYR . 85.6 m-85 -101.04 161.2 13.76 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.641 0.734 . . . . 0.0 111.759 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . 0.635 ' CA ' ' HB2' ' R' ' 165' ' ' GLU . 36.9 m -55.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.648 0.737 . . . . 0.0 111.696 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . 0.867 ' HA ' ' HA ' ' R' ' 164' ' ' ASP . 0.4 OUTLIER -74.49 168.71 24.32 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.48 -0.762 . . . . 0.0 109.373 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 36.5 Cg_endo -62.52 98.88 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.579 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 57.5 t30 -60.9 -118.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.126 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . 0.479 ' C ' ' CG ' ' R' ' 48' ' ' HIS . 0.5 OUTLIER -128.43 89.31 2.88 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.479 -1.388 . . . . 0.0 110.893 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.724 ' CD2' HG21 ' R' ' 79' ' ' THR . 0.9 OUTLIER 166.62 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.041 0.448 . . . . 0.0 109.795 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' R' ' 95' ' ' HIS . 12.6 m-20 58.68 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.107 -0.996 . . . . 0.0 109.07 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.833 ' HB3' HG21 ' R' ' 79' ' ' THR . 3.4 p30 -141.09 -2.64 1.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.53 -0.731 . . . . 0.0 109.576 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.257 . . -61.94 -35.8 79.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.615 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 15.3 m95 -61.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 117.355 -1.738 . . . . 0.0 106.478 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.913 HD13 HG22 ' R' ' 71' ' ' VAL . 12.0 mt -68.75 -42.02 78.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . 0.504 ' HB3' ' HE2' ' R' ' 151' ' ' PHE . 45.5 t-20 -50.65 -28.0 8.05 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . 0.949 ' O ' HD23 ' R' ' 59' ' ' LEU . . . -67.67 -71.8 0.19 Allowed 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -59.54 -34.64 55.49 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 O-C-N 120.467 -1.396 . . . . 0.0 110.003 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . 1.024 HD11 ' HB ' ' R' ' 71' ' ' VAL . 3.9 mm? -64.1 -66.72 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.795 . . . . 0.0 111.125 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . 0.705 HE21 HD22 ' R' ' 59' ' ' LEU . 0.1 OUTLIER -59.85 -29.26 68.16 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.949 HD23 ' O ' ' R' ' 55' ' ' ALA . 3.7 mm? -70.02 -38.98 76.06 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.683 ' HB3' ' O ' ' R' ' 56' ' ' ILE . 0.0 OUTLIER -66.48 -40.96 89.62 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.592 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . 0.546 ' HG2' ' CE2' ' R' ' 60' ' ' PHE . 1.3 mtp180 -56.5 -41.61 76.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.824 -1.173 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.881 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 2.4 p90 -86.39 -47.12 9.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.264 -1.523 . . . . 0.0 111.981 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.881 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.7 t -70.63 -16.77 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.877 -1.764 . . . . 0.0 109.018 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 71.4 tt0 74.75 42.38 0.28 Allowed 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' R' ' 60' ' ' PHE . 7.4 mt-10 -140.28 90.74 10.19 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.945 -1.097 . . . . 0.0 108.751 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' R' ' 60' ' ' PHE . 46.5 Cg_endo -75.53 95.06 0.99 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.393 1.207 . . . . 0.0 112.401 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' R' ' 111' ' ' LEU . 14.4 m-85 -76.78 -27.19 55.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' R' ' 103' ' ' VAL . 32.3 m-85 -104.99 50.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.696 1.236 . . . . 0.0 108.643 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.605 ' HA ' ' CD1' ' R' ' 72' ' ' TYR . 38.0 m-20 -45.13 -34.28 2.59 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.713 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -63.0 -34.99 78.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.706 -1.247 . . . . 0.0 109.917 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 1.024 ' HB ' HD11 ' R' ' 57' ' ' LEU . 59.4 t -66.22 -58.44 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.674 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' R' ' 69' ' ' ASP . 1.3 p90 -69.15 -31.4 70.03 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.864 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -63.23 -25.86 68.52 Favored 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.906 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 1.0 OUTLIER -79.32 134.41 58.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.55 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.24 -24.8 31.65 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.644 1.339 . . . . 0.0 110.125 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . 0.453 ' CG ' HD23 ' R' ' 78' ' ' LEU . 22.4 pt-20 -117.71 -158.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.435 -0.791 . . . . 0.0 109.906 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.489 ' O ' HD22 ' R' ' 78' ' ' LEU . 87.6 m-20 -85.22 103.55 14.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.504 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mm? -122.58 47.88 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . 0.833 HG21 ' HB3' ' R' ' 50' ' ' ASN . 0.0 OUTLIER -61.51 -59.25 5.52 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.687 -0.633 . . . . 0.0 110.461 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.653 ' H ' HG23 ' R' ' 79' ' ' THR . 1.0 OUTLIER -49.56 -51.65 35.47 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.789 -178.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . 0.512 ' OE1' HD12 ' R' ' 78' ' ' LEU . 84.3 tt0 -59.95 -32.48 70.84 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.826 -1.796 . . . . 0.0 109.532 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.824 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.18 -58.31 5.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.862 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -87.26 -35.62 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.032 -177.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' R' ' 80' ' ' LEU . 25.7 tptt -49.2 -36.35 19.58 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 63.2 tt0 -68.38 -42.03 79.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' R' ' 94' ' ' LEU . 2.8 tm? -62.26 -37.84 87.01 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . 0.527 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -56.13 -38.56 70.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 108.465 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 89.4 m-20 -58.36 -30.36 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.241 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.735 HD23 ' N ' ' R' ' 90' ' ' THR . 4.9 tt -91.1 -53.68 4.26 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.498 -0.751 . . . . 0.0 112.434 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . 0.735 ' N ' HD23 ' R' ' 89' ' ' LEU . 36.1 p -80.14 -31.58 39.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 64.78 30.04 76.89 Favored Glycine 0 N--CA 1.505 3.28 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.906 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . 0.841 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.4 OUTLIER -119.5 9.79 11.64 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.961 -1.317 . . . . 0.0 113.131 -177.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . 0.754 ' C ' ' HG ' ' R' ' 94' ' ' LEU . 93.8 mt-10 68.21 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.162 -0.961 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' R' ' 86' ' ' LEU . 0.0 OUTLIER -138.57 -62.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . 0.534 ' HB3' HD13 ' R' ' 83' ' ' ILE . 3.9 p80 -42.5 -37.06 1.51 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' R' ' 93' ' ' GLU . 22.5 pt-20 -104.5 -16.57 15.02 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' R' ' 94' ' ' LEU . . . -93.22 -141.78 11.12 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . -130.71 175.16 19.51 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.737 ' HB3' ' HB3' ' R' ' 55' ' ' ALA . 34.4 Cg_endo -70.76 -58.68 0.08 OUTLIER 'Trans proline' 0 CA--C 1.556 1.581 0 O-C-N 123.773 1.407 . . . . 0.0 114.799 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.947 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.2 Cg_endo -59.07 -22.68 65.21 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.841 ' O ' HD22 ' R' ' 92' ' ' LEU . . . -31.34 58.92 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.083 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' R' ' 100' ' ' PRO . 71.1 mt 36.46 3.27 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.248 -174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.863 HG13 HD11 ' R' ' 86' ' ' LEU . 2.7 t -55.02 -39.6 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.825 HD12 ' HA ' ' R' ' 100' ' ' PRO . 85.8 mt -68.34 -37.45 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.872 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' R' ' 102' ' ' LEU . 68.1 t-105 -63.36 -46.9 84.39 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.876 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' R' ' 90' ' ' THR . 69.6 m-80 -76.32 -30.04 57.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.716 -1.24 . . . . 0.0 111.107 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . 0.695 HG23 HD23 ' R' ' 110' ' ' LEU . 54.8 mt -81.58 7.22 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.702 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' R' ' 112' ' ' HIS . 24.2 tttm -34.37 -53.14 0.5 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.739 ' C ' HD13 ' R' ' 110' ' ' LEU . 0.5 OUTLIER -60.02 -14.39 16.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.093 -2.255 . . . . 0.0 111.675 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.739 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -106.49 -40.89 5.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.954 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -74.88 -106.18 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.668 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . 0.653 ' HA ' ' O ' ' R' ' 122' ' ' SER . 30.1 m-70 -25.1 73.56 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 123.833 1.778 . . . . 0.0 109.901 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 1.046 HG22 ' HA ' ' R' ' 123' ' ' GLU . 3.0 t -60.39 -105.31 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.398 -2.183 . . . . 0.0 110.612 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.769 ' O ' HD13 ' R' ' 115' ' ' ILE . . . -134.92 82.15 0.29 Allowed Glycine 0 N--CA 1.505 3.247 1 N-CA-C 102.877 -4.089 . . . . 0.0 102.877 177.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 1.288 HG23 ' O ' ' R' ' 124' ' ' VAL 0.356 32.4 mm -126.33 162.14 30.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -170.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.12 75.6 0.37 Allowed Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.221 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 1.037 HG23 HG21 ' R' ' 126' ' ' VAL . 8.1 m -72.74 149.21 43.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' CG2' ' R' ' 130' ' ' THR . . . -63.85 -24.79 67.88 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.552 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 60.5 p -97.38 -22.25 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 111.097 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . 0.695 ' O ' ' HB ' ' R' ' 117' ' ' THR . 0.0 OUTLIER -178.12 -164.51 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 O-C-N 120.96 -1.087 . . . . 0.0 110.607 -178.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' R' ' 120' ' ' ARG . 49.1 Cg_endo -85.52 161.99 10.97 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 120.671 0.914 . . . . 0.0 110.295 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.901 ' H ' ' HB ' ' R' ' 115' ' ' ILE . 19.9 m -164.96 -134.78 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.07 -1.019 . . . . 0.0 113.216 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 1.046 ' HA ' HG22 ' R' ' 113' ' ' THR . 82.5 tt0 -103.8 -19.18 14.37 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 124.726 1.21 . . . . 0.0 112.886 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 1.288 ' O ' HG23 ' R' ' 115' ' ' ILE . 10.4 m -161.93 -157.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-O 122.573 1.177 . . . . 0.0 111.74 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.584 ' HB2' ' HG3' ' R' ' 182' ' ' PRO . 48.7 t -95.12 137.31 34.35 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.525 -1.984 . . . . 0.0 107.275 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 1.037 HG21 HG23 ' R' ' 117' ' ' THR . 77.5 t -102.51 154.22 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 -174.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.924 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.0 m -83.19 -21.42 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 112.905 -1.952 . . . . 0.0 114.14 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.748 ' H ' HG12 ' R' ' 126' ' ' VAL . 56.2 t0 -45.3 87.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.094 -1.004 . . . . 0.0 111.437 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 51.6 25.15 13.5 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . 0.825 ' CG2' ' HB2' ' R' ' 118' ' ' ALA . 0.0 OUTLIER -109.88 152.11 26.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.324 -1.104 . . . . 0.0 112.306 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 40.43 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.041 0.924 . . . . 0.0 112.98 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.507 ' HB2' ' HB2' ' R' ' 136' ' ' ASP . 89.6 mtp -90.4 174.19 7.7 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' R' ' 135' ' ' ALA . 62.4 m -100.87 -174.99 2.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.341 -0.85 . . . . 0.0 112.682 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 1.089 HD11 HG23 ' R' ' 171' ' ' THR . 0.4 OUTLIER 31.3 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.098 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . 0.465 ' HA ' ' NE2' ' R' ' 138' ' ' HIS . . . -62.29 -26.75 68.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.119 -0.988 . . . . 0.0 112.841 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' R' ' 132' ' ' MET . 19.2 t70 -55.99 -42.67 76.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.105 -0.997 . . . . 0.0 112.278 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . 0.685 ' CG ' ' CD1' ' R' ' 180' ' ' PHE . 52.5 p90 -155.23 159.59 40.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.788 -1.195 . . . . 0.0 109.479 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.651 ' CG ' ' CE3' ' R' ' 159' ' ' TRP . 68.5 m-70 -143.76 79.18 1.62 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.139 -1.424 . . . . 0.0 110.857 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 174.88 162.04 0.22 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.175 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 130.06 -170.56 20.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.212 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . 0.73 HG23 ' CE1' ' R' ' 151' ' ' PHE . 70.1 mt -104.23 124.61 58.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.742 -0.858 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.989 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 4.2 m-85 -113.76 151.53 31.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.662 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.646 HD21 ' HG2' ' R' ' 146' ' ' GLN . 26.1 tp -101.66 124.14 46.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.715 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' R' ' 148' ' ' HIS . 38.1 tttt -108.85 113.54 26.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.073 -1.017 . . . . 0.0 110.422 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' R' ' 146' ' ' GLN . . . 50.23 25.63 8.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . 0.646 ' HG2' HD21 ' R' ' 143' ' ' LEU . 95.2 mt-30 54.62 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -1.01 . . . . 0.0 110.631 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.41 23.57 2.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 83.2 m-70 -144.7 131.68 20.36 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.896 . . . . 0.0 108.882 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . 0.935 ' HB1' ' HZ ' ' R' ' 151' ' ' PHE . . . -104.5 115.82 31.03 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . 0.67 ' O ' ' CD1' ' R' ' 151' ' ' PHE . 34.9 m -129.27 152.18 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.935 ' HZ ' ' HB1' ' R' ' 149' ' ' ALA . 7.7 m-85 -149.89 129.69 13.3 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.791 -1.564 . . . . 0.0 112.012 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -110.56 167.65 10.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.593 -1.317 . . . . 0.0 110.735 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 38.0 t -169.63 134.49 1.41 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' R' ' 138' ' ' HIS . 36.9 t -53.38 102.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.383 -1.448 . . . . 0.0 111.283 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . 0.661 ' CG2' ' HB2' ' R' ' 160' ' ' TYR . 25.1 p -78.82 -165.36 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.713 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . 0.472 ' N ' ' O ' ' R' ' 32' ' ' THR . 81.1 p -65.41 -18.69 65.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . 0.466 ' CB ' ' CZ ' ' R' ' 160' ' ' TYR . 83.0 m-20 -102.03 2.9 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.273 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 112.93 -166.14 12.11 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.151 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.651 ' CE3' ' CG ' ' R' ' 138' ' ' HIS . 0.0 OUTLIER -55.58 99.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.495 1.14 . . . . 0.0 108.685 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . 0.661 ' HB2' ' CG2' ' R' ' 155' ' ' THR . 4.0 m-85 -121.83 -178.39 3.82 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -158.07 136.37 10.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.751 -1.843 . . . . 0.0 110.987 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . 0.981 ' CD1' HD11 ' R' ' 31' ' ' LEU . 0.6 OUTLIER -75.79 88.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.526 1.155 . . . . 0.0 109.188 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -94.98 122.83 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . 0.867 ' HA ' ' HA ' ' R' ' 44' ' ' ARG . 78.0 m-20 28.19 74.51 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.365 -0.834 . . . . 0.0 112.968 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.654 ' CB ' ' N ' ' R' ' 44' ' ' ARG . 0.1 OUTLIER 68.66 -15.31 0.24 Allowed 'General case' 0 N--CA 1.522 3.149 0 O-C-N 119.597 -1.939 . . . . 0.0 113.448 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.74 134.29 45.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.83 -1.794 . . . . 0.0 112.694 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . 0.699 ' CD1' HG13 ' R' ' 162' ' ' ILE . 6.4 m-85 -101.62 121.66 42.42 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . 0.599 ' CE2' ' CD1' ' R' ' 170' ' ' TRP . 2.8 p90 -150.67 162.05 28.39 Favored Pre-proline 0 C--N 1.281 -2.406 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.314 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . 0.471 ' HA ' ' CD1' ' R' ' 160' ' ' TYR . 39.5 Cg_endo -66.62 114.71 3.21 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.231 1.648 . . . . 0.0 109.044 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.599 ' CD1' ' CE2' ' R' ' 168' ' ' TYR . 0.1 OUTLIER -126.4 150.18 48.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . 1.089 HG23 HD11 ' R' ' 134' ' ' LEU . 2.3 m -94.26 108.26 34.8 Favored Pre-proline 0 C--N 1.271 -2.816 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.053 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' R' ' 138' ' ' HIS . 46.1 Cg_endo -72.94 67.03 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 124.048 1.552 . . . . 0.0 110.823 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' R' ' 134' ' ' LEU . 8.6 t70 -81.86 139.13 46.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.406 -0.809 . . . . 0.0 109.097 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.783 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.3 Cg_endo -70.72 35.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.223 1.117 . . . . 0.0 109.95 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . 0.494 ' H ' ' C ' ' R' ' 173' ' ' ASP . 83.4 p -81.34 -43.38 19.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 111.323 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' R' ' 143' ' ' LEU . 86.4 m-20 -126.16 1.6 7.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.017 -1.052 . . . . 0.0 109.934 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.989 ' HB ' ' CG ' ' R' ' 142' ' ' PHE . 0.2 OUTLIER -95.1 169.37 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.059 0.933 . . . . 0.0 110.464 -178.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.797 HD22 ' O ' ' R' ' 177' ' ' VAL . 0.7 OUTLIER -128.48 -91.45 0.48 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -177.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' R' ' 126' ' ' VAL . 34.7 m -72.43 124.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.685 ' CD1' ' CG ' ' R' ' 137' ' ' PHE . 0.3 OUTLIER -130.45 178.14 6.83 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -175.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . 0.874 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -127.26 127.24 24.27 Favored Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.952 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . 0.584 ' HG3' ' HB2' ' R' ' 125' ' ' CYS . 56.2 Cg_endo -87.47 131.93 2.99 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.384 1.202 . . . . 0.0 109.998 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 1.1 p90 -64.6 -34.06 77.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.096 -1.003 . . . . 0.0 109.709 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.0 t0 . . . . . 0 N--CA 1.5 2.031 0 O-C-N 121.416 -0.802 . . . . 0.0 111.62 179.038 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.151 0.501 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 22.7 pt-20 -93.86 120.37 34.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.388 -0.82 . . . . 0.0 110.382 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . 0.931 HD11 ' CZ ' ' R' ' 167' ' ' PHE . 0.7 OUTLIER -94.04 127.96 40.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 111.3 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . 0.55 ' O ' ' N ' ' R' ' 156' ' ' SER . 92.6 m -102.19 146.76 27.51 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.701 HD22 ' H ' ' R' ' 33' ' ' LEU . 0.0 OUTLIER -139.64 167.83 21.2 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 118.5 -1.28 . . . . 0.0 113.007 -178.523 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . 0.62 ' HB2' HG11 ' R' ' 154' ' ' VAL . 63.6 t80 -41.19 -44.27 2.54 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -75.93 15.47 0.53 Allowed 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 122.594 2.452 . . . . 0.0 113.927 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.59 -5.92 42.41 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 119.87 -1.769 . . . . 0.0 112.963 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . 0.643 ' HB3' HD21 ' R' ' 33' ' ' LEU . 82.9 tt0 -79.97 137.7 36.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.504 -1.586 . . . . 0.0 110.354 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -120.13 113.96 21.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 109.392 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.546 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 22.2 tptt -122.93 131.74 53.86 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' R' ' 30' ' ' GLU . 0.9 OUTLIER -85.9 122.72 30.36 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.924 0.868 . . . . 0.0 112.203 -177.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.717 ' CD2' HD13 ' R' ' 162' ' ' ILE . 0.5 OUTLIER -107.54 159.91 16.07 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' R' ' 42' ' ' TYR . 68.2 m-85 -98.94 134.1 42.28 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.414 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' R' ' 164' ' ' ASP . 7.0 m -112.7 94.75 5.06 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.362 -0.836 . . . . 0.0 110.498 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' R' ' 77' ' ' ASN . 0.4 OUTLIER -152.67 136.09 9.79 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.757 . . . . 0.0 109.283 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.58 126.83 12.49 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.374 1.197 . . . . 0.0 110.008 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' R' ' 50' ' ' ASN . 0.3 OUTLIER -97.35 -120.81 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.801 . . . . 0.0 109.396 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . 0.524 ' ND2' HD23 ' R' ' 80' ' ' LEU . 1.2 p-10 -128.61 77.23 1.76 Allowed 'General case' 0 N--CA 1.512 2.634 0 O-C-N 120.242 -1.536 . . . . 0.0 111.262 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 74.6 m80 48.44 16.98 0.11 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.801 -0.562 . . . . 0.0 112.345 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.529 ' HB3' ' HA ' ' R' ' 96' ' ' GLU . 37.3 m-20 -146.66 47.65 1.18 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.062 -1.024 . . . . 0.0 108.725 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.743 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 24.1 p30 -114.72 -21.68 10.08 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.693 ' CB ' ' HB3' ' R' ' 149' ' ' ALA 0.282 . . -66.32 -41.93 88.97 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.282 179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.705 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 39.6 m95 -59.71 -34.78 73.35 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.912 -1.515 . . . . 0.0 107.256 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.825 HD11 HG13 ' R' ' 83' ' ' ILE . 20.2 mt -68.18 -35.2 77.65 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . 0.591 ' HB3' ' O ' ' R' ' 51' ' ' ALA . 56.6 t-20 -48.92 -28.11 3.59 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . 0.873 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.13 -64.72 0.8 Allowed 'General case' 0 C--O 1.203 -1.371 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.594 ' N ' HD13 ' R' ' 56' ' ' ILE . 0.0 OUTLIER -57.13 -36.32 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 C-N-CA 118.974 -1.09 . . . . 0.0 108.751 178.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . 0.987 HD21 HG21 ' R' ' 71' ' ' VAL . 3.9 mm? -68.61 -72.52 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.623 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . 0.568 ' NE2' ' OD1' ' R' ' 54' ' ' ASN . 0.7 OUTLIER -57.85 -29.68 65.19 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.637 -1.289 . . . . 0.0 108.536 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.873 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 0.2 OUTLIER -70.43 -37.26 74.35 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.908 ' HA ' ' HD3' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -50.68 -53.02 34.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . 0.614 ' N ' ' CG ' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -55.87 -48.46 75.52 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.104 -1.039 . . . . 0.0 113.343 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' R' ' 153' ' ' CYS . 0.1 OUTLIER -90.69 -47.7 7.5 Favored 'General case' 0 N--CA 1.516 2.852 0 O-C-N 119.962 -1.711 . . . . 0.0 113.921 -176.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.888 HG22 HG12 ' R' ' 124' ' ' VAL . 47.7 t -77.76 -24.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.169 -0.957 . . . . 0.0 111.811 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . 0.776 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 88.2 tt0 124.33 117.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 122.131 0.967 . . . . 0.0 109.346 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' R' ' 68' ' ' PHE . 0.1 OUTLIER -44.28 100.32 0.23 Allowed Pre-proline 0 C--N 1.287 -2.13 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -178.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.908 ' HD3' ' HA ' ' R' ' 60' ' ' PHE . 51.8 Cg_endo -85.45 -162.12 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.589 2.192 . . . . 0.0 107.399 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' R' ' 69' ' ' ASP . 34.4 t80 -45.0 -17.98 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.323 0 O-C-N 121.769 -0.582 . . . . 0.0 112.022 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . 0.942 ' HD2' HD13 ' R' ' 57' ' ' LEU . 0.7 OUTLIER -37.52 -18.74 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 O-C-N 121.008 -1.057 . . . . 0.0 113.031 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' R' ' 67' ' ' PHE . 51.0 m-20 -49.12 -34.34 13.87 Favored 'General case' 0 C--N 1.292 -1.908 0 O-C-N 121.62 -0.675 . . . . 0.0 112.234 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.616 ' HB3' ' HA ' ' R' ' 82' ' ' ALA . 70.2 m95 -64.43 -31.24 72.37 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.572 -1.33 . . . . 0.0 109.858 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.987 HG21 HD21 ' R' ' 57' ' ' LEU . 46.9 t -70.81 -67.63 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . 0.925 ' CE2' HD12 ' R' ' 57' ' ' LEU . 13.3 m-30 -77.42 -30.36 53.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.517 -0.739 . . . . 0.0 111.878 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . 0.584 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 22.4 t -60.83 -19.34 59.66 Favored 'General case' 0 N--CA 1.512 2.657 0 C-N-CA 118.318 -1.353 . . . . 0.0 109.049 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . 0.687 ' OG ' HD22 ' R' ' 78' ' ' LEU . 38.5 m -77.2 139.87 65.18 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.771 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.44 -27.55 39.77 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -119.92 164.76 15.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.437 -0.79 . . . . 0.0 109.679 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' R' ' 44' ' ' ARG . 36.1 p-10 -52.59 110.26 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.197 -0.94 . . . . 0.0 110.088 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . 0.687 HD22 ' OG ' ' R' ' 74' ' ' SER . 1.5 mp -126.81 47.36 2.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.677 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . 0.745 ' OG1' HD12 ' R' ' 53' ' ' LEU . 0.5 OUTLIER -65.99 -52.19 51.63 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.398 -0.814 . . . . 0.0 109.009 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.524 HD23 ' ND2' ' R' ' 47' ' ' ASN . 0.0 OUTLIER -51.04 -59.39 4.21 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 118.741 -1.184 . . . . 0.0 111.678 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.38 -28.0 69.69 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.498 -1.376 . . . . 0.0 109.736 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.813 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -56.29 -51.1 69.43 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.48 -0.762 . . . . 0.0 111.624 -178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.825 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -85.41 -36.28 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 118.618 -1.233 . . . . 0.0 111.045 -179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' R' ' 87' ' ' GLU . 32.9 tttt -49.82 -33.52 16.97 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.43 ' HG2' ' CE2' ' R' ' 70' ' ' TRP . 50.9 tp60 -77.15 -36.4 55.28 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . 1.013 HD11 HG13 ' R' ' 103' ' ' VAL . 2.7 tm? -66.75 -40.62 88.38 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.807 -0.558 . . . . 0.0 110.176 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' R' ' 91' ' ' GLY . 10.7 pt-20 -66.08 -31.73 72.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.944 -1.098 . . . . 0.0 108.27 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.06 -31.36 69.91 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.389 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.833 HD23 ' N ' ' R' ' 90' ' ' THR . 1.1 tt -93.59 -48.89 6.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.581 -0.699 . . . . 0.0 111.042 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . 0.833 ' N ' HD23 ' R' ' 89' ' ' LEU . 68.1 p -74.89 -24.06 58.47 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' R' ' 87' ' ' GLU . . . 68.95 26.35 74.73 Favored Glycine 0 N--CA 1.498 2.776 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.033 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . 0.795 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.3 OUTLIER -105.94 -17.53 14.32 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.823 -1.398 . . . . 0.0 111.354 -179.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . 0.532 ' H ' ' HB2' ' R' ' 87' ' ' GLU . 81.6 tt0 65.44 122.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.813 HD13 ' CG2' ' R' ' 83' ' ' ILE . 0.3 OUTLIER -166.39 12.5 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . 0.728 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.7 OUTLIER -42.39 -29.12 0.25 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.607 -0.683 . . . . 0.0 109.234 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.529 ' HA ' ' HB3' ' R' ' 49' ' ' ASP . 98.5 mt-10 -116.15 23.33 12.25 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.647 -0.658 . . . . 0.0 110.854 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.683 ' HA2' ' CG ' ' R' ' 52' ' ' TRP . . . 156.08 128.56 1.11 Allowed Glycine 0 N--CA 1.496 2.634 0 C-N-CA 118.972 -1.585 . . . . 0.0 110.651 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . 0.567 ' HA2' ' HB2' ' R' ' 101' ' ' ALA . . . 152.02 75.5 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.686 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.889 ' HG2' ' HD2' ' R' ' 100' ' ' PRO . 33.5 Cg_endo -86.13 -90.69 0.0 OUTLIER 'Trans proline' 0 CA--C 1.564 1.999 0 C-N-CA 121.32 1.347 . . . . 0.0 110.406 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.889 ' HD2' ' HG2' ' R' ' 99' ' ' PRO . 37.1 Cg_endo -62.55 -16.97 55.78 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 N-CA-C 106.108 -2.305 . . . . 0.0 106.108 177.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.795 ' O ' HD22 ' R' ' 92' ' ' LEU 0.263 . . -30.87 61.82 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 113.61 -1.632 . . . . 0.0 112.587 175.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.837 ' N ' ' O ' ' R' ' 100' ' ' PRO . 48.2 mt 39.38 0.74 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.411 0 CA-C-O 117.849 -1.072 . . . . 0.0 112.671 -175.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 1.013 HG13 HD11 ' R' ' 86' ' ' LEU . 21.8 t -52.68 -40.58 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.64 ' HA ' ' HG ' ' R' ' 111' ' ' LEU . 32.3 pt -75.56 -36.54 34.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.373 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.632 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 61.5 t90 -64.63 -43.0 95.1 Favored 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 118.147 -1.421 . . . . 0.0 112.579 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.705 ' HB2' HG22 ' R' ' 90' ' ' THR . 27.3 m120 -78.35 -27.08 46.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.723 -1.236 . . . . 0.0 112.066 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . 0.743 HG23 HD23 ' R' ' 110' ' ' LEU . 63.3 mt -78.18 16.69 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.145 -0.972 . . . . 0.0 111.762 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.67 ' HA ' ' H ' ' R' ' 112' ' ' HIS . 80.4 mttt -30.49 -52.22 0.16 Allowed 'General case' 0 N--CA 1.513 2.709 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.588 ' CD2' HD22 ' R' ' 110' ' ' LEU . 36.9 p-80 -57.51 -26.98 62.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 119.143 -2.223 . . . . 0.0 112.458 -178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.743 HD23 HG23 ' R' ' 107' ' ' ILE . 0.2 OUTLIER -100.43 -39.49 7.93 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 176.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.823 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.1 OUTLIER -78.49 -96.91 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 111.523 -2.581 . . . . 0.0 114.608 -176.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . 0.67 ' H ' ' HA ' ' R' ' 108' ' ' LYS . 85.4 t60 -13.62 74.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 123.897 1.808 . . . . 0.0 109.986 -173.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.994 HG23 HD11 ' R' ' 115' ' ' ILE . 7.2 t -97.85 -173.43 2.61 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 112.152 -2.295 . . . . 0.0 107.446 177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.824 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.66 105.8 1.57 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 1.0 HD12 HG22 ' R' ' 124' ' ' VAL . 3.5 mm -109.88 143.55 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.539 -1.565 . . . . 0.0 110.581 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . 0.585 ' O ' HG13 ' R' ' 126' ' ' VAL . . . -143.11 -154.65 6.19 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.183 -1.484 . . . . 0.0 112.114 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.934 ' HA ' HG22 ' R' ' 126' ' ' VAL . 5.1 m -133.03 165.08 25.56 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 1.01 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -53.21 -36.35 60.91 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.38 -1.45 . . . . 0.0 110.369 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.2 m -64.59 -36.28 83.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 109.425 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm105 -124.19 94.18 45.67 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.502 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.44 134.32 30.56 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.753 1.396 . . . . 0.0 112.061 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . . . . . . . . . 3.5 m -134.11 -162.88 1.29 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' R' ' 114' ' ' GLY . 77.1 mm-40 -55.01 -41.24 71.04 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 120.567 -1.333 . . . . 0.0 108.377 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 1.0 HG22 HD12 ' R' ' 115' ' ' ILE . 0.9 OUTLIER -129.07 147.35 33.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' R' ' 182' ' ' PRO . 5.9 t -127.74 159.35 35.04 Favored 'General case' 0 C--N 1.278 -2.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 110.218 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.934 HG22 ' HA ' ' R' ' 117' ' ' THR . 15.7 m -85.2 -163.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.938 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 1.1 p -60.68 -160.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.726 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.743 ' HA ' ' HB2' ' R' ' 118' ' ' ALA . 28.9 p-10 -96.55 -74.91 0.55 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.746 -1.221 . . . . 0.0 113.21 -177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . 0.457 ' H ' ' CG ' ' R' ' 128' ' ' ASP . . . 58.7 5.38 2.72 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 107.258 -2.337 . . . . 0.0 107.258 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . 1.01 HG21 ' HB1' ' R' ' 118' ' ' ALA . 11.3 t -127.93 167.33 16.78 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 123.279 0.632 . . . . 0.0 109.355 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.4 74.44 2.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.42 -0.8 . . . . 0.0 110.897 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.585 ' HG3' HG23 ' R' ' 130' ' ' THR . 56.2 mtt -127.88 167.0 17.2 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.208 -0.933 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.85 -170.87 3.57 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.281 -0.887 . . . . 0.0 111.381 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 1.07 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -38.87 -56.36 1.38 Allowed 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 121.591 0.71 . . . . 0.0 112.538 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.57 -19.96 62.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . 0.469 ' O ' ' CE2' ' R' ' 183' ' ' TYR . 0.8 OUTLIER -55.71 -38.37 69.63 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.455 -1.403 . . . . 0.0 112.369 -178.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . 0.55 ' CB ' ' CD1' ' R' ' 180' ' ' PHE . 0.3 OUTLIER -142.38 168.69 19.15 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.947 -1.095 . . . . 0.0 108.173 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' R' ' 139' ' ' ALA . 14.8 m-70 -134.8 63.58 1.62 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.218 -1.393 . . . . 0.0 111.272 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.867 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 166.52 165.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.786 -0.571 . . . . 0.0 110.119 175.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . . . . . . . . . . . 156.02 -178.97 32.28 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.216 -1.468 . . . . 0.0 111.954 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . 1.04 HG23 ' CE2' ' R' ' 151' ' ' PHE . 10.7 mt -112.05 119.23 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 122.015 -0.697 . . . . 0.0 110.392 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.84 ' CZ ' HG11 ' R' ' 177' ' ' VAL . 8.0 m-85 -109.28 134.94 51.15 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.097 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.476 HD13 ' HA ' ' R' ' 143' ' ' LEU . 4.6 mm? -85.72 101.23 12.59 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.523 ' HD2' HG11 ' R' ' 150' ' ' VAL . 33.9 tttm -93.55 124.53 37.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.351 -0.843 . . . . 0.0 110.934 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 49.69 -145.32 8.41 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -111.52 138.98 47.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.507 -0.996 . . . . 0.0 110.043 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.413 ' HA ' ' CH2' ' R' ' 52' ' ' TRP . 79.7 tt0 54.67 44.34 28.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 0.1 OUTLIER -141.41 122.03 14.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.178 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.705 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -109.56 139.26 44.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.586 -0.696 . . . . 0.0 110.641 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . 0.733 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.7 m -139.52 153.27 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.055 -1.028 . . . . 0.0 109.174 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 1.04 ' CE2' HG23 ' R' ' 141' ' ' ILE . 82.0 m-85 -147.19 124.68 11.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.769 -1.207 . . . . 0.0 110.438 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.03 171.93 7.3 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.365 -1.459 . . . . 0.0 112.743 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 9.1 t -167.3 136.05 2.65 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' R' ' 34' ' ' TYR . 53.2 t -56.5 109.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.354 -1.466 . . . . 0.0 111.654 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . 0.693 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 77.2 p -89.63 -169.59 2.52 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . 0.55 ' N ' ' O ' ' R' ' 32' ' ' THR . 44.7 t -60.34 -21.25 61.84 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.777 -1.202 . . . . 0.0 108.428 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . 0.457 ' CB ' ' CE1' ' R' ' 160' ' ' TYR . 79.4 m-20 -95.96 3.71 53.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.483 -0.761 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . 0.497 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 106.23 -160.78 14.46 Favored Glycine 0 N--CA 1.483 1.821 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.625 ' CE2' HD12 ' R' ' 134' ' ' LEU . 5.5 m-90 -57.36 101.58 0.07 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.625 -0.927 . . . . 0.0 108.687 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . 0.693 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 4.2 m-85 -127.52 131.47 50.07 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . 1.033 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -106.27 146.73 29.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 119.979 -1.701 . . . . 0.0 110.937 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . 0.913 ' CD1' HD13 ' R' ' 31' ' ' LEU . 96.9 mt -102.66 90.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.381 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.575 ' O ' ' C ' ' R' ' 164' ' ' ASP . 3.6 t0 -88.58 122.46 32.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . 0.575 ' C ' ' O ' ' R' ' 163' ' ' ASP . 26.0 t0 -3.45 -64.69 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.435 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' R' ' 163' ' ' ASP . 97.1 mt-10 -59.34 -42.21 90.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.696 -1.253 . . . . 0.0 114.37 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -167.26 172.92 9.4 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 119.811 -1.806 . . . . 0.0 113.215 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . 0.931 ' CZ ' HD11 ' R' ' 31' ' ' LEU . 3.5 m-30 -98.43 129.13 45.05 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' R' ' 161' ' ' ALA . 2.1 p90 -141.15 163.86 39.39 Favored Pre-proline 0 C--N 1.29 -2.01 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.94 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 42.3 Cg_endo -69.84 108.52 2.11 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.014 1.534 . . . . 0.0 110.144 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.525 ' CD1' ' CD1' ' R' ' 168' ' ' TYR . 0.5 OUTLIER -138.9 153.81 48.31 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . 1.07 ' CG2' HD11 ' R' ' 134' ' ' LEU . 1.0 OUTLIER -101.93 151.23 37.95 Favored Pre-proline 0 C--N 1.278 -2.541 0 C-N-CA 119.136 -1.025 . . . . 0.0 112.29 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.749 ' HD2' HD13 ' R' ' 134' ' ' LEU . 45.3 Cg_endo -94.37 32.97 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.865 1.71 . . . . 0.0 109.411 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . 0.582 ' O ' ' CG1' ' R' ' 177' ' ' VAL . 0.6 OUTLIER -76.77 153.27 83.17 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.357 179.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.58 ' HA ' HG13 ' R' ' 177' ' ' VAL . 49.5 Cg_endo -75.67 26.2 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.968 1.51 . . . . 0.0 111.206 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 23.3 t -69.89 -48.3 59.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.985 -1.072 . . . . 0.0 110.897 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' R' ' 143' ' ' LEU . 91.1 m-20 -125.6 13.45 8.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.206 -0.934 . . . . 0.0 110.491 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.84 HG11 ' CZ ' ' R' ' 142' ' ' PHE . 0.1 OUTLIER -121.48 153.93 25.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.832 . . . . 0.0 109.736 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.938 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 2.1 mm? -127.63 46.6 2.52 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.062 -1.455 . . . . 0.0 108.932 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.733 ' HA ' ' C ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.61 124.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.55 ' CD1' ' CB ' ' R' ' 137' ' ' PHE . 4.2 p90 -125.12 168.17 13.78 Favored 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 118.335 -1.346 . . . . 0.0 108.544 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . 0.867 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 1.0 OUTLIER -122.87 111.99 30.73 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.122 -179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' R' ' 125' ' ' CYS . 47.7 Cg_endo -76.04 156.14 38.34 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 O-C-N 123.615 1.324 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.53 ' CD2' ' CD2' ' R' ' 138' ' ' HIS . 1.1 p90 -91.43 -2.21 57.34 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.517 -0.739 . . . . 0.0 110.873 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 53.64 48.34 21.82 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.108 -0.995 . . . . 0.0 111.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -100.58 130.12 46.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -116.31 163.86 20.23 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.347 -0.845 . . . . 0.0 110.205 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.33 143.81 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.796 1.419 . . . . 0.0 110.522 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.1 1.44 54.31 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.42 -0.8 . . . . 0.0 110.75 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -102.04 131.42 48.5 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.128 -0.983 . . . . 0.0 110.364 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.37 -175.24 47.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 50.84 94.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.448 -1.03 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -112.24 139.23 47.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.336 -0.853 . . . . 0.0 110.149 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -80.56 133.33 35.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.86 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.4 145.54 30.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.823 . . . . 0.0 110.438 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 19.0 tptt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.19 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.05 0.452 . . . . 0.0 110.486 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . 0.482 ' C ' HD22 ' R' ' 31' ' ' LEU . 44.9 tp10 -117.5 119.43 35.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.16 -0.962 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . 0.961 HD23 ' CD1' ' R' ' 41' ' ' PHE . 3.8 mm? -94.8 166.81 11.8 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.392 -0.817 . . . . 0.0 109.546 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . 0.88 ' C ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -126.47 140.23 52.63 Favored 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 118.958 2.947 . . . . 0.0 118.958 -173.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 1.111 ' N ' HD22 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -17.64 -85.04 0.0 OUTLIER 'General case' 0 N--CA 1.536 3.84 0 CA-C-N 111.837 -2.438 . . . . 0.0 116.463 176.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . 0.776 ' C ' ' O ' ' R' ' 33' ' ' LEU . 92.5 m-85 -19.58 -56.28 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.977 -174.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' R' ' 33' ' ' LEU . 7.0 m120 -131.84 62.41 1.63 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 110.035 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . 1.216 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 141.75 36.8 0.09 OUTLIER Glycine 0 N--CA 1.479 1.521 0 C-N-CA 117.055 -2.498 . . . . 0.0 110.465 -176.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . 1.216 ' O ' ' O ' ' R' ' 36' ' ' GLY . 80.7 mm-40 -11.68 -167.21 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 122.455 0.302 . . . . 0.0 110.848 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -67.33 92.73 0.29 Allowed 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 116.23 -2.188 . . . . 0.0 106.809 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' R' ' 37' ' ' GLU . 36.2 mmtt -123.76 119.87 31.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . 0.588 HG22 ' O ' ' R' ' 40' ' ' THR . 0.9 OUTLIER -91.29 115.08 27.74 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.455 -1.298 . . . . 0.0 112.452 -178.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.961 ' CD1' HD23 ' R' ' 31' ' ' LEU . 3.0 m-85 -98.42 162.83 12.96 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' R' ' 165' ' ' GLU . 97.4 m-85 -95.4 158.58 15.4 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' R' ' 165' ' ' GLU . 46.7 m -115.57 94.9 4.9 Favored 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.28 -0.888 . . . . 0.0 110.386 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . 0.529 ' H ' ' CB ' ' R' ' 165' ' ' GLU . 0.0 OUTLIER -167.64 124.16 0.89 Allowed Pre-proline 0 N--CA 1.485 1.302 0 O-C-N 121.306 -0.871 . . . . 0.0 109.096 179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.18 126.35 13.59 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 N-CA-C 108.625 -1.336 . . . . 0.0 108.625 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.522 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 74.4 m-20 -88.12 152.97 21.62 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.149 -0.97 . . . . 0.0 109.033 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.39 80.24 1.82 Allowed 'General case' 0 N--CA 1.507 2.387 0 C-N-CA 118.231 -1.388 . . . . 0.0 110.257 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.586 ' CD2' HD23 ' R' ' 80' ' ' LEU . 5.3 p-80 178.62 -36.81 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.57 ' HB3' ' O ' ' R' ' 48' ' ' HIS . 1.5 p30 157.16 108.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' OG1' ' R' ' 79' ' ' THR . 8.4 p30 -142.88 -25.75 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.911 -1.118 . . . . 0.0 109.37 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.751 ' HA ' ' HB3' ' R' ' 54' ' ' ASN 0.271 . . -64.98 -44.24 89.96 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.056 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.498 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 75.3 m95 -58.01 -36.17 72.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 117.782 -1.567 . . . . 0.0 107.898 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.877 HD11 HG13 ' R' ' 83' ' ' ILE . 11.6 mt -69.38 -44.73 70.92 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' R' ' 51' ' ' ALA . 0.0 OUTLIER -43.28 -32.26 0.76 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 108.921 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . 0.866 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -64.93 -67.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.591 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.733 HG21 ' O ' ' R' ' 100' ' ' PRO . 0.2 OUTLIER -84.19 -41.74 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 C-N-CA 117.884 -1.527 . . . . 0.0 109.885 178.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . 0.917 ' CD2' HG21 ' R' ' 71' ' ' VAL 0.265 1.5 tm? -48.25 -61.87 1.77 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.604 0.716 . . . . 0.0 111.207 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . 0.653 ' CD ' HG21 ' R' ' 162' ' ' ILE . 73.4 mt-30 -70.06 -27.77 64.9 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.866 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 3.4 tp -55.93 -38.51 70.38 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.923 ' CE1' HD21 ' R' ' 111' ' ' LEU . 22.9 m-30 -58.41 -41.18 84.35 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.144 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . 0.51 ' CB ' ' CZ ' ' R' ' 41' ' ' PHE . 0.0 OUTLIER -64.88 -38.52 91.24 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.344 -1.472 . . . . 0.0 114.473 -179.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.769 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 1.4 p90 -82.78 -42.39 17.99 Favored 'General case' 0 N--CA 1.516 2.826 0 O-C-N 119.575 -1.953 . . . . 0.0 114.731 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.769 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.5 t -73.77 -14.99 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 119.825 -1.797 . . . . 0.0 111.179 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . 0.698 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 65.0 tt0 98.91 29.29 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.559 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 1.8 tp10 -132.33 90.15 34.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.663 -1.273 . . . . 0.0 107.788 177.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.561 ' HA ' ' HB3' ' R' ' 60' ' ' PHE . 48.3 Cg_endo -78.09 83.55 2.18 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.706 1.372 . . . . 0.0 113.966 -176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . 0.657 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 48.0 t80 -83.35 -19.11 36.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 174.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . 0.671 ' HB2' ' CD1' ' R' ' 57' ' ' LEU . 0.0 OUTLIER -62.38 11.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.012 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.664 ' O ' ' HB3' ' R' ' 73' ' ' SER . 94.8 m-20 -46.8 -39.37 11.7 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.457 -0.777 . . . . 0.0 111.775 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.504 ' HA ' ' HB2' ' R' ' 74' ' ' SER . 35.3 m95 -69.82 -37.28 76.19 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.766 -1.208 . . . . 0.0 109.635 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.917 HG21 ' CD2' ' R' ' 57' ' ' LEU 0.252 43.5 t -70.34 -75.97 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . 0.632 ' CD1' HG12 ' R' ' 71' ' ' VAL . 18.8 m-30 -86.65 -35.96 19.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.283 -0.886 . . . . 0.0 111.737 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . 0.664 ' HB3' ' O ' ' R' ' 69' ' ' ASP . 9.6 t -71.03 -17.33 62.63 Favored 'General case' 0 N--CA 1.509 2.511 0 C-N-CA 117.702 -1.599 . . . . 0.0 108.909 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' R' ' 70' ' ' TRP . 0.4 OUTLIER -117.47 114.41 38.22 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.366 -0.834 . . . . 0.0 109.334 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.34 -11.65 32.32 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.539 1.283 . . . . 0.0 110.528 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . 0.514 ' O ' HD13 ' R' ' 78' ' ' LEU . 84.6 tt0 -104.84 -64.47 1.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 111.169 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.479 ' CA ' ' HB2' ' R' ' 81' ' ' GLU . 11.6 m120 -44.54 -44.18 8.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 112.047 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . 0.709 ' O ' ' HB2' ' R' ' 82' ' ' ALA . 6.1 mp 49.57 -154.83 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.893 -1.129 . . . . 0.0 111.008 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . 0.832 ' OG1' HD12 ' R' ' 53' ' ' LEU . 2.0 t -68.67 -59.23 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.877 -0.729 . . . . 0.0 112.899 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.65 ' H ' HG23 ' R' ' 79' ' ' THR . 0.4 OUTLIER -50.13 -52.26 36.59 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . 0.589 ' HG3' HD12 ' R' ' 80' ' ' LEU . 72.2 mt-10 -69.75 -27.92 65.35 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 120.077 -1.639 . . . . 0.0 109.302 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.749 ' CB ' HG23 ' R' ' 71' ' ' VAL . . . -58.9 -53.7 55.49 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.683 -0.636 . . . . 0.0 112.152 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 1.12 HG21 HD11 ' R' ' 94' ' ' LEU . 0.2 OUTLIER -86.4 -33.62 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.178 -1.409 . . . . 0.0 111.44 -178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' R' ' 83' ' ' ILE . 16.4 tttt -49.81 -36.36 26.11 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.89 -41.01 92.07 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . 0.978 HD13 HG13 ' R' ' 103' ' ' VAL . 13.2 mt -67.03 -34.29 77.4 Favored 'General case' 0 C--O 1.206 -1.229 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.804 178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . 0.591 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -51.63 -42.06 61.74 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -63.8 -36.03 82.56 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.551 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.691 ' CD2' HG23 ' R' ' 107' ' ' ILE . 5.1 tt -99.07 -52.45 3.54 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.695 -1.253 . . . . 0.0 111.824 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . 0.963 ' CG2' HD22 ' R' ' 86' ' ' LEU . 64.8 p -70.72 -24.74 62.7 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 61.83 21.89 61.52 Favored Glycine 0 N--CA 1.502 3.052 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.673 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . 1.04 ' CD1' HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -93.59 -16.09 24.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.225 -1.162 . . . . 0.0 111.193 -178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . 0.741 ' N ' HD12 ' R' ' 92' ' ' LEU . 95.9 mt-10 52.13 93.77 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.387 -0.821 . . . . 0.0 108.835 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 1.12 HD11 HG21 ' R' ' 83' ' ' ILE . 2.5 pp -145.09 4.94 1.1 Allowed 'General case' 0 C--N 1.308 -1.225 0 O-C-N 120.977 -1.077 . . . . 0.0 109.91 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . 0.841 ' HA ' HD13 ' R' ' 83' ' ' ILE . 0.9 OUTLIER -39.31 -33.87 0.17 Allowed 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.422 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.49 21.82 11.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.568 -0.707 . . . . 0.0 110.658 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.652 ' O ' ' HB2' ' R' ' 94' ' ' LEU . . . 160.16 -115.26 0.65 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.087 -1.53 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' R' ' 97' ' ' GLY . . . 55.81 166.48 0.05 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.497 ' HG2' ' CG ' ' R' ' 102' ' ' LEU . 47.9 Cg_endo -79.43 125.23 6.19 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 123.73 1.384 . . . . 0.0 110.575 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.733 ' O ' HG21 ' R' ' 56' ' ' ILE . 39.3 Cg_endo -64.71 -34.35 51.04 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.487 1.257 . . . . 0.0 109.859 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.6 ' O ' HG12 ' R' ' 104' ' ' ILE 0.251 . . -57.6 -39.73 77.5 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.956 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' R' ' 92' ' ' LEU . 3.5 mm? -56.08 -31.75 63.5 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.027 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.978 HG13 HD13 ' R' ' 86' ' ' LEU . 14.8 t -59.18 -52.85 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 117.444 -1.702 . . . . 0.0 110.27 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.705 HG22 HD11 ' R' ' 111' ' ' LEU . 43.5 pt -66.04 -34.53 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.538 -0.726 . . . . 0.0 111.108 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.498 ' N ' HG13 ' R' ' 104' ' ' ILE . 8.4 m95 -60.7 -38.97 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 0.0 111.816 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.787 ' CB ' ' HA ' ' R' ' 90' ' ' THR . 71.3 m-80 -82.26 -34.56 28.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.702 -1.249 . . . . 0.0 113.265 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . 0.728 HG22 HD23 ' R' ' 110' ' ' LEU . 0.2 OUTLIER -92.76 22.88 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.601 -1.312 . . . . 0.0 110.368 -179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' R' ' 112' ' ' HIS . 32.3 tttt -29.58 -58.99 0.16 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.848 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.3 m-70 -63.12 -13.59 38.5 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 122.129 2.24 . . . . 0.0 111.232 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.848 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -111.11 -7.46 14.49 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.923 HD21 ' CE1' ' R' ' 60' ' ' PHE . 0.2 OUTLIER -142.99 -111.34 0.12 Allowed 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.197 -1.365 . . . . 0.0 114.449 -173.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . 0.626 ' C ' ' O ' ' R' ' 111' ' ' LEU . 82.8 t60 -19.47 81.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 123.768 1.747 . . . . 0.0 109.871 -173.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 1.094 ' CG2' HD11 ' R' ' 115' ' ' ILE 0.25 4.5 t -70.12 -162.55 0.06 Allowed 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.14 177.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.837 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -68.1 97.84 0.46 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 1.094 HD11 ' CG2' ' R' ' 113' ' ' THR . 3.3 mm -113.01 145.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.784 -1.421 . . . . 0.0 110.601 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . 0.453 ' N ' ' HB2' ' R' ' 122' ' ' SER . . . -124.92 -143.99 6.23 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 119.627 -1.273 . . . . 0.0 110.925 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.977 ' HA ' HG22 ' R' ' 126' ' ' VAL . 24.9 m -138.05 174.5 10.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.889 ' HB1' HG21 ' R' ' 130' ' ' THR . . . -55.66 -29.45 59.32 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.389 -1.325 . . . . 0.0 109.62 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 39.6 m -87.11 -33.19 19.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.561 -0.712 . . . . 0.0 110.206 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -101.16 119.8 56.89 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.247 -0.908 . . . . 0.0 110.384 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -81.79 124.91 4.68 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.627 1.33 . . . . 0.0 112.228 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER -140.74 -170.08 2.94 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' R' ' 114' ' ' GLY . 52.7 mt-10 -55.59 -44.74 77.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.52 -1.362 . . . . 0.0 107.862 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 1.008 ' CG2' HD12 ' R' ' 115' ' ' ILE . 1.9 m -120.25 138.33 51.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.542 ' O ' ' O ' ' R' ' 180' ' ' PHE . 43.1 t -123.05 135.22 54.34 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.237 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.977 HG22 ' HA ' ' R' ' 117' ' ' THR . 10.4 m -80.64 -173.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.417 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.931 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 3.6 m -117.16 -42.01 2.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 C-N-CA 118.463 -1.295 . . . . 0.0 113.802 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.526 ' N ' HG23 ' R' ' 127' ' ' VAL . 89.2 m-20 42.55 37.12 0.9 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.566 -1.334 . . . . 0.0 111.021 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.33 39.92 91.83 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . 0.889 HG21 ' HB1' ' R' ' 118' ' ' ALA . 90.7 m -113.34 152.62 29.7 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.694 -0.886 . . . . 0.0 111.627 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' R' ' 130' ' ' THR . 65.6 m-20 70.73 -166.88 0.15 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.864 0.84 . . . . 0.0 111.987 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.522 ' O ' ' OD2' ' R' ' 173' ' ' ASP . 87.2 mtp -83.83 177.5 8.31 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.889 -0.507 . . . . 0.0 111.111 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.532 ' O ' ' C ' ' R' ' 134' ' ' LEU . 0.5 OUTLIER -89.22 -171.22 3.17 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.69 -0.631 . . . . 0.0 111.253 -179.009 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 1.077 ' HA ' ' HB2' ' R' ' 173' ' ' ASP . 0.3 OUTLIER -3.76 -70.35 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' R' ' 133' ' ' CYS . . . -54.19 3.41 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 -177.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . 0.607 ' O ' ' CZ ' ' R' ' 183' ' ' TYR . 14.5 t70 -84.98 -90.47 0.1 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 119.396 -2.065 . . . . 0.0 111.598 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . 0.84 ' CE1' ' HB2' ' R' ' 180' ' ' PHE . 14.3 p90 -102.47 -176.19 3.03 Favored 'General case' 0 C--O 1.199 -1.567 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.888 ' HB2' HG23 ' R' ' 154' ' ' VAL . 0.0 OUTLIER -149.53 79.96 1.39 Allowed 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.183 -1.807 . . . . 0.0 111.196 176.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.767 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 176.96 161.29 0.41 Allowed 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.656 175.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 131.45 -165.62 23.17 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.751 -1.214 . . . . 0.0 111.826 177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . 0.794 HD11 ' CD2' ' R' ' 59' ' ' LEU . 62.0 mt -106.8 119.18 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.8 -0.823 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.826 ' HB2' HG23 ' R' ' 150' ' ' VAL . 0.4 OUTLIER -109.72 140.01 44.09 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.718 0.771 . . . . 0.0 109.688 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 28.9 tp -100.42 119.36 38.34 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.33 -0.857 . . . . 0.0 108.978 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -100.73 121.26 41.37 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.268 -0.895 . . . . 0.0 110.751 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.75 -124.08 32.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -133.92 154.64 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.503 -0.998 . . . . 0.0 109.498 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.8 31.0 2.88 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.261 -0.9 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -138.99 125.23 20.2 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.508 -0.745 . . . . 0.0 109.407 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.747 ' HB3' ' C ' ' R' ' 51' ' ' ALA . . . -112.43 142.91 44.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.613 -0.679 . . . . 0.0 110.233 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' R' ' 142' ' ' PHE . 35.3 m -142.15 167.63 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.1 -1.0 . . . . 0.0 109.7 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.752 ' CE1' HD12 ' R' ' 59' ' ' LEU . 52.2 t80 -150.35 121.68 7.86 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.257 -0.902 . . . . 0.0 112.214 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -114.44 168.0 10.23 Favored 'General case' 0 N--CA 1.508 2.428 0 O-C-N 119.985 -1.697 . . . . 0.0 110.264 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . 0.79 ' HB2' ' CE2' ' R' ' 160' ' ' TYR . 0.5 OUTLIER -168.56 144.82 3.7 Favored 'General case' 0 C--O 1.207 -1.151 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.361 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.888 HG23 ' HB2' ' R' ' 138' ' ' HIS . 41.4 t -55.55 123.01 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 O-C-N 120.081 -1.637 . . . . 0.0 114.028 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . 0.608 ' CG2' ' HB3' ' R' ' 160' ' ' TYR . 21.9 p -126.88 -179.56 4.89 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.127 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 42.1 m -56.36 -20.29 18.59 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.169 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . 0.506 ' HB3' ' HG3' ' R' ' 169' ' ' PRO . 79.1 m-20 -92.66 -5.2 51.93 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.576 -0.702 . . . . 0.0 111.855 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 116.96 -135.44 11.96 Favored Glycine 0 N--CA 1.487 2.066 0 C-N-CA 118.965 -1.588 . . . . 0.0 109.996 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.857 ' O ' ' HA ' ' R' ' 169' ' ' PRO . 0.0 OUTLIER -82.34 82.17 7.92 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . 0.982 ' O ' ' HB1' ' R' ' 152' ' ' ALA . 0.0 OUTLIER -64.22 160.04 19.42 Favored 'General case' 0 C--O 1.2 -1.519 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . 1.006 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -147.12 113.23 5.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . 0.866 ' O ' HG23 ' R' ' 162' ' ' ILE . 0.7 OUTLIER -72.43 83.69 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 123.103 1.43 . . . . 0.0 111.101 -175.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.485 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -80.01 131.0 35.7 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' R' ' 163' ' ' ASP . 92.6 m-20 32.82 65.16 0.24 Allowed 'General case' 0 N--CA 1.518 2.94 0 O-C-N 120.884 -1.135 . . . . 0.0 112.465 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.763 ' HB3' ' O ' ' R' ' 42' ' ' TYR . 5.3 mt-10 58.75 8.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.232 -1.542 . . . . 0.0 112.129 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 74.5 m-20 -109.44 152.54 25.24 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 119.977 -1.702 . . . . 0.0 108.754 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . 0.662 ' CB ' HD11 ' R' ' 31' ' ' LEU . 19.5 p90 -124.7 130.39 52.33 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.868 1.318 . . . . 0.0 110.91 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . 0.543 ' CD1' ' O ' ' R' ' 161' ' ' ALA . 2.0 p90 -159.42 144.03 11.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 CA-C-N 114.22 -1.355 . . . . 0.0 107.685 -178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' R' ' 159' ' ' TRP . 50.3 Cg_endo -72.89 107.7 2.41 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 O-C-N 123.088 1.046 . . . . 0.0 112.802 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.79 ' O ' HG23 ' R' ' 171' ' ' THR . 0.6 OUTLIER -135.3 18.28 3.4 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 117.123 -1.831 . . . . 0.0 112.66 175.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . 1.029 HG22 HD11 ' R' ' 134' ' ' LEU . 0.1 OUTLIER 167.43 121.01 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.965 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 175.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 1.037 ' CD ' HD13 ' R' ' 134' ' ' LEU . 42.2 Cg_endo -101.65 16.76 0.3 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.235 1.29 . . . . 0.0 113.421 176.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' R' ' 134' ' ' LEU . 0.1 OUTLIER -144.48 -173.1 0.34 Allowed Pre-proline 0 N--CA 1.511 2.583 0 O-C-N 118.216 -2.802 . . . . 0.0 114.923 -178.05 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 1.06 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.4 Cg_endo -86.39 34.07 0.45 Allowed 'Trans proline' 0 C--O 1.217 -0.57 0 O-C-N 124.29 1.679 . . . . 0.0 112.143 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . 0.729 ' OG ' HD23 ' R' ' 134' ' ' LEU . 15.0 m -62.18 -43.45 98.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.816 -1.178 . . . . 0.0 108.436 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -123.09 0.82 9.13 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.63 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 1.06 HG13 ' HA ' ' R' ' 174' ' ' PRO . 0.2 OUTLIER -109.34 157.07 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.304 -0.873 . . . . 0.0 109.838 -178.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.931 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.5 OUTLIER -132.1 38.34 3.51 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 117.529 -1.668 . . . . 0.0 110.606 177.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.974 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 7.7 p -165.63 129.13 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.84 ' HB2' ' CE1' ' R' ' 137' ' ' PHE . 7.1 p90 -136.72 179.44 6.37 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.174 -1.41 . . . . 0.0 111.227 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . 0.767 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -112.21 137.98 21.67 Favored Pre-proline 0 C--N 1.282 -2.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.395 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . 0.412 ' HD2' HG22 ' R' ' 181' ' ' VAL . 41.0 Cg_endo -66.49 141.34 60.88 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.5 1.263 . . . . 0.0 111.866 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.607 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 15.7 p90 -138.35 172.74 12.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.654 -0.654 . . . . 0.0 109.464 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -154.29 164.27 38.84 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.18 -0.95 . . . . 0.0 110.947 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -131.25 158.19 41.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.557 -0.715 . . . . 0.0 109.86 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -101.51 106.51 46.53 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 110.308 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 150.9 64.01 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.68 1.358 . . . . 0.0 110.437 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 25.2 tp -97.56 126.01 42.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.362 -0.836 . . . . 0.0 110.252 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -125.81 116.44 21.58 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.243 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -167.38 150.85 17.91 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 48.28 -169.13 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.517 -0.99 . . . . 0.0 110.712 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -139.12 163.26 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.398 -0.814 . . . . 0.0 110.209 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.16 110.05 22.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.293 -0.879 . . . . 0.0 110.077 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -102.63 144.5 30.94 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.887 . . . . 0.0 110.344 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.257 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . 0.54 ' HB2' ' CE2' ' R' ' 167' ' ' PHE . 89.2 mtp . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 121.291 0.567 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' R' ' 40' ' ' THR . 93.2 mt-10 -97.77 114.71 26.79 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.441 -0.787 . . . . 0.0 111.372 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . 1.028 HD13 HG21 ' R' ' 162' ' ' ILE . 1.2 pt? -122.9 135.52 54.53 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.49 -1.284 . . . . 0.0 111.025 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' R' ' 38' ' ' LYS . 8.8 t -91.58 156.24 17.79 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.484 0.659 . . . . 0.0 112.158 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' R' ' 37' ' ' GLU . 0.0 OUTLIER -106.26 -173.97 2.42 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.655 -0.653 . . . . 0.0 110.595 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . 0.713 ' N ' ' O ' ' R' ' 154' ' ' VAL . 19.2 p90 -48.14 -49.8 31.01 Favored 'General case' 0 N--CA 1.508 2.436 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . 0.629 ' OD1' HD23 ' R' ' 33' ' ' LEU . 12.4 p-10 -76.57 17.99 0.36 Allowed 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 122.417 2.371 . . . . 0.0 114.303 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -13.74 40.47 Favored Glycine 0 N--CA 1.493 2.445 0 O-C-N 120.07 -1.644 . . . . 0.0 112.795 177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . 0.791 ' HB3' HD21 ' R' ' 33' ' ' LEU . 81.2 tt0 -61.18 131.88 51.91 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 119.637 1.718 . . . . 0.0 108.96 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' R' ' 38' ' ' LYS . 52.6 pttt -100.93 113.03 25.63 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.925 0.869 . . . . 0.0 111.062 -178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.57 ' HB3' ' HD2' ' R' ' 61' ' ' ARG . 67.1 mttm -113.21 117.77 32.81 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' R' ' 40' ' ' THR . 1.3 t -94.69 133.0 38.82 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.358 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 1.179 ' CE2' HD11 ' R' ' 162' ' ' ILE . 0.1 OUTLIER -145.67 166.73 24.95 Favored 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.739 176.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . 0.512 ' O ' ' OG ' ' R' ' 43' ' ' SER . 87.0 m-85 -79.35 175.86 10.21 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.964 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . 0.689 ' O ' ' O ' ' R' ' 44' ' ' ARG . 0.8 OUTLIER 169.62 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.509 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . 0.689 ' O ' ' O ' ' R' ' 43' ' ' SER . 5.7 ptt180 -32.87 163.97 0.02 OUTLIER Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.019 -1.05 . . . . 0.0 111.483 -175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 29.3 Cg_endo -52.28 104.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.347 1.183 . . . . 0.0 110.874 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' R' ' 76' ' ' GLU . 7.3 t-20 -92.63 -127.67 0.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.555 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' R' ' 48' ' ' HIS . 0.4 OUTLIER -134.55 138.12 44.36 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.613 -1.304 . . . . 0.0 111.661 179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.55 ' CD2' HD22 ' R' ' 80' ' ' LEU . 92.9 m-70 72.52 42.98 0.5 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.423 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.406 ' O ' ' O ' ' R' ' 48' ' ' HIS . 80.1 m-20 55.26 102.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.439 -0.788 . . . . 0.0 109.357 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' R' ' 77' ' ' ASN . 31.1 p-10 -111.63 1.98 17.06 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.623 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.253 . . -68.51 -41.86 79.36 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.696 -0.628 . . . . 0.0 111.716 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 1.006 ' CE3' ' HB2' ' R' ' 149' ' ' ALA . 33.2 m95 -60.13 -33.64 72.42 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.08 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 1.074 HD11 HG12 ' R' ' 83' ' ' ILE . 2.3 mt -79.53 -40.37 29.75 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . 0.569 ' O ' ' HG3' ' R' ' 58' ' ' GLN . 8.3 t30 -55.15 -28.79 55.31 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . 0.942 ' HB1' ' CE1' ' R' ' 151' ' ' PHE . . . -64.43 -64.37 0.9 Allowed 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.798 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.856 HD12 HG11 ' R' ' 103' ' ' VAL . 0.6 OUTLIER -67.27 -29.2 45.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 O-C-N 120.231 -1.543 . . . . 0.0 108.174 177.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . 0.997 ' HG ' HG11 ' R' ' 71' ' ' VAL . 1.8 mm? -52.62 -54.57 31.31 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.008 0.909 . . . . 0.0 109.139 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' R' ' 54' ' ' ASN . 1.8 mt-30 -55.03 -31.73 61.31 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' R' ' 151' ' ' PHE . 1.4 tp -67.84 -40.71 83.69 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.783 ' HB2' ' HD2' ' R' ' 66' ' ' PRO . 0.0 OUTLIER -54.14 -47.28 72.09 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.262 -0.975 . . . . 0.0 109.955 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . 0.581 ' HG2' ' CZ ' ' R' ' 60' ' ' PHE . 16.2 mmt180 -57.8 -54.32 48.22 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.884 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.806 ' CZ ' ' HB1' ' R' ' 139' ' ' ALA . 21.6 p90 -92.6 -31.76 15.04 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 119.598 -1.939 . . . . 0.0 114.016 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.74 HG22 HG12 ' R' ' 124' ' ' VAL . 56.1 t -77.18 -24.85 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 120.137 -1.602 . . . . 0.0 110.233 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . 0.73 ' CB ' ' O ' ' R' ' 63' ' ' VAL . 87.3 tt0 123.22 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.574 ' HB3' ' HD1' ' R' ' 60' ' ' PHE . 3.5 pt-20 -50.44 100.92 0.24 Allowed Pre-proline 0 N--CA 1.496 1.872 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.783 ' HD2' ' HB2' ' R' ' 60' ' ' PHE . 46.7 Cg_endo -86.69 -165.23 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 N-CA-C 106.023 -2.337 . . . . 0.0 106.023 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . 0.593 ' CE1' HD21 ' R' ' 89' ' ' LEU . 76.6 m-85 -41.95 -19.35 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . 0.802 ' HB3' HD22 ' R' ' 57' ' ' LEU . 3.2 m-30 -58.24 -3.01 0.22 Allowed 'General case' 0 N--CA 1.513 2.685 0 O-C-N 120.286 -1.509 . . . . 0.0 110.452 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' R' ' 72' ' ' TYR . 19.8 t70 -58.35 -30.39 66.71 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.717 -178.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -61.58 -33.51 74.01 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.848 -1.158 . . . . 0.0 108.886 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.997 HG11 ' HG ' ' R' ' 57' ' ' LEU . 55.5 t -68.39 -62.2 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.535 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' R' ' 69' ' ' ASP . 0.8 OUTLIER -71.98 -30.75 65.58 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.207 -177.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . 0.444 ' CB ' ' O ' ' R' ' 69' ' ' ASP . 34.0 t -63.99 -23.24 67.26 Favored 'General case' 0 N--CA 1.51 2.573 0 C-N-CA 119.416 -0.914 . . . . 0.0 109.434 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.62 148.93 80.45 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . 0.415 ' O ' ' CE1' ' R' ' 42' ' ' TYR . 38.8 Cg_endo -65.03 -17.46 59.32 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.712 1.375 . . . . 0.0 110.025 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' R' ' 78' ' ' LEU . 96.1 mt-10 -141.28 58.84 1.52 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.5 -0.75 . . . . 0.0 109.499 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.539 ' ND2' HG13 ' R' ' 71' ' ' VAL . 28.7 t-20 57.38 -84.51 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.698 -0.626 . . . . 0.0 110.818 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . 0.554 HD12 ' HB2' ' R' ' 81' ' ' GLU . 0.1 OUTLIER 78.33 67.28 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . 0.646 ' O ' HG12 ' R' ' 83' ' ' ILE . 5.3 t -65.25 -52.64 53.14 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.834 -0.541 . . . . 0.0 110.573 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.593 HD12 ' HG3' ' R' ' 81' ' ' GLU . 0.4 OUTLIER -49.85 -53.12 27.65 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.126 -1.03 . . . . 0.0 113.56 -177.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . 0.593 ' HG3' HD12 ' R' ' 80' ' ' LEU . 95.4 mt-10 -68.12 -28.22 67.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.059 -1.651 . . . . 0.0 110.277 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.921 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.61 -46.74 74.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.768 0.794 . . . . 0.0 112.436 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 1.074 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.36 -39.97 13.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.565 -176.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' R' ' 80' ' ' LEU . 35.4 mttm -49.74 -35.86 23.63 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.614 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 68.3 tp60 -70.93 -44.57 65.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . 0.806 HD13 ' OG1' ' R' ' 90' ' ' THR . 1.4 tm? -55.11 -38.4 68.12 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . 0.554 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.8 tt0 -59.37 -33.22 70.91 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.915 -1.115 . . . . 0.0 108.15 177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 82.0 m-20 -55.14 -32.49 62.14 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.689 -1.204 . . . . 0.0 108.956 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.905 HD12 ' H ' ' R' ' 89' ' ' LEU . 0.3 OUTLIER -102.61 -49.1 3.93 Favored 'General case' 0 N--CA 1.509 2.51 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.938 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . 0.887 ' OG1' HD22 ' R' ' 92' ' ' LEU . 35.0 p -78.6 -27.79 45.64 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 73.12 23.61 77.32 Favored Glycine 0 N--CA 1.506 3.333 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.154 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . 1.017 HD11 HD21 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -108.12 -160.88 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.063 -1.257 . . . . 0.0 112.042 -178.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . 0.83 ' C ' HD13 ' R' ' 94' ' ' LEU . 95.5 mt-10 -144.56 104.79 4.09 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 1.017 HD21 HD11 ' R' ' 92' ' ' LEU . 0.3 OUTLIER -105.28 9.97 33.76 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.853 -1.155 . . . . 0.0 110.762 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' R' ' 94' ' ' LEU . 17.0 m170 -45.29 -29.75 1.09 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.451 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 80.4 tt0 -150.49 33.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.503 ' O ' ' CD2' ' R' ' 52' ' ' TRP . . . -95.64 -111.58 2.59 Favored Glycine 0 N--CA 1.497 2.701 0 O-C-N 121.02 -1.05 . . . . 0.0 110.731 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . 0.737 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . 178.14 -161.44 28.32 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.696 ' CD ' ' HD2' ' R' ' 100' ' ' PRO . 31.3 Cg_endo -72.69 -64.84 0.03 OUTLIER 'Trans proline' 0 CA--C 1.559 1.773 0 O-C-N 123.849 1.447 . . . . 0.0 114.108 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.932 ' O ' ' N ' ' R' ' 102' ' ' LEU . 33.6 Cg_endo -57.22 -28.32 78.9 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 N-CA-C 107.181 -1.892 . . . . 0.0 107.181 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.971 ' O ' HD12 ' R' ' 92' ' ' LEU 0.251 . . -29.35 60.44 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.197 175.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.932 ' N ' ' O ' ' R' ' 100' ' ' PRO . 7.3 mp 35.45 -4.74 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.937 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -175.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.959 ' O ' ' HB ' ' R' ' 107' ' ' ILE . 34.3 t -61.74 -44.99 99.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 C-N-CA 114.855 -2.738 . . . . 0.0 105.641 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' R' ' 100' ' ' PRO . 19.0 pt -84.14 -36.09 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.339 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.73 ' HB3' ' HA ' ' R' ' 102' ' ' LEU . 48.0 t-105 -60.27 -45.26 93.91 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.152 -1.419 . . . . 0.0 111.419 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.719 HD21 HD23 ' R' ' 102' ' ' LEU . 86.4 m-20 -84.88 -22.53 29.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.891 -1.131 . . . . 0.0 111.794 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . 0.959 ' HB ' ' O ' ' R' ' 103' ' ' VAL . 0.2 OUTLIER -67.48 -14.43 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 111.33 -177.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 107' ' ' ILE . 75.2 tttt -33.96 -59.73 0.41 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.425 ' C ' HD13 ' R' ' 110' ' ' LEU . 2.0 m80 -84.0 -7.67 59.34 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 119.274 -2.141 . . . . 0.0 111.451 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.761 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.1 OUTLIER -84.26 -30.85 25.32 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.516 -1.365 . . . . 0.0 109.199 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.815 ' CG ' HG23 ' R' ' 107' ' ' ILE 0.281 57.6 mt -68.11 161.03 27.79 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.692 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -117.14 60.13 0.75 Allowed 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 171.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.623 HG22 HD13 ' R' ' 115' ' ' ILE . 97.4 m -145.12 138.36 26.56 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.395 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' R' ' 123' ' ' GLU . . . -74.67 98.4 1.05 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 105.615 -2.994 . . . . 0.0 105.615 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.948 HG23 ' CG2' ' R' ' 124' ' ' VAL . 31.1 mm -93.24 142.5 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.814 -1.404 . . . . 0.0 109.828 -178.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' R' ' 122' ' ' SER . . . -133.46 -165.78 11.18 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.869 -1.634 . . . . 0.0 111.952 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.691 ' HA ' HG22 ' R' ' 126' ' ' VAL . 7.2 m -134.63 -175.43 3.88 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' R' ' 130' ' ' THR . . . -64.58 -37.86 89.0 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.234 -1.387 . . . . 0.0 109.795 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -66.71 -36.35 82.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.396 -0.815 . . . . 0.0 109.754 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.67 101.79 36.26 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.463 -0.773 . . . . 0.0 110.022 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.07 135.73 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.667 1.351 . . . . 0.0 111.621 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.499 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 0.2 OUTLIER -145.22 -158.99 0.94 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.637 -0.665 . . . . 0.0 109.426 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.403 ' HB2' HG22 ' R' ' 113' ' ' THR . 77.0 mm-40 -56.13 -43.9 78.67 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.796 -1.19 . . . . 0.0 108.433 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.948 ' CG2' HG23 ' R' ' 115' ' ' ILE . 10.7 m -115.95 135.14 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.446 ' O ' ' CD1' ' R' ' 180' ' ' PHE . 7.0 t -134.3 136.9 43.83 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.966 0.888 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 179' ' ' VAL . 6.1 m -82.53 -179.92 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.31 1.053 . . . . 0.0 111.18 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.973 ' CG2' ' HA ' ' R' ' 178' ' ' LEU . 5.0 m -121.55 -1.01 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.709 ' HB2' HD12 ' R' ' 178' ' ' LEU . 55.9 t0 -60.49 92.96 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.764 -1.21 . . . . 0.0 110.374 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 72.54 28.49 67.45 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.519 -1.832 . . . . 0.0 108.519 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . 0.756 HG23 ' CB ' ' R' ' 118' ' ' ALA . 1.4 m -97.38 146.71 24.92 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.685 -0.891 . . . . 0.0 111.267 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -66.32 -32.39 73.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 121.129 0.49 . . . . 0.0 110.465 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.491 ' HB3' ' CZ ' ' R' ' 180' ' ' PHE . 64.0 mtt -90.34 141.62 28.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.0 110.962 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.31 -165.32 1.78 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.71 -0.619 . . . . 0.0 110.228 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 1.085 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.9 OUTLIER -45.67 -30.0 1.42 Allowed 'General case' 0 N--CA 1.508 2.435 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -48.77 -41.45 32.36 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . 0.644 ' O ' ' CD2' ' R' ' 137' ' ' PHE . 94.0 m-20 -71.15 -140.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 175.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . 0.715 ' HB2' ' CE2' ' R' ' 183' ' ' TYR . 0.4 OUTLIER -173.37 101.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 116.593 -2.043 . . . . 0.0 112.266 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.973 ' HB3' ' O ' ' R' ' 181' ' ' VAL . 0.2 OUTLIER -163.32 -138.63 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.214 1.007 . . . . 0.0 109.857 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' SG ' ' R' ' 153' ' ' CYS 0.261 . . -104.81 179.69 4.2 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.744 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 161.52 -178.68 37.33 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . 1.094 HG23 ' CE1' ' R' ' 151' ' ' PHE . 3.6 mt -108.35 115.69 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.627 -0.925 . . . . 0.0 110.616 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 1.045 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 3.0 m-85 -114.82 154.64 28.24 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 87.4 mt -102.8 129.37 49.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.468 ' HB2' HG11 ' R' ' 150' ' ' VAL . 36.1 tttp -109.12 122.37 47.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 110.495 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.24 -130.6 49.73 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -90.49 -129.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.353 -1.087 . . . . 0.0 109.554 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.63 92.65 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.701 -1.249 . . . . 0.0 109.802 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.414 ' CB ' ' O ' ' R' ' 144' ' ' LYS . 1.9 t60 -146.47 122.15 10.5 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.462 -0.773 . . . . 0.0 108.92 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 1.006 ' HB2' ' CE3' ' R' ' 52' ' ' TRP . . . -94.47 118.87 32.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.797 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . 0.618 HG22 ' O ' ' R' ' 142' ' ' PHE . 34.7 m -133.62 147.63 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 118.545 -1.262 . . . . 0.0 110.005 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 1.094 ' CE1' HG23 ' R' ' 141' ' ' ILE . 3.3 m-85 -136.11 131.78 35.23 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.493 -0.883 . . . . 0.0 109.713 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 161' ' ' ALA . . . -114.63 169.91 8.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.597 -1.314 . . . . 0.0 111.29 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . 0.83 ' SG ' ' HB2' ' R' ' 139' ' ' ALA . 3.9 t -163.37 133.09 4.21 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' R' ' 34' ' ' TYR . 48.3 t -50.91 117.68 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 C-N-CA 118.101 -1.44 . . . . 0.0 111.919 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . 0.764 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 66.4 p -104.4 -158.34 0.66 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 83.5 p -65.73 -15.47 62.86 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.189 -1.004 . . . . 0.0 108.672 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 86.0 m-20 -113.01 9.47 18.7 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.358 -0.839 . . . . 0.0 111.969 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 100.92 -153.96 19.18 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.757 ' CG ' ' O ' ' R' ' 171' ' ' THR . 0.0 OUTLIER -57.91 94.64 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.322 -179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . 0.764 ' HB2' ' OG1' ' R' ' 155' ' ' THR . 0.2 OUTLIER -115.79 119.04 34.72 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 176.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . 1.047 ' HB2' ' HB2' ' R' ' 152' ' ' ALA . . . -109.94 147.99 32.42 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.44 -1.413 . . . . 0.0 110.114 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . 1.179 HD11 ' CE2' ' R' ' 41' ' ' PHE . 6.0 pt -117.51 91.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-O 124.191 1.948 . . . . 0.0 112.029 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.666 ' O ' ' C ' ' R' ' 164' ' ' ASP . 63.6 m-20 -83.0 120.26 25.5 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 111.784 -2.462 . . . . 0.0 106.169 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . 0.675 ' HA ' ' C ' ' R' ' 43' ' ' SER . 96.8 m-20 11.93 -84.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.113 0.959 . . . . 0.0 111.553 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' R' ' 163' ' ' ASP . 98.6 mt-10 -31.41 -52.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' R' ' 162' ' ' ILE . 19.8 t0 -172.5 177.9 2.88 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 119.339 -2.101 . . . . 0.0 113.496 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . 1.132 ' HA ' HG22 ' R' ' 162' ' ' ILE . 2.1 m-30 -93.52 129.35 39.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . 0.521 ' HB2' ' HD2' ' R' ' 169' ' ' PRO . 36.9 p90 -155.42 170.18 9.13 Favored Pre-proline 0 C--N 1.289 -2.035 0 C-N-CA 118.44 -1.304 . . . . 0.0 112.556 -176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . 0.521 ' HD2' ' HB2' ' R' ' 168' ' ' TYR . 41.3 Cg_endo -68.61 113.38 3.15 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 N-CA-C 107.748 -1.674 . . . . 0.0 107.748 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.696 ' HA ' ' HE3' ' R' ' 170' ' ' TRP . 0.0 OUTLIER -117.66 -129.24 0.29 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-O 123.361 1.553 . . . . 0.0 111.956 -177.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . 1.085 ' CG2' HD11 ' R' ' 134' ' ' LEU 0.319 1.4 m -32.22 97.74 0.11 Allowed Pre-proline 0 C--N 1.292 -1.908 0 CA-C-N 112.904 -1.953 . . . . 0.0 115.389 -174.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' R' ' 173' ' ' ASP . 53.2 Cg_endo -92.93 -30.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.53 1.805 . . . . 0.0 108.037 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . 0.55 ' CA ' ' HG ' ' R' ' 134' ' ' LEU . 18.0 p30 -148.15 170.43 7.7 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.448 -0.783 . . . . 0.0 108.915 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' R' ' 134' ' ' LEU . 49.5 Cg_endo -85.64 51.36 2.87 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 83.4 p -82.15 -34.13 29.28 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -125.41 6.11 7.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.557 -1.339 . . . . 0.0 111.054 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 1.045 ' HB ' ' CG ' ' R' ' 142' ' ' PHE 0.259 2.3 p -112.31 148.49 15.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 121.231 -0.918 . . . . 0.0 110.687 -177.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.973 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 0.4 OUTLIER -133.05 46.26 2.63 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 117.485 -1.686 . . . . 0.0 108.893 175.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.968 ' HA ' ' HA ' ' R' ' 126' ' ' VAL . 0.2 OUTLIER -176.43 131.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' R' ' 182' ' ' PRO . 2.3 p90 -132.46 178.53 6.76 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 122.686 1.231 . . . . 0.0 108.987 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . 0.973 ' O ' ' HB3' ' R' ' 138' ' ' HIS . 0.8 OUTLIER -121.64 93.3 48.73 Favored Pre-proline 0 C--N 1.265 -3.088 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . 0.495 ' HB3' ' CE2' ' R' ' 180' ' ' PHE . 36.5 Cg_endo -60.05 109.29 0.59 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 120.862 1.041 . . . . 0.0 113.629 -175.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.715 ' CE2' ' HB2' ' R' ' 137' ' ' PHE . 0.0 OUTLIER -67.12 -151.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.036 177.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -74.81 123.18 24.52 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.109 -0.994 . . . . 0.0 110.483 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -85.74 155.26 21.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.454 -0.779 . . . . 0.0 110.098 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -54.9 138.6 63.88 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.455 -0.778 . . . . 0.0 110.394 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.6 154.75 64.2 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.752 1.396 . . . . 0.0 110.698 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 75.1 mt -84.5 146.14 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.42 -0.8 . . . . 0.0 109.976 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -100.6 137.56 38.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.316 -0.865 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -85.08 -173.48 49.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 51.77 -162.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.361 -1.082 . . . . 0.0 110.445 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 98.2 m95 52.09 84.41 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 52.9 tttt -80.62 135.23 36.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.0 110.258 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.44 154.27 45.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.383 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.202 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . 0.432 ' HB2' ' CZ ' ' R' ' 167' ' ' PHE . 88.0 mtp . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.162 0.506 . . . . 0.0 110.287 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' R' ' 40' ' ' THR . 84.1 tt0 -110.44 126.95 54.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 0.0 110.822 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . 1.078 ' CD1' HG21 ' R' ' 162' ' ' ILE . 1.7 pt? -139.02 163.4 32.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.459 -0.776 . . . . 0.0 109.632 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . 0.784 HG22 ' HB3' ' R' ' 38' ' ' LYS . 31.8 p -104.78 129.26 53.06 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.868 -1.145 . . . . 0.0 111.973 -177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.97 ' N ' HD13 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -130.68 136.03 48.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.41 -0.806 . . . . 0.0 109.773 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' R' ' 33' ' ' LEU . 58.2 t80 -33.48 -36.18 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' R' ' 62' ' ' TYR . 97.4 m-20 -105.34 65.13 0.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 119.837 -1.789 . . . . 0.0 111.287 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . 0.972 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 128.33 35.27 0.51 Allowed Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -176.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . 0.972 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.0 mt-10 -13.82 -150.43 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . 0.784 ' HB3' HG22 ' R' ' 32' ' ' THR . 9.5 pttm -52.29 109.1 0.35 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.356 -1.465 . . . . 0.0 112.518 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.514 ' HB3' ' HD3' ' R' ' 61' ' ' ARG . 30.0 mmtm -150.09 147.19 27.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.315 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . 0.566 ' O ' ' CD1' ' R' ' 72' ' ' TYR . 0.8 OUTLIER -85.4 125.42 32.97 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.126 -0.984 . . . . 0.0 110.019 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.714 ' CD2' ' CE2' ' R' ' 151' ' ' PHE . 84.2 m-85 -110.09 154.02 23.85 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.934 1.349 . . . . 0.0 114.42 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . 0.686 ' HA ' ' HB2' ' R' ' 164' ' ' ASP . 76.2 m-85 -116.45 164.22 14.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.256 177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . 0.726 ' HA ' ' HA ' ' R' ' 51' ' ' ALA . 0.6 OUTLIER 155.71 -78.73 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 119.446 1.021 . . . . 0.0 113.304 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . 0.576 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 4.5 mtt180 -72.28 175.74 2.92 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.881 -1.137 . . . . 0.0 109.24 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' R' ' 44' ' ' ARG . 37.5 Cg_endo -61.65 100.59 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.286 1.15 . . . . 0.0 113.204 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 47' ' ' ASN . 2.1 m-20 -150.73 -11.85 0.24 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . 0.434 ' H ' ' H ' ' R' ' 46' ' ' ASN . 0.2 OUTLIER -135.78 -178.67 5.24 Favored 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' R' ' 49' ' ' ASP . 77.4 m80 -92.7 -6.93 48.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.639 -1.288 . . . . 0.0 109.824 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.749 ' O ' HG21 ' R' ' 79' ' ' THR . 12.5 p30 172.17 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.78 -0.575 . . . . 0.0 109.605 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.465 ' CG ' ' HB ' ' R' ' 79' ' ' THR . 0.2 OUTLIER -138.58 -3.13 1.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.796 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.255 . . -66.3 -44.54 83.18 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.712 -0.617 . . . . 0.0 110.718 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.656 ' CD2' ' HA2' ' R' ' 97' ' ' GLY . 55.2 m95 -61.1 -36.63 80.21 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 117.555 -1.658 . . . . 0.0 107.795 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 1.086 HD11 HG12 ' R' ' 83' ' ' ILE . 2.4 mt -68.49 -34.86 76.65 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . 0.63 ' HB2' ' O ' ' R' ' 42' ' ' TYR . 0.0 OUTLIER -47.6 -26.98 1.64 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . 0.834 ' O ' ' HB2' ' R' ' 59' ' ' LEU . . . -67.52 -56.98 7.37 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.953 HG23 ' CE2' ' R' ' 60' ' ' PHE 0.291 1.2 mp -62.58 -42.39 95.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 122.379 1.085 . . . . 0.0 108.311 177.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . 1.014 HD12 ' CE1' ' R' ' 72' ' ' TYR . 4.2 mm? -65.03 -60.7 2.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.953 -178.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . 0.702 ' HB2' ' CD1' ' R' ' 151' ' ' PHE . 4.6 pt20 -63.88 -34.03 77.04 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.834 ' HB2' ' O ' ' R' ' 55' ' ' ALA . 1.6 mp -70.97 -48.54 52.77 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 118.503 -1.279 . . . . 0.0 107.566 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.953 ' CE2' HG23 ' R' ' 56' ' ' ILE . 12.7 m-30 -61.51 -45.93 92.12 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.474 -1.29 . . . . 0.0 110.59 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' R' ' 39' ' ' LYS . 1.5 tpm_? -58.3 -31.23 67.29 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 119.67 -1.894 . . . . 0.0 110.139 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 1.016 ' HB3' HG21 ' R' ' 181' ' ' VAL . 22.0 m-30 -61.7 -54.01 48.32 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.541 -1.35 . . . . 0.0 111.986 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.811 HG11 HG23 ' R' ' 113' ' ' THR . 3.9 t -85.79 3.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.363 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 74.4 tt0 67.04 44.91 1.85 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.515 ' CG ' ' CE1' ' R' ' 112' ' ' HIS . 4.4 mp0 -133.88 89.18 30.46 Favored Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' CZ ' ' R' ' 68' ' ' PHE . 53.1 Cg_endo -79.27 87.56 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.543 1.286 . . . . 0.0 113.757 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . 0.554 ' HB3' ' CE2' ' R' ' 60' ' ' PHE . 55.1 t80 -82.98 -25.71 32.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . 0.869 ' CG ' HD13 ' R' ' 57' ' ' LEU . 2.0 p90 -72.6 19.15 0.08 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.991 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' R' ' 73' ' ' SER . 95.5 m-20 -38.2 -37.29 0.27 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.451 -0.781 . . . . 0.0 112.868 -176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.463 ' HB2' ' HA ' ' R' ' 82' ' ' ALA . 84.8 m95 -62.03 -30.44 70.97 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.24 -1.538 . . . . 0.0 110.113 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.943 ' HB ' HD11 ' R' ' 57' ' ' LEU . 65.5 t -78.7 -67.22 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . 1.014 ' CE1' HD12 ' R' ' 57' ' ' LEU . 9.9 m-30 -67.89 -38.8 83.45 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.239 -0.913 . . . . 0.0 110.94 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . 0.547 ' HB2' ' O ' ' R' ' 69' ' ' ASP . 6.1 m -63.35 -21.62 66.38 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 118.739 -1.185 . . . . 0.0 109.561 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . 0.585 ' OG ' HD23 ' R' ' 78' ' ' LEU . 16.4 t -99.6 119.71 59.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.17 -0.957 . . . . 0.0 110.513 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.97 -19.25 46.2 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.569 1.299 . . . . 0.0 110.279 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -101.61 165.19 11.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.449 -0.782 . . . . 0.0 109.849 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -58.52 89.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.825 . . . . 0.0 110.728 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . 0.585 HD23 ' OG ' ' R' ' 74' ' ' SER . 1.4 mm? -107.82 21.81 16.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . 0.749 HG21 ' O ' ' R' ' 49' ' ' ASP . 3.1 t -55.48 -52.64 62.97 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.506 -0.746 . . . . 0.0 109.956 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.606 ' H ' HG23 ' R' ' 79' ' ' THR . 1.2 pp -49.86 -50.84 44.2 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.692 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . 0.553 ' N ' HD12 ' R' ' 80' ' ' LEU . 84.8 tt0 -67.08 -28.63 68.34 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.28 -1.513 . . . . 0.0 110.104 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.697 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -67.01 -48.45 68.34 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.93 0.871 . . . . 0.0 111.572 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 1.086 HG12 HD11 ' R' ' 53' ' ' LEU . 0.1 OUTLIER -87.76 -38.52 11.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.443 -177.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' R' ' 83' ' ' ILE . 36.7 tttm -50.49 -35.34 28.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -73.55 -36.56 65.65 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . 1.019 HD12 HD21 ' R' ' 94' ' ' LEU . 2.6 tm? -63.13 -38.18 90.17 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . 0.571 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 83.0 tt0 -60.9 -39.71 90.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 0.0 108.824 178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.08 -32.3 72.82 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.273 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.808 HD23 ' N ' ' R' ' 90' ' ' THR . 2.6 tt -94.91 -51.25 4.76 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.08 -1.013 . . . . 0.0 111.805 -178.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . 0.838 HG22 ' HB2' ' R' ' 106' ' ' ASN . 69.7 p -76.58 -25.64 54.21 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . 0.571 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 67.29 26.15 73.52 Favored Glycine 0 N--CA 1.5 2.958 0 C-N-CA 119.996 -1.097 . . . . 0.0 110.692 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . 1.098 HD13 HD23 ' R' ' 94' ' ' LEU . 0.3 OUTLIER -104.54 -17.98 14.52 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.02 -1.283 . . . . 0.0 111.756 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . 0.74 ' N ' HD12 ' R' ' 92' ' ' LEU . 84.1 tt0 58.42 115.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 1.098 HD23 HD13 ' R' ' 92' ' ' LEU . 3.7 pp -156.75 21.75 0.33 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 120.688 -1.257 . . . . 0.0 111.181 -177.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . 0.839 ' HA ' HD12 ' R' ' 83' ' ' ILE . 5.7 p80 -42.42 -28.35 0.2 Allowed 'General case' 0 N--CA 1.51 2.563 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.2 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.485 ' HA ' ' CD1' ' R' ' 52' ' ' TRP . 23.1 pt-20 -120.39 36.11 4.66 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.6 -0.688 . . . . 0.0 110.368 178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.656 ' HA2' ' CD2' ' R' ' 52' ' ' TRP . . . 145.87 110.78 0.67 Allowed Glycine 0 N--CA 1.504 3.182 0 C-N-CA 119.272 -1.442 . . . . 0.0 111.329 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' R' ' 94' ' ' LEU . . . -170.68 65.29 0.16 Allowed Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.004 -1.093 . . . . 0.0 111.023 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.843 ' HB2' ' CD ' ' R' ' 100' ' ' PRO . 42.8 Cg_endo -84.56 -108.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.965 0 O-C-N 123.322 1.169 . . . . 0.0 109.211 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.881 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.3 Cg_endo -60.18 -17.88 48.49 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 N-CA-C 106.845 -2.021 . . . . 0.0 106.845 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.765 ' O ' ' N ' ' R' ' 103' ' ' VAL 0.254 . . -31.22 61.27 0.0 OUTLIER 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.318 -1.31 . . . . 0.0 112.195 175.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.881 ' N ' ' O ' ' R' ' 100' ' ' PRO . 80.8 mt 41.0 -3.42 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.369 0 CA-C-O 117.551 -1.214 . . . . 0.0 113.008 -174.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.968 HG13 HD11 ' R' ' 86' ' ' LEU . 13.4 t -56.98 -47.75 82.85 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.263 0 C-N-CA 114.335 -2.946 . . . . 0.0 104.079 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 38.8 mm -63.46 -39.36 85.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.494 -1.23 . . . . 0.0 108.932 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.635 ' CB ' ' HA ' ' R' ' 102' ' ' LEU . 51.9 t90 -63.02 -36.31 83.14 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 118.12 -1.432 . . . . 0.0 111.25 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.838 ' HB2' HG22 ' R' ' 90' ' ' THR . 22.3 m120 -84.87 -23.19 29.07 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.086 -1.009 . . . . 0.0 113.26 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . 0.905 HG12 ' O ' ' R' ' 103' ' ' VAL . 3.4 mm -70.6 -10.95 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 120.242 -1.536 . . . . 0.0 110.02 -178.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' R' ' 107' ' ' ILE . 62.1 mttt -33.47 -57.93 0.41 Allowed 'General case' 0 N--CA 1.512 2.636 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.827 ' C ' HD13 ' R' ' 110' ' ' LEU . 4.1 m-70 -72.91 -9.68 58.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 119.181 -2.199 . . . . 0.0 111.506 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.838 HD13 ' N ' ' R' ' 110' ' ' LEU . 0.2 OUTLIER -106.54 -16.82 14.43 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.859 HD23 HG21 ' R' ' 107' ' ' ILE 0.323 0.1 OUTLIER -109.71 127.62 54.71 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.835 -176.52 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . 0.546 ' N ' HD13 ' R' ' 111' ' ' LEU . 55.4 p-80 -115.37 76.91 1.03 Allowed 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 175.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.886 HG22 ' CD1' ' R' ' 115' ' ' ILE . 18.0 m -132.14 136.42 47.09 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.278 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.539 ' C ' HD13 ' R' ' 115' ' ' ILE . . . -75.73 104.36 1.78 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 107.747 -2.141 . . . . 0.0 107.747 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 1.1 HD12 HG22 ' R' ' 124' ' ' VAL . 3.3 mm -90.9 144.75 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.634 -1.509 . . . . 0.0 109.358 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' R' ' 125' ' ' CYS . . . -145.42 -118.79 1.2 Allowed Glycine 0 N--CA 1.509 3.562 0 C-N-CA 118.408 -1.853 . . . . 0.0 112.462 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.53 HG23 ' O ' ' R' ' 116' ' ' GLY . 0.0 OUTLIER -178.95 -175.2 0.38 Allowed 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.204 -1.174 . . . . 0.0 108.814 179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.702 ' CA ' HG22 ' R' ' 126' ' ' VAL 0.278 . . -66.84 -43.62 83.22 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.31 179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 23.1 m -64.66 -37.77 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.887 . . . . 0.0 108.889 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . 0.427 ' HA ' ' HD2' ' R' ' 121' ' ' PRO . 0.0 OUTLIER -123.22 104.11 35.28 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' R' ' 120' ' ' ARG . 39.8 Cg_endo -65.33 131.17 27.38 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.524 1.276 . . . . 0.0 111.224 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' R' ' 116' ' ' GLY . 46.7 m -146.05 -168.91 3.12 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.569 ' O ' HG23 ' R' ' 181' ' ' VAL . 76.8 mm-40 -63.18 -43.16 99.02 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.8 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 1.1 HG22 HD12 ' R' ' 115' ' ' ILE . 0.6 OUTLIER -149.17 122.0 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.337 -1.477 . . . . 0.0 112.566 179.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.784 ' HB3' ' O ' ' R' ' 116' ' ' GLY . 0.1 OUTLIER 152.74 138.03 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.061 176.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.995 ' CG1' HG13 ' R' ' 127' ' ' VAL . 1.1 t -176.55 -172.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 1.095 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.4 m 36.91 -3.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.521 3.082 0 C-N-CA 127.779 2.432 . . . . 0.0 116.863 -177.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' R' ' 126' ' ' VAL . 44.9 t0 -57.22 55.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.659 -1.276 . . . . 0.0 111.752 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 105.28 15.56 19.12 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . 0.661 HG21 ' CB ' ' R' ' 118' ' ' ALA . 87.1 m -116.53 154.32 30.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -1.175 . . . . 0.0 112.164 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -58.78 159.59 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.773 -0.579 . . . . 0.0 109.52 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.447 ' HG2' HG12 ' R' ' 127' ' ' VAL . 28.2 mtt -123.81 136.36 54.35 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.283 -0.885 . . . . 0.0 111.326 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.415 ' N ' ' HG2' ' R' ' 174' ' ' PRO . 49.1 t -137.3 134.64 36.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.027 -1.045 . . . . 0.0 111.086 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 1.006 HD11 ' CG2' ' R' ' 171' ' ' THR . 0.2 OUTLIER -59.89 -42.22 93.34 Favored 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 122.244 1.021 . . . . 0.0 110.587 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.4 0.52 9.95 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.484 -0.76 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' R' ' 133' ' ' CYS . 47.4 t0 -73.31 -65.74 0.77 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.931 -1.106 . . . . 0.0 111.827 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . 0.714 ' CG ' ' CD2' ' R' ' 180' ' ' PHE . 19.5 p90 -146.85 178.23 8.5 Favored 'General case' 0 C--N 1.309 -1.167 0 O-C-N 121.091 -1.006 . . . . 0.0 110.2 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.619 ' HA ' ' O ' ' R' ' 172' ' ' PRO . 29.3 m80 -143.14 72.66 1.37 Allowed 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 118.245 -1.382 . . . . 0.0 112.212 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.968 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 171.81 153.37 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.278 174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.626 ' O ' ' OE1' ' R' ' 58' ' ' GLN . . . 144.16 -176.23 23.53 Favored Glycine 0 N--CA 1.498 2.807 0 C-N-CA 119.997 -1.096 . . . . 0.0 111.283 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . 0.71 ' CG1' ' HA ' ' R' ' 55' ' ' ALA . 0.5 OUTLIER -98.8 128.91 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.829 ' HA ' ' HA ' ' R' ' 177' ' ' VAL . 0.2 OUTLIER -111.48 141.56 44.89 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.501 -1.279 . . . . 0.0 109.021 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.487 ' N ' HD22 ' R' ' 143' ' ' LEU . 4.6 mm? -88.95 109.38 20.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.934 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.519 ' HD2' HG11 ' R' ' 150' ' ' VAL . 24.6 tttt -108.79 120.3 42.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.17 -137.72 44.16 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . 0.435 ' O ' ' CD2' ' R' ' 148' ' ' HIS . 93.9 mt-30 -126.52 150.73 48.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.442 -1.034 . . . . 0.0 110.16 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 51.27 37.56 18.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.435 ' CD2' ' O ' ' R' ' 146' ' ' GLN . 56.1 m-70 -142.86 123.61 14.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.31 -0.869 . . . . 0.0 109.672 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.796 ' HB3' ' HB1' ' R' ' 51' ' ' ALA . . . -105.33 136.27 45.18 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . 0.706 HG22 ' O ' ' R' ' 142' ' ' PHE . 31.2 m -127.9 165.72 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.025 -1.047 . . . . 0.0 109.548 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.714 ' CE2' ' CD2' ' R' ' 41' ' ' PHE 0.26 0.0 OUTLIER -148.11 125.22 11.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.736 -1.186 . . . . 0.0 113.494 -177.613 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -132.81 164.29 27.16 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.606 -1.309 . . . . 0.0 109.238 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . 0.604 ' HA ' ' O ' ' R' ' 138' ' ' HIS . 22.6 p -176.29 176.39 1.68 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' R' ' 158' ' ' GLY . 64.9 t -63.59 103.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.788 0 CA-C-O 121.684 0.754 . . . . 0.0 110.992 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . 0.712 ' OG1' ' HB2' ' R' ' 160' ' ' TYR . 41.7 p -88.75 -160.27 0.64 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 84.5 p -61.82 -18.65 60.79 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . 0.529 ' HB2' ' CE1' ' R' ' 160' ' ' TYR . 90.4 m-20 -111.39 2.69 17.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.579 -0.7 . . . . 0.0 111.502 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' R' ' 154' ' ' VAL . . . 92.91 -118.15 5.55 Favored Glycine 0 N--CA 1.49 2.291 0 O-C-N 120.704 -1.248 . . . . 0.0 112.124 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.674 ' HB3' ' HD2' ' R' ' 172' ' ' PRO . 0.0 OUTLIER -60.79 92.5 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.645 1.212 . . . . 0.0 108.89 -177.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . 0.763 ' HA ' ' H ' ' R' ' 170' ' ' TRP . 3.3 m-85 -145.0 163.47 34.1 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . 0.945 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -134.72 131.24 37.4 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 120.774 -1.204 . . . . 0.0 107.767 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . 1.078 HG21 ' CD1' ' R' ' 31' ' ' LEU . 1.2 pt -122.53 92.46 2.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 CA-C-O 123.981 1.848 . . . . 0.0 112.811 -178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.697 ' HA ' ' CB ' ' R' ' 43' ' ' SER . 74.8 m-20 -96.06 129.0 43.46 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 112.105 -2.316 . . . . 0.0 108.637 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . 0.699 ' O ' ' CB ' ' R' ' 165' ' ' GLU . 11.2 t0 -34.37 117.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.699 ' CB ' ' O ' ' R' ' 164' ' ' ASP . 42.9 tp10 135.06 -50.74 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -176.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -169.19 161.14 10.12 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.32 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . 1.017 ' HA ' HG22 ' R' ' 162' ' ' ILE . 10.1 m-30 -107.38 122.07 45.85 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' R' ' 168' ' ' TYR . 9.7 p90 -141.63 160.54 56.11 Favored Pre-proline 0 C--N 1.294 -1.817 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.835 -176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' R' ' 160' ' ' TYR . 42.1 Cg_endo -69.52 113.45 3.34 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.36 1.716 . . . . 0.0 108.591 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.763 ' H ' ' HA ' ' R' ' 160' ' ' TYR . 0.0 OUTLIER -142.47 169.73 17.02 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . 1.006 ' CG2' HD11 ' R' ' 134' ' ' LEU . 0.2 OUTLIER -100.27 99.83 10.49 Favored Pre-proline 0 C--N 1.274 -2.684 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.433 178.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.674 ' HD2' ' HB3' ' R' ' 159' ' ' TRP . 52.0 Cg_endo -75.61 55.67 4.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.884 1.465 . . . . 0.0 108.639 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . 0.755 ' CG ' HD13 ' R' ' 134' ' ' LEU . 3.7 m-20 -115.39 -176.76 0.39 Allowed Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.546 -0.721 . . . . 0.0 109.89 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' R' ' 173' ' ' ASP . 52.8 Cg_endo -79.81 31.36 0.48 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.568 1.299 . . . . 0.0 112.352 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 20.2 t -63.3 -51.19 67.09 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.733 -1.229 . . . . 0.0 109.387 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -131.86 13.99 4.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.708 . . . . 0.0 110.284 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 1.095 ' O ' HG21 ' R' ' 127' ' ' VAL . 0.5 OUTLIER -102.69 168.32 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.894 -1.129 . . . . 0.0 113.221 -177.518 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 1.089 ' HA ' ' CG2' ' R' ' 127' ' ' VAL . 1.1 mm? -100.59 -95.12 0.27 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.939 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.661 ' HA ' ' N ' ' R' ' 126' ' ' VAL . 28.6 m -80.69 135.42 25.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.714 ' CD2' ' CG ' ' R' ' 137' ' ' PHE 0.261 2.9 p90 -128.85 -178.81 4.77 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.549 1.166 . . . . 0.0 112.315 -173.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . 1.016 HG21 ' HB3' ' R' ' 62' ' ' TYR . 0.5 OUTLIER -134.19 122.42 16.12 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.554 177.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . 0.429 ' N ' ' CE2' ' R' ' 180' ' ' PHE . 50.1 Cg_endo -76.34 161.35 34.92 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.49 1.258 . . . . 0.0 112.142 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.64 ' CD2' ' HA ' ' R' ' 137' ' ' PHE . 25.4 p90 -127.14 -173.97 3.03 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -138.99 145.41 39.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 0.0 111.434 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -126.43 166.0 18.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.624 -0.672 . . . . 0.0 109.601 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.27 70.2 8.25 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 110.502 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.82 149.88 54.73 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.716 1.377 . . . . 0.0 110.395 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 188' ' ' LEU . . . . . 0.724 ' O ' HD13 ' R' ' 188' ' ' LEU . 0.7 OUTLIER -59.41 -36.89 76.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.361 -0.837 . . . . 0.0 109.761 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -109.21 136.93 47.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.382 -0.824 . . . . 0.0 110.267 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.49 104.39 3.0 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -136.26 162.22 33.59 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.399 -1.06 . . . . 0.0 110.317 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 192' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' R' ' 192' ' ' TRP . 49.8 m0 -99.6 143.78 29.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 110.027 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -125.46 134.96 51.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.387 -0.82 . . . . 0.0 110.354 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.92 -174.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.423 -0.798 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 52.9 mttp . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.238 -179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.054 0.454 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.89 137.39 53.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.064 -1.022 . . . . 0.0 110.785 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . 0.981 HD11 ' CD1' ' R' ' 162' ' ' ILE . 1.3 pt? -145.63 153.0 40.56 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . 0.536 HG22 ' HA ' ' R' ' 38' ' ' LYS . 1.9 p -112.26 142.88 44.21 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.202 -0.936 . . . . 0.0 109.562 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.927 ' N ' HD13 ' R' ' 33' ' ' LEU . 0.0 OUTLIER -134.37 141.91 47.02 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.268 -179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . 0.469 ' N ' ' O ' ' R' ' 154' ' ' VAL . 45.3 t80 -37.56 -38.69 0.27 Allowed 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . 0.409 ' O ' ' O ' ' R' ' 62' ' ' TYR . 24.0 m120 -104.21 66.1 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.736 -1.852 . . . . 0.0 110.678 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . 0.94 ' O ' ' O ' ' R' ' 37' ' ' GLU . . . 129.63 35.25 0.46 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . 0.94 ' O ' ' O ' ' R' ' 36' ' ' GLY . 95.3 mt-10 -11.37 -159.14 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . 0.536 ' HA ' HG22 ' R' ' 32' ' ' THR . 5.1 pttt -44.98 110.96 0.27 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 123.053 1.406 . . . . 0.0 113.845 -173.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.527 ' HG2' ' CA ' ' R' ' 61' ' ' ARG . 32.2 tptt -141.49 135.54 30.33 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . 0.522 HG22 ' O ' ' R' ' 40' ' ' THR . 0.9 OUTLIER -84.26 125.57 32.36 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.066 -1.021 . . . . 0.0 113.609 -176.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.853 ' CD1' HD21 ' R' ' 31' ' ' LEU . 31.3 m-85 -100.95 169.82 8.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . 0.477 ' OH ' ' HA ' ' R' ' 72' ' ' TYR . 85.6 m-85 -101.04 161.2 13.76 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.641 0.734 . . . . 0.0 111.759 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . 0.635 ' CA ' ' HB2' ' R' ' 165' ' ' GLU . 36.9 m -55.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.648 0.737 . . . . 0.0 111.696 -178.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . 0.867 ' HA ' ' HA ' ' R' ' 164' ' ' ASP . 0.4 OUTLIER -74.49 168.71 24.32 Favored Pre-proline 0 N--CA 1.487 1.398 0 O-C-N 121.48 -0.762 . . . . 0.0 109.373 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' R' ' 44' ' ' ARG . 36.5 Cg_endo -62.52 98.88 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.579 ' HB3' ' CE1' ' R' ' 48' ' ' HIS . 57.5 t30 -60.9 -118.3 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.126 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . 0.479 ' C ' ' CG ' ' R' ' 48' ' ' HIS . 0.5 OUTLIER -128.43 89.31 2.88 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 120.479 -1.388 . . . . 0.0 110.893 179.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.724 ' CD2' HG21 ' R' ' 79' ' ' THR . 0.9 OUTLIER 166.62 12.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.041 0.448 . . . . 0.0 109.795 178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' R' ' 95' ' ' HIS . 12.6 m-20 58.68 99.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.107 -0.996 . . . . 0.0 109.07 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.833 ' HB3' HG21 ' R' ' 79' ' ' THR . 3.4 p30 -141.09 -2.64 1.28 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.53 -0.731 . . . . 0.0 109.576 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.774 ' HB1' ' HB3' ' R' ' 149' ' ' ALA 0.257 . . -61.94 -35.8 79.5 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.659 -0.651 . . . . 0.0 109.439 179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.615 ' O ' ' HB3' ' R' ' 55' ' ' ALA . 15.3 m95 -61.28 -35.9 78.57 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 117.355 -1.738 . . . . 0.0 106.478 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.913 HD13 HG22 ' R' ' 71' ' ' VAL . 12.0 mt -68.75 -42.02 78.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . 0.504 ' HB3' ' HE2' ' R' ' 151' ' ' PHE . 45.5 t-20 -50.65 -28.0 8.05 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . 0.949 ' O ' HD23 ' R' ' 59' ' ' LEU . . . -67.67 -71.8 0.19 Allowed 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.683 ' O ' ' HB3' ' R' ' 60' ' ' PHE . 0.0 OUTLIER -59.54 -34.64 55.49 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.359 0 O-C-N 120.467 -1.396 . . . . 0.0 110.003 178.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . 1.024 HD11 ' HB ' ' R' ' 71' ' ' VAL . 3.9 mm? -64.1 -66.72 0.5 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.795 . . . . 0.0 111.125 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . 0.705 HE21 HD22 ' R' ' 59' ' ' LEU . 0.1 OUTLIER -59.85 -29.26 68.16 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.949 HD23 ' O ' ' R' ' 55' ' ' ALA . 3.7 mm? -70.02 -38.98 76.06 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.683 ' HB3' ' O ' ' R' ' 56' ' ' ILE . 0.0 OUTLIER -66.48 -40.96 89.62 Favored 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.592 178.013 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . 0.546 ' HG2' ' CE2' ' R' ' 60' ' ' PHE . 1.3 mtp180 -56.5 -41.61 76.94 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.824 -1.173 . . . . 0.0 112.329 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.881 ' CZ ' HG23 ' R' ' 63' ' ' VAL . 2.4 p90 -86.39 -47.12 9.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.264 -1.523 . . . . 0.0 111.981 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.881 HG23 ' CZ ' ' R' ' 62' ' ' TYR . 24.7 t -70.63 -16.77 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 119.877 -1.764 . . . . 0.0 109.018 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' R' ' 63' ' ' VAL . 71.4 tt0 74.75 42.38 0.28 Allowed 'General case' 0 N--CA 1.512 2.672 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' R' ' 60' ' ' PHE . 7.4 mt-10 -140.28 90.74 10.19 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 120.945 -1.097 . . . . 0.0 108.751 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' R' ' 60' ' ' PHE . 46.5 Cg_endo -75.53 95.06 0.99 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.393 1.207 . . . . 0.0 112.401 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . 0.592 ' CE1' HD22 ' R' ' 111' ' ' LEU . 14.4 m-85 -76.78 -27.19 55.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . 0.628 ' CE2' HG11 ' R' ' 103' ' ' VAL . 32.3 m-85 -104.99 50.38 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.696 1.236 . . . . 0.0 108.643 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.605 ' HA ' ' CD1' ' R' ' 72' ' ' TYR . 38.0 m-20 -45.13 -34.28 2.59 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.713 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -63.0 -34.99 78.72 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.706 -1.247 . . . . 0.0 109.917 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 1.024 ' HB ' HD11 ' R' ' 57' ' ' LEU . 59.4 t -66.22 -58.44 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.128 -1.029 . . . . 0.0 111.674 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . 0.605 ' CD1' ' HA ' ' R' ' 69' ' ' ASP . 1.3 p90 -69.15 -31.4 70.03 Favored 'General case' 0 N--CA 1.501 2.119 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.864 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 34.9 t -63.23 -25.86 68.52 Favored 'General case' 0 N--CA 1.508 2.459 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.906 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . 0.563 ' CB ' ' HB2' ' R' ' 78' ' ' LEU . 1.0 OUTLIER -79.32 134.41 58.83 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.55 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.24 -24.8 31.65 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.644 1.339 . . . . 0.0 110.125 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . 0.453 ' CG ' HD23 ' R' ' 78' ' ' LEU . 22.4 pt-20 -117.71 -158.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.435 -0.791 . . . . 0.0 109.906 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.489 ' O ' HD22 ' R' ' 78' ' ' LEU . 87.6 m-20 -85.22 103.55 14.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.504 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . 0.563 ' HB2' ' CB ' ' R' ' 74' ' ' SER . 1.5 mm? -122.58 47.88 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . 0.833 HG21 ' HB3' ' R' ' 50' ' ' ASN . 0.0 OUTLIER -61.51 -59.25 5.52 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.687 -0.633 . . . . 0.0 110.461 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.653 ' H ' HG23 ' R' ' 79' ' ' THR . 1.0 OUTLIER -49.56 -51.65 35.47 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.487 -0.885 . . . . 0.0 112.789 -178.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . 0.512 ' OE1' HD12 ' R' ' 78' ' ' LEU . 84.3 tt0 -59.95 -32.48 70.84 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 119.826 -1.796 . . . . 0.0 109.532 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.824 ' HB1' HG23 ' R' ' 71' ' ' VAL . . . -66.18 -58.31 5.69 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.862 HG13 HD11 ' R' ' 53' ' ' LEU . 0.2 OUTLIER -87.26 -35.62 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 118.841 -1.144 . . . . 0.0 112.032 -177.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' R' ' 80' ' ' LEU . 25.7 tptt -49.2 -36.35 19.58 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' R' ' 88' ' ' ASP . 63.2 tt0 -68.38 -42.03 79.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' R' ' 94' ' ' LEU . 2.8 tm? -62.26 -37.84 87.01 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . 0.527 ' O ' ' HA2' ' R' ' 91' ' ' GLY . 85.0 tt0 -56.13 -38.56 70.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 108.465 178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' R' ' 85' ' ' GLN . 89.4 m-20 -58.36 -30.36 66.71 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.931 -1.108 . . . . 0.0 108.241 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.735 HD23 ' N ' ' R' ' 90' ' ' THR . 4.9 tt -91.1 -53.68 4.26 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.498 -0.751 . . . . 0.0 112.434 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . 0.735 ' N ' HD23 ' R' ' 89' ' ' LEU . 36.1 p -80.14 -31.58 39.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' R' ' 87' ' ' GLU . . . 64.78 30.04 76.89 Favored Glycine 0 N--CA 1.505 3.28 0 C-N-CA 120.203 -0.998 . . . . 0.0 110.906 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . 0.841 HD22 ' O ' ' R' ' 101' ' ' ALA . 0.4 OUTLIER -119.5 9.79 11.64 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.961 -1.317 . . . . 0.0 113.131 -177.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . 0.754 ' C ' ' HG ' ' R' ' 94' ' ' LEU . 93.8 mt-10 68.21 129.46 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.162 -0.961 . . . . 0.0 110.759 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.872 ' CD2' HD12 ' R' ' 86' ' ' LEU . 0.0 OUTLIER -138.57 -62.46 0.56 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . 0.534 ' HB3' HD13 ' R' ' 83' ' ' ILE . 3.9 p80 -42.5 -37.06 1.51 Allowed 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' R' ' 93' ' ' GLU . 22.5 pt-20 -104.5 -16.57 15.02 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' R' ' 94' ' ' LEU . . . -93.22 -141.78 11.12 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' R' ' 101' ' ' ALA . . . -130.71 175.16 19.51 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 121.215 -1.168 . . . . 0.0 110.415 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.737 ' HB3' ' HB3' ' R' ' 55' ' ' ALA . 34.4 Cg_endo -70.76 -58.68 0.08 OUTLIER 'Trans proline' 0 CA--C 1.556 1.581 0 O-C-N 123.773 1.407 . . . . 0.0 114.799 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.947 ' O ' ' N ' ' R' ' 102' ' ' LEU . 36.2 Cg_endo -59.07 -22.68 65.21 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.841 ' O ' HD22 ' R' ' 92' ' ' LEU . . . -31.34 58.92 0.0 OUTLIER 'General case' 0 CA--C 1.481 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.083 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' R' ' 100' ' ' PRO . 71.1 mt 36.46 3.27 0.0 OUTLIER 'General case' 0 C--N 1.264 -3.132 0 CA-C-O 118.183 -0.913 . . . . 0.0 112.248 -174.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.863 HG13 HD11 ' R' ' 86' ' ' LEU . 2.7 t -55.02 -39.6 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.825 HD12 ' HA ' ' R' ' 100' ' ' PRO . 85.8 mt -68.34 -37.45 77.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 113.821 -1.536 . . . . 0.0 107.872 177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.619 ' HB3' ' HB3' ' R' ' 102' ' ' LEU . 68.1 t-105 -63.36 -46.9 84.39 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.876 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.72 ' HB2' HG22 ' R' ' 90' ' ' THR . 69.6 m-80 -76.32 -30.04 57.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.716 -1.24 . . . . 0.0 111.107 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . 0.695 HG23 HD23 ' R' ' 110' ' ' LEU . 54.8 mt -81.58 7.22 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.702 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' R' ' 112' ' ' HIS . 24.2 tttm -34.37 -53.14 0.5 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.739 ' C ' HD13 ' R' ' 110' ' ' LEU . 0.5 OUTLIER -60.02 -14.39 16.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.093 -2.255 . . . . 0.0 111.675 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.739 HD13 ' C ' ' R' ' 109' ' ' HIS . 0.3 OUTLIER -106.49 -40.89 5.44 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 176.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.954 ' O ' ' N ' ' R' ' 113' ' ' THR . 0.2 OUTLIER -74.88 -106.18 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 111.77 -2.468 . . . . 0.0 112.668 -178.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . 0.653 ' HA ' ' O ' ' R' ' 122' ' ' SER . 30.1 m-70 -25.1 73.56 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.736 0 CA-C-O 123.833 1.778 . . . . 0.0 109.901 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 1.046 HG22 ' HA ' ' R' ' 123' ' ' GLU . 3.0 t -60.39 -105.31 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.398 -2.183 . . . . 0.0 110.612 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.769 ' O ' HD13 ' R' ' 115' ' ' ILE . . . -134.92 82.15 0.29 Allowed Glycine 0 N--CA 1.505 3.247 1 N-CA-C 102.877 -4.089 . . . . 0.0 102.877 177.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 1.288 HG23 ' O ' ' R' ' 124' ' ' VAL 0.356 32.4 mm -126.33 162.14 30.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 N-CA-C 114.741 1.385 . . . . 0.0 114.741 -170.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.12 75.6 0.37 Allowed Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.221 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 1.037 HG23 HG21 ' R' ' 126' ' ' VAL . 8.1 m -72.74 149.21 43.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' CG2' ' R' ' 130' ' ' THR . . . -63.85 -24.79 67.88 Favored 'General case' 0 C--N 1.276 -2.629 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.552 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 60.5 p -97.38 -22.25 16.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.447 -0.783 . . . . 0.0 111.097 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . 0.695 ' O ' ' HB ' ' R' ' 117' ' ' THR . 0.0 OUTLIER -178.12 -164.51 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.537 0 O-C-N 120.96 -1.087 . . . . 0.0 110.607 -178.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.541 ' CD ' ' CB ' ' R' ' 120' ' ' ARG . 49.1 Cg_endo -85.52 161.99 10.97 Favored 'Trans proline' 0 N--CA 1.488 1.147 0 C-N-CA 120.671 0.914 . . . . 0.0 110.295 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.901 ' H ' ' HB ' ' R' ' 115' ' ' ILE . 19.9 m -164.96 -134.78 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.07 -1.019 . . . . 0.0 113.216 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 1.046 ' HA ' HG22 ' R' ' 113' ' ' THR . 82.5 tt0 -103.8 -19.18 14.37 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 124.726 1.21 . . . . 0.0 112.886 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 1.288 ' O ' HG23 ' R' ' 115' ' ' ILE . 10.4 m -161.93 -157.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.957 0 CA-C-O 122.573 1.177 . . . . 0.0 111.74 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.584 ' HB2' ' HG3' ' R' ' 182' ' ' PRO . 48.7 t -95.12 137.31 34.35 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 119.525 -1.984 . . . . 0.0 107.275 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 1.037 HG21 HG23 ' R' ' 117' ' ' THR . 77.5 t -102.51 154.22 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.647 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 -174.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.924 HG21 ' O ' ' R' ' 177' ' ' VAL . 33.0 m -83.19 -21.42 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-N 112.905 -1.952 . . . . 0.0 114.14 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.748 ' H ' HG12 ' R' ' 126' ' ' VAL . 56.2 t0 -45.3 87.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.094 -1.004 . . . . 0.0 111.437 -178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' R' ' 127' ' ' VAL . . . 51.6 25.15 13.5 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . 0.825 ' CG2' ' HB2' ' R' ' 118' ' ' ALA . 0.0 OUTLIER -109.88 152.11 26.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.324 -1.104 . . . . 0.0 112.306 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 40.43 -167.16 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.041 0.924 . . . . 0.0 112.98 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.507 ' HB2' ' HB2' ' R' ' 136' ' ' ASP . 89.6 mtp -90.4 174.19 7.7 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.794 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' R' ' 135' ' ' ALA . 62.4 m -100.87 -174.99 2.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.341 -0.85 . . . . 0.0 112.682 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 1.089 HD11 HG23 ' R' ' 171' ' ' THR . 0.4 OUTLIER 31.3 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.098 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . 0.465 ' HA ' ' NE2' ' R' ' 138' ' ' HIS . . . -62.29 -26.75 68.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.119 -0.988 . . . . 0.0 112.841 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' R' ' 132' ' ' MET . 19.2 t70 -55.99 -42.67 76.71 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.105 -0.997 . . . . 0.0 112.278 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . 0.685 ' CG ' ' CD1' ' R' ' 180' ' ' PHE . 52.5 p90 -155.23 159.59 40.19 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.788 -1.195 . . . . 0.0 109.479 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.651 ' CG ' ' CE3' ' R' ' 159' ' ' TRP . 68.5 m-70 -143.76 79.18 1.62 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 118.139 -1.424 . . . . 0.0 110.857 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.874 ' HB3' ' CG1' ' R' ' 181' ' ' VAL . . . 174.88 162.04 0.22 Allowed 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.175 175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' R' ' 180' ' ' PHE . . . 130.06 -170.56 20.72 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.212 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . 0.73 HG23 ' CE1' ' R' ' 151' ' ' PHE . 70.1 mt -104.23 124.61 58.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.742 -0.858 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.989 ' CG ' ' HB ' ' R' ' 177' ' ' VAL . 4.2 m-85 -113.76 151.53 31.84 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.325 -0.95 . . . . 0.0 108.662 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.646 HD21 ' HG2' ' R' ' 146' ' ' GLN . 26.1 tp -101.66 124.14 46.82 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.555 -0.715 . . . . 0.0 109.882 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' R' ' 148' ' ' HIS . 38.1 tttt -108.85 113.54 26.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.073 -1.017 . . . . 0.0 110.422 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' R' ' 146' ' ' GLN . . . 50.23 25.63 8.3 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . 0.646 ' HG2' HD21 ' R' ' 143' ' ' LEU . 95.2 mt-30 54.62 168.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.483 -1.01 . . . . 0.0 110.631 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 52.41 23.57 2.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' R' ' 144' ' ' LYS . 83.2 m-70 -144.7 131.68 20.36 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.266 -0.896 . . . . 0.0 108.882 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.935 ' HB1' ' HZ ' ' R' ' 151' ' ' PHE . . . -104.5 115.82 31.03 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.222 -0.924 . . . . 0.0 109.581 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . 0.67 ' O ' ' CD1' ' R' ' 151' ' ' PHE . 34.9 m -129.27 152.18 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.34 -0.85 . . . . 0.0 108.834 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.935 ' HZ ' ' HB1' ' R' ' 149' ' ' ALA . 7.7 m-85 -149.89 129.69 13.3 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 117.791 -1.564 . . . . 0.0 112.012 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 161' ' ' ALA . . . -110.56 167.65 10.05 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.593 -1.317 . . . . 0.0 110.735 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' R' ' 62' ' ' TYR . 38.0 t -169.63 134.49 1.41 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' R' ' 138' ' ' HIS . 36.9 t -53.38 102.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.383 -1.448 . . . . 0.0 111.283 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . 0.661 ' CG2' ' HB2' ' R' ' 160' ' ' TYR . 25.1 p -78.82 -165.36 0.72 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.713 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . 0.472 ' N ' ' O ' ' R' ' 32' ' ' THR . 81.1 p -65.41 -18.69 65.51 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . 0.466 ' CB ' ' CZ ' ' R' ' 160' ' ' TYR . 83.0 m-20 -102.03 2.9 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.273 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' R' ' 154' ' ' VAL . . . 112.93 -166.14 12.11 Favored Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.485 -1.34 . . . . 0.0 110.151 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.651 ' CE3' ' CG ' ' R' ' 138' ' ' HIS . 0.0 OUTLIER -55.58 99.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.495 1.14 . . . . 0.0 108.685 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . 0.661 ' HB2' ' CG2' ' R' ' 155' ' ' THR . 4.0 m-85 -121.83 -178.39 3.82 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . 0.905 ' HA ' ' HA ' ' R' ' 152' ' ' ALA . . . -158.07 136.37 10.95 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 119.751 -1.843 . . . . 0.0 110.987 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . 0.981 ' CD1' HD11 ' R' ' 31' ' ' LEU . 0.6 OUTLIER -75.79 88.28 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-O 122.526 1.155 . . . . 0.0 109.188 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' R' ' 168' ' ' TYR . 1.0 OUTLIER -94.98 122.83 38.03 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . 0.867 ' HA ' ' HA ' ' R' ' 44' ' ' ARG . 78.0 m-20 28.19 74.51 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.635 0 O-C-N 121.365 -0.834 . . . . 0.0 112.968 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.654 ' CB ' ' N ' ' R' ' 44' ' ' ARG . 0.1 OUTLIER 68.66 -15.31 0.24 Allowed 'General case' 0 N--CA 1.522 3.149 0 O-C-N 119.597 -1.939 . . . . 0.0 113.448 179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.74 134.29 45.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.83 -1.794 . . . . 0.0 112.694 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . 0.699 ' CD1' HG13 ' R' ' 162' ' ' ILE . 6.4 m-85 -101.62 121.66 42.42 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . 0.599 ' CE2' ' CD1' ' R' ' 170' ' ' TRP . 2.8 p90 -150.67 162.05 28.39 Favored Pre-proline 0 C--N 1.281 -2.406 0 C-N-CA 118.173 -1.411 . . . . 0.0 111.314 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . 0.471 ' HA ' ' CD1' ' R' ' 160' ' ' TYR . 39.5 Cg_endo -66.62 114.71 3.21 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.231 1.648 . . . . 0.0 109.044 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.599 ' CD1' ' CE2' ' R' ' 168' ' ' TYR . 0.1 OUTLIER -126.4 150.18 48.78 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . 1.089 HG23 HD11 ' R' ' 134' ' ' LEU . 2.3 m -94.26 108.26 34.8 Favored Pre-proline 0 C--N 1.271 -2.816 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.053 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.638 ' CG ' ' HA ' ' R' ' 138' ' ' HIS . 46.1 Cg_endo -72.94 67.03 4.04 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 124.048 1.552 . . . . 0.0 110.823 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . 0.741 ' OD2' HD23 ' R' ' 134' ' ' LEU . 8.6 t70 -81.86 139.13 46.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.406 -0.809 . . . . 0.0 109.097 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.783 ' HA ' HG13 ' R' ' 177' ' ' VAL . 44.3 Cg_endo -70.72 35.26 0.25 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.223 1.117 . . . . 0.0 109.95 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . 0.494 ' H ' ' C ' ' R' ' 173' ' ' ASP . 83.4 p -81.34 -43.38 19.15 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.917 . . . . 0.0 111.323 -179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' R' ' 143' ' ' LEU . 86.4 m-20 -126.16 1.6 7.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.017 -1.052 . . . . 0.0 109.934 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.989 ' HB ' ' CG ' ' R' ' 142' ' ' PHE . 0.2 OUTLIER -95.1 169.37 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 122.059 0.933 . . . . 0.0 110.464 -178.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.797 HD22 ' O ' ' R' ' 177' ' ' VAL . 0.7 OUTLIER -128.48 -91.45 0.48 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -177.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' R' ' 126' ' ' VAL . 34.7 m -72.43 124.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.685 ' CD1' ' CG ' ' R' ' 137' ' ' PHE . 0.3 OUTLIER -130.45 178.14 6.83 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -175.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . 0.874 ' CG1' ' HB3' ' R' ' 139' ' ' ALA . 0.4 OUTLIER -127.26 127.24 24.27 Favored Pre-proline 0 C--N 1.283 -2.284 0 C-N-CA 118.256 -1.378 . . . . 0.0 111.952 -177.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . 0.584 ' HG3' ' HB2' ' R' ' 125' ' ' CYS . 56.2 Cg_endo -87.47 131.93 2.99 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.384 1.202 . . . . 0.0 109.998 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.474 ' CZ ' ' O ' ' R' ' 136' ' ' ASP . 1.1 p90 -64.6 -34.06 77.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.096 -1.003 . . . . 0.0 109.709 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . . . . . . . . . 57.0 t0 47.9 46.32 18.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.416 -0.802 . . . . 0.0 111.62 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' R' ' 183' ' ' TYR . 99.8 mm-40 -94.67 19.54 9.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.224 -0.923 . . . . 0.0 110.772 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 186' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -117.38 78.7 11.08 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.913 . . . . 0.0 110.137 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 187' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.16 -12.88 35.1 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.869 1.457 . . . . 0.0 110.858 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 188' ' ' LEU . . . . . . . . . . . . . 83.0 mt -58.34 -33.23 69.3 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 189' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -75.03 172.9 11.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.293 -0.879 . . . . 0.0 110.329 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.69 138.1 7.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 191' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 50.54 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.479 -1.012 . . . . 0.0 110.674 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 192' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -104.04 140.05 38.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 0.0 110.138 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -131.73 132.29 43.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.373 -0.829 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -145.29 -44.26 0.22 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 110.472 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.269 179.926 . . . . . . . . 1 1 . 1 stop_ save_